drugbank-id,description,name,parent_key
DB06605,Apixaban may increase the anticoagulant activities of Lepirudin.,Apixaban,DB00001
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Lepirudin.,Dabigatran etexilate,DB00001
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Lepirudin.,Dasatinib,DB00001
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Lepirudin is combined with Deferasirox.,Deferasirox,DB00001
DB01586,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00001
DB02123,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00001
DB02659,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Cholic Acid.,Cholic Acid,DB00001
DB02691,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycocholic acid.,Glycocholic acid,DB00001
DB03619,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Deoxycholic acid.,Deoxycholic acid,DB00001
DB04348,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurocholic acid.,Taurocholic acid,DB00001
DB05990,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Obeticholic acid.,Obeticholic acid,DB00001
DB06777,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00001
DB08833,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00001
DB08834,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00001
DB08857,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Bamet-UD2.,Bamet-UD2,DB00001
DB11622,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00001
DB11789,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00001
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Lepirudin.,Edoxaban,DB00001
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Lepirudin.,Ibrutinib,DB00001
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Obinutuzumab.,Obinutuzumab,DB00001
DB06228,Lepirudin may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00001
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Sugammadex.,Sugammadex,DB00001
DB09070,Tibolone may increase the anticoagulant activities of Lepirudin.,Tibolone,DB00001
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Lepirudin.,Tipranavir,DB00001
DB00013,Urokinase may increase the anticoagulant activities of Lepirudin.,Urokinase,DB00001
DB00163,Vitamin E may increase the anticoagulant activities of Lepirudin.,Vitamin E,DB00001
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Lepirudin.,Vorapaxar,DB00001
DB01381,The therapeutic efficacy of Lepirudin can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00001
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Lepirudin.,Ifosfamide,DB00001
DB00468,The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinine.,Quinine,DB00001
DB00908,The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.,Quinidine,DB00001
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Lepirudin.,Tamoxifen,DB00001
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Lepirudin.,Toremifene,DB00001
DB00806,The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00001
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Lepirudin.,Pentosan polysulfate,DB00001
DB00583,The therapeutic efficacy of Lepirudin can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00001
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Lepirudin.,Diethylstilbestrol,DB00001
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Lepirudin.,Chlorotrianisene,DB00001
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.,Conjugated estrogens,DB00001
DB00783,Estradiol may decrease the anticoagulant activities of Lepirudin.,Estradiol,DB00001
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Lepirudin.,Ethinylestradiol,DB00001
DB01357,Mestranol may decrease the anticoagulant activities of Lepirudin.,Mestranol,DB00001
DB04573,Estriol may decrease the anticoagulant activities of Lepirudin.,Estriol,DB00001
DB04574,Estrone sulfate may decrease the anticoagulant activities of Lepirudin.,Estrone sulfate,DB00001
DB04575,Quinestrol may decrease the anticoagulant activities of Lepirudin.,Quinestrol,DB00001
DB07931,Hexestrol may decrease the anticoagulant activities of Lepirudin.,Hexestrol,DB00001
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Lepirudin.","Synthetic Conjugated Estrogens, A",DB00001
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Lepirudin.","Synthetic Conjugated Estrogens, B",DB00001
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin.,Polyestradiol phosphate,DB00001
DB09381,Esterified estrogens may decrease the anticoagulant activities of Lepirudin.,Esterified estrogens,DB00001
DB11478,Zeranol may decrease the anticoagulant activities of Lepirudin.,Zeranol,DB00001
DB11674,Equol may decrease the anticoagulant activities of Lepirudin.,Equol,DB00001
DB12487,Promestriene may decrease the anticoagulant activities of Lepirudin.,Promestriene,DB00001
DB13143,Methallenestril may decrease the anticoagulant activities of Lepirudin.,Methallenestril,DB00001
DB13386,Epimestrol may decrease the anticoagulant activities of Lepirudin.,Epimestrol,DB00001
DB13418,Moxestrol may decrease the anticoagulant activities of Lepirudin.,Moxestrol,DB00001
DB13952,Estradiol acetate may decrease the anticoagulant activities of Lepirudin.,Estradiol acetate,DB00001
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Lepirudin.,Estradiol benzoate,DB00001
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Lepirudin.,Estradiol cypionate,DB00001
DB13956,Estradiol valerate may decrease the anticoagulant activities of Lepirudin.,Estradiol valerate,DB00001
DB15334,Biochanin A may decrease the anticoagulant activities of Lepirudin.,Biochanin A,DB00001
DB15335,Formononetin may decrease the anticoagulant activities of Lepirudin.,Formononetin,DB00001
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin.,Limaprost,DB00001
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Lepirudin.,Icosapent,DB00001
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Lepirudin.,Mesalazine,DB00001
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Lepirudin.,Indomethacin,DB00001
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Lepirudin.,Nabumetone,DB00001
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Lepirudin.,Ketorolac,DB00001
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Lepirudin.,Tenoxicam,DB00001
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Lepirudin.,Celecoxib,DB00001
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Lepirudin.,Tolmetin,DB00001
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Lepirudin.,Rofecoxib,DB00001
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Lepirudin.,Piroxicam,DB00001
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Lepirudin.,Fenoprofen,DB00001
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Lepirudin.,Valdecoxib,DB00001
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Lepirudin.,Diclofenac,DB00001
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Lepirudin.,Sulindac,DB00001
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Lepirudin.,Flurbiprofen,DB00001
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Lepirudin.,Etodolac,DB00001
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Lepirudin.,Mefenamic acid,DB00001
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Lepirudin.,Naproxen,DB00001
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Lepirudin.,Sulfasalazine,DB00001
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Lepirudin.,Phenylbutazone,DB00001
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Lepirudin.,Meloxicam,DB00001
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Lepirudin.,Carprofen,DB00001
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Lepirudin.,Diflunisal,DB00001
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Lepirudin.,Salicylic acid,DB00001
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Lepirudin.,Meclofenamic acid,DB00001
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Lepirudin.,Oxaprozin,DB00001
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Lepirudin.,Ketoprofen,DB00001
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Lepirudin.,Balsalazide,DB00001
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Lepirudin.,Olsalazine,DB00001
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Lepirudin.,Lumiracoxib,DB00001
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Lepirudin.,Magnesium salicylate,DB00001
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Lepirudin.,Salsalate,DB00001
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Lepirudin.,Choline magnesium trisalicylate,DB00001
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Lepirudin.,Antrafenine,DB00001
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Lepirudin.,Aminophenazone,DB00001
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Lepirudin.,Antipyrine,DB00001
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Lepirudin.,Tiaprofenic acid,DB00001
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Lepirudin.,Etoricoxib,DB00001
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Lepirudin.,Taxifolin,DB00001
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Lepirudin.,Oxyphenbutazone,DB00001
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Lepirudin.,Niflumic acid,DB00001
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Lepirudin.,Licofelone,DB00001
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Lepirudin.,Benoxaprofen,DB00001
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Lepirudin.,Metamizole,DB00001
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Lepirudin.,Zomepirac,DB00001
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Lepirudin.,Cimicoxib,DB00001
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Lepirudin.,Lornoxicam,DB00001
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Lepirudin.,Aceclofenac,DB00001
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Lepirudin.,Zaltoprofen,DB00001
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Lepirudin.,Azapropazone,DB00001
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Lepirudin.,Felbinac,DB00001
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Lepirudin.,Parecoxib,DB00001
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Lepirudin.,Salicylamide,DB00001
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Lepirudin.,Kebuzone,DB00001
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Lepirudin.,Isoxicam,DB00001
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Lepirudin.,Indoprofen,DB00001
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Lepirudin.,Ibuproxam,DB00001
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Lepirudin.,Floctafenine,DB00001
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin.,Fenbufen,DB00001
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Lepirudin.,Etofenamate,DB00001
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Lepirudin.,Epirizole,DB00001
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Lepirudin.,Benzydamine,DB00001
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Lepirudin.,Loxoprofen,DB00001
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Lepirudin.,Dexketoprofen,DB00001
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Lepirudin.,Droxicam,DB00001
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Lepirudin.,Tolfenamic acid,DB00001
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Lepirudin.,Firocoxib,DB00001
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Lepirudin.,Clonixin,DB00001
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Lepirudin.,Morniflumate,DB00001
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Lepirudin.,Propacetamol,DB00001
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Lepirudin.,Talniflumate,DB00001
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Lepirudin.,Robenacoxib,DB00001
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Lepirudin.,Tepoxalin,DB00001
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Lepirudin.,Flunixin,DB00001
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Lepirudin.,Polmacoxib,DB00001
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Lepirudin.,Betulinic Acid,DB00001
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Lepirudin.,Ebselen,DB00001
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Lepirudin.,Tinoridine,DB00001
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Lepirudin.,Alclofenac,DB00001
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Lepirudin.,Fentiazac,DB00001
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Lepirudin.,Suxibuzone,DB00001
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Lepirudin.,Bumadizone,DB00001
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Lepirudin.,Alminoprofen,DB00001
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Lepirudin.,Flunoxaprofen,DB00001
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Lepirudin.,Feprazone,DB00001
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Lepirudin.,Difenpiramide,DB00001
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Lepirudin.,Nifenazone,DB00001
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Lepirudin.,Lonazolac,DB00001
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Lepirudin.,Tenidap,DB00001
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Lepirudin.,Bendazac,DB00001
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Lepirudin.,Pranoprofen,DB00001
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Lepirudin.,Propyphenazone,DB00001
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Lepirudin.,Proglumetacin,DB00001
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Lepirudin.,Guacetisal,DB00001
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Lepirudin.,Ethenzamide,DB00001
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Lepirudin.,Carbaspirin calcium,DB00001
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Lepirudin.,Mofebutazone,DB00001
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Lepirudin.,Proquazone,DB00001
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Lepirudin.,Benorilate,DB00001
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Lepirudin.,Pirprofen,DB00001
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Lepirudin.,Imidazole salicylate,DB00001
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Lepirudin.,SC-236,DB00001
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Lepirudin.,NS-398,DB00001
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Lepirudin.,Flurbiprofen axetil,DB00001
DB04865,The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00001
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Lepirudin.,Omega-3 fatty acids,DB00001
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab.,Tositumomab,DB00001
DB00048,The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00001
DB00389,Carbimazole may increase the anticoagulant activities of Lepirudin.,Carbimazole,DB00001
DB00550,Propylthiouracil may increase the anticoagulant activities of Lepirudin.,Propylthiouracil,DB00001
DB00763,Methimazole may increase the anticoagulant activities of Lepirudin.,Methimazole,DB00001
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin.","3,5-Diiodotyrosine",DB00001
DB06715,Potassium Iodide may increase the anticoagulant activities of Lepirudin.,Potassium Iodide,DB00001
DB07637,Dibromotyrosine may increase the anticoagulant activities of Lepirudin.,Dibromotyrosine,DB00001
DB09418,Potassium perchlorate may increase the anticoagulant activities of Lepirudin.,Potassium perchlorate,DB00001
DB13644,Methylthiouracil may increase the anticoagulant activities of Lepirudin.,Methylthiouracil,DB00001
DB13804,Benzylthiouracil may increase the anticoagulant activities of Lepirudin.,Benzylthiouracil,DB00001
DB00834,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mifepristone.,Mifepristone,DB00001
DB04066,The therapeutic efficacy of Lepirudin can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00001
DB04682,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00001
DB05830,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trestolone.,Trestolone,DB00001
DB06266,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Lonidamine.,Lonidamine,DB00001
DB08867,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ulipristal.,Ulipristal,DB00001
DB09401,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Isosorbide.,Isosorbide,DB00001
DB11507,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00001
DB12025,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triptolide.,Triptolide,DB00001
DB13044,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gossypol.,Gossypol,DB00001
DB13310,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00001
DB00294,Etonogestrel may decrease the anticoagulant activities of Lepirudin.,Etonogestrel,DB00001
DB00304,Desogestrel may decrease the anticoagulant activities of Lepirudin.,Desogestrel,DB00001
DB00351,Megestrol acetate may decrease the anticoagulant activities of Lepirudin.,Megestrol acetate,DB00001
DB00367,Levonorgestrel may decrease the anticoagulant activities of Lepirudin.,Levonorgestrel,DB00001
DB00378,Dydrogesterone may decrease the anticoagulant activities of Lepirudin.,Dydrogesterone,DB00001
DB00396,Progesterone may decrease the anticoagulant activities of Lepirudin.,Progesterone,DB00001
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Lepirudin.,Medroxyprogesterone acetate,DB00001
DB00717,Norethisterone may decrease the anticoagulant activities of Lepirudin.,Norethisterone,DB00001
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Lepirudin.,Ethynodiol diacetate,DB00001
DB00957,Norgestimate may decrease the anticoagulant activities of Lepirudin.,Norgestimate,DB00001
DB01395,Drospirenone may decrease the anticoagulant activities of Lepirudin.,Drospirenone,DB00001
DB01431,Allylestrenol may decrease the anticoagulant activities of Lepirudin.,Allylestrenol,DB00001
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Lepirudin.,Cyproterone acetate,DB00001
DB06713,Norelgestromin may decrease the anticoagulant activities of Lepirudin.,Norelgestromin,DB00001
DB06730,Gestodene may decrease the anticoagulant activities of Lepirudin.,Gestodene,DB00001
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Lepirudin.,Hydroxyprogesterone caproate,DB00001
DB09123,Dienogest may decrease the anticoagulant activities of Lepirudin.,Dienogest,DB00001
DB09124,Medrogestone may decrease the anticoagulant activities of Lepirudin.,Medrogestone,DB00001
DB09371,Norethynodrel may decrease the anticoagulant activities of Lepirudin.,Norethynodrel,DB00001
DB09389,Norgestrel may decrease the anticoagulant activities of Lepirudin.,Norgestrel,DB00001
DB11372,Altrenogest may decrease the anticoagulant activities of Lepirudin.,Altrenogest,DB00001
DB11619,Gestrinone may decrease the anticoagulant activities of Lepirudin.,Gestrinone,DB00001
DB11636,Nomegestrol may decrease the anticoagulant activities of Lepirudin.,Nomegestrol,DB00001
DB12474,Lynestrenol may decrease the anticoagulant activities of Lepirudin.,Lynestrenol,DB00001
DB13230,Gestonorone may decrease the anticoagulant activities of Lepirudin.,Gestonorone,DB00001
DB13528,Chlormadinone may decrease the anticoagulant activities of Lepirudin.,Chlormadinone,DB00001
DB13533,Methylestrenolone may decrease the anticoagulant activities of Lepirudin.,Methylestrenolone,DB00001
DB13563,Norgestrienone may decrease the anticoagulant activities of Lepirudin.,Norgestrienone,DB00001
DB13602,Promegestone may decrease the anticoagulant activities of Lepirudin.,Promegestone,DB00001
DB13685,Quingestanol may decrease the anticoagulant activities of Lepirudin.,Quingestanol,DB00001
DB13857,Demegestone may decrease the anticoagulant activities of Lepirudin.,Demegestone,DB00001
DB13866,Etynodiol may decrease the anticoagulant activities of Lepirudin.,Etynodiol,DB00001
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Lepirudin.,Nomegestrol acetate,DB00001
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Lepirudin.,Hydroxyprogesterone,DB00001
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Lepirudin.,Norethindrone enanthate,DB00001
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Lepirudin.,Quingestanol acetate,DB00001
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin.,Aminosalicylic acid,DB00001
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin.,Bismuth subsalicylate,DB00001
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Lepirudin.,Dersalazine,DB00001
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Lepirudin.,Phenyl aminosalicylate,DB00001
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin.,Methyl salicylate,DB00001
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Lepirudin.,Trolamine salicylate,DB00001
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Lepirudin.,Aloxiprin,DB00001
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Lepirudin.,Choline salicylate,DB00001
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Lepirudin.,Thiosalicylic acid,DB00001
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.,Abciximab,DB00001
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Lepirudin.,Eptifibatide,DB00001
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Lepirudin.,Ticlopidine,DB00001
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin.,Anagrelide,DB00001
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.,Clopidogrel,DB00001
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Lepirudin.,Tirofiban,DB00001
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Lepirudin.,Dipyridamole,DB00001
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Lepirudin.,Iloprost,DB00001
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lepirudin.,Sulfinpyrazone,DB00001
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Lepirudin.,Cilostazol,DB00001
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Lepirudin.,Ridogrel,DB00001
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Lepirudin.,Sevoflurane,DB00001
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin.,Epoprostenol,DB00001
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Lepirudin.,Resveratrol,DB00001
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Lepirudin.,Nimesulide,DB00001
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Lepirudin.,Tesmilifene,DB00001
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Lepirudin.,Defibrotide,DB00001
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Lepirudin.,Beraprost,DB00001
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Lepirudin.,Ibudilast,DB00001
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Lepirudin.,Andrographolide,DB00001
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Lepirudin.,Caplacizumab,DB00001
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Lepirudin.,Prasugrel,DB00001
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Lepirudin.,Cangrelor,DB00001
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Lepirudin.,Tranilast,DB00001
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Lepirudin.,Triflusal,DB00001
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Lepirudin.,Ticagrelor,DB00001
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Lepirudin.,Icosapent ethyl,DB00001
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Lepirudin.,Trapidil,DB00001
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Lepirudin.,Naftopidil,DB00001
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Lepirudin.,Sarpogrelate,DB00001
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Lepirudin.,Ifetroban,DB00001
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Lepirudin.,Nitroaspirin,DB00001
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Lepirudin.,Ketanserin,DB00001
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Lepirudin.,Indobufen,DB00001
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Lepirudin.,Butylphthalide,DB00001
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Lepirudin.,Hydroxytyrosol,DB00001
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Lepirudin.,Ramatroban,DB00001
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Lepirudin.,Picotamide,DB00001
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Lepirudin.,Cloricromen,DB00001
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Lepirudin.,Linsidomine,DB00001
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Lepirudin.,Buflomedil,DB00001
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Lepirudin.,Relcovaptan,DB00001
DB00374,The risk or severity of bleeding can be increased when Treprostinil is combined with Lepirudin.,Treprostinil,DB00001
DB03404,Hemin may increase the anticoagulant activities of Lepirudin.,Hemin,DB00001
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Lepirudin.,Acemetacin,DB00001
DB00624,Testosterone may increase the anticoagulant activities of Lepirudin.,Testosterone,DB00001
DB01420,Testosterone propionate may increase the anticoagulant activities of Lepirudin.,Testosterone propionate,DB00001
DB01481,1-Testosterone may increase the anticoagulant activities of Lepirudin.,1-Testosterone,DB00001
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Lepirudin.,4-Hydroxytestosterone,DB00001
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Lepirudin.,Dehydrochloromethyltestosterone,DB00001
DB01541,Boldenone may increase the anticoagulant activities of Lepirudin.,Boldenone,DB00001
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Lepirudin.,18-methyl-19-nortestosterone,DB00001
DB01564,Calusterone may increase the anticoagulant activities of Lepirudin.,Calusterone,DB00001
DB01569,Formebolone may increase the anticoagulant activities of Lepirudin.,Formebolone,DB00001
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Lepirudin.,Methyl-1-testosterone,DB00001
DB02901,Stanolone may increase the anticoagulant activities of Lepirudin.,Stanolone,DB00001
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Lepirudin.,5beta-dihydrotestosterone,DB00001
DB08619,Testosterone succinate may increase the anticoagulant activities of Lepirudin.,Testosterone succinate,DB00001
DB11429,Mibolerone may increase the anticoagulant activities of Lepirudin.,Mibolerone,DB00001
DB13943,Testosterone cypionate may increase the anticoagulant activities of Lepirudin.,Testosterone cypionate,DB00001
DB13944,Testosterone enanthate may increase the anticoagulant activities of Lepirudin.,Testosterone enanthate,DB00001
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Lepirudin.,Testosterone undecanoate,DB00001
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Lepirudin.,Testosterone enantate benzilic acid hydrazone,DB00001
DB13951,Stanolone acetate may increase the anticoagulant activities of Lepirudin.,Stanolone acetate,DB00001
DB13958,Trestolone acetate may increase the anticoagulant activities of Lepirudin.,Trestolone acetate,DB00001
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Lepirudin.","(1,2,6,7-3H)Testosterone",DB00001
DB14655,Drostanolone propionate may increase the anticoagulant activities of Lepirudin.,Drostanolone propionate,DB00001
DB11051,The risk or severity of adverse effects can be increased when Lepirudin is combined with Azficel-T.,Azficel-T,DB00001
DB09568,The therapeutic efficacy of Lepirudin can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00001
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin.","Antihemophilic factor, human recombinant",DB00001
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.,Coagulation factor VIIa Recombinant Human,DB00001
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Lepirudin.,Coagulation Factor IX (Recombinant),DB00001
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Lepirudin.,Calcium acetate,DB00001
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Lepirudin.,Calcium chloride,DB00001
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Lepirudin.,Calcium,DB00001
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Lepirudin.,Pantothenic acid,DB00001
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Lepirudin.,Formic acid,DB00001
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Lepirudin.,Platelet Activating Factor,DB00001
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Lepirudin.,Calcium carbonate,DB00001
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Lepirudin.,Turoctocog alfa,DB00001
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Lepirudin.,Fibrinogen human,DB00001
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Lepirudin.,Catridecacog,DB00001
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Lepirudin.","Antihemophilic Factor (Recombinant), PEGylated",DB00001
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Lepirudin.,Calcium citrate,DB00001
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Lepirudin.,Calcium gluconate,DB00001
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Lepirudin.,Calcium threonate,DB00001
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Lepirudin.,Prothrombin,DB00001
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Lepirudin.,Factor IX Complex (Human),DB00001
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lepirudin.,Calcium Phosphate,DB00001
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Lepirudin.,Susoctocog alfa,DB00001
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Lepirudin.,Eftrenonacog alfa,DB00001
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Lepirudin.,Rusalatide acetate,DB00001
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Lepirudin.,Vatreptacog alfa,DB00001
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Lepirudin.,Factor XIII (human),DB00001
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Lepirudin.,Von Willebrand Factor Human,DB00001
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Lepirudin.,Coagulation factor X human,DB00001
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Lepirudin.,Coagulation factor VII human,DB00001
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Lepirudin.,Anti-inhibitor coagulant complex,DB00001
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Lepirudin.,Coagulation Factor IX Human,DB00001
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Lepirudin.,Antihemophilic factor human,DB00001
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin.,Kallidinogenase,DB00001
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Lepirudin.,Trenonacog alfa,DB00001
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Lepirudin.,Albutrepenonacog alfa,DB00001
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Lepirudin.,Emicizumab,DB00001
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Lepirudin.,Nonacog beta pegol,DB00001
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Lepirudin.,Moroctocog alfa,DB00001
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Lepirudin.,Beroctocog alfa,DB00001
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Lepirudin.,Andexanet alfa,DB00001
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Lepirudin.,Calcium cation,DB00001
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Lepirudin.,Damoctocog alfa pegol,DB00001
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Lepirudin.,Turoctocog alfa pegol,DB00001
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Lepirudin.,Fluvoxamine,DB00001
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Lepirudin.,Citalopram,DB00001
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Lepirudin.,Fluoxetine,DB00001
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Lepirudin.,Paroxetine,DB00001
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Lepirudin.,Nefazodone,DB00001
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Lepirudin.,Zimelidine,DB00001
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Lepirudin.,Dapoxetine,DB00001
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Lepirudin.,Seproxetine,DB00001
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin.,Indalpine,DB00001
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Lepirudin.,Ritanserin,DB00001
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Lepirudin.,Alaproclate,DB00001
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Lepirudin.,Duloxetine,DB00001
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Lepirudin.,Sibutramine,DB00001
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Lepirudin.,Milnacipran,DB00001
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Lepirudin.,Desvenlafaxine,DB00001
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Lepirudin.,Levomilnacipran,DB00001
DB00285,Venlafaxine may increase the antiplatelet activities of Lepirudin.,Venlafaxine,DB00001
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Lepirudin.,Amphetamine,DB00001
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.,Linezolid,DB00001
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Lepirudin.,Furazolidone,DB00001
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.,Procaine,DB00001
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Lepirudin.,Tranylcypromine,DB00001
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Lepirudin.,Phenelzine,DB00001
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Lepirudin.,Minaprine,DB00001
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Lepirudin.,Selegiline,DB00001
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Lepirudin.,Procarbazine,DB00001
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Lepirudin.,Moclobemide,DB00001
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Lepirudin.,Isocarboxazid,DB00001
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Lepirudin.,Rasagiline,DB00001
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Lepirudin.,Pargyline,DB00001
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Lepirudin.,Clorgiline,DB00001
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Lepirudin.,Iproniazid,DB00001
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Lepirudin.,Nialamide,DB00001
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Lepirudin.,Safinamide,DB00001
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Lepirudin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00001
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Lepirudin.,Methylene blue,DB00001
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Lepirudin.,Hydracarbazine,DB00001
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Lepirudin.,Pirlindole,DB00001
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Lepirudin.,Toloxatone,DB00001
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Lepirudin.,Benmoxin,DB00001
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Lepirudin.,Mebanazine,DB00001
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Lepirudin.,Octamoxin,DB00001
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Lepirudin.,Pheniprazine,DB00001
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Lepirudin.,Phenoxypropazine,DB00001
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Lepirudin.,Pivhydrazine,DB00001
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Lepirudin.,Safrazine,DB00001
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Lepirudin.,Caroxazone,DB00001
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Lepirudin.,Harmaline,DB00001
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Lepirudin.,Brofaromine,DB00001
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.,Bivalirudin,DB00001
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Lepirudin.,Dicoumarol,DB00001
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Lepirudin.,Argatroban,DB00001
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Lepirudin.,Ardeparin,DB00001
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Lepirudin.,Phenindione,DB00001
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Lepirudin.,Fondaparinux,DB00001
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Lepirudin.,Warfarin,DB00001
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Lepirudin.,Phenprocoumon,DB00001
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Lepirudin.,Edetic acid,DB00001
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Lepirudin.,Heparin,DB00001
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Lepirudin.,Enoxaparin,DB00001
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Lepirudin.,Acenocoumarol,DB00001
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Lepirudin.,Ximelagatran,DB00001
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Lepirudin.,Ancrod,DB00001
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Lepirudin.,Sulodexide,DB00001
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Lepirudin.,Idraparinux,DB00001
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Lepirudin.,Otamixaban,DB00001
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Lepirudin.,Danaparoid,DB00001
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Lepirudin.,Dalteparin,DB00001
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Lepirudin.,Ferulic acid,DB00001
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Lepirudin.,Ethyl biscoumacetate,DB00001
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Lepirudin.,Nadroparin,DB00001
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Lepirudin.,Dextran,DB00001
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Lepirudin.,Reviparin,DB00001
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Lepirudin.,Certoparin,DB00001
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Lepirudin.,Desirudin,DB00001
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Lepirudin.,Protocatechualdehyde,DB00001
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Lepirudin.,Protein C,DB00001
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Lepirudin.,Antithrombin III human,DB00001
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Lepirudin.,Letaxaban,DB00001
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Lepirudin.,Darexaban,DB00001
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Lepirudin.,Nafamostat,DB00001
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Lepirudin.,Gabexate,DB00001
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Lepirudin.,Troxerutin,DB00001
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Lepirudin.,Fluindione,DB00001
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Lepirudin.,Protein S human,DB00001
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Lepirudin.,Melagatran,DB00001
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Lepirudin.,Potassium citrate,DB00001
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Lepirudin.,Sodium citrate,DB00001
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.,Tenecteplase,DB00001
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Lepirudin.,Drotrecogin alfa,DB00001
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Lepirudin.,Tinzaparin,DB00001
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Lepirudin.,Brinase,DB00001
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Lepirudin.,Saruplase,DB00001
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Lepirudin.,Streptokinase,DB00001
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Lepirudin.,Desmoteplase,DB00001
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Lepirudin.,Fibrinolysin,DB00001
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Lepirudin.,Astaxanthin,DB00001
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Lepirudin.,Ditazole,DB00001
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Lepirudin.,Bemiparin,DB00001
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Lepirudin.,Parnaparin,DB00001
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Lepirudin.,Clorindione,DB00001
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Lepirudin.,Diphenadione,DB00001
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Lepirudin.,Tioclomarol,DB00001
DB00009,The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.,Alteplase,DB00001
DB00015,The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.,Reteplase,DB00001
DB00029,The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.,Anistreplase,DB00001
DB14094,The risk or severity of bleeding can be increased when Lepirudin is combined with Tocopherylquinone.,Tocopherylquinone,DB00001
DB06679,The risk or severity of bleeding can be increased when Lepirudin is combined with Amediplase.,Amediplase,DB00001
DB03410,The risk or severity of bleeding can be increased when Lepirudin is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00001
DB08496,The risk or severity of bleeding can be increased when Lepirudin is combined with (R)-warfarin.,(R)-warfarin,DB00001
DB14055,The risk or severity of bleeding can be increased when Lepirudin is combined with (S)-Warfarin.,(S)-Warfarin,DB00001
DB12364,The risk or severity of bleeding can be increased when Lepirudin is combined with Betrixaban.,Betrixaban,DB00001
DB14598,The risk or severity of bleeding can be increased when Lepirudin is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00001
DB11154,The risk or severity of bleeding can be increased when Lepirudin is combined with Zinc citrate.,Zinc citrate,DB00001
DB11166,The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00001
DB04665,The risk or severity of bleeding can be increased when Lepirudin is combined with Coumarin.,Coumarin,DB00001
DB14726,The risk or severity of bleeding can be increased when Lepirudin is combined with Dabigatran.,Dabigatran,DB00001
DB06294,The risk or severity of bleeding can be increased when Lepirudin is combined with Semuloparin.,Semuloparin,DB00001
DB12726,The risk or severity of bleeding can be increased when Lepirudin is combined with Monteplase.,Monteplase,DB00001
DB00203,The risk or severity of hemorrhage can be increased when Lepirudin is combined with Sildenafil.,Sildenafil,DB00001
DB00008,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00001
DB00011,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00001
DB00018,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00001
DB00022,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00001
DB00033,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00001
DB00034,"The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00001
DB00041,The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.,Aldesleukin,DB00001
DB00056,The risk or severity of bleeding can be increased when Lepirudin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00001
DB00068,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon beta-1b.,Interferon beta-1b,DB00001
DB00069,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00001
DB00073,The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab.,Rituximab,DB00001
DB00078,The risk or severity of bleeding can be increased when Lepirudin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00001
DB00087,The risk or severity of bleeding can be increased when Lepirudin is combined with Alemtuzumab.,Alemtuzumab,DB00001
DB00105,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00001
DB00120,The risk or severity of bleeding can be increased when Lepirudin is combined with Phenylalanine.,Phenylalanine,DB00001
DB00188,The risk or severity of bleeding can be increased when Lepirudin is combined with Bortezomib.,Bortezomib,DB00001
DB00242,The risk or severity of bleeding can be increased when Lepirudin is combined with Cladribine.,Cladribine,DB00001
DB00262,The risk or severity of bleeding can be increased when Lepirudin is combined with Carmustine.,Carmustine,DB00001
DB00276,The risk or severity of bleeding can be increased when Lepirudin is combined with Amsacrine.,Amsacrine,DB00001
DB00291,The risk or severity of bleeding can be increased when Lepirudin is combined with Chlorambucil.,Chlorambucil,DB00001
DB00293,The risk or severity of bleeding can be increased when Lepirudin is combined with Raltitrexed.,Raltitrexed,DB00001
DB00305,The risk or severity of bleeding can be increased when Lepirudin is combined with Mitomycin.,Mitomycin,DB00001
DB00307,The risk or severity of bleeding can be increased when Lepirudin is combined with Bexarotene.,Bexarotene,DB00001
DB00309,The risk or severity of bleeding can be increased when Lepirudin is combined with Vindesine.,Vindesine,DB00001
DB00322,The risk or severity of bleeding can be increased when Lepirudin is combined with Floxuridine.,Floxuridine,DB00001
DB00352,The risk or severity of bleeding can be increased when Lepirudin is combined with Tioguanine.,Tioguanine,DB00001
DB00361,The risk or severity of bleeding can be increased when Lepirudin is combined with Vinorelbine.,Vinorelbine,DB00001
DB00380,The risk or severity of bleeding can be increased when Lepirudin is combined with Dexrazoxane.,Dexrazoxane,DB00001
DB00398,The risk or severity of bleeding can be increased when Lepirudin is combined with Sorafenib.,Sorafenib,DB00001
DB00428,The risk or severity of bleeding can be increased when Lepirudin is combined with Streptozocin.,Streptozocin,DB00001
DB00441,The risk or severity of bleeding can be increased when Lepirudin is combined with Gemcitabine.,Gemcitabine,DB00001
DB00444,The risk or severity of bleeding can be increased when Lepirudin is combined with Teniposide.,Teniposide,DB00001
DB00445,The risk or severity of bleeding can be increased when Lepirudin is combined with Epirubicin.,Epirubicin,DB00001
DB00446,The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.,Chloramphenicol,DB00001
DB00480,The risk or severity of bleeding can be increased when Lepirudin is combined with Lenalidomide.,Lenalidomide,DB00001
DB00488,The risk or severity of bleeding can be increased when Lepirudin is combined with Altretamine.,Altretamine,DB00001
DB00495,The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.,Zidovudine,DB00001
DB00515,The risk or severity of bleeding can be increased when Lepirudin is combined with Cisplatin.,Cisplatin,DB00001
DB00526,The risk or severity of bleeding can be increased when Lepirudin is combined with Oxaliplatin.,Oxaliplatin,DB00001
DB00531,The risk or severity of bleeding can be increased when Lepirudin is combined with Cyclophosphamide.,Cyclophosphamide,DB00001
DB00544,The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.,Fluorouracil,DB00001
DB00552,The risk or severity of bleeding can be increased when Lepirudin is combined with Pentostatin.,Pentostatin,DB00001
DB00563,The risk or severity of bleeding can be increased when Lepirudin is combined with Methotrexate.,Methotrexate,DB00001
DB00564,The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.,Carbamazepine,DB00001
DB00570,The risk or severity of bleeding can be increased when Lepirudin is combined with Vinblastine.,Vinblastine,DB00001
DB00619,The risk or severity of bleeding can be increased when Lepirudin is combined with Imatinib.,Imatinib,DB00001
DB00631,The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.,Clofarabine,DB00001
DB00642,The risk or severity of bleeding can be increased when Lepirudin is combined with Pemetrexed.,Pemetrexed,DB00001
DB00694,The risk or severity of bleeding can be increased when Lepirudin is combined with Daunorubicin.,Daunorubicin,DB00001
DB00762,The risk or severity of bleeding can be increased when Lepirudin is combined with Irinotecan.,Irinotecan,DB00001
DB00773,The risk or severity of bleeding can be increased when Lepirudin is combined with Etoposide.,Etoposide,DB00001
DB00851,The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.,Dacarbazine,DB00001
DB00853,The risk or severity of bleeding can be increased when Lepirudin is combined with Temozolomide.,Temozolomide,DB00001
DB00859,The risk or severity of bleeding can be increased when Lepirudin is combined with Penicillamine.,Penicillamine,DB00001
DB00864,The risk or severity of bleeding can be increased when Lepirudin is combined with Tacrolimus.,Tacrolimus,DB00001
DB00877,The risk or severity of bleeding can be increased when Lepirudin is combined with Sirolimus.,Sirolimus,DB00001
DB00888,The risk or severity of bleeding can be increased when Lepirudin is combined with Mechlorethamine.,Mechlorethamine,DB00001
DB00928,The risk or severity of bleeding can be increased when Lepirudin is combined with Azacitidine.,Azacitidine,DB00001
DB00958,The risk or severity of bleeding can be increased when Lepirudin is combined with Carboplatin.,Carboplatin,DB00001
DB00970,The risk or severity of bleeding can be increased when Lepirudin is combined with Dactinomycin.,Dactinomycin,DB00001
DB00987,The risk or severity of bleeding can be increased when Lepirudin is combined with Cytarabine.,Cytarabine,DB00001
DB00997,The risk or severity of bleeding can be increased when Lepirudin is combined with Doxorubicin.,Doxorubicin,DB00001
DB01005,The risk or severity of bleeding can be increased when Lepirudin is combined with Hydroxyurea.,Hydroxyurea,DB00001
DB01008,The risk or severity of bleeding can be increased when Lepirudin is combined with Busulfan.,Busulfan,DB00001
DB01030,The risk or severity of bleeding can be increased when Lepirudin is combined with Topotecan.,Topotecan,DB00001
DB01033,The risk or severity of bleeding can be increased when Lepirudin is combined with Mercaptopurine.,Mercaptopurine,DB00001
DB01041,The risk or severity of bleeding can be increased when Lepirudin is combined with Thalidomide.,Thalidomide,DB00001
DB01042,The risk or severity of bleeding can be increased when Lepirudin is combined with Melphalan.,Melphalan,DB00001
DB01073,The risk or severity of bleeding can be increased when Lepirudin is combined with Fludarabine.,Fludarabine,DB00001
DB01099,The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine.,Flucytosine,DB00001
DB01101,The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.,Capecitabine,DB00001
DB01169,The risk or severity of bleeding can be increased when Lepirudin is combined with Arsenic trioxide.,Arsenic trioxide,DB00001
DB01177,The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.,Idarubicin,DB00001
DB01204,The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone.,Mitoxantrone,DB00001
DB01206,The risk or severity of bleeding can be increased when Lepirudin is combined with Lomustine.,Lomustine,DB00001
DB01229,The risk or severity of bleeding can be increased when Lepirudin is combined with Paclitaxel.,Paclitaxel,DB00001
DB01248,The risk or severity of bleeding can be increased when Lepirudin is combined with Docetaxel.,Docetaxel,DB00001
DB01262,The risk or severity of bleeding can be increased when Lepirudin is combined with Decitabine.,Decitabine,DB00001
DB01280,The risk or severity of bleeding can be increased when Lepirudin is combined with Nelarabine.,Nelarabine,DB00001
DB01590,The risk or severity of bleeding can be increased when Lepirudin is combined with Everolimus.,Everolimus,DB00001
DB02546,The risk or severity of bleeding can be increased when Lepirudin is combined with Vorinostat.,Vorinostat,DB00001
DB04572,The risk or severity of bleeding can be increased when Lepirudin is combined with Thiotepa.,Thiotepa,DB00001
DB04845,The risk or severity of bleeding can be increased when Lepirudin is combined with Ixabepilone.,Ixabepilone,DB00001
DB04868,The risk or severity of bleeding can be increased when Lepirudin is combined with Nilotinib.,Nilotinib,DB00001
DB05015,The risk or severity of bleeding can be increased when Lepirudin is combined with Belinostat.,Belinostat,DB00001
DB05109,The risk or severity of bleeding can be increased when Lepirudin is combined with Trabectedin.,Trabectedin,DB00001
DB05258,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa.,Interferon alfa,DB00001
DB05472,The risk or severity of bleeding can be increased when Lepirudin is combined with omega interferon.,omega interferon,DB00001
DB05773,The risk or severity of bleeding can be increased when Lepirudin is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00001
DB06287,The risk or severity of bleeding can be increased when Lepirudin is combined with Temsirolimus.,Temsirolimus,DB00001
DB06616,The risk or severity of bleeding can be increased when Lepirudin is combined with Bosutinib.,Bosutinib,DB00001
DB06769,The risk or severity of bleeding can be increased when Lepirudin is combined with Bendamustine.,Bendamustine,DB00001
DB06772,The risk or severity of bleeding can be increased when Lepirudin is combined with Cabazitaxel.,Cabazitaxel,DB00001
DB08871,The risk or severity of bleeding can be increased when Lepirudin is combined with Eribulin.,Eribulin,DB00001
DB08877,The risk or severity of bleeding can be increased when Lepirudin is combined with Ruxolitinib.,Ruxolitinib,DB00001
DB08889,The risk or severity of bleeding can be increased when Lepirudin is combined with Carfilzomib.,Carfilzomib,DB00001
DB08895,The risk or severity of bleeding can be increased when Lepirudin is combined with Tofacitinib.,Tofacitinib,DB00001
DB08901,The risk or severity of bleeding can be increased when Lepirudin is combined with Ponatinib.,Ponatinib,DB00001
DB08910,The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide.,Pomalidomide,DB00001
DB09042,The risk or severity of bleeding can be increased when Lepirudin is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00001
DB09052,The risk or severity of bleeding can be increased when Lepirudin is combined with Blinatumomab.,Blinatumomab,DB00001
DB09073,The risk or severity of bleeding can be increased when Lepirudin is combined with Palbociclib.,Palbociclib,DB00001
DB09074,The risk or severity of bleeding can be increased when Lepirudin is combined with Olaparib.,Olaparib,DB00001
DB09077,The risk or severity of bleeding can be increased when Lepirudin is combined with Dinutuximab.,Dinutuximab,DB00001
DB09122,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00001
DB12814,The risk or severity of bleeding can be increased when Lepirudin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00001
DB00229,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotiam.,Cefotiam,DB00001
DB00267,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00001
DB00274,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00001
DB00430,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00001
DB00438,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00001
DB00447,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Loracarbef.,Loracarbef,DB00001
DB00456,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefalotin.,Cefalotin,DB00001
DB00493,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00001
DB00535,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefdinir.,Cefdinir,DB00001
DB00567,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.,Cephalexin,DB00001
DB00671,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.,Cefixime,DB00001
DB00689,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00001
DB00833,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaclor.,Cefaclor,DB00001
DB00923,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceforanide.,Ceforanide,DB00001
DB01066,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefditoren.,Cefditoren,DB00001
DB01112,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00001
DB01139,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefapirin.,Cefapirin,DB00001
DB01140,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00001
DB01150,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefprozil.,Cefprozil,DB00001
DB01212,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00001
DB01326,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole.,Cefamandole,DB00001
DB01327,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazolin.,Cefazolin,DB00001
DB01328,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefonicid.,Cefonicid,DB00001
DB01329,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00001
DB01330,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.,Cefotetan,DB00001
DB01331,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00001
DB01332,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00001
DB01333,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefradine.,Cefradine,DB00001
DB01413,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefepime.,Cefepime,DB00001
DB01414,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00001
DB01415,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00001
DB01416,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00001
DB04570,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Latamoxef.,Latamoxef,DB00001
DB04918,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00001
DB06590,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00001
DB09008,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00001
DB09050,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00001
DB09062,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefminox.,Cefminox,DB00001
DB11367,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00001
DB11935,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Flomoxef.,Flomoxef,DB00001
DB13266,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00001
DB13461,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefcapene.,Cefcapene,DB00001
DB13470,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefodizime.,Cefodizime,DB00001
DB13499,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00001
DB13504,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefetamet.,Cefetamet,DB00001
DB13638,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00001
DB13667,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefozopran.,Cefozopran,DB00001
DB13682,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpirome.,Cefpirome,DB00001
DB13778,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazedone.,Cefazedone,DB00001
DB13821,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftezole.,Ceftezole,DB00001
DB14725,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00001
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Lepirudin.,Doxycycline,DB00001
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.,Azithromycin,DB00001
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Lepirudin.,Omega-3-acid ethyl esters,DB00001
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.,Acetylsalicylic acid,DB00001
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Lepirudin.,Tazobactam,DB00001
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin.,Erythromycin,DB00001
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Lepirudin.,Trazodone,DB00001
DB00620,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00001
DB09079,The risk or severity of bleeding can be increased when Lepirudin is combined with Nintedanib.,Nintedanib,DB00001
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Lepirudin.,Escitalopram,DB00001
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Lepirudin.,Sertraline,DB00001
DB00232,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00001
DB00436,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00001
DB00562,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00001
DB00606,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00001
DB00774,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00001
DB00880,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00001
DB00999,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00001
DB01021,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00001
DB01324,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Polythiazide.,Polythiazide,DB00001
DB13430,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mebutizide.,Mebutizide,DB00001
DB13532,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00001
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cetuximab.,Darbepoetin alfa,DB00002
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.,Erythropoietin,DB00002
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Cetuximab.,Peginesatide,DB00002
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Cetuximab.,Methoxy polyethylene glycol-epoetin beta,DB00002
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Cetuximab.,Diethylstilbestrol,DB00002
DB00269,Chlorotrianisene may increase the thrombogenic activities of Cetuximab.,Chlorotrianisene,DB00002
DB00286,Conjugated estrogens may increase the thrombogenic activities of Cetuximab.,Conjugated estrogens,DB00002
DB00655,Estrone may increase the thrombogenic activities of Cetuximab.,Estrone,DB00002
DB00783,Estradiol may increase the thrombogenic activities of Cetuximab.,Estradiol,DB00002
DB00890,Dienestrol may increase the thrombogenic activities of Cetuximab.,Dienestrol,DB00002
DB00977,Ethinylestradiol may increase the thrombogenic activities of Cetuximab.,Ethinylestradiol,DB00002
DB01357,Mestranol may increase the thrombogenic activities of Cetuximab.,Mestranol,DB00002
DB04573,Estriol may increase the thrombogenic activities of Cetuximab.,Estriol,DB00002
DB04574,Estrone sulfate may increase the thrombogenic activities of Cetuximab.,Estrone sulfate,DB00002
DB04575,Quinestrol may increase the thrombogenic activities of Cetuximab.,Quinestrol,DB00002
DB07931,Hexestrol may increase the thrombogenic activities of Cetuximab.,Hexestrol,DB00002
DB09070,Tibolone may increase the thrombogenic activities of Cetuximab.,Tibolone,DB00002
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Cetuximab.","Synthetic Conjugated Estrogens, A",DB00002
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Cetuximab.","Synthetic Conjugated Estrogens, B",DB00002
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Cetuximab.,Polyestradiol phosphate,DB00002
DB09381,Esterified estrogens may increase the thrombogenic activities of Cetuximab.,Esterified estrogens,DB00002
DB11478,Zeranol may increase the thrombogenic activities of Cetuximab.,Zeranol,DB00002
DB11674,Equol may increase the thrombogenic activities of Cetuximab.,Equol,DB00002
DB12487,Promestriene may increase the thrombogenic activities of Cetuximab.,Promestriene,DB00002
DB13143,Methallenestril may increase the thrombogenic activities of Cetuximab.,Methallenestril,DB00002
DB13386,Epimestrol may increase the thrombogenic activities of Cetuximab.,Epimestrol,DB00002
DB13418,Moxestrol may increase the thrombogenic activities of Cetuximab.,Moxestrol,DB00002
DB13952,Estradiol acetate may increase the thrombogenic activities of Cetuximab.,Estradiol acetate,DB00002
DB13953,Estradiol benzoate may increase the thrombogenic activities of Cetuximab.,Estradiol benzoate,DB00002
DB13954,Estradiol cypionate may increase the thrombogenic activities of Cetuximab.,Estradiol cypionate,DB00002
DB13956,Estradiol valerate may increase the thrombogenic activities of Cetuximab.,Estradiol valerate,DB00002
DB15334,Biochanin A may increase the thrombogenic activities of Cetuximab.,Biochanin A,DB00002
DB15335,Formononetin may increase the thrombogenic activities of Cetuximab.,Formononetin,DB00002
DB00028,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.,Human immunoglobulin G,DB00002
DB00043,The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.,Omalizumab,DB00002
DB00051,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.,Adalimumab,DB00002
DB00054,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.,Abciximab,DB00002
DB00056,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00002
DB00057,The risk or severity of adverse effects can be increased when Cetuximab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide,DB00002
DB00065,The risk or severity of adverse effects can be increased when Cetuximab is combined with Infliximab.,Infliximab,DB00002
DB00072,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab.,Trastuzumab,DB00002
DB00073,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rituximab.,Rituximab,DB00002
DB00074,The risk or severity of adverse effects can be increased when Cetuximab is combined with Basiliximab.,Basiliximab,DB00002
DB00075,The risk or severity of adverse effects can be increased when Cetuximab is combined with Muromonab.,Muromonab,DB00002
DB00076,The risk or severity of adverse effects can be increased when Cetuximab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine),DB00002
DB00078,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00002
DB00081,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tositumomab.,Tositumomab,DB00002
DB00087,The risk or severity of adverse effects can be increased when Cetuximab is combined with Alemtuzumab.,Alemtuzumab,DB00002
DB00089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Capromab pendetide.,Capromab pendetide,DB00002
DB00095,The risk or severity of adverse effects can be increased when Cetuximab is combined with Efalizumab.,Efalizumab,DB00002
DB00098,The risk or severity of adverse effects can be increased when Cetuximab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00002
DB00108,The risk or severity of adverse effects can be increased when Cetuximab is combined with Natalizumab.,Natalizumab,DB00002
DB00110,The risk or severity of adverse effects can be increased when Cetuximab is combined with Palivizumab.,Palivizumab,DB00002
DB00111,The risk or severity of adverse effects can be increased when Cetuximab is combined with Daclizumab.,Daclizumab,DB00002
DB00112,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab.,Bevacizumab,DB00002
DB00113,The risk or severity of adverse effects can be increased when Cetuximab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab,DB00002
DB01257,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eculizumab.,Eculizumab,DB00002
DB01269,The risk or severity of adverse effects can be increased when Cetuximab is combined with Panitumumab.,Panitumumab,DB00002
DB01270,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ranibizumab.,Ranibizumab,DB00002
DB04901,The risk or severity of adverse effects can be increased when Cetuximab is combined with Galiximab.,Galiximab,DB00002
DB04949,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pexelizumab.,Pexelizumab,DB00002
DB04956,The risk or severity of adverse effects can be increased when Cetuximab is combined with Afelimomab.,Afelimomab,DB00002
DB04958,The risk or severity of adverse effects can be increased when Cetuximab is combined with Epratuzumab.,Epratuzumab,DB00002
DB04962,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bectumomab.,Bectumomab,DB00002
DB04964,The risk or severity of adverse effects can be increased when Cetuximab is combined with Oregovomab.,Oregovomab,DB00002
DB04988,The risk or severity of adverse effects can be increased when Cetuximab is combined with IGN311.,IGN311,DB00002
DB05006,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adecatumumab.,Adecatumumab,DB00002
DB05097,The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab.,Labetuzumab,DB00002
DB05101,The risk or severity of adverse effects can be increased when Cetuximab is combined with Matuzumab.,Matuzumab,DB00002
DB05111,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fontolizumab.,Fontolizumab,DB00002
DB05136,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bavituximab.,Bavituximab,DB00002
DB05139,The risk or severity of adverse effects can be increased when Cetuximab is combined with CR002.,CR002,DB00002
DB05209,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozrolimupab.,Rozrolimupab,DB00002
DB05304,The risk or severity of adverse effects can be increased when Cetuximab is combined with Girentuximab.,Girentuximab,DB00002
DB05336,The risk or severity of adverse effects can be increased when Cetuximab is combined with Obiltoxaximab.,Obiltoxaximab,DB00002
DB05405,The risk or severity of adverse effects can be increased when Cetuximab is combined with XTL-001.,XTL-001,DB00002
DB05437,The risk or severity of adverse effects can be increased when Cetuximab is combined with NAV 1800.,NAV 1800,DB00002
DB05459,The risk or severity of adverse effects can be increased when Cetuximab is combined with Briakinumab.,Briakinumab,DB00002
DB05496,The risk or severity of adverse effects can be increased when Cetuximab is combined with Otelixizumab.,Otelixizumab,DB00002
DB05545,The risk or severity of adverse effects can be increased when Cetuximab is combined with AMG 108.,AMG 108,DB00002
DB05550,The risk or severity of adverse effects can be increased when Cetuximab is combined with Iratumumab.,Iratumumab,DB00002
DB05555,The risk or severity of adverse effects can be increased when Cetuximab is combined with Enokizumab.,Enokizumab,DB00002
DB05578,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ramucirumab.,Ramucirumab,DB00002
DB05595,The risk or severity of adverse effects can be increased when Cetuximab is combined with Farletuzumab.,Farletuzumab,DB00002
DB05656,The risk or severity of adverse effects can be increased when Cetuximab is combined with Veltuzumab.,Veltuzumab,DB00002
DB05679,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ustekinumab.,Ustekinumab,DB00002
DB05773,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00002
DB05793,The risk or severity of adverse effects can be increased when Cetuximab is combined with PRO-542.,PRO-542,DB00002
DB05797,The risk or severity of adverse effects can be increased when Cetuximab is combined with TNX-901.,TNX-901,DB00002
DB05889,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00002
DB05892,The risk or severity of adverse effects can be increased when Cetuximab is combined with RI 624.,RI 624,DB00002
DB05915,The risk or severity of adverse effects can be increased when Cetuximab is combined with MYO-029.,MYO-029,DB00002
DB05916,The risk or severity of adverse effects can be increased when Cetuximab is combined with CT-011.,CT-011,DB00002
DB05941,The risk or severity of adverse effects can be increased when Cetuximab is combined with Leronlimab.,Leronlimab,DB00002
DB05996,The risk or severity of adverse effects can be increased when Cetuximab is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00002
DB06043,The risk or severity of adverse effects can be increased when Cetuximab is combined with Olaratumab.,Olaratumab,DB00002
DB06049,The risk or severity of adverse effects can be increased when Cetuximab is combined with IPH 2101.,IPH 2101,DB00002
DB06050,The risk or severity of adverse effects can be increased when Cetuximab is combined with TB-402.,TB-402,DB00002
DB06081,The risk or severity of adverse effects can be increased when Cetuximab is combined with Caplacizumab.,Caplacizumab,DB00002
DB06101,The risk or severity of adverse effects can be increased when Cetuximab is combined with IMC-1C11.,IMC-1C11,DB00002
DB06116,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eldelumab.,Eldelumab,DB00002
DB06162,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumiliximab.,Lumiliximab,DB00002
DB06168,The risk or severity of adverse effects can be increased when Cetuximab is combined with Canakinumab.,Canakinumab,DB00002
DB06186,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipilimumab.,Ipilimumab,DB00002
DB06192,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nimotuzumab.,Nimotuzumab,DB00002
DB06241,The risk or severity of adverse effects can be increased when Cetuximab is combined with Clenoliximab.,Clenoliximab,DB00002
DB06273,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tocilizumab.,Tocilizumab,DB00002
DB06304,The risk or severity of adverse effects can be increased when Cetuximab is combined with BIIB015.,BIIB015,DB00002
DB06305,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sonepcizumab.,Sonepcizumab,DB00002
DB06310,The risk or severity of adverse effects can be increased when Cetuximab is combined with Motavizumab.,Motavizumab,DB00002
DB06317,The risk or severity of adverse effects can be increased when Cetuximab is combined with Elotuzumab.,Elotuzumab,DB00002
DB06318,The risk or severity of adverse effects can be increased when Cetuximab is combined with AVE9633.,AVE9633,DB00002
DB06322,The risk or severity of adverse effects can be increased when Cetuximab is combined with Carotuximab.,Carotuximab,DB00002
DB06324,The risk or severity of adverse effects can be increased when Cetuximab is combined with XmAb 2513.,XmAb 2513,DB00002
DB06342,The risk or severity of adverse effects can be increased when Cetuximab is combined with Coltuximab ravtansine.,Coltuximab ravtansine,DB00002
DB06343,The risk or severity of adverse effects can be increased when Cetuximab is combined with Teprotumumab.,Teprotumumab,DB00002
DB06360,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lucatumumab.,Lucatumumab,DB00002
DB06366,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pertuzumab.,Pertuzumab,DB00002
DB06371,The risk or severity of adverse effects can be increased when Cetuximab is combined with Siplizumab.,Siplizumab,DB00002
DB06467,The risk or severity of adverse effects can be increased when Cetuximab is combined with Apolizumab.,Apolizumab,DB00002
DB06474,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sibrotuzumab.,Sibrotuzumab,DB00002
DB06550,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bivatuzumab.,Bivatuzumab,DB00002
DB06557,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lerdelimumab.,Lerdelimumab,DB00002
DB06599,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lexatumumab.,Lexatumumab,DB00002
DB06602,The risk or severity of adverse effects can be increased when Cetuximab is combined with Reslizumab.,Reslizumab,DB00002
DB06606,The risk or severity of adverse effects can be increased when Cetuximab is combined with Teplizumab.,Teplizumab,DB00002
DB06607,The risk or severity of adverse effects can be increased when Cetuximab is combined with Catumaxomab.,Catumaxomab,DB00002
DB06612,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mepolizumab.,Mepolizumab,DB00002
DB06643,The risk or severity of adverse effects can be increased when Cetuximab is combined with Denosumab.,Denosumab,DB00002
DB06647,The risk or severity of adverse effects can be increased when Cetuximab is combined with Volociximab.,Volociximab,DB00002
DB06650,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ofatumumab.,Ofatumumab,DB00002
DB06674,The risk or severity of adverse effects can be increased when Cetuximab is combined with Golimumab.,Golimumab,DB00002
DB08870,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00002
DB08879,The risk or severity of adverse effects can be increased when Cetuximab is combined with Belimumab.,Belimumab,DB00002
DB08902,The risk or severity of adverse effects can be increased when Cetuximab is combined with Raxibacumab.,Raxibacumab,DB00002
DB08904,The risk or severity of adverse effects can be increased when Cetuximab is combined with Certolizumab pegol.,Certolizumab pegol,DB00002
DB08935,The risk or severity of adverse effects can be increased when Cetuximab is combined with Obinutuzumab.,Obinutuzumab,DB00002
DB09029,The risk or severity of adverse effects can be increased when Cetuximab is combined with Secukinumab.,Secukinumab,DB00002
DB09033,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vedolizumab.,Vedolizumab,DB00002
DB09035,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nivolumab.,Nivolumab,DB00002
DB09036,The risk or severity of adverse effects can be increased when Cetuximab is combined with Siltuximab.,Siltuximab,DB00002
DB09037,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pembrolizumab.,Pembrolizumab,DB00002
DB09045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dulaglutide.,Dulaglutide,DB00002
DB09052,The risk or severity of adverse effects can be increased when Cetuximab is combined with Blinatumomab.,Blinatumomab,DB00002
DB09057,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anthrax immune globulin human.,Anthrax immune globulin human,DB00002
DB09077,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dinutuximab.,Dinutuximab,DB00002
DB09105,The risk or severity of adverse effects can be increased when Cetuximab is combined with Asfotase alfa.,Asfotase alfa,DB00002
DB09264,The risk or severity of adverse effects can be increased when Cetuximab is combined with Idarucizumab.,Idarucizumab,DB00002
DB09302,The risk or severity of adverse effects can be increased when Cetuximab is combined with Alirocumab.,Alirocumab,DB00002
DB09303,The risk or severity of adverse effects can be increased when Cetuximab is combined with Evolocumab.,Evolocumab,DB00002
DB09312,The risk or severity of adverse effects can be increased when Cetuximab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00002
DB09331,The risk or severity of adverse effects can be increased when Cetuximab is combined with Daratumumab.,Daratumumab,DB00002
DB09559,The risk or severity of adverse effects can be increased when Cetuximab is combined with Necitumumab.,Necitumumab,DB00002
DB11569,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ixekizumab.,Ixekizumab,DB00002
DB11580,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ravulizumab.,Ravulizumab,DB00002
DB11595,The risk or severity of adverse effects can be increased when Cetuximab is combined with Atezolizumab.,Atezolizumab,DB00002
DB11604,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin,DB00002
DB11608,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eftrenonacog alfa.,Eftrenonacog alfa,DB00002
DB11621,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin,DB00002
DB11646,The risk or severity of adverse effects can be increased when Cetuximab is combined with Conatumumab.,Conatumumab,DB00002
DB11657,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tabalumab.,Tabalumab,DB00002
DB11680,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ficlatuzumab.,Ficlatuzumab,DB00002
DB11685,The risk or severity of adverse effects can be increased when Cetuximab is combined with Figitumumab.,Figitumumab,DB00002
DB11714,The risk or severity of adverse effects can be increased when Cetuximab is combined with Durvalumab.,Durvalumab,DB00002
DB11715,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bapineuzumab.,Bapineuzumab,DB00002
DB11731,The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin,DB00002
DB11746,The risk or severity of adverse effects can be increased when Cetuximab is combined with Onartuzumab.,Onartuzumab,DB00002
DB11756,The risk or severity of adverse effects can be increased when Cetuximab is combined with Solanezumab.,Solanezumab,DB00002
DB11767,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sarilumab.,Sarilumab,DB00002
DB11771,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tremelimumab.,Tremelimumab,DB00002
DB11776,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brodalumab.,Brodalumab,DB00002
DB11803,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sirukumab.,Sirukumab,DB00002
DB11826,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lampalizumab.,Lampalizumab,DB00002
DB11834,The risk or severity of adverse effects can be increased when Cetuximab is combined with Guselkumab.,Guselkumab,DB00002
DB11840,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalotuzumab.,Dalotuzumab,DB00002
DB11849,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emibetuzumab.,Emibetuzumab,DB00002
DB11850,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ublituximab.,Ublituximab,DB00002
DB11856,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ligelizumab.,Ligelizumab,DB00002
DB11857,The risk or severity of adverse effects can be increased when Cetuximab is combined with Seribantumab.,Seribantumab,DB00002
DB11862,The risk or severity of adverse effects can be increased when Cetuximab is combined with Landogrozumab.,Landogrozumab,DB00002
DB11866,The risk or severity of adverse effects can be increased when Cetuximab is combined with Romosozumab.,Romosozumab,DB00002
DB11884,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vadastuximab Talirine.,Vadastuximab Talirine,DB00002
DB11914,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lebrikizumab.,Lebrikizumab,DB00002
DB11930,The risk or severity of adverse effects can be increased when Cetuximab is combined with Varlilumab.,Varlilumab,DB00002
DB11945,The risk or severity of adverse effects can be increased when Cetuximab is combined with Avelumab.,Avelumab,DB00002
DB11959,The risk or severity of adverse effects can be increased when Cetuximab is combined with Crenezumab.,Crenezumab,DB00002
DB11972,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rilotumumab.,Rilotumumab,DB00002
DB11976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anifrolumab.,Anifrolumab,DB00002
DB11988,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ocrelizumab.,Ocrelizumab,DB00002
DB12023,The risk or severity of adverse effects can be increased when Cetuximab is combined with Benralizumab.,Benralizumab,DB00002
DB12034,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gantenerumab.,Gantenerumab,DB00002
DB12053,The risk or severity of adverse effects can be increased when Cetuximab is combined with Visilizumab.,Visilizumab,DB00002
DB12077,The risk or severity of adverse effects can be increased when Cetuximab is combined with Urelumab.,Urelumab,DB00002
DB12089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00002
DB12090,The risk or severity of adverse effects can be increased when Cetuximab is combined with Patritumab.,Patritumab,DB00002
DB12102,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fulranumab.,Fulranumab,DB00002
DB12104,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tarextumab.,Tarextumab,DB00002
DB12118,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sotatercept.,Sotatercept,DB00002
DB12119,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gevokizumab.,Gevokizumab,DB00002
DB12142,The risk or severity of adverse effects can be increased when Cetuximab is combined with Duligotuzumab.,Duligotuzumab,DB00002
DB12152,The risk or severity of adverse effects can be increased when Cetuximab is combined with Simtuzumab.,Simtuzumab,DB00002
DB12157,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fasinumab.,Fasinumab,DB00002
DB12159,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dupilumab.,Dupilumab,DB00002
DB12169,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tralokinumab.,Tralokinumab,DB00002
DB12189,The risk or severity of adverse effects can be increased when Cetuximab is combined with Etrolizumab.,Etrolizumab,DB00002
DB12202,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zalutumumab.,Zalutumumab,DB00002
DB12205,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ganitumab.,Ganitumab,DB00002
DB12213,The risk or severity of adverse effects can be increased when Cetuximab is combined with Etaracizumab.,Etaracizumab,DB00002
DB12240,The risk or severity of adverse effects can be increased when Cetuximab is combined with Polatuzumab vedotin.,Polatuzumab vedotin,DB00002
DB12246,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inclacumab.,Inclacumab,DB00002
DB12250,The risk or severity of adverse effects can be increased when Cetuximab is combined with Cixutumumab.,Cixutumumab,DB00002
DB12261,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ascrinvacumab.,Ascrinvacumab,DB00002
DB12274,The risk or severity of adverse effects can be increased when Cetuximab is combined with Aducanumab.,Aducanumab,DB00002
DB12281,The risk or severity of adverse effects can be increased when Cetuximab is combined with Luspatercept.,Luspatercept,DB00002
DB12296,The risk or severity of adverse effects can be increased when Cetuximab is combined with GS-5745.,GS-5745,DB00002
DB12317,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vanucizumab.,Vanucizumab,DB00002
DB12331,The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab govitecan.,Labetuzumab govitecan,DB00002
DB12335,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tanezumab.,Tanezumab,DB00002
DB12342,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ensituximab.,Ensituximab,DB00002
DB12344,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fezakinumab.,Fezakinumab,DB00002
DB12363,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dusigitumab.,Dusigitumab,DB00002
DB12396,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fresolimumab.,Fresolimumab,DB00002
DB12413,The risk or severity of adverse effects can be increased when Cetuximab is combined with Indusatumab vedotin.,Indusatumab vedotin,DB00002
DB12456,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bococizumab.,Bococizumab,DB00002
DB12489,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine,DB00002
DB12498,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mogamulizumab.,Mogamulizumab,DB00002
DB12520,The risk or severity of adverse effects can be increased when Cetuximab is combined with Plozalizumab.,Plozalizumab,DB00002
DB12530,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inebilizumab.,Inebilizumab,DB00002
DB12534,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mavrilimumab.,Mavrilimumab,DB00002
DB12560,The risk or severity of adverse effects can be increased when Cetuximab is combined with Blosozumab.,Blosozumab,DB00002
DB12584,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimagrumab.,Bimagrumab,DB00002
DB12589,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dacetuzumab.,Dacetuzumab,DB00002
DB12609,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tovetumab.,Tovetumab,DB00002
DB12683,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumretuzumab.,Lumretuzumab,DB00002
DB12698,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibalizumab.,Ibalizumab,DB00002
DB12701,The risk or severity of adverse effects can be increased when Cetuximab is combined with Intetumumab.,Intetumumab,DB00002
DB12718,The risk or severity of adverse effects can be increased when Cetuximab is combined with Carlumab.,Carlumab,DB00002
DB12734,The risk or severity of adverse effects can be increased when Cetuximab is combined with Demcizumab.,Demcizumab,DB00002
DB12773,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sifalimumab.,Sifalimumab,DB00002
DB12775,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abituzumab.,Abituzumab,DB00002
DB12797,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ecromeximab.,Ecromeximab,DB00002
DB12807,The risk or severity of adverse effects can be increased when Cetuximab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox,DB00002
DB12815,The risk or severity of adverse effects can be increased when Cetuximab is combined with Crotedumab.,Crotedumab,DB00002
DB12820,The risk or severity of adverse effects can be increased when Cetuximab is combined with Concizumab.,Concizumab,DB00002
DB12826,The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab.,Depatuxizumab,DB00002
DB12844,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rontalizumab.,Rontalizumab,DB00002
DB12845,The risk or severity of adverse effects can be increased when Cetuximab is combined with Amatuximab.,Amatuximab,DB00002
DB12849,The risk or severity of adverse effects can be increased when Cetuximab is combined with Clazakizumab.,Clazakizumab,DB00002
DB12891,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ozanezumab.,Ozanezumab,DB00002
DB12893,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sacituzumab govitecan.,Sacituzumab govitecan,DB00002
DB12917,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimekizumab.,Bimekizumab,DB00002
DB12943,The risk or severity of adverse effects can be increased when Cetuximab is combined with Milatuzumab.,Milatuzumab,DB00002
DB12976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Robatumumab.,Robatumumab,DB00002
DB13017,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine,DB00002
DB13037,The risk or severity of adverse effects can be increased when Cetuximab is combined with Namilumab.,Namilumab,DB00002
DB13045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Racotumomab.,Racotumomab,DB00002
DB13073,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tregalizumab.,Tregalizumab,DB00002
DB13127,The risk or severity of adverse effects can be increased when Cetuximab is combined with Olokizumab.,Olokizumab,DB00002
DB13140,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bezlotoxumab.,Bezlotoxumab,DB00002
DB13375,The risk or severity of adverse effects can be increased when Cetuximab is combined with Edrecolomab.,Edrecolomab,DB00002
DB13535,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nebacumab.,Nebacumab,DB00002
DB13886,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin,DB00002
DB13923,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emicizumab.,Emicizumab,DB00002
DB13976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sulesomab.,Sulesomab,DB00002
DB13979,The risk or severity of adverse effects can be increased when Cetuximab is combined with Besilesomab.,Besilesomab,DB00002
DB14004,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tildrakizumab.,Tildrakizumab,DB00002
DB14012,The risk or severity of adverse effects can be increased when Cetuximab is combined with Burosumab.,Burosumab,DB00002
DB14039,The risk or severity of adverse effects can be increased when Cetuximab is combined with Erenumab.,Erenumab,DB00002
DB14040,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eptinezumab.,Eptinezumab,DB00002
DB14041,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fremanezumab.,Fremanezumab,DB00002
DB14042,The risk or severity of adverse effects can be increased when Cetuximab is combined with Galcanezumab.,Galcanezumab,DB00002
DB14211,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fanolesomab.,Fanolesomab,DB00002
DB14580,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lecanemab.,Lecanemab,DB00002
DB14597,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lanadelumab.,Lanadelumab,DB00002
DB14707,The risk or severity of adverse effects can be increased when Cetuximab is combined with Cemiplimab.,Cemiplimab,DB00002
DB14724,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emapalumab.,Emapalumab,DB00002
DB14762,The risk or severity of adverse effects can be increased when Cetuximab is combined with Risankizumab.,Risankizumab,DB00002
DB14776,The risk or severity of adverse effects can be increased when Cetuximab is combined with Camrelizumab.,Camrelizumab,DB00002
DB14778,The risk or severity of adverse effects can be increased when Cetuximab is combined with Setrusumab.,Setrusumab,DB00002
DB14784,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gancotamab.,Gancotamab,DB00002
DB14809,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anetumab ravtansine.,Anetumab ravtansine,DB00002
DB14811,The risk or severity of adverse effects can be increased when Cetuximab is combined with Isatuximab.,Isatuximab,DB00002
DB14824,The risk or severity of adverse effects can be increased when Cetuximab is combined with Icrucumab.,Icrucumab,DB00002
DB14843,The risk or severity of adverse effects can be increased when Cetuximab is combined with Codrituzumab.,Codrituzumab,DB00002
DB14864,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brolucizumab.,Brolucizumab,DB00002
DB14871,The risk or severity of adverse effects can be increased when Cetuximab is combined with Xentuzumab.,Xentuzumab,DB00002
DB14877,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lintuzumab.,Lintuzumab,DB00002
DB14891,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vobarilizumab.,Vobarilizumab,DB00002
DB14897,The risk or severity of adverse effects can be increased when Cetuximab is combined with Parsatuzumab.,Parsatuzumab,DB00002
DB14905,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emactuzumab.,Emactuzumab,DB00002
DB14907,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89,DB00002
DB14908,The risk or severity of adverse effects can be increased when Cetuximab is combined with Refanezumab.,Refanezumab,DB00002
DB14919,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozanolixizumab.,Rozanolixizumab,DB00002
DB14947,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bermekimab.,Bermekimab,DB00002
DB14952,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pamrevlumab.,Pamrevlumab,DB00002
DB14959,The risk or severity of adverse effects can be increased when Cetuximab is combined with Opicinumab.,Opicinumab,DB00002
DB14962,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan,DB00002
DB14967,The risk or severity of adverse effects can be increased when Cetuximab is combined with Margetuximab.,Margetuximab,DB00002
DB14988,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalantercept.,Dalantercept,DB00002
DB14997,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pateclizumab.,Pateclizumab,DB00002
DB15014,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gremubamab.,Gremubamab,DB00002
DB15022,The risk or severity of adverse effects can be increased when Cetuximab is combined with Apomab.,Apomab,DB00002
DB15044,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tafasitamab.,Tafasitamab,DB00002
DB15045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipafricept.,Ipafricept,DB00002
DB15076,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abrilumab.,Abrilumab,DB00002
DB15089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Frovocimab.,Frovocimab,DB00002
DB15090,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tezepelumab.,Tezepelumab,DB00002
DB15101,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tigatuzumab.,Tigatuzumab,DB00002
DB15104,The risk or severity of adverse effects can be increased when Cetuximab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin,DB00002
DB15113,The risk or severity of adverse effects can be increased when Cetuximab is combined with Utomilumab.,Utomilumab,DB00002
DB15118,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zolbetuximab.,Zolbetuximab,DB00002
DB15135,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ponezumab.,Ponezumab,DB00002
DB15160,The risk or severity of adverse effects can be increased when Cetuximab is combined with Asunercept.,Asunercept,DB00002
DB15172,The risk or severity of adverse effects can be increased when Cetuximab is combined with Suvratoxumab.,Suvratoxumab,DB00002
DB15225,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mitazalimab.,Mitazalimab,DB00002
DB15252,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nemolizumab.,Nemolizumab,DB00002
DB15253,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bleselumab.,Bleselumab,DB00002
DB15277,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gedivumab.,Gedivumab,DB00002
DB15336,The risk or severity of adverse effects can be increased when Cetuximab is combined with Valanafusp alfa.,Valanafusp alfa,DB00002
DB15349,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sofituzumab vedotin.,Sofituzumab vedotin,DB00002
DB15354,The risk or severity of adverse effects can be increased when Cetuximab is combined with Evinacumab.,Evinacumab,DB00002
DB15363,The risk or severity of adverse effects can be increased when Cetuximab is combined with Istiratumab.,Istiratumab,DB00002
DB15383,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pidilizumab.,Pidilizumab,DB00002
DB15397,The risk or severity of adverse effects can be increased when Cetuximab is combined with GMA-161.,GMA-161,DB00002
DB15409,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin,DB00002
DB15415,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tomaralimab.,Tomaralimab,DB00002
DB15428,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vesencumab.,Vesencumab,DB00002
DB15432,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin,DB00002
DB15441,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lulizumab pegol.,Lulizumab pegol,DB00002
DB15443,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorukafusp alfa.,Lorukafusp alfa,DB00002
DB15453,The risk or severity of adverse effects can be increased when Cetuximab is combined with Naratuximab emtansine.,Naratuximab emtansine,DB00002
DB15559,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zenocutuzumab.,Zenocutuzumab,DB00002
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Cetuximab.","Ebola Zaire vaccine (live, attenuated)",DB00002
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Denileukin diftitox.,Darbepoetin alfa,DB00004
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.,Erythropoietin,DB00004
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Denileukin diftitox.,Peginesatide,DB00004
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Denileukin diftitox.,Methoxy polyethylene glycol-epoetin beta,DB00004
DB01281,The risk or severity of infection can be increased when Etanercept is combined with Abatacept.,Abatacept,DB00005
DB00026,The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.,Anakinra,DB00005
DB08879,The risk or severity of adverse effects can be increased when Etanercept is combined with Belimumab.,Belimumab,DB00005
DB06168,The risk or severity of infection and neutropenia can be increased when Etanercept is combined with Canakinumab.,Canakinumab,DB00005
DB08904,The risk or severity of infection can be increased when Etanercept is combined with Certolizumab pegol.,Certolizumab pegol,DB00005
DB00531,The risk or severity of adverse effects can be increased when Etanercept is combined with Cyclophosphamide.,Cyclophosphamide,DB00005
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Etanercept.,Denosumab,DB00005
DB00065,Etanercept may increase the immunosuppressive activities of Infliximab.,Infliximab,DB00005
DB00008,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00005
DB00011,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00005
DB00018,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00005
DB00022,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00005
DB00033,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00005
DB00034,"The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00005
DB00041,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.,Aldesleukin,DB00005
DB00051,The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.,Adalimumab,DB00005
DB00056,The risk or severity of adverse effects can be increased when Etanercept is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00005
DB00059,The risk or severity of adverse effects can be increased when Etanercept is combined with Pegaspargase.,Pegaspargase,DB00005
DB00068,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon beta-1b.,Interferon beta-1b,DB00005
DB00069,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00005
DB00073,The risk or severity of adverse effects can be increased when Etanercept is combined with Rituximab.,Rituximab,DB00005
DB00074,The risk or severity of adverse effects can be increased when Etanercept is combined with Basiliximab.,Basiliximab,DB00005
DB00075,The risk or severity of adverse effects can be increased when Etanercept is combined with Muromonab.,Muromonab,DB00005
DB00078,The risk or severity of adverse effects can be increased when Etanercept is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00005
DB00081,The risk or severity of adverse effects can be increased when Etanercept is combined with Tositumomab.,Tositumomab,DB00005
DB00087,The risk or severity of adverse effects can be increased when Etanercept is combined with Alemtuzumab.,Alemtuzumab,DB00005
DB00092,The risk or severity of adverse effects can be increased when Etanercept is combined with Alefacept.,Alefacept,DB00005
DB00095,The risk or severity of adverse effects can be increased when Etanercept is combined with Efalizumab.,Efalizumab,DB00005
DB00098,The risk or severity of adverse effects can be increased when Etanercept is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00005
DB00105,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00005
DB00111,The risk or severity of adverse effects can be increased when Etanercept is combined with Daclizumab.,Daclizumab,DB00005
DB00112,The risk or severity of adverse effects can be increased when Etanercept is combined with Bevacizumab.,Bevacizumab,DB00005
DB00120,The risk or severity of adverse effects can be increased when Etanercept is combined with Phenylalanine.,Phenylalanine,DB00005
DB00242,The risk or severity of adverse effects can be increased when Etanercept is combined with Cladribine.,Cladribine,DB00005
DB00276,The risk or severity of adverse effects can be increased when Etanercept is combined with Amsacrine.,Amsacrine,DB00005
DB00290,The risk or severity of adverse effects can be increased when Etanercept is combined with Bleomycin.,Bleomycin,DB00005
DB00291,The risk or severity of adverse effects can be increased when Etanercept is combined with Chlorambucil.,Chlorambucil,DB00005
DB00293,The risk or severity of adverse effects can be increased when Etanercept is combined with Raltitrexed.,Raltitrexed,DB00005
DB00305,The risk or severity of adverse effects can be increased when Etanercept is combined with Mitomycin.,Mitomycin,DB00005
DB00322,The risk or severity of adverse effects can be increased when Etanercept is combined with Floxuridine.,Floxuridine,DB00005
DB00352,The risk or severity of adverse effects can be increased when Etanercept is combined with Tioguanine.,Tioguanine,DB00005
DB00380,The risk or severity of adverse effects can be increased when Etanercept is combined with Dexrazoxane.,Dexrazoxane,DB00005
DB00428,The risk or severity of adverse effects can be increased when Etanercept is combined with Streptozocin.,Streptozocin,DB00005
DB00432,The risk or severity of adverse effects can be increased when Etanercept is combined with Trifluridine.,Trifluridine,DB00005
DB00441,The risk or severity of adverse effects can be increased when Etanercept is combined with Gemcitabine.,Gemcitabine,DB00005
DB00445,The risk or severity of adverse effects can be increased when Etanercept is combined with Epirubicin.,Epirubicin,DB00005
DB00446,The risk or severity of adverse effects can be increased when Etanercept is combined with Chloramphenicol.,Chloramphenicol,DB00005
DB00480,The risk or severity of adverse effects can be increased when Etanercept is combined with Lenalidomide.,Lenalidomide,DB00005
DB00488,The risk or severity of adverse effects can be increased when Etanercept is combined with Altretamine.,Altretamine,DB00005
DB00515,The risk or severity of adverse effects can be increased when Etanercept is combined with Cisplatin.,Cisplatin,DB00005
DB00526,The risk or severity of adverse effects can be increased when Etanercept is combined with Oxaliplatin.,Oxaliplatin,DB00005
DB00550,The risk or severity of adverse effects can be increased when Etanercept is combined with Propylthiouracil.,Propylthiouracil,DB00005
DB00552,The risk or severity of adverse effects can be increased when Etanercept is combined with Pentostatin.,Pentostatin,DB00005
DB00601,The risk or severity of adverse effects can be increased when Etanercept is combined with Linezolid.,Linezolid,DB00005
DB00631,The risk or severity of adverse effects can be increased when Etanercept is combined with Clofarabine.,Clofarabine,DB00005
DB00763,The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.,Methimazole,DB00005
DB00853,The risk or severity of adverse effects can be increased when Etanercept is combined with Temozolomide.,Temozolomide,DB00005
DB00859,The risk or severity of adverse effects can be increased when Etanercept is combined with Penicillamine.,Penicillamine,DB00005
DB00888,The risk or severity of adverse effects can be increased when Etanercept is combined with Mechlorethamine.,Mechlorethamine,DB00005
DB00928,The risk or severity of adverse effects can be increased when Etanercept is combined with Azacitidine.,Azacitidine,DB00005
DB00958,The risk or severity of adverse effects can be increased when Etanercept is combined with Carboplatin.,Carboplatin,DB00005
DB00970,The risk or severity of adverse effects can be increased when Etanercept is combined with Dactinomycin.,Dactinomycin,DB00005
DB01005,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydroxyurea.,Hydroxyurea,DB00005
DB01024,The risk or severity of adverse effects can be increased when Etanercept is combined with Mycophenolic acid.,Mycophenolic acid,DB00005
DB01030,The risk or severity of adverse effects can be increased when Etanercept is combined with Topotecan.,Topotecan,DB00005
DB01033,The risk or severity of adverse effects can be increased when Etanercept is combined with Mercaptopurine.,Mercaptopurine,DB00005
DB01042,The risk or severity of adverse effects can be increased when Etanercept is combined with Melphalan.,Melphalan,DB00005
DB01073,The risk or severity of adverse effects can be increased when Etanercept is combined with Fludarabine.,Fludarabine,DB00005
DB01099,The risk or severity of adverse effects can be increased when Etanercept is combined with Flucytosine.,Flucytosine,DB00005
DB01168,The risk or severity of adverse effects can be increased when Etanercept is combined with Procarbazine.,Procarbazine,DB00005
DB01169,The risk or severity of adverse effects can be increased when Etanercept is combined with Arsenic trioxide.,Arsenic trioxide,DB00005
DB01204,The risk or severity of adverse effects can be increased when Etanercept is combined with Mitoxantrone.,Mitoxantrone,DB00005
DB01206,The risk or severity of adverse effects can be increased when Etanercept is combined with Lomustine.,Lomustine,DB00005
DB01257,The risk or severity of adverse effects can be increased when Etanercept is combined with Eculizumab.,Eculizumab,DB00005
DB01262,The risk or severity of adverse effects can be increased when Etanercept is combined with Decitabine.,Decitabine,DB00005
DB01280,The risk or severity of adverse effects can be increased when Etanercept is combined with Nelarabine.,Nelarabine,DB00005
DB01423,The risk or severity of adverse effects can be increased when Etanercept is combined with Stepronin.,Stepronin,DB00005
DB01816,The risk or severity of adverse effects can be increased when Etanercept is combined with Castanospermine.,Castanospermine,DB00005
DB02546,The risk or severity of adverse effects can be increased when Etanercept is combined with Vorinostat.,Vorinostat,DB00005
DB02806,The risk or severity of adverse effects can be increased when Etanercept is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00005
DB03523,The risk or severity of adverse effects can be increased when Etanercept is combined with Brequinar.,Brequinar,DB00005
DB04956,The risk or severity of adverse effects can be increased when Etanercept is combined with Afelimomab.,Afelimomab,DB00005
DB05258,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa.,Interferon alfa,DB00005
DB05259,The risk or severity of adverse effects can be increased when Etanercept is combined with Glatiramer.,Glatiramer,DB00005
DB05260,The risk or severity of adverse effects can be increased when Etanercept is combined with Gallium nitrate.,Gallium nitrate,DB00005
DB05459,The risk or severity of adverse effects can be increased when Etanercept is combined with Briakinumab.,Briakinumab,DB00005
DB05472,The risk or severity of adverse effects can be increased when Etanercept is combined with omega interferon.,omega interferon,DB00005
DB06612,The risk or severity of adverse effects can be increased when Etanercept is combined with Mepolizumab.,Mepolizumab,DB00005
DB06662,The risk or severity of adverse effects can be increased when Etanercept is combined with Abetimus.,Abetimus,DB00005
DB06674,The risk or severity of adverse effects can be increased when Etanercept is combined with Golimumab.,Golimumab,DB00005
DB06681,The risk or severity of adverse effects can be increased when Etanercept is combined with Belatacept.,Belatacept,DB00005
DB06813,The risk or severity of adverse effects can be increased when Etanercept is combined with Pralatrexate.,Pralatrexate,DB00005
DB08059,The risk or severity of adverse effects can be increased when Etanercept is combined with Wortmannin.,Wortmannin,DB00005
DB08871,The risk or severity of adverse effects can be increased when Etanercept is combined with Eribulin.,Eribulin,DB00005
DB08880,The risk or severity of adverse effects can be increased when Etanercept is combined with Teriflunomide.,Teriflunomide,DB00005
DB08889,The risk or severity of adverse effects can be increased when Etanercept is combined with Carfilzomib.,Carfilzomib,DB00005
DB08908,The risk or severity of adverse effects can be increased when Etanercept is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00005
DB08935,The risk or severity of adverse effects can be increased when Etanercept is combined with Obinutuzumab.,Obinutuzumab,DB00005
DB09029,The risk or severity of adverse effects can be increased when Etanercept is combined with Secukinumab.,Secukinumab,DB00005
DB09036,The risk or severity of adverse effects can be increased when Etanercept is combined with Siltuximab.,Siltuximab,DB00005
DB09052,The risk or severity of adverse effects can be increased when Etanercept is combined with Blinatumomab.,Blinatumomab,DB00005
DB09077,The risk or severity of adverse effects can be increased when Etanercept is combined with Dinutuximab.,Dinutuximab,DB00005
DB09091,The risk or severity of adverse effects can be increased when Etanercept is combined with Tixocortol.,Tixocortol,DB00005
DB09122,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00005
DB09312,The risk or severity of adverse effects can be increased when Etanercept is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00005
DB11466,The risk or severity of adverse effects can be increased when Etanercept is combined with Tepoxalin.,Tepoxalin,DB00005
DB11569,The risk or severity of adverse effects can be increased when Etanercept is combined with Ixekizumab.,Ixekizumab,DB00005
DB11580,The risk or severity of adverse effects can be increased when Etanercept is combined with Ravulizumab.,Ravulizumab,DB00005
DB11616,The risk or severity of adverse effects can be increased when Etanercept is combined with Pirarubicin.,Pirarubicin,DB00005
DB11693,The risk or severity of adverse effects can be increased when Etanercept is combined with Voclosporin.,Voclosporin,DB00005
DB11708,The risk or severity of adverse effects can be increased when Etanercept is combined with Peficitinib.,Peficitinib,DB00005
DB11767,The risk or severity of adverse effects can be increased when Etanercept is combined with Sarilumab.,Sarilumab,DB00005
DB11776,The risk or severity of adverse effects can be increased when Etanercept is combined with Brodalumab.,Brodalumab,DB00005
DB11803,The risk or severity of adverse effects can be increased when Etanercept is combined with Sirukumab.,Sirukumab,DB00005
DB11834,The risk or severity of adverse effects can be increased when Etanercept is combined with Guselkumab.,Guselkumab,DB00005
DB11988,The risk or severity of adverse effects can be increased when Etanercept is combined with Ocrelizumab.,Ocrelizumab,DB00005
DB12025,The risk or severity of adverse effects can be increased when Etanercept is combined with Triptolide.,Triptolide,DB00005
DB12612,The risk or severity of adverse effects can be increased when Etanercept is combined with Ozanimod.,Ozanimod,DB00005
DB12617,The risk or severity of adverse effects can be increased when Etanercept is combined with Mizoribine.,Mizoribine,DB00005
DB12692,The risk or severity of adverse effects can be increased when Etanercept is combined with Gusperimus.,Gusperimus,DB00005
DB12814,The risk or severity of adverse effects can be increased when Etanercept is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00005
DB12902,The risk or severity of adverse effects can be increased when Etanercept is combined with Trofosfamide.,Trofosfamide,DB00005
DB12947,The risk or severity of adverse effects can be increased when Etanercept is combined with Doxifluridine.,Doxifluridine,DB00005
DB12991,The risk or severity of adverse effects can be increased when Etanercept is combined with Deoxyspergualin.,Deoxyspergualin,DB00005
DB12996,The risk or severity of adverse effects can be increased when Etanercept is combined with Acteoside.,Acteoside,DB00005
DB13003,The risk or severity of adverse effects can be increased when Etanercept is combined with Cortivazol.,Cortivazol,DB00005
DB13014,The risk or severity of adverse effects can be increased when Etanercept is combined with Hypericin.,Hypericin,DB00005
DB13068,The risk or severity of adverse effects can be increased when Etanercept is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00005
DB13223,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortin.,Fluocortin,DB00005
DB13241,The risk or severity of adverse effects can be increased when Etanercept is combined with Begelomab.,Begelomab,DB00005
DB13491,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluperolone.,Fluperolone,DB00005
DB13664,The risk or severity of adverse effects can be increased when Etanercept is combined with Formocortal.,Formocortal,DB00005
DB13728,The risk or severity of adverse effects can be increased when Etanercept is combined with Halometasone.,Halometasone,DB00005
DB13843,The risk or severity of adverse effects can be increased when Etanercept is combined with Cloprednol.,Cloprednol,DB00005
DB13856,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluclorolone.,Fluclorolone,DB00005
DB14219,The risk or severity of adverse effects can be increased when Etanercept is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00005
DB14724,The risk or severity of adverse effects can be increased when Etanercept is combined with Emapalumab.,Emapalumab,DB00005
DB14762,The risk or severity of adverse effects can be increased when Etanercept is combined with Risankizumab.,Risankizumab,DB00005
DB14919,The risk or severity of adverse effects can be increased when Etanercept is combined with Rozanolixizumab.,Rozanolixizumab,DB00005
DB15253,The risk or severity of adverse effects can be increased when Etanercept is combined with Bleselumab.,Bleselumab,DB00005
DB00180,The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.,Flunisolide,DB00005
DB00394,The risk or severity of adverse effects can be increased when Etanercept is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00005
DB00443,The risk or severity of adverse effects can be increased when Etanercept is combined with Betamethasone.,Betamethasone,DB00005
DB00591,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00005
DB00635,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.,Prednisone,DB00005
DB00687,The risk or severity of adverse effects can be increased when Etanercept is combined with Fludrocortisone.,Fludrocortisone,DB00005
DB00764,The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone.,Mometasone,DB00005
DB00860,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisolone.,Prednisolone,DB00005
DB00959,The risk or severity of adverse effects can be increased when Etanercept is combined with Methylprednisolone.,Methylprednisolone,DB00005
DB01196,The risk or severity of adverse effects can be increased when Etanercept is combined with Estramustine.,Estramustine,DB00005
DB01285,The risk or severity of adverse effects can be increased when Etanercept is combined with Corticotropin.,Corticotropin,DB00005
DB01380,The risk or severity of adverse effects can be increased when Etanercept is combined with Cortisone acetate.,Cortisone acetate,DB00005
DB01384,The risk or severity of adverse effects can be increased when Etanercept is combined with Paramethasone.,Paramethasone,DB00005
DB01611,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00005
DB04630,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldosterone.,Aldosterone,DB00005
DB08970,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednidene.,Fluprednidene,DB00005
DB08971,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortolone.,Fluocortolone,DB00005
DB09082,The risk or severity of adverse effects can be increased when Etanercept is combined with Vilanterol.,Vilanterol,DB00005
DB09378,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednisolone.,Fluprednisolone,DB00005
DB09383,The risk or severity of adverse effects can be increased when Etanercept is combined with Meprednisone.,Meprednisone,DB00005
DB11487,The risk or severity of adverse effects can be increased when Etanercept is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00005
DB11529,The risk or severity of adverse effects can be increased when Etanercept is combined with Melengestrol.,Melengestrol,DB00005
DB11750,The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol.,Clobetasol,DB00005
DB11817,The risk or severity of adverse effects can be increased when Etanercept is combined with Baricitinib.,Baricitinib,DB00005
DB11921,The risk or severity of adverse effects can be increased when Etanercept is combined with Deflazacort.,Deflazacort,DB00005
DB13208,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednylidene.,Prednylidene,DB00005
DB14066,The risk or severity of adverse effects can be increased when Etanercept is combined with Tetrandrine.,Tetrandrine,DB00005
DB14512,The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone furoate.,Mometasone furoate,DB00005
DB14545,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00005
DB01222,The risk or severity of adverse effects can be increased when Etanercept is combined with Budesonide.,Budesonide,DB00005
DB01394,The risk or severity of adverse effects can be increased when Etanercept is combined with Colchicine.,Colchicine,DB00005
DB00108,The risk or severity of adverse effects can be increased when Etanercept is combined with Natalizumab.,Natalizumab,DB00005
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etanercept.,Pimecrolimus,DB00005
DB06372,The risk or severity of adverse effects can be increased when Etanercept is combined with Rilonacept.,Rilonacept,DB00005
DB01656,Etanercept may increase the immunosuppressive activities of Roflumilast.,Roflumilast,DB00005
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Etanercept.,Sipuleucel-T,DB00005
DB06273,Tocilizumab may increase the immunosuppressive activities of Etanercept.,Tocilizumab,DB00005
DB08895,The risk or severity of adverse effects can be increased when Etanercept is combined with Tofacitinib.,Tofacitinib,DB00005
DB09033,The risk or severity of infection can be increased when Etanercept is combined with Vedolizumab.,Vedolizumab,DB00005
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Etanercept.,Sulfamethoxazole,DB00005
DB01097,The risk or severity of adverse effects can be increased when Etanercept is combined with Leflunomide.,Leflunomide,DB00005
DB00072,Trastuzumab may increase the neutropenic activities of Etanercept.,Trastuzumab,DB00005
DB08868,Etanercept may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00005
DB00864,Tacrolimus may increase the immunosuppressive activities of Etanercept.,Tacrolimus,DB00005
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Etanercept.,G17DT,DB00005
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Etanercept.,PEV3A,DB00005
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Etanercept.,INGN 225,DB00005
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Etanercept.,Rindopepimut,DB00005
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Etanercept.,SRP 299,DB00005
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Etanercept.,GI-5005,DB00005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Etanercept.,Vitespen,DB00005
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Etanercept.,TG4010,DB00005
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Etanercept.,Anthrax immune globulin human,DB00005
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Etanercept.","Rabies virus inactivated antigen, B",DB00005
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00005
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Etanercept.,Rotavirus vaccine,DB00005
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Etanercept.","Rabies virus inactivated antigen, A",DB00005
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00005
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00005
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00005
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00005
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00005
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00005
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Etanercept.,Typhoid Vi polysaccharide vaccine,DB00005
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Etanercept.,Hepatitis A Vaccine,DB00005
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00005
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00005
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00005
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00005
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00005
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Etanercept.,Human rabies virus immune globulin,DB00005
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Etanercept.,Hepatitis B Vaccine (Recombinant),DB00005
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Etanercept.,Tecemotide,DB00005
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Etanercept.,Typhoid vaccine,DB00005
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00005
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00005
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00005
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00005
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Etanercept.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00005
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00005
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00005
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Etanercept.,Vaccinia virus strain new york city board of health live antigen,DB00005
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Etanercept.,Pertussis vaccine,DB00005
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00005
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Etanercept.,Varicella Zoster Vaccine (Recombinant),DB00005
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Etanercept.,Modified vaccinia ankara,DB00005
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Etanercept.","Ebola Zaire vaccine (live, attenuated)",DB00005
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Etanercept.,Rubella virus vaccine,DB00005
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Etanercept.,Varicella Zoster Vaccine (Live/attenuated),DB00005
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain tice live antigen,DB00005
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain connaught live antigen,DB00005
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Etanercept.,Yellow Fever Vaccine,DB00005
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Etanercept.,Anthrax vaccine,DB00005
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Etanercept.,Typhoid Vaccine Live,DB00005
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00005
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Etanercept.,BCG vaccine,DB00005
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Etanercept.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00005
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Etanercept.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00005
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Etanercept.,Adenovirus type 7 vaccine live,DB00005
DB00795,The risk or severity of neutropenia can be increased when Etanercept is combined with Sulfasalazine.,Sulfasalazine,DB00005
DB00201,The metabolism of Caffeine can be increased when combined with Etanercept.,Caffeine,DB00005
DB00176,The metabolism of Fluvoxamine can be increased when combined with Etanercept.,Fluvoxamine,DB00005
DB00195,The metabolism of Betaxolol can be increased when combined with Etanercept.,Betaxolol,DB00005
DB00261,The metabolism of Anagrelide can be increased when combined with Etanercept.,Anagrelide,DB00005
DB00262,The metabolism of Carmustine can be increased when combined with Etanercept.,Carmustine,DB00005
DB00268,The metabolism of Ropinirole can be increased when combined with Etanercept.,Ropinirole,DB00005
DB00280,The metabolism of Disopyramide can be increased when combined with Etanercept.,Disopyramide,DB00005
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Etanercept.,Conjugated estrogens,DB00005
DB00296,The metabolism of Ropivacaine can be increased when combined with Etanercept.,Ropivacaine,DB00005
DB00315,The metabolism of Zolmitriptan can be increased when combined with Etanercept.,Zolmitriptan,DB00005
DB00316,The metabolism of Acetaminophen can be increased when combined with Etanercept.,Acetaminophen,DB00005
DB00334,The metabolism of Olanzapine can be increased when combined with Etanercept.,Olanzapine,DB00005
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Etanercept.,Chlorzoxazone,DB00005
DB00365,The metabolism of Grepafloxacin can be increased when combined with Etanercept.,Grepafloxacin,DB00005
DB00370,The metabolism of Mirtazapine can be increased when combined with Etanercept.,Mirtazapine,DB00005
DB00379,The metabolism of Mexiletine can be increased when combined with Etanercept.,Mexiletine,DB00005
DB00382,The metabolism of Tacrine can be increased when combined with Etanercept.,Tacrine,DB00005
DB00384,The metabolism of Triamterene can be increased when combined with Etanercept.,Triamterene,DB00005
DB00442,The metabolism of Entecavir can be increased when combined with Etanercept.,Entecavir,DB00005
DB00477,The metabolism of Chlorpromazine can be increased when combined with Etanercept.,Chlorpromazine,DB00005
DB00518,The metabolism of Albendazole can be increased when combined with Etanercept.,Albendazole,DB00005
DB00544,The metabolism of Fluorouracil can be increased when combined with Etanercept.,Fluorouracil,DB00005
DB00629,The metabolism of Guanabenz can be increased when combined with Etanercept.,Guanabenz,DB00005
DB00642,The metabolism of Pemetrexed can be increased when combined with Etanercept.,Pemetrexed,DB00005
DB00730,The metabolism of Thiabendazole can be increased when combined with Etanercept.,Thiabendazole,DB00005
DB00740,The metabolism of Riluzole can be increased when combined with Etanercept.,Riluzole,DB00005
DB00787,The metabolism of Acyclovir can be increased when combined with Etanercept.,Acyclovir,DB00005
DB00806,The metabolism of Pentoxifylline can be increased when combined with Etanercept.,Pentoxifylline,DB00005
DB00831,The metabolism of Trifluoperazine can be increased when combined with Etanercept.,Trifluoperazine,DB00005
DB00863,The metabolism of Ranitidine can be increased when combined with Etanercept.,Ranitidine,DB00005
DB00898,The metabolism of Ethanol can be increased when combined with Etanercept.,Ethanol,DB00005
DB00934,The metabolism of Maprotiline can be increased when combined with Etanercept.,Maprotiline,DB00005
DB00978,The metabolism of Lomefloxacin can be increased when combined with Etanercept.,Lomefloxacin,DB00005
DB00993,The metabolism of Azathioprine can be increased when combined with Etanercept.,Azathioprine,DB00005
DB00998,The metabolism of Frovatriptan can be increased when combined with Etanercept.,Frovatriptan,DB00005
DB01002,The metabolism of Levobupivacaine can be increased when combined with Etanercept.,Levobupivacaine,DB00005
DB01012,The metabolism of Cinacalcet can be increased when combined with Etanercept.,Cinacalcet,DB00005
DB01056,The metabolism of Tocainide can be increased when combined with Etanercept.,Tocainide,DB00005
DB01087,The metabolism of Primaquine can be increased when combined with Etanercept.,Primaquine,DB00005
DB01094,The metabolism of Hesperetin can be increased when combined with Etanercept.,Hesperetin,DB00005
DB01182,The metabolism of Propafenone can be increased when combined with Etanercept.,Propafenone,DB00005
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Etanercept.,Dexfenfluramine,DB00005
DB01303,The metabolism of Oxtriphylline can be increased when combined with Etanercept.,Oxtriphylline,DB00005
DB01367,The metabolism of Rasagiline can be increased when combined with Etanercept.,Rasagiline,DB00005
DB01405,The metabolism of Temafloxacin can be increased when combined with Etanercept.,Temafloxacin,DB00005
DB01412,The metabolism of Theobromine can be increased when combined with Etanercept.,Theobromine,DB00005
DB01482,The metabolism of Fenethylline can be increased when combined with Etanercept.,Fenethylline,DB00005
DB01558,The metabolism of Bromazepam can be increased when combined with Etanercept.,Bromazepam,DB00005
DB01623,The metabolism of Thiothixene can be increased when combined with Etanercept.,Thiothixene,DB00005
DB01645,The metabolism of Genistein can be increased when combined with Etanercept.,Genistein,DB00005
DB01667,The metabolism of 8-azaguanine can be increased when combined with Etanercept.,8-azaguanine,DB00005
DB02134,The metabolism of Xanthine can be increased when combined with Etanercept.,Xanthine,DB00005
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Etanercept.,9-Methylguanine,DB00005
DB02568,The metabolism of Peldesine can be increased when combined with Etanercept.,Peldesine,DB00005
DB02709,The metabolism of Resveratrol can be increased when combined with Etanercept.,Resveratrol,DB00005
DB04076,The metabolism of Hypoxanthine can be increased when combined with Etanercept.,Hypoxanthine,DB00005
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Etanercept.,9-Deazaguanine,DB00005
DB04871,The metabolism of Lorcaserin can be increased when combined with Etanercept.,Lorcaserin,DB00005
DB04948,The metabolism of Lofexidine can be increased when combined with Etanercept.,Lofexidine,DB00005
DB04951,The metabolism of Pirfenidone can be increased when combined with Etanercept.,Pirfenidone,DB00005
DB06148,The metabolism of Mianserin can be increased when combined with Etanercept.,Mianserin,DB00005
DB06210,The metabolism of Eltrombopag can be increased when combined with Etanercept.,Eltrombopag,DB00005
DB06216,The metabolism of Asenapine can be increased when combined with Etanercept.,Asenapine,DB00005
DB06235,The metabolism of Vadimezan can be increased when combined with Etanercept.,Vadimezan,DB00005
DB06479,The metabolism of Propentofylline can be increased when combined with Etanercept.,Propentofylline,DB00005
DB06594,The metabolism of Agomelatine can be increased when combined with Etanercept.,Agomelatine,DB00005
DB06769,The metabolism of Bendamustine can be increased when combined with Etanercept.,Bendamustine,DB00005
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Etanercept.,Benzyl alcohol,DB00005
DB06774,The metabolism of Capsaicin can be increased when combined with Etanercept.,Capsaicin,DB00005
DB08496,The metabolism of (R)-warfarin can be increased when combined with Etanercept.,(R)-warfarin,DB00005
DB09071,The metabolism of Tasimelteon can be increased when combined with Etanercept.,Tasimelteon,DB00005
DB09118,The metabolism of Stiripentol can be increased when combined with Etanercept.,Stiripentol,DB00005
DB09225,The metabolism of Zotepine can be increased when combined with Etanercept.,Zotepine,DB00005
DB09273,The metabolism of Doxofylline can be increased when combined with Etanercept.,Doxofylline,DB00005
DB09290,The metabolism of Ramosetron can be increased when combined with Etanercept.,Ramosetron,DB00005
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Etanercept.,6-O-benzylguanine,DB00005
DB11967,The metabolism of Binimetinib can be increased when combined with Etanercept.,Binimetinib,DB00005
DB12026,The metabolism of Voxilaprevir can be increased when combined with Etanercept.,Voxilaprevir,DB00005
DB12245,The metabolism of Triclabendazole can be increased when combined with Etanercept.,Triclabendazole,DB00005
DB12332,The metabolism of Rucaparib can be increased when combined with Etanercept.,Rucaparib,DB00005
DB12406,The metabolism of Lisofylline can be increased when combined with Etanercept.,Lisofylline,DB00005
DB12531,The metabolism of Lobucavir can be increased when combined with Etanercept.,Lobucavir,DB00005
DB12926,The metabolism of Cafedrine can be increased when combined with Etanercept.,Cafedrine,DB00005
DB12927,The metabolism of Theodrenaline can be increased when combined with Etanercept.,Theodrenaline,DB00005
DB12945,The metabolism of Dihydralazine can be increased when combined with Etanercept.,Dihydralazine,DB00005
DB13203,The metabolism of Bamifylline can be increased when combined with Etanercept.,Bamifylline,DB00005
DB13449,The metabolism of Proxyphylline can be increased when combined with Etanercept.,Proxyphylline,DB00005
DB13573,The metabolism of Acefylline can be increased when combined with Etanercept.,Acefylline,DB00005
DB13592,The metabolism of Etamiphylline can be increased when combined with Etanercept.,Etamiphylline,DB00005
DB13634,The metabolism of Pentifylline can be increased when combined with Etanercept.,Pentifylline,DB00005
DB13812,The metabolism of Bufylline can be increased when combined with Etanercept.,Bufylline,DB00005
DB14018,The metabolism of Bromotheophylline can be increased when combined with Etanercept.,Bromotheophylline,DB00005
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Etanercept.,8-chlorotheophylline,DB00005
DB11757,The metabolism of Istradefylline can be increased when combined with Etanercept.,Istradefylline,DB00005
DB04889,The metabolism of Bicifadine can be increased when combined with Etanercept.,Bicifadine,DB00005
DB05708,The metabolism of GTS-21 can be increased when combined with Etanercept.,GTS-21,DB00005
DB00977,The metabolism of Ethinylestradiol can be increased when combined with Etanercept.,Ethinylestradiol,DB00005
DB00425,The metabolism of Zolpidem can be increased when combined with Etanercept.,Zolpidem,DB00005
DB00458,The metabolism of Imipramine can be increased when combined with Etanercept.,Imipramine,DB00005
DB00532,The metabolism of Mephenytoin can be increased when combined with Etanercept.,Mephenytoin,DB00005
DB00540,The metabolism of Nortriptyline can be increased when combined with Etanercept.,Nortriptyline,DB00005
DB00575,The metabolism of Clonidine can be increased when combined with Etanercept.,Clonidine,DB00005
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Etanercept.,Cyclobenzaprine,DB00005
DB01242,The metabolism of Clomipramine can be increased when combined with Etanercept.,Clomipramine,DB00005
DB11689,The metabolism of Selumetinib can be increased when combined with Etanercept.,Selumetinib,DB00005
DB00277,The metabolism of Theophylline can be increased when combined with Etanercept.,Theophylline,DB00005
DB00564,The metabolism of Carbamazepine can be increased when combined with Etanercept.,Carbamazepine,DB00005
DB00682,The metabolism of Warfarin can be increased when combined with Etanercept.,Warfarin,DB00005
DB00697,The metabolism of Tizanidine can be increased when combined with Etanercept.,Tizanidine,DB00005
DB01100,The metabolism of Pimozide can be increased when combined with Etanercept.,Pimozide,DB00005
DB01223,The metabolism of Aminophylline can be increased when combined with Etanercept.,Aminophylline,DB00005
DB01418,The metabolism of Acenocoumarol can be increased when combined with Etanercept.,Acenocoumarol,DB00005
DB09256,The metabolism of Tegafur can be increased when combined with Etanercept.,Tegafur,DB00005
DB00851,The metabolism of Dacarbazine can be increased when combined with Etanercept.,Dacarbazine,DB00005
DB08910,The metabolism of Pomalidomide can be increased when combined with Etanercept.,Pomalidomide,DB00005
DB00238,The metabolism of Nevirapine can be increased when combined with Etanercept.,Nevirapine,DB00005
DB00471,The metabolism of Montelukast can be increased when combined with Etanercept.,Montelukast,DB00005
DB00690,The metabolism of Flurazepam can be increased when combined with Etanercept.,Flurazepam,DB00005
DB00916,The metabolism of Metronidazole can be increased when combined with Etanercept.,Metronidazole,DB00005
DB00983,The metabolism of Formoterol can be increased when combined with Etanercept.,Formoterol,DB00005
DB01006,The metabolism of Letrozole can be increased when combined with Etanercept.,Letrozole,DB00005
DB01028,The metabolism of Methoxyflurane can be increased when combined with Etanercept.,Methoxyflurane,DB00005
DB01159,The metabolism of Halothane can be increased when combined with Etanercept.,Halothane,DB00005
DB01236,The metabolism of Sevoflurane can be increased when combined with Etanercept.,Sevoflurane,DB00005
DB01274,The metabolism of Arformoterol can be increased when combined with Etanercept.,Arformoterol,DB00005
DB01544,The metabolism of Flunitrazepam can be increased when combined with Etanercept.,Flunitrazepam,DB00005
DB06292,The metabolism of Dapagliflozin can be increased when combined with Etanercept.,Dapagliflozin,DB00005
DB06470,The metabolism of Clomethiazole can be increased when combined with Etanercept.,Clomethiazole,DB00005
DB09068,The metabolism of Vortioxetine can be increased when combined with Etanercept.,Vortioxetine,DB00005
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Etanercept.,Tegafur-uracil,DB00005
DB11586,The metabolism of Asunaprevir can be increased when combined with Etanercept.,Asunaprevir,DB00005
DB04977,The metabolism of Plitidepsin can be increased when combined with Etanercept.,Plitidepsin,DB00005
DB06119,The metabolism of Cenobamate can be increased when combined with Etanercept.,Cenobamate,DB00005
DB00193,The metabolism of Tramadol can be increased when combined with Etanercept.,Tramadol,DB00005
DB00333,The metabolism of Methadone can be increased when combined with Etanercept.,Methadone,DB00005
DB00349,The metabolism of Clobazam can be increased when combined with Etanercept.,Clobazam,DB00005
DB00625,The metabolism of Efavirenz can be increased when combined with Etanercept.,Efavirenz,DB00005
DB00753,The metabolism of Isoflurane can be increased when combined with Etanercept.,Isoflurane,DB00005
DB00818,The metabolism of Propofol can be increased when combined with Etanercept.,Propofol,DB00005
DB00835,The metabolism of Brompheniramine can be increased when combined with Etanercept.,Brompheniramine,DB00005
DB00836,The metabolism of Loperamide can be increased when combined with Etanercept.,Loperamide,DB00005
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Etanercept.,Methylphenobarbital,DB00005
DB00865,The metabolism of Benzphetamine can be increased when combined with Etanercept.,Benzphetamine,DB00005
DB01069,The metabolism of Promethazine can be increased when combined with Etanercept.,Promethazine,DB00005
DB01074,The metabolism of Perhexiline can be increased when combined with Etanercept.,Perhexiline,DB00005
DB01221,The metabolism of Ketamine can be increased when combined with Etanercept.,Ketamine,DB00005
DB01466,The metabolism of Ethylmorphine can be increased when combined with Etanercept.,Ethylmorphine,DB00005
DB01559,The metabolism of Clotiazepam can be increased when combined with Etanercept.,Clotiazepam,DB00005
DB04938,The metabolism of Ospemifene can be increased when combined with Etanercept.,Ospemifene,DB00005
DB04975,The metabolism of Banoxantrone can be increased when combined with Etanercept.,Banoxantrone,DB00005
DB05541,The metabolism of Brivaracetam can be increased when combined with Etanercept.,Brivaracetam,DB00005
DB06176,The metabolism of Romidepsin can be increased when combined with Etanercept.,Romidepsin,DB00005
DB06209,The metabolism of Prasugrel can be increased when combined with Etanercept.,Prasugrel,DB00005
DB06697,The metabolism of Artemether can be increased when combined with Etanercept.,Artemether,DB00005
DB06710,The metabolism of Methyltestosterone can be increased when combined with Etanercept.,Methyltestosterone,DB00005
DB06738,The metabolism of Ketobemidone can be increased when combined with Etanercept.,Ketobemidone,DB00005
DB06739,The metabolism of Seratrodast can be increased when combined with Etanercept.,Seratrodast,DB00005
DB11613,The metabolism of Velpatasvir can be increased when combined with Etanercept.,Velpatasvir,DB00005
DB13132,The metabolism of Artemisinin can be increased when combined with Etanercept.,Artemisinin,DB00005
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Etanercept.,Testosterone cypionate,DB00005
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Etanercept.,Testosterone enanthate,DB00005
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Etanercept.,Testosterone undecanoate,DB00005
DB01156,The metabolism of Bupropion can be increased when combined with Etanercept.,Bupropion,DB00005
DB00956,The metabolism of Hydrocodone can be increased when combined with Etanercept.,Hydrocodone,DB00005
DB14975,The metabolism of Voxelotor can be increased when combined with Etanercept.,Voxelotor,DB00005
DB11837,The metabolism of Osilodrostat can be increased when combined with Etanercept.,Osilodrostat,DB00005
DB13384,The metabolism of Melitracen can be increased when combined with Etanercept.,Melitracen,DB00005
DB13411,The metabolism of Lofepramine can be increased when combined with Etanercept.,Lofepramine,DB00005
DB00714,The metabolism of Apomorphine can be increased when combined with Etanercept.,Apomorphine,DB00005
DB09167,The metabolism of Dosulepin can be increased when combined with Etanercept.,Dosulepin,DB00005
DB00213,The metabolism of Pantoprazole can be increased when combined with Etanercept.,Pantoprazole,DB00005
DB00215,The metabolism of Citalopram can be increased when combined with Etanercept.,Citalopram,DB00005
DB00312,The metabolism of Pentobarbital can be increased when combined with Etanercept.,Pentobarbital,DB00005
DB00338,The metabolism of Omeprazole can be increased when combined with Etanercept.,Omeprazole,DB00005
DB00347,The metabolism of Trimethadione can be increased when combined with Etanercept.,Trimethadione,DB00005
DB00395,The metabolism of Carisoprodol can be increased when combined with Etanercept.,Carisoprodol,DB00005
DB00448,The metabolism of Lansoprazole can be increased when combined with Etanercept.,Lansoprazole,DB00005
DB00474,The metabolism of Methohexital can be increased when combined with Etanercept.,Methohexital,DB00005
DB00582,The metabolism of Voriconazole can be increased when combined with Etanercept.,Voriconazole,DB00005
DB00679,The metabolism of Thioridazine can be increased when combined with Etanercept.,Thioridazine,DB00005
DB00736,The metabolism of Esomeprazole can be increased when combined with Etanercept.,Esomeprazole,DB00005
DB00794,The metabolism of Primidone can be increased when combined with Etanercept.,Primidone,DB00005
DB00909,The metabolism of Zonisamide can be increased when combined with Etanercept.,Zonisamide,DB00005
DB01129,The metabolism of Rabeprazole can be increased when combined with Etanercept.,Rabeprazole,DB00005
DB01131,The metabolism of Proguanil can be increased when combined with Etanercept.,Proguanil,DB00005
DB01175,The metabolism of Escitalopram can be increased when combined with Etanercept.,Escitalopram,DB00005
DB01259,The metabolism of Lapatinib can be increased when combined with Etanercept.,Lapatinib,DB00005
DB01323,The metabolism of St. John's Wort can be increased when combined with Etanercept.,St. John's Wort,DB00005
DB01355,The metabolism of Hexobarbital can be increased when combined with Etanercept.,Hexobarbital,DB00005
DB01483,The metabolism of Barbital can be increased when combined with Etanercept.,Barbital,DB00005
DB05246,The metabolism of Methsuximide can be increased when combined with Etanercept.,Methsuximide,DB00005
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Etanercept.,Dexlansoprazole,DB00005
DB06218,The metabolism of Lacosamide can be increased when combined with Etanercept.,Lacosamide,DB00005
DB06414,The metabolism of Etravirine can be increased when combined with Etanercept.,Etravirine,DB00005
DB06605,The metabolism of Apixaban can be increased when combined with Etanercept.,Apixaban,DB00005
DB09166,The metabolism of Etizolam can be increased when combined with Etanercept.,Etizolam,DB00005
DB12130,The metabolism of Lorlatinib can be increased when combined with Etanercept.,Lorlatinib,DB00005
DB12474,The metabolism of Lynestrenol can be increased when combined with Etanercept.,Lynestrenol,DB00005
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Etanercept.,Dexrabeprazole,DB00005
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Etanercept.,(S)-Warfarin,DB00005
DB00715,The metabolism of Paroxetine can be increased when combined with Etanercept.,Paroxetine,DB00005
DB12500,The metabolism of Fedratinib can be increased when combined with Etanercept.,Fedratinib,DB00005
DB04861,The metabolism of Nebivolol can be increased when combined with Etanercept.,Nebivolol,DB00005
DB06684,The metabolism of Vilazodone can be increased when combined with Etanercept.,Vilazodone,DB00005
DB01104,The metabolism of Sertraline can be increased when combined with Etanercept.,Sertraline,DB00005
DB11823,The metabolism of Esketamine can be increased when combined with Etanercept.,Esketamine,DB00005
DB00252,The metabolism of Phenytoin can be increased when combined with Etanercept.,Phenytoin,DB00005
DB00599,The metabolism of Thiopental can be increased when combined with Etanercept.,Thiopental,DB00005
DB01174,The metabolism of Phenobarbital can be increased when combined with Etanercept.,Phenobarbital,DB00005
DB01320,The metabolism of Fosphenytoin can be increased when combined with Etanercept.,Fosphenytoin,DB00005
DB00613,The metabolism of Amodiaquine can be increased when combined with Etanercept.,Amodiaquine,DB00005
DB00799,The metabolism of Tazarotene can be increased when combined with Etanercept.,Tazarotene,DB00005
DB05229,The metabolism of Beraprost can be increased when combined with Etanercept.,Beraprost,DB00005
DB06510,The metabolism of Muraglitazar can be increased when combined with Etanercept.,Muraglitazar,DB00005
DB09296,The metabolism of Ombitasvir can be increased when combined with Etanercept.,Ombitasvir,DB00005
DB01217,The metabolism of Anastrozole can be increased when combined with Etanercept.,Anastrozole,DB00005
DB00255,The metabolism of Diethylstilbestrol can be increased when combined with Etanercept.,Diethylstilbestrol,DB00005
DB00295,The metabolism of Morphine can be increased when combined with Etanercept.,Morphine,DB00005
DB00359,The metabolism of Sulfadiazine can be increased when combined with Etanercept.,Sulfadiazine,DB00005
DB00402,The metabolism of Eszopiclone can be increased when combined with Etanercept.,Eszopiclone,DB00005
DB00622,The metabolism of Nicardipine can be increased when combined with Etanercept.,Nicardipine,DB00005
DB00912,The metabolism of Repaglinide can be increased when combined with Etanercept.,Repaglinide,DB00005
DB01261,The metabolism of Sitagliptin can be increased when combined with Etanercept.,Sitagliptin,DB00005
DB06670,The metabolism of Odanacatib can be increased when combined with Etanercept.,Odanacatib,DB00005
DB08502,The metabolism of Capravirine can be increased when combined with Etanercept.,Capravirine,DB00005
DB08931,The metabolism of Riociguat can be increased when combined with Etanercept.,Riociguat,DB00005
DB09198,The metabolism of Lobeglitazone can be increased when combined with Etanercept.,Lobeglitazone,DB00005
DB09199,The metabolism of Netoglitazone can be increased when combined with Etanercept.,Netoglitazone,DB00005
DB09200,The metabolism of Rivoglitazone can be increased when combined with Etanercept.,Rivoglitazone,DB00005
DB09201,The metabolism of Ciglitazone can be increased when combined with Etanercept.,Ciglitazone,DB00005
DB11362,The metabolism of Selexipag can be increased when combined with Etanercept.,Selexipag,DB00005
DB11901,The metabolism of Apalutamide can be increased when combined with Etanercept.,Apalutamide,DB00005
DB11978,The metabolism of Glasdegib can be increased when combined with Etanercept.,Glasdegib,DB00005
DB12781,The metabolism of Balaglitazone can be increased when combined with Etanercept.,Balaglitazone,DB00005
DB01132,The metabolism of Pioglitazone can be increased when combined with Etanercept.,Pioglitazone,DB00005
DB11652,The metabolism of Tucatinib can be increased when combined with Etanercept.,Tucatinib,DB00005
DB00946,The metabolism of Phenprocoumon can be increased when combined with Etanercept.,Phenprocoumon,DB00005
DB01229,The metabolism of Paclitaxel can be increased when combined with Etanercept.,Paclitaxel,DB00005
DB00177,The metabolism of Valsartan can be increased when combined with Etanercept.,Valsartan,DB00005
DB00184,The metabolism of Nicotine can be increased when combined with Etanercept.,Nicotine,DB00005
DB00197,The metabolism of Troglitazone can be increased when combined with Etanercept.,Troglitazone,DB00005
DB00214,The metabolism of Torasemide can be increased when combined with Etanercept.,Torasemide,DB00005
DB00222,The metabolism of Glimepiride can be increased when combined with Etanercept.,Glimepiride,DB00005
DB00285,The metabolism of Venlafaxine can be increased when combined with Etanercept.,Venlafaxine,DB00005
DB00304,The metabolism of Desogestrel can be increased when combined with Etanercept.,Desogestrel,DB00005
DB00307,The metabolism of Bexarotene can be increased when combined with Etanercept.,Bexarotene,DB00005
DB00327,The metabolism of Hydromorphone can be increased when combined with Etanercept.,Hydromorphone,DB00005
DB00328,The metabolism of Indomethacin can be increased when combined with Etanercept.,Indomethacin,DB00005
DB00343,The metabolism of Diltiazem can be increased when combined with Etanercept.,Diltiazem,DB00005
DB00374,The metabolism of Treprostinil can be increased when combined with Etanercept.,Treprostinil,DB00005
DB00412,The metabolism of Rosiglitazone can be increased when combined with Etanercept.,Rosiglitazone,DB00005
DB00414,The metabolism of Acetohexamide can be increased when combined with Etanercept.,Acetohexamide,DB00005
DB00420,The metabolism of Promazine can be increased when combined with Etanercept.,Promazine,DB00005
DB00440,The metabolism of Trimethoprim can be increased when combined with Etanercept.,Trimethoprim,DB00005
DB00461,The metabolism of Nabumetone can be increased when combined with Etanercept.,Nabumetone,DB00005
DB00468,The metabolism of Quinine can be increased when combined with Etanercept.,Quinine,DB00005
DB00469,The metabolism of Tenoxicam can be increased when combined with Etanercept.,Tenoxicam,DB00005
DB00472,The metabolism of Fluoxetine can be increased when combined with Etanercept.,Fluoxetine,DB00005
DB00476,The metabolism of Duloxetine can be increased when combined with Etanercept.,Duloxetine,DB00005
DB00482,The metabolism of Celecoxib can be increased when combined with Etanercept.,Celecoxib,DB00005
DB00495,The metabolism of Zidovudine can be increased when combined with Etanercept.,Zidovudine,DB00005
DB00502,The metabolism of Haloperidol can be increased when combined with Etanercept.,Haloperidol,DB00005
DB00533,The metabolism of Rofecoxib can be increased when combined with Etanercept.,Rofecoxib,DB00005
DB00549,The metabolism of Zafirlukast can be increased when combined with Etanercept.,Zafirlukast,DB00005
DB00554,The metabolism of Piroxicam can be increased when combined with Etanercept.,Piroxicam,DB00005
DB00559,The metabolism of Bosentan can be increased when combined with Etanercept.,Bosentan,DB00005
DB00568,The metabolism of Cinnarizine can be increased when combined with Etanercept.,Cinnarizine,DB00005
DB00580,The metabolism of Valdecoxib can be increased when combined with Etanercept.,Valdecoxib,DB00005
DB00586,The metabolism of Diclofenac can be increased when combined with Etanercept.,Diclofenac,DB00005
DB00617,The metabolism of Paramethadione can be increased when combined with Etanercept.,Paramethadione,DB00005
DB00661,The metabolism of Verapamil can be increased when combined with Etanercept.,Verapamil,DB00005
DB00672,The metabolism of Chlorpropamide can be increased when combined with Etanercept.,Chlorpropamide,DB00005
DB00678,The metabolism of Losartan can be increased when combined with Etanercept.,Losartan,DB00005
DB00701,The metabolism of Amprenavir can be increased when combined with Etanercept.,Amprenavir,DB00005
DB00712,The metabolism of Flurbiprofen can be increased when combined with Etanercept.,Flurbiprofen,DB00005
DB00731,The metabolism of Nateglinide can be increased when combined with Etanercept.,Nateglinide,DB00005
DB00744,The metabolism of Zileuton can be increased when combined with Etanercept.,Zileuton,DB00005
DB00749,The metabolism of Etodolac can be increased when combined with Etanercept.,Etodolac,DB00005
DB00755,The metabolism of Tretinoin can be increased when combined with Etanercept.,Tretinoin,DB00005
DB00758,The metabolism of Clopidogrel can be increased when combined with Etanercept.,Clopidogrel,DB00005
DB00783,The metabolism of Estradiol can be increased when combined with Etanercept.,Estradiol,DB00005
DB00784,The metabolism of Mefenamic acid can be increased when combined with Etanercept.,Mefenamic acid,DB00005
DB00788,The metabolism of Naproxen can be increased when combined with Etanercept.,Naproxen,DB00005
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Etanercept.,Candesartan cilexetil,DB00005
DB00812,The metabolism of Phenylbutazone can be increased when combined with Etanercept.,Phenylbutazone,DB00005
DB00814,The metabolism of Meloxicam can be increased when combined with Etanercept.,Meloxicam,DB00005
DB00839,The metabolism of Tolazamide can be increased when combined with Etanercept.,Tolazamide,DB00005
DB00843,The metabolism of Donepezil can be increased when combined with Etanercept.,Donepezil,DB00005
DB00857,The metabolism of Terbinafine can be increased when combined with Etanercept.,Terbinafine,DB00005
DB00904,The metabolism of Ondansetron can be increased when combined with Etanercept.,Ondansetron,DB00005
DB00921,The metabolism of Buprenorphine can be increased when combined with Etanercept.,Buprenorphine,DB00005
DB00936,The metabolism of Salicylic acid can be increased when combined with Etanercept.,Salicylic acid,DB00005
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Etanercept.,Acetylsalicylic acid,DB00005
DB00969,The metabolism of Alosetron can be increased when combined with Etanercept.,Alosetron,DB00005
DB00972,The metabolism of Azelastine can be increased when combined with Etanercept.,Azelastine,DB00005
DB00980,The metabolism of Ramelteon can be increased when combined with Etanercept.,Ramelteon,DB00005
DB01016,The metabolism of Glyburide can be increased when combined with Etanercept.,Glyburide,DB00005
DB01029,The metabolism of Irbesartan can be increased when combined with Etanercept.,Irbesartan,DB00005
DB01036,The metabolism of Tolterodine can be increased when combined with Etanercept.,Tolterodine,DB00005
DB01037,The metabolism of Selegiline can be increased when combined with Etanercept.,Selegiline,DB00005
DB01041,The metabolism of Thalidomide can be increased when combined with Etanercept.,Thalidomide,DB00005
DB01050,The metabolism of Ibuprofen can be increased when combined with Etanercept.,Ibuprofen,DB00005
DB01065,The metabolism of Melatonin can be increased when combined with Etanercept.,Melatonin,DB00005
DB01067,The metabolism of Glipizide can be increased when combined with Etanercept.,Glipizide,DB00005
DB01072,The metabolism of Atazanavir can be increased when combined with Etanercept.,Atazanavir,DB00005
DB01075,The metabolism of Diphenhydramine can be increased when combined with Etanercept.,Diphenhydramine,DB00005
DB01095,The metabolism of Fluvastatin can be increased when combined with Etanercept.,Fluvastatin,DB00005
DB01098,The metabolism of Rosuvastatin can be increased when combined with Etanercept.,Rosuvastatin,DB00005
DB01120,The metabolism of Gliclazide can be increased when combined with Etanercept.,Gliclazide,DB00005
DB01124,The metabolism of Tolbutamide can be increased when combined with Etanercept.,Tolbutamide,DB00005
DB01136,The metabolism of Carvedilol can be increased when combined with Etanercept.,Carvedilol,DB00005
DB01154,The metabolism of Thiamylal can be increased when combined with Etanercept.,Thiamylal,DB00005
DB01171,The metabolism of Moclobemide can be increased when combined with Etanercept.,Moclobemide,DB00005
DB01177,The metabolism of Idarubicin can be increased when combined with Etanercept.,Idarubicin,DB00005
DB01198,The metabolism of Zopiclone can be increased when combined with Etanercept.,Zopiclone,DB00005
DB01251,The metabolism of Gliquidone can be increased when combined with Etanercept.,Gliquidone,DB00005
DB01283,The metabolism of Lumiracoxib can be increased when combined with Etanercept.,Lumiracoxib,DB00005
DB01289,The metabolism of Glisoxepide can be increased when combined with Etanercept.,Glisoxepide,DB00005
DB01357,The metabolism of Mestranol can be increased when combined with Etanercept.,Mestranol,DB00005
DB01424,The metabolism of Aminophenazone can be increased when combined with Etanercept.,Aminophenazone,DB00005
DB01435,The metabolism of Antipyrine can be increased when combined with Etanercept.,Antipyrine,DB00005
DB01589,The metabolism of Quazepam can be increased when combined with Etanercept.,Quazepam,DB00005
DB01628,The metabolism of Etoricoxib can be increased when combined with Etanercept.,Etoricoxib,DB00005
DB03756,The metabolism of Doconexent can be increased when combined with Etanercept.,Doconexent,DB00005
DB03783,The metabolism of Phenacetin can be increased when combined with Etanercept.,Phenacetin,DB00005
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Etanercept.,Arachidonic Acid,DB00005
DB04574,The metabolism of Estrone sulfate can be increased when combined with Etanercept.,Estrone sulfate,DB00005
DB04665,The metabolism of Coumarin can be increased when combined with Etanercept.,Coumarin,DB00005
DB04725,The metabolism of Licofelone can be increased when combined with Etanercept.,Licofelone,DB00005
DB04841,The metabolism of Flunarizine can be increased when combined with Etanercept.,Flunarizine,DB00005
DB04898,The metabolism of Ximelagatran can be increased when combined with Etanercept.,Ximelagatran,DB00005
DB06204,The metabolism of Tapentadol can be increased when combined with Etanercept.,Tapentadol,DB00005
DB06268,The metabolism of Sitaxentan can be increased when combined with Etanercept.,Sitaxentan,DB00005
DB06370,The metabolism of Indisulam can be increased when combined with Etanercept.,Indisulam,DB00005
DB06652,The metabolism of Vicriviroc can be increased when combined with Etanercept.,Vicriviroc,DB00005
DB06725,The metabolism of Lornoxicam can be increased when combined with Etanercept.,Lornoxicam,DB00005
DB06737,The metabolism of Zaltoprofen can be increased when combined with Etanercept.,Zaltoprofen,DB00005
DB06803,The metabolism of Niclosamide can be increased when combined with Etanercept.,Niclosamide,DB00005
DB07615,The metabolism of Tranilast can be increased when combined with Etanercept.,Tranilast,DB00005
DB08439,The metabolism of Parecoxib can be increased when combined with Etanercept.,Parecoxib,DB00005
DB08828,The metabolism of Vismodegib can be increased when combined with Etanercept.,Vismodegib,DB00005
DB08860,The metabolism of Pitavastatin can be increased when combined with Etanercept.,Pitavastatin,DB00005
DB08875,The metabolism of Cabozantinib can be increased when combined with Etanercept.,Cabozantinib,DB00005
DB08899,The metabolism of Enzalutamide can be increased when combined with Etanercept.,Enzalutamide,DB00005
DB08962,The metabolism of Glibornuride can be increased when combined with Etanercept.,Glibornuride,DB00005
DB09048,The metabolism of Netupitant can be increased when combined with Etanercept.,Netupitant,DB00005
DB09061,The metabolism of Cannabidiol can be increased when combined with Etanercept.,Cannabidiol,DB00005
DB09080,The metabolism of Olodaterol can be increased when combined with Etanercept.,Olodaterol,DB00005
DB09288,The metabolism of Propacetamol can be increased when combined with Etanercept.,Propacetamol,DB00005
DB11560,The metabolism of Lesinurad can be increased when combined with Etanercept.,Lesinurad,DB00005
DB11614,The metabolism of Rupatadine can be increased when combined with Etanercept.,Rupatadine,DB00005
DB13406,The metabolism of Carbutamide can be increased when combined with Etanercept.,Carbutamide,DB00005
DB13675,The metabolism of Metahexamide can be increased when combined with Etanercept.,Metahexamide,DB00005
DB13919,The metabolism of Candesartan can be increased when combined with Etanercept.,Candesartan,DB00005
DB13941,The metabolism of Piperaquine can be increased when combined with Etanercept.,Piperaquine,DB00005
DB13952,The metabolism of Estradiol acetate can be increased when combined with Etanercept.,Estradiol acetate,DB00005
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Etanercept.,Estradiol benzoate,DB00005
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Etanercept.,Estradiol cypionate,DB00005
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Etanercept.,Estradiol dienanthate,DB00005
DB13956,The metabolism of Estradiol valerate can be increased when combined with Etanercept.,Estradiol valerate,DB00005
DB14009,The metabolism of Medical Cannabis can be increased when combined with Etanercept.,Medical Cannabis,DB00005
DB14011,The metabolism of Nabiximols can be increased when combined with Etanercept.,Nabiximols,DB00005
DB00829,The metabolism of Diazepam can be increased when combined with Etanercept.,Diazepam,DB00005
DB00514,The metabolism of Dextromethorphan can be increased when combined with Etanercept.,Dextromethorphan,DB00005
DB00470,The metabolism of Dronabinol can be increased when combined with Etanercept.,Dronabinol,DB00005
DB09213,The metabolism of Dexibuprofen can be increased when combined with Etanercept.,Dexibuprofen,DB00005
DB00465,The metabolism of Ketorolac can be increased when combined with Etanercept.,Ketorolac,DB00005
DB15233,The metabolism of Avapritinib can be increased when combined with Etanercept.,Avapritinib,DB00005
DB00321,The metabolism of Amitriptyline can be increased when combined with Etanercept.,Amitriptyline,DB00005
DB01142,The metabolism of Doxepin can be increased when combined with Etanercept.,Doxepin,DB00005
DB00216,The metabolism of Eletriptan can be increased when combined with Etanercept.,Eletriptan,DB00005
DB00404,The metabolism of Alprazolam can be increased when combined with Etanercept.,Alprazolam,DB00005
DB00726,The metabolism of Trimipramine can be increased when combined with Etanercept.,Trimipramine,DB00005
DB01101,The metabolism of Capecitabine can be increased when combined with Etanercept.,Capecitabine,DB00005
DB00266,The metabolism of Dicoumarol can be increased when combined with Etanercept.,Dicoumarol,DB00005
DB00313,The metabolism of Valproic acid can be increased when combined with Etanercept.,Valproic acid,DB00005
DB00908,The metabolism of Quinidine can be increased when combined with Etanercept.,Quinidine,DB00005
DB13136,The metabolism of Fluindione can be increased when combined with Etanercept.,Fluindione,DB00005
DB01224,The metabolism of Quetiapine can be increased when combined with Etanercept.,Quetiapine,DB00005
DB00182,The metabolism of Amphetamine can be increased when combined with Etanercept.,Amphetamine,DB00005
DB00187,The metabolism of Esmolol can be increased when combined with Etanercept.,Esmolol,DB00005
DB00245,The metabolism of Benzatropine can be increased when combined with Etanercept.,Benzatropine,DB00005
DB00289,The metabolism of Atomoxetine can be increased when combined with Etanercept.,Atomoxetine,DB00005
DB00335,The metabolism of Atenolol can be increased when combined with Etanercept.,Atenolol,DB00005
DB00373,The metabolism of Timolol can be increased when combined with Etanercept.,Timolol,DB00005
DB00409,The metabolism of Remoxipride can be increased when combined with Etanercept.,Remoxipride,DB00005
DB00592,The metabolism of Piperazine can be increased when combined with Etanercept.,Piperazine,DB00005
DB00699,The metabolism of Nicergoline can be increased when combined with Etanercept.,Nicergoline,DB00005
DB00737,The metabolism of Meclizine can be increased when combined with Etanercept.,Meclizine,DB00005
DB00805,The metabolism of Minaprine can be increased when combined with Etanercept.,Minaprine,DB00005
DB00866,The metabolism of Alprenolol can be increased when combined with Etanercept.,Alprenolol,DB00005
DB00914,The metabolism of Phenformin can be increased when combined with Etanercept.,Phenformin,DB00005
DB00933,The metabolism of Mesoridazine can be increased when combined with Etanercept.,Mesoridazine,DB00005
DB00960,The metabolism of Pindolol can be increased when combined with Etanercept.,Pindolol,DB00005
DB01071,The metabolism of Mequitazine can be increased when combined with Etanercept.,Mequitazine,DB00005
DB01079,The metabolism of Tegaserod can be increased when combined with Etanercept.,Tegaserod,DB00005
DB01193,The metabolism of Acebutolol can be increased when combined with Etanercept.,Acebutolol,DB00005
DB01203,The metabolism of Nadolol can be increased when combined with Etanercept.,Nadolol,DB00005
DB01228,The metabolism of Encainide can be increased when combined with Etanercept.,Encainide,DB00005
DB01233,The metabolism of Metoclopramide can be increased when combined with Etanercept.,Metoclopramide,DB00005
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Etanercept.,Lisdexamfetamine,DB00005
DB01295,The metabolism of Bevantolol can be increased when combined with Etanercept.,Bevantolol,DB00005
DB01297,The metabolism of Practolol can be increased when combined with Etanercept.,Practolol,DB00005
DB01359,The metabolism of Penbutolol can be increased when combined with Etanercept.,Penbutolol,DB00005
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Etanercept.,Methotrimeprazine,DB00005
DB01429,The metabolism of Aprindine can be increased when combined with Etanercept.,Aprindine,DB00005
DB01454,The metabolism of Midomafetamine can be increased when combined with Etanercept.,Midomafetamine,DB00005
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Etanercept.,4-Methoxyamphetamine,DB00005
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Etanercept.,Dextroamphetamine,DB00005
DB01577,The metabolism of Metamfetamine can be increased when combined with Etanercept.,Metamfetamine,DB00005
DB01580,The metabolism of Oxprenolol can be increased when combined with Etanercept.,Oxprenolol,DB00005
DB04840,The metabolism of Debrisoquine can be increased when combined with Etanercept.,Debrisoquine,DB00005
DB04844,The metabolism of Tetrabenazine can be increased when combined with Etanercept.,Tetrabenazine,DB00005
DB04846,The metabolism of Celiprolol can be increased when combined with Etanercept.,Celiprolol,DB00005
DB06217,The metabolism of Vernakalant can be increased when combined with Etanercept.,Vernakalant,DB00005
DB06506,The metabolism of Repinotan can be increased when combined with Etanercept.,Repinotan,DB00005
DB06608,The metabolism of Tafenoquine can be increased when combined with Etanercept.,Tafenoquine,DB00005
DB06678,The metabolism of Esmirtazapine can be increased when combined with Etanercept.,Esmirtazapine,DB00005
DB06726,The metabolism of Bufuralol can be increased when combined with Etanercept.,Bufuralol,DB00005
DB06727,The metabolism of Sparteine can be increased when combined with Etanercept.,Sparteine,DB00005
DB06735,The metabolism of Enclomiphene can be increased when combined with Etanercept.,Enclomiphene,DB00005
DB08807,The metabolism of Bopindolol can be increased when combined with Etanercept.,Bopindolol,DB00005
DB08808,The metabolism of Bupranolol can be increased when combined with Etanercept.,Bupranolol,DB00005
DB08952,The metabolism of Indenolol can be increased when combined with Etanercept.,Indenolol,DB00005
DB09013,The metabolism of Befunolol can be increased when combined with Etanercept.,Befunolol,DB00005
DB09076,The metabolism of Umeclidinium can be increased when combined with Etanercept.,Umeclidinium,DB00005
DB09204,The metabolism of Arotinolol can be increased when combined with Etanercept.,Arotinolol,DB00005
DB09351,The metabolism of Levobetaxolol can be increased when combined with Etanercept.,Levobetaxolol,DB00005
DB11770,The metabolism of Talinolol can be increased when combined with Etanercept.,Talinolol,DB00005
DB11785,The metabolism of Anisodamine can be increased when combined with Etanercept.,Anisodamine,DB00005
DB11855,The metabolism of Revefenacin can be increased when combined with Etanercept.,Revefenacin,DB00005
DB11979,The metabolism of Elagolix can be increased when combined with Etanercept.,Elagolix,DB00005
DB12070,The metabolism of Letermovir can be increased when combined with Etanercept.,Letermovir,DB00005
DB12212,The metabolism of Landiolol can be increased when combined with Etanercept.,Landiolol,DB00005
DB12752,The metabolism of Bucindolol can be increased when combined with Etanercept.,Bucindolol,DB00005
DB13443,The metabolism of Esatenolol can be increased when combined with Etanercept.,Esatenolol,DB00005
DB13508,The metabolism of Cloranolol can be increased when combined with Etanercept.,Cloranolol,DB00005
DB13530,The metabolism of Mepindolol can be increased when combined with Etanercept.,Mepindolol,DB00005
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Etanercept.,Dexchlorpheniramine,DB00005
DB13757,The metabolism of Epanolol can be increased when combined with Etanercept.,Epanolol,DB00005
DB13775,The metabolism of Tertatolol can be increased when combined with Etanercept.,Tertatolol,DB00005
DB00850,The metabolism of Perphenazine can be increased when combined with Etanercept.,Perphenazine,DB00005
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Etanercept.,Butyrfentanyl,DB00005
DB00281,The metabolism of Lidocaine can be increased when combined with Etanercept.,Lidocaine,DB00005
DB00598,The metabolism of Labetalol can be increased when combined with Etanercept.,Labetalol,DB00005
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Etanercept.","5-methoxy-N,N-dimethyltryptamine",DB00005
DB01410,The metabolism of Ciclesonide can be increased when combined with Etanercept.,Ciclesonide,DB00005
DB00918,The metabolism of Almotriptan can be increased when combined with Etanercept.,Almotriptan,DB00005
DB08918,The metabolism of Levomilnacipran can be increased when combined with Etanercept.,Levomilnacipran,DB00005
DB08922,The metabolism of Perospirone can be increased when combined with Etanercept.,Perospirone,DB00005
DB09183,The metabolism of Dasabuvir can be increased when combined with Etanercept.,Dasabuvir,DB00005
DB00185,The metabolism of Cevimeline can be increased when combined with Etanercept.,Cevimeline,DB00005
DB00243,The metabolism of Ranolazine can be increased when combined with Etanercept.,Ranolazine,DB00005
DB00297,The metabolism of Bupivacaine can be increased when combined with Etanercept.,Bupivacaine,DB00005
DB00318,The metabolism of Codeine can be increased when combined with Etanercept.,Codeine,DB00005
DB00377,The metabolism of Palonosetron can be increased when combined with Etanercept.,Palonosetron,DB00005
DB00589,The metabolism of Lisuride can be increased when combined with Etanercept.,Lisuride,DB00005
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Etanercept.,Dextropropoxyphene,DB00005
DB00674,The metabolism of Galantamine can be increased when combined with Etanercept.,Galantamine,DB00005
DB00705,The metabolism of Delavirdine can be increased when combined with Etanercept.,Delavirdine,DB00005
DB00706,The metabolism of Tamsulosin can be increased when combined with Etanercept.,Tamsulosin,DB00005
DB00757,The metabolism of Dolasetron can be increased when combined with Etanercept.,Dolasetron,DB00005
DB01149,The metabolism of Nefazodone can be increased when combined with Etanercept.,Nefazodone,DB00005
DB01192,The metabolism of Oxymorphone can be increased when combined with Etanercept.,Oxymorphone,DB00005
DB01244,The metabolism of Bepridil can be increased when combined with Etanercept.,Bepridil,DB00005
DB01392,The metabolism of Yohimbine can be increased when combined with Etanercept.,Yohimbine,DB00005
DB01409,The metabolism of Tiotropium can be increased when combined with Etanercept.,Tiotropium,DB00005
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Etanercept.,Dihydrocodeine,DB00005
DB01591,The metabolism of Solifenacin can be increased when combined with Etanercept.,Solifenacin,DB00005
DB01621,The metabolism of Pipotiazine can be increased when combined with Etanercept.,Pipotiazine,DB00005
DB02703,The metabolism of Fusidic acid can be increased when combined with Etanercept.,Fusidic acid,DB00005
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Etanercept.,Lysergic acid diethylamide,DB00005
DB04884,The metabolism of Dapoxetine can be increased when combined with Etanercept.,Dapoxetine,DB00005
DB04905,The metabolism of Tesmilifene can be increased when combined with Etanercept.,Tesmilifene,DB00005
DB04920,The metabolism of Clevidipine can be increased when combined with Etanercept.,Clevidipine,DB00005
DB05271,The metabolism of Rotigotine can be increased when combined with Etanercept.,Rotigotine,DB00005
DB06016,The metabolism of Cariprazine can be increased when combined with Etanercept.,Cariprazine,DB00005
DB06144,The metabolism of Sertindole can be increased when combined with Etanercept.,Sertindole,DB00005
DB06203,The metabolism of Alogliptin can be increased when combined with Etanercept.,Alogliptin,DB00005
DB06702,The metabolism of Fesoterodine can be increased when combined with Etanercept.,Fesoterodine,DB00005
DB08893,The metabolism of Mirabegron can be increased when combined with Etanercept.,Mirabegron,DB00005
DB09128,The metabolism of Brexpiprazole can be increased when combined with Etanercept.,Brexpiprazole,DB00005
DB09195,The metabolism of Lorpiprazole can be increased when combined with Etanercept.,Lorpiprazole,DB00005
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Etanercept.,Dexchlorpheniramine maleate,DB00005
DB11130,The metabolism of Opium can be increased when combined with Etanercept.,Opium,DB00005
DB11642,The metabolism of Pitolisant can be increased when combined with Etanercept.,Pitolisant,DB00005
DB13293,The metabolism of Ipecac can be increased when combined with Etanercept.,Ipecac,DB00005
DB00344,The metabolism of Protriptyline can be increased when combined with Etanercept.,Protriptyline,DB00005
DB00496,The metabolism of Darifenacin can be increased when combined with Etanercept.,Darifenacin,DB00005
DB00543,The metabolism of Amoxapine can be increased when combined with Etanercept.,Amoxapine,DB00005
DB00932,The metabolism of Tipranavir can be increased when combined with Etanercept.,Tipranavir,DB00005
DB09039,The metabolism of Eliglustat can be increased when combined with Etanercept.,Eliglustat,DB00005
DB12930,The metabolism of Opipramol can be increased when combined with Etanercept.,Opipramol,DB00005
DB00489,The metabolism of Sotalol can be increased when combined with Etanercept.,Sotalol,DB00005
DB01035,The metabolism of Procainamide can be increased when combined with Etanercept.,Procainamide,DB00005
DB01195,The metabolism of Flecainide can be increased when combined with Etanercept.,Flecainide,DB00005
DB00228,The metabolism of Enflurane can be increased when combined with Etanercept.,Enflurane,DB00005
DB06712,The metabolism of Nilvadipine can be increased when combined with Etanercept.,Nilvadipine,DB00005
DB06728,The metabolism of Aniline can be increased when combined with Etanercept.,Aniline,DB00005
DB00949,The metabolism of Felbamate can be increased when combined with Etanercept.,Felbamate,DB00005
DB00593,The metabolism of Ethosuximide can be increased when combined with Etanercept.,Ethosuximide,DB00005
DB00186,The metabolism of Lorazepam can be increased when combined with Etanercept.,Lorazepam,DB00005
DB00191,The metabolism of Phentermine can be increased when combined with Etanercept.,Phentermine,DB00005
DB00207,The metabolism of Azithromycin can be increased when combined with Etanercept.,Azithromycin,DB00005
DB00208,The metabolism of Ticlopidine can be increased when combined with Etanercept.,Ticlopidine,DB00005
DB00264,The metabolism of Metoprolol can be increased when combined with Etanercept.,Metoprolol,DB00005
DB00426,The metabolism of Famciclovir can be increased when combined with Etanercept.,Famciclovir,DB00005
DB00433,The metabolism of Prochlorperazine can be increased when combined with Etanercept.,Prochlorperazine,DB00005
DB00567,The metabolism of Cephalexin can be increased when combined with Etanercept.,Cephalexin,DB00005
DB00590,The metabolism of Doxazosin can be increased when combined with Etanercept.,Doxazosin,DB00005
DB01039,The metabolism of Fenofibrate can be increased when combined with Etanercept.,Fenofibrate,DB00005
DB01395,The metabolism of Drospirenone can be increased when combined with Etanercept.,Drospirenone,DB00005
DB01411,The metabolism of Pranlukast can be increased when combined with Etanercept.,Pranlukast,DB00005
DB01431,The metabolism of Allylestrenol can be increased when combined with Etanercept.,Allylestrenol,DB00005
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Etanercept.,Zuclopenthixol,DB00005
DB06201,The metabolism of Rufinamide can be increased when combined with Etanercept.,Rufinamide,DB00005
DB06480,The metabolism of Prucalopride can be increased when combined with Etanercept.,Prucalopride,DB00005
DB08882,The metabolism of Linagliptin can be increased when combined with Etanercept.,Linagliptin,DB00005
DB09030,The metabolism of Vorapaxar can be increased when combined with Etanercept.,Vorapaxar,DB00005
DB09034,The metabolism of Suvorexant can be increased when combined with Etanercept.,Suvorexant,DB00005
DB09079,The metabolism of Nintedanib can be increased when combined with Etanercept.,Nintedanib,DB00005
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Etanercept.,Tenofovir alafenamide,DB00005
DB09330,The metabolism of Osimertinib can be increased when combined with Etanercept.,Osimertinib,DB00005
DB11094,The metabolism of Vitamin D can be increased when combined with Etanercept.,Vitamin D,DB00005
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Etanercept.,Dihydroergocornine,DB00005
DB11730,The metabolism of Ribociclib can be increased when combined with Etanercept.,Ribociclib,DB00005
DB11952,The metabolism of Duvelisib can be increased when combined with Etanercept.,Duvelisib,DB00005
DB12141,The metabolism of Gilteritinib can be increased when combined with Etanercept.,Gilteritinib,DB00005
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Etanercept.,9-aminocamptothecin,DB00005
DB12952,The metabolism of Methylprednisone can be increased when combined with Etanercept.,Methylprednisone,DB00005
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Etanercept.,Dihydroergocristine,DB00005
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Etanercept.,Dihydroergocryptine,DB00005
DB14126,The metabolism of Tenofovir can be increased when combined with Etanercept.,Tenofovir,DB00005
DB15444,The metabolism of Elexacaftor can be increased when combined with Etanercept.,Elexacaftor,DB00005
DB06717,The metabolism of Fosaprepitant can be increased when combined with Etanercept.,Fosaprepitant,DB00005
DB12825,The metabolism of Lefamulin can be increased when combined with Etanercept.,Lefamulin,DB00005
DB12887,The metabolism of Tazemetostat can be increased when combined with Etanercept.,Tazemetostat,DB00005
DB00454,The metabolism of Meperidine can be increased when combined with Etanercept.,Meperidine,DB00005
DB01151,The metabolism of Desipramine can be increased when combined with Etanercept.,Desipramine,DB00005
DB12371,The metabolism of Siponimod can be increased when combined with Etanercept.,Siponimod,DB00005
DB00247,The metabolism of Methysergide can be increased when combined with Etanercept.,Methysergide,DB00005
DB08827,The metabolism of Lomitapide can be increased when combined with Etanercept.,Lomitapide,DB00005
DB11742,The metabolism of Ebastine can be increased when combined with Etanercept.,Ebastine,DB00005
DB05015,The metabolism of Belinostat can be increased when combined with Etanercept.,Belinostat,DB00005
DB01118,The metabolism of Amiodarone can be increased when combined with Etanercept.,Amiodarone,DB00005
DB00675,The metabolism of Tamoxifen can be increased when combined with Etanercept.,Tamoxifen,DB00005
DB00204,The metabolism of Dofetilide can be increased when combined with Etanercept.,Dofetilide,DB00005
DB00342,The metabolism of Terfenadine can be increased when combined with Etanercept.,Terfenadine,DB00005
DB00451,The metabolism of Levothyroxine can be increased when combined with Etanercept.,Levothyroxine,DB00005
DB00604,The metabolism of Cisapride can be increased when combined with Etanercept.,Cisapride,DB00005
DB00877,The metabolism of Sirolimus can be increased when combined with Etanercept.,Sirolimus,DB00005
DB01008,The metabolism of Busulfan can be increased when combined with Etanercept.,Busulfan,DB00005
DB01254,The metabolism of Dasatinib can be increased when combined with Etanercept.,Dasatinib,DB00005
DB01396,The metabolism of Digitoxin can be increased when combined with Etanercept.,Digitoxin,DB00005
DB01590,The metabolism of Everolimus can be increased when combined with Etanercept.,Everolimus,DB00005
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Etanercept.,4-hydroxycoumarin,DB00005
DB04855,The metabolism of Dronedarone can be increased when combined with Etanercept.,Dronedarone,DB00005
DB06287,The metabolism of Temsirolimus can be increased when combined with Etanercept.,Temsirolimus,DB00005
DB09053,The metabolism of Ibrutinib can be increased when combined with Etanercept.,Ibrutinib,DB00005
DB09289,The metabolism of Tianeptine can be increased when combined with Etanercept.,Tianeptine,DB00005
DB11633,The metabolism of Isavuconazole can be increased when combined with Etanercept.,Isavuconazole,DB00005
DB13275,The metabolism of Clorindione can be increased when combined with Etanercept.,Clorindione,DB00005
DB00398,The metabolism of Sorafenib can be increased when combined with Etanercept.,Sorafenib,DB00005
DB00444,The metabolism of Teniposide can be increased when combined with Etanercept.,Teniposide,DB00005
DB00530,The metabolism of Erlotinib can be increased when combined with Etanercept.,Erlotinib,DB00005
DB00541,The metabolism of Vincristine can be increased when combined with Etanercept.,Vincristine,DB00005
DB00619,The metabolism of Imatinib can be increased when combined with Etanercept.,Imatinib,DB00005
DB00773,The metabolism of Etoposide can be increased when combined with Etanercept.,Etoposide,DB00005
DB01248,The metabolism of Docetaxel can be increased when combined with Etanercept.,Docetaxel,DB00005
DB01268,The metabolism of Sunitinib can be increased when combined with Etanercept.,Sunitinib,DB00005
DB06626,The metabolism of Axitinib can be increased when combined with Etanercept.,Axitinib,DB00005
DB08865,The metabolism of Crizotinib can be increased when combined with Etanercept.,Crizotinib,DB00005
DB08901,The metabolism of Ponatinib can be increased when combined with Etanercept.,Ponatinib,DB00005
DB12483,The metabolism of Copanlisib can be increased when combined with Etanercept.,Copanlisib,DB00005
DB00188,The metabolism of Bortezomib can be increased when combined with Etanercept.,Bortezomib,DB00005
DB00363,The metabolism of Clozapine can be increased when combined with Etanercept.,Clozapine,DB00005
DB01181,The metabolism of Ifosfamide can be increased when combined with Etanercept.,Ifosfamide,DB00005
DB05109,The metabolism of Trabectedin can be increased when combined with Etanercept.,Trabectedin,DB00005
DB12147,The metabolism of Erdafitinib can be increased when combined with Etanercept.,Erdafitinib,DB00005
DB13874,The metabolism of Enasidenib can be increased when combined with Etanercept.,Enasidenib,DB00005
DB06589,The metabolism of Pazopanib can be increased when combined with Etanercept.,Pazopanib,DB00005
DB05239,The metabolism of Cobimetinib can be increased when combined with Etanercept.,Cobimetinib,DB00005
DB09063,The metabolism of Ceritinib can be increased when combined with Etanercept.,Ceritinib,DB00005
DB11963,The metabolism of Dacomitinib can be increased when combined with Etanercept.,Dacomitinib,DB00005
DB12015,The metabolism of Alpelisib can be increased when combined with Etanercept.,Alpelisib,DB00005
DB00309,The metabolism of Vindesine can be increased when combined with Etanercept.,Vindesine,DB00005
DB00361,The metabolism of Vinorelbine can be increased when combined with Etanercept.,Vinorelbine,DB00005
DB00570,The metabolism of Vinblastine can be increased when combined with Etanercept.,Vinblastine,DB00005
DB00694,The metabolism of Daunorubicin can be increased when combined with Etanercept.,Daunorubicin,DB00005
DB00987,The metabolism of Cytarabine can be increased when combined with Etanercept.,Cytarabine,DB00005
DB00997,The metabolism of Doxorubicin can be increased when combined with Etanercept.,Doxorubicin,DB00005
DB01108,The metabolism of Trilostane can be increased when combined with Etanercept.,Trilostane,DB00005
DB04572,The metabolism of Thiotepa can be increased when combined with Etanercept.,Thiotepa,DB00005
DB04845,The metabolism of Ixabepilone can be increased when combined with Etanercept.,Ixabepilone,DB00005
DB04868,The metabolism of Nilotinib can be increased when combined with Etanercept.,Nilotinib,DB00005
DB06603,The metabolism of Panobinostat can be increased when combined with Etanercept.,Panobinostat,DB00005
DB06616,The metabolism of Bosutinib can be increased when combined with Etanercept.,Bosutinib,DB00005
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Etanercept.,Brentuximab vedotin,DB00005
DB08877,The metabolism of Ruxolitinib can be increased when combined with Etanercept.,Ruxolitinib,DB00005
DB09073,The metabolism of Palbociclib can be increased when combined with Etanercept.,Palbociclib,DB00005
DB08912,The metabolism of Dabrafenib can be increased when combined with Etanercept.,Dabrafenib,DB00005
DB12267,The metabolism of Brigatinib can be increased when combined with Etanercept.,Brigatinib,DB00005
DB11718,The metabolism of Encorafenib can be increased when combined with Etanercept.,Encorafenib,DB00005
DB00563,The metabolism of Methotrexate can be increased when combined with Etanercept.,Methotrexate,DB00005
DB05294,The metabolism of Vandetanib can be increased when combined with Etanercept.,Vandetanib,DB00005
DB05812,The metabolism of Abiraterone can be increased when combined with Etanercept.,Abiraterone,DB00005
DB08881,The metabolism of Vemurafenib can be increased when combined with Etanercept.,Vemurafenib,DB00005
DB11363,The metabolism of Alectinib can be increased when combined with Etanercept.,Alectinib,DB00005
DB11581,The metabolism of Venetoclax can be increased when combined with Etanercept.,Venetoclax,DB00005
DB11641,The metabolism of Vinflunine can be increased when combined with Etanercept.,Vinflunine,DB00005
DB11703,The metabolism of Acalabrutinib can be increased when combined with Etanercept.,Acalabrutinib,DB00005
DB15035,The metabolism of Zanubrutinib can be increased when combined with Etanercept.,Zanubrutinib,DB00005
DB00248,The metabolism of Cabergoline can be increased when combined with Etanercept.,Cabergoline,DB00005
DB06595,The metabolism of Midostaurin can be increased when combined with Etanercept.,Midostaurin,DB00005
DB09143,The metabolism of Sonidegib can be increased when combined with Etanercept.,Sonidegib,DB00005
DB11828,The metabolism of Neratinib can be increased when combined with Etanercept.,Neratinib,DB00005
DB11986,The metabolism of Entrectinib can be increased when combined with Etanercept.,Entrectinib,DB00005
DB12978,The metabolism of Pexidartinib can be increased when combined with Etanercept.,Pexidartinib,DB00005
DB14568,The metabolism of Ivosidenib can be increased when combined with Etanercept.,Ivosidenib,DB00005
DB09054,The metabolism of Idelalisib can be increased when combined with Etanercept.,Idelalisib,DB00005
DB09570,The metabolism of Ixazomib can be increased when combined with Etanercept.,Ixazomib,DB00005
DB00199,The metabolism of Erythromycin can be increased when combined with Etanercept.,Erythromycin,DB00005
DB00246,The metabolism of Ziprasidone can be increased when combined with Etanercept.,Ziprasidone,DB00005
DB00439,The metabolism of Cerivastatin can be increased when combined with Etanercept.,Cerivastatin,DB00005
DB00499,The metabolism of Flutamide can be increased when combined with Etanercept.,Flutamide,DB00005
DB00528,The metabolism of Lercanidipine can be increased when combined with Etanercept.,Lercanidipine,DB00005
DB00571,The metabolism of Propranolol can be increased when combined with Etanercept.,Propranolol,DB00005
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Etanercept.,Fluticasone propionate,DB00005
DB00608,The metabolism of Chloroquine can be increased when combined with Etanercept.,Chloroquine,DB00005
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Etanercept.,Mycophenolate mofetil,DB00005
DB00717,The metabolism of Norethisterone can be increased when combined with Etanercept.,Norethisterone,DB00005
DB00738,The metabolism of Pentamidine can be increased when combined with Etanercept.,Pentamidine,DB00005
DB00741,The metabolism of Hydrocortisone can be increased when combined with Etanercept.,Hydrocortisone,DB00005
DB00762,The metabolism of Irinotecan can be increased when combined with Etanercept.,Irinotecan,DB00005
DB00822,The metabolism of Disulfiram can be increased when combined with Etanercept.,Disulfiram,DB00005
DB00834,The metabolism of Mifepristone can be increased when combined with Etanercept.,Mifepristone,DB00005
DB00938,The metabolism of Salmeterol can be increased when combined with Etanercept.,Salmeterol,DB00005
DB00962,The metabolism of Zaleplon can be increased when combined with Etanercept.,Zaleplon,DB00005
DB00976,The metabolism of Telithromycin can be increased when combined with Etanercept.,Telithromycin,DB00005
DB01054,The metabolism of Nitrendipine can be increased when combined with Etanercept.,Nitrendipine,DB00005
DB01058,The metabolism of Praziquantel can be increased when combined with Etanercept.,Praziquantel,DB00005
DB01062,The metabolism of Oxybutynin can be increased when combined with Etanercept.,Oxybutynin,DB00005
DB01076,The metabolism of Atorvastatin can be increased when combined with Etanercept.,Atorvastatin,DB00005
DB01103,The metabolism of Quinacrine can be increased when combined with Etanercept.,Quinacrine,DB00005
DB01115,The metabolism of Nifedipine can be increased when combined with Etanercept.,Nifedipine,DB00005
DB01126,The metabolism of Dutasteride can be increased when combined with Etanercept.,Dutasteride,DB00005
DB01166,The metabolism of Cilostazol can be increased when combined with Etanercept.,Cilostazol,DB00005
DB01184,The metabolism of Domperidone can be increased when combined with Etanercept.,Domperidone,DB00005
DB01211,The metabolism of Clarithromycin can be increased when combined with Etanercept.,Clarithromycin,DB00005
DB01216,The metabolism of Finasteride can be increased when combined with Etanercept.,Finasteride,DB00005
DB01218,The metabolism of Halofantrine can be increased when combined with Etanercept.,Halofantrine,DB00005
DB05521,The metabolism of Telaprevir can be increased when combined with Etanercept.,Telaprevir,DB00005
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Etanercept.,Trastuzumab emtansine,DB00005
DB06267,The metabolism of Udenafil can be increased when combined with Etanercept.,Udenafil,DB00005
DB06335,The metabolism of Saxagliptin can be increased when combined with Etanercept.,Saxagliptin,DB00005
DB06403,The metabolism of Ambrisentan can be increased when combined with Etanercept.,Ambrisentan,DB00005
DB06419,The metabolism of Cethromycin can be increased when combined with Etanercept.,Cethromycin,DB00005
DB06772,The metabolism of Cabazitaxel can be increased when combined with Etanercept.,Cabazitaxel,DB00005
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Etanercept.,Hydroxyprogesterone caproate,DB00005
DB08820,The metabolism of Ivacaftor can be increased when combined with Etanercept.,Ivacaftor,DB00005
DB08873,The metabolism of Boceprevir can be increased when combined with Etanercept.,Boceprevir,DB00005
DB08883,The metabolism of Perampanel can be increased when combined with Etanercept.,Perampanel,DB00005
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Etanercept.,Fluticasone furoate,DB00005
DB09065,The metabolism of Cobicistat can be increased when combined with Etanercept.,Cobicistat,DB00005
DB09074,The metabolism of Olaparib can be increased when combined with Etanercept.,Olaparib,DB00005
DB09102,The metabolism of Daclatasvir can be increased when combined with Etanercept.,Daclatasvir,DB00005
DB09231,The metabolism of Benidipine can be increased when combined with Etanercept.,Benidipine,DB00005
DB09297,The metabolism of Paritaprevir can be increased when combined with Etanercept.,Paritaprevir,DB00005
DB11574,The metabolism of Elbasvir can be increased when combined with Etanercept.,Elbasvir,DB00005
DB11712,The metabolism of Tezacaftor can be increased when combined with Etanercept.,Tezacaftor,DB00005
DB11737,The metabolism of Icotinib can be increased when combined with Etanercept.,Icotinib,DB00005
DB12301,The metabolism of Doravirine can be increased when combined with Etanercept.,Doravirine,DB00005
DB13867,The metabolism of Fluticasone can be increased when combined with Etanercept.,Fluticasone,DB00005
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Etanercept.,Hydrocortisone aceponate,DB00005
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Etanercept.,Hydrocortisone acetate,DB00005
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Etanercept.,Hydrocortisone cypionate,DB00005
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Etanercept.,Hydrocortisone phosphate,DB00005
DB00396,The metabolism of Progesterone can be increased when combined with Etanercept.,Progesterone,DB00005
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Etanercept.,Dexloxiglumide,DB00005
DB04957,The metabolism of Azimilide can be increased when combined with Etanercept.,Azimilide,DB00005
DB00250,The metabolism of Dapsone can be increased when combined with Etanercept.,Dapsone,DB00005
DB00317,The metabolism of Gefitinib can be increased when combined with Etanercept.,Gefitinib,DB00005
DB00367,The metabolism of Levonorgestrel can be increased when combined with Etanercept.,Levonorgestrel,DB00005
DB00497,The metabolism of Oxycodone can be increased when combined with Etanercept.,Oxycodone,DB00005
DB00620,The metabolism of Triamcinolone can be increased when combined with Etanercept.,Triamcinolone,DB00005
DB00624,The metabolism of Testosterone can be increased when combined with Etanercept.,Testosterone,DB00005
DB00656,The metabolism of Trazodone can be increased when combined with Etanercept.,Trazodone,DB00005
DB00734,The metabolism of Risperidone can be increased when combined with Etanercept.,Risperidone,DB00005
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Etanercept.,Chlorpheniramine,DB00005
DB01238,The metabolism of Aripiprazole can be increased when combined with Etanercept.,Aripiprazole,DB00005
DB01267,The metabolism of Paliperidone can be increased when combined with Etanercept.,Paliperidone,DB00005
DB04946,The metabolism of Iloperidone can be increased when combined with Etanercept.,Iloperidone,DB00005
DB11915,The metabolism of Valbenazine can be increased when combined with Etanercept.,Valbenazine,DB00005
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Etanercept.,Deutetrabenazine,DB00005
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Etanercept.,Aripiprazole lauroxil,DB00005
DB01234,The metabolism of Dexamethasone can be increased when combined with Etanercept.,Dexamethasone,DB00005
DB09237,The metabolism of Levamlodipine can be increased when combined with Etanercept.,Levamlodipine,DB00005
DB11951,The metabolism of Lemborexant can be increased when combined with Etanercept.,Lemborexant,DB00005
DB00557,The metabolism of Hydroxyzine can be increased when combined with Etanercept.,Hydroxyzine,DB00005
DB00203,The metabolism of Sildenafil can be increased when combined with Etanercept.,Sildenafil,DB00005
DB00227,The metabolism of Lovastatin can be increased when combined with Etanercept.,Lovastatin,DB00005
DB00490,The metabolism of Buspirone can be increased when combined with Etanercept.,Buspirone,DB00005
DB00641,The metabolism of Simvastatin can be increased when combined with Etanercept.,Simvastatin,DB00005
DB00673,The metabolism of Aprepitant can be increased when combined with Etanercept.,Aprepitant,DB00005
DB00820,The metabolism of Tadalafil can be increased when combined with Etanercept.,Tadalafil,DB00005
DB00862,The metabolism of Vardenafil can be increased when combined with Etanercept.,Vardenafil,DB00005
DB01190,The metabolism of Clindamycin can be increased when combined with Etanercept.,Clindamycin,DB00005
DB00503,The metabolism of Ritonavir can be increased when combined with Etanercept.,Ritonavir,DB00005
DB00224,The metabolism of Indinavir can be increased when combined with Etanercept.,Indinavir,DB00005
DB00401,The metabolism of Nisoldipine can be increased when combined with Etanercept.,Nisoldipine,DB00005
DB00637,The metabolism of Astemizole can be increased when combined with Etanercept.,Astemizole,DB00005
DB00683,The metabolism of Midazolam can be increased when combined with Etanercept.,Midazolam,DB00005
DB00700,The metabolism of Eplerenone can be increased when combined with Etanercept.,Eplerenone,DB00005
DB00802,The metabolism of Alfentanil can be increased when combined with Etanercept.,Alfentanil,DB00005
DB00813,The metabolism of Fentanyl can be increased when combined with Etanercept.,Fentanyl,DB00005
DB00897,The metabolism of Triazolam can be increased when combined with Etanercept.,Triazolam,DB00005
DB01023,The metabolism of Felodipine can be increased when combined with Etanercept.,Felodipine,DB00005
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Etanercept.,Levacetylmethadol,DB00005
DB01232,The metabolism of Saquinavir can be increased when combined with Etanercept.,Saquinavir,DB00005
DB06228,The metabolism of Rivaroxaban can be increased when combined with Etanercept.,Rivaroxaban,DB00005
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Etanercept.,Prasterone sulfate,DB00005
DB00091,Etanercept may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00005
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Etanercept.,Apremilast,DB00005
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Etanercept.,Magnesium,DB00005
DB01601,The serum concentration of Etanercept can be increased when it is combined with Lopinavir.,Lopinavir,DB00005
DB12530,The risk or severity of infection can be increased when Etanercept is combined with Inebilizumab.,Inebilizumab,DB00005
DB06605,Apixaban may increase the anticoagulant activities of Bivalirudin.,Apixaban,DB00006
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Bivalirudin.,Dabigatran etexilate,DB00006
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bivalirudin.,Dasatinib,DB00006
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Bivalirudin is combined with Deferasirox.,Deferasirox,DB00006
DB01586,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00006
DB02123,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00006
DB02659,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Cholic Acid.,Cholic Acid,DB00006
DB02691,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Glycocholic acid.,Glycocholic acid,DB00006
DB03619,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Deoxycholic acid.,Deoxycholic acid,DB00006
DB04348,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Taurocholic acid.,Taurocholic acid,DB00006
DB05990,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Obeticholic acid.,Obeticholic acid,DB00006
DB06777,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00006
DB08833,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00006
DB08834,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00006
DB08857,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Bamet-UD2.,Bamet-UD2,DB00006
DB11622,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00006
DB11789,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00006
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Bivalirudin.,Edoxaban,DB00006
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Bivalirudin.,Ibrutinib,DB00006
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Obinutuzumab.,Obinutuzumab,DB00006
DB06228,Bivalirudin may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00006
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Sugammadex.,Sugammadex,DB00006
DB09070,Tibolone may increase the anticoagulant activities of Bivalirudin.,Tibolone,DB00006
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Bivalirudin.,Tipranavir,DB00006
DB00013,Urokinase may increase the anticoagulant activities of Bivalirudin.,Urokinase,DB00006
DB00163,Vitamin E may increase the anticoagulant activities of Bivalirudin.,Vitamin E,DB00006
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Bivalirudin.,Vorapaxar,DB00006
DB01381,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00006
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Bivalirudin.,Ifosfamide,DB00006
DB00468,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinine.,Quinine,DB00006
DB00908,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.,Quinidine,DB00006
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Bivalirudin.,Tamoxifen,DB00006
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Bivalirudin.,Toremifene,DB00006
DB00806,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00006
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Bivalirudin.,Pentosan polysulfate,DB00006
DB00583,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00006
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Bivalirudin.,Diethylstilbestrol,DB00006
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Bivalirudin.,Chlorotrianisene,DB00006
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Bivalirudin.,Conjugated estrogens,DB00006
DB00783,Estradiol may decrease the anticoagulant activities of Bivalirudin.,Estradiol,DB00006
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Bivalirudin.,Ethinylestradiol,DB00006
DB01357,Mestranol may decrease the anticoagulant activities of Bivalirudin.,Mestranol,DB00006
DB04573,Estriol may decrease the anticoagulant activities of Bivalirudin.,Estriol,DB00006
DB04574,Estrone sulfate may decrease the anticoagulant activities of Bivalirudin.,Estrone sulfate,DB00006
DB04575,Quinestrol may decrease the anticoagulant activities of Bivalirudin.,Quinestrol,DB00006
DB07931,Hexestrol may decrease the anticoagulant activities of Bivalirudin.,Hexestrol,DB00006
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Bivalirudin.","Synthetic Conjugated Estrogens, A",DB00006
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Bivalirudin.","Synthetic Conjugated Estrogens, B",DB00006
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Bivalirudin.,Polyestradiol phosphate,DB00006
DB09381,Esterified estrogens may decrease the anticoagulant activities of Bivalirudin.,Esterified estrogens,DB00006
DB11478,Zeranol may decrease the anticoagulant activities of Bivalirudin.,Zeranol,DB00006
DB11674,Equol may decrease the anticoagulant activities of Bivalirudin.,Equol,DB00006
DB12487,Promestriene may decrease the anticoagulant activities of Bivalirudin.,Promestriene,DB00006
DB13143,Methallenestril may decrease the anticoagulant activities of Bivalirudin.,Methallenestril,DB00006
DB13386,Epimestrol may decrease the anticoagulant activities of Bivalirudin.,Epimestrol,DB00006
DB13418,Moxestrol may decrease the anticoagulant activities of Bivalirudin.,Moxestrol,DB00006
DB13952,Estradiol acetate may decrease the anticoagulant activities of Bivalirudin.,Estradiol acetate,DB00006
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Bivalirudin.,Estradiol benzoate,DB00006
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Bivalirudin.,Estradiol cypionate,DB00006
DB13956,Estradiol valerate may decrease the anticoagulant activities of Bivalirudin.,Estradiol valerate,DB00006
DB15334,Biochanin A may decrease the anticoagulant activities of Bivalirudin.,Biochanin A,DB00006
DB15335,Formononetin may decrease the anticoagulant activities of Bivalirudin.,Formononetin,DB00006
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Bivalirudin.,Limaprost,DB00006
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Bivalirudin.,Icosapent,DB00006
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Bivalirudin.,Mesalazine,DB00006
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Bivalirudin.,Indomethacin,DB00006
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Bivalirudin.,Nabumetone,DB00006
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Bivalirudin.,Ketorolac,DB00006
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Bivalirudin.,Tenoxicam,DB00006
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Bivalirudin.,Celecoxib,DB00006
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Bivalirudin.,Tolmetin,DB00006
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Bivalirudin.,Rofecoxib,DB00006
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Bivalirudin.,Piroxicam,DB00006
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Bivalirudin.,Fenoprofen,DB00006
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Bivalirudin.,Valdecoxib,DB00006
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Bivalirudin.,Diclofenac,DB00006
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Bivalirudin.,Sulindac,DB00006
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Bivalirudin.,Flurbiprofen,DB00006
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Bivalirudin.,Etodolac,DB00006
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Bivalirudin.,Mefenamic acid,DB00006
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Bivalirudin.,Naproxen,DB00006
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Bivalirudin.,Sulfasalazine,DB00006
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Bivalirudin.,Phenylbutazone,DB00006
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Bivalirudin.,Meloxicam,DB00006
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Bivalirudin.,Carprofen,DB00006
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Bivalirudin.,Diflunisal,DB00006
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bivalirudin.,Salicylic acid,DB00006
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Bivalirudin.,Meclofenamic acid,DB00006
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Bivalirudin.,Oxaprozin,DB00006
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Bivalirudin.,Ketoprofen,DB00006
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Bivalirudin.,Balsalazide,DB00006
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Bivalirudin.,Olsalazine,DB00006
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Bivalirudin.,Lumiracoxib,DB00006
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Bivalirudin.,Magnesium salicylate,DB00006
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Bivalirudin.,Salsalate,DB00006
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Bivalirudin.,Choline magnesium trisalicylate,DB00006
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Bivalirudin.,Antrafenine,DB00006
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Bivalirudin.,Aminophenazone,DB00006
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Bivalirudin.,Antipyrine,DB00006
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Bivalirudin.,Tiaprofenic acid,DB00006
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Bivalirudin.,Etoricoxib,DB00006
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Bivalirudin.,Taxifolin,DB00006
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Bivalirudin.,Oxyphenbutazone,DB00006
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Bivalirudin.,Niflumic acid,DB00006
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Bivalirudin.,Licofelone,DB00006
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Bivalirudin.,Benoxaprofen,DB00006
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Bivalirudin.,Metamizole,DB00006
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Bivalirudin.,Zomepirac,DB00006
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Bivalirudin.,Cimicoxib,DB00006
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Bivalirudin.,Lornoxicam,DB00006
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Bivalirudin.,Aceclofenac,DB00006
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Bivalirudin.,Zaltoprofen,DB00006
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Bivalirudin.,Azapropazone,DB00006
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Bivalirudin.,Felbinac,DB00006
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Bivalirudin.,Parecoxib,DB00006
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Bivalirudin.,Salicylamide,DB00006
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Bivalirudin.,Kebuzone,DB00006
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Bivalirudin.,Isoxicam,DB00006
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Bivalirudin.,Indoprofen,DB00006
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Bivalirudin.,Ibuproxam,DB00006
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Bivalirudin.,Floctafenine,DB00006
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bivalirudin.,Fenbufen,DB00006
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Bivalirudin.,Etofenamate,DB00006
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Bivalirudin.,Epirizole,DB00006
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Bivalirudin.,Benzydamine,DB00006
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Bivalirudin.,Loxoprofen,DB00006
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Bivalirudin.,Dexketoprofen,DB00006
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Bivalirudin.,Droxicam,DB00006
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Bivalirudin.,Tolfenamic acid,DB00006
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Bivalirudin.,Firocoxib,DB00006
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Bivalirudin.,Clonixin,DB00006
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Bivalirudin.,Morniflumate,DB00006
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Bivalirudin.,Propacetamol,DB00006
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Bivalirudin.,Talniflumate,DB00006
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Bivalirudin.,Robenacoxib,DB00006
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Bivalirudin.,Tepoxalin,DB00006
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Bivalirudin.,Flunixin,DB00006
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Bivalirudin.,Polmacoxib,DB00006
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Bivalirudin.,Betulinic Acid,DB00006
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Bivalirudin.,Ebselen,DB00006
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Bivalirudin.,Tinoridine,DB00006
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Bivalirudin.,Alclofenac,DB00006
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Bivalirudin.,Fentiazac,DB00006
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Bivalirudin.,Suxibuzone,DB00006
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Bivalirudin.,Bumadizone,DB00006
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Bivalirudin.,Alminoprofen,DB00006
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Bivalirudin.,Flunoxaprofen,DB00006
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Bivalirudin.,Feprazone,DB00006
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Bivalirudin.,Difenpiramide,DB00006
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Bivalirudin.,Nifenazone,DB00006
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Bivalirudin.,Lonazolac,DB00006
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Bivalirudin.,Tenidap,DB00006
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Bivalirudin.,Bendazac,DB00006
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Bivalirudin.,Pranoprofen,DB00006
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Bivalirudin.,Propyphenazone,DB00006
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Bivalirudin.,Proglumetacin,DB00006
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Bivalirudin.,Guacetisal,DB00006
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Bivalirudin.,Ethenzamide,DB00006
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Bivalirudin.,Carbaspirin calcium,DB00006
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Bivalirudin.,Mofebutazone,DB00006
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Bivalirudin.,Proquazone,DB00006
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Bivalirudin.,Benorilate,DB00006
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Bivalirudin.,Pirprofen,DB00006
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Bivalirudin.,Imidazole salicylate,DB00006
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Bivalirudin.,SC-236,DB00006
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Bivalirudin.,NS-398,DB00006
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Bivalirudin.,Flurbiprofen axetil,DB00006
DB04865,The risk or severity of bleeding can be increased when Bivalirudin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00006
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Bivalirudin.,Omega-3 fatty acids,DB00006
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Tositumomab.,Tositumomab,DB00006
DB00048,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00006
DB00389,Carbimazole may increase the anticoagulant activities of Bivalirudin.,Carbimazole,DB00006
DB00550,Propylthiouracil may increase the anticoagulant activities of Bivalirudin.,Propylthiouracil,DB00006
DB00763,Methimazole may increase the anticoagulant activities of Bivalirudin.,Methimazole,DB00006
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Bivalirudin.","3,5-Diiodotyrosine",DB00006
DB06715,Potassium Iodide may increase the anticoagulant activities of Bivalirudin.,Potassium Iodide,DB00006
DB07637,Dibromotyrosine may increase the anticoagulant activities of Bivalirudin.,Dibromotyrosine,DB00006
DB09418,Potassium perchlorate may increase the anticoagulant activities of Bivalirudin.,Potassium perchlorate,DB00006
DB13644,Methylthiouracil may increase the anticoagulant activities of Bivalirudin.,Methylthiouracil,DB00006
DB13804,Benzylthiouracil may increase the anticoagulant activities of Bivalirudin.,Benzylthiouracil,DB00006
DB00834,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mifepristone.,Mifepristone,DB00006
DB04066,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00006
DB04682,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00006
DB05830,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trestolone.,Trestolone,DB00006
DB06266,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Lonidamine.,Lonidamine,DB00006
DB08867,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ulipristal.,Ulipristal,DB00006
DB09401,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Isosorbide.,Isosorbide,DB00006
DB11507,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00006
DB12025,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triptolide.,Triptolide,DB00006
DB13044,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Gossypol.,Gossypol,DB00006
DB13310,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00006
DB00294,Etonogestrel may decrease the anticoagulant activities of Bivalirudin.,Etonogestrel,DB00006
DB00304,Desogestrel may decrease the anticoagulant activities of Bivalirudin.,Desogestrel,DB00006
DB00351,Megestrol acetate may decrease the anticoagulant activities of Bivalirudin.,Megestrol acetate,DB00006
DB00367,Levonorgestrel may decrease the anticoagulant activities of Bivalirudin.,Levonorgestrel,DB00006
DB00378,Dydrogesterone may decrease the anticoagulant activities of Bivalirudin.,Dydrogesterone,DB00006
DB00396,Progesterone may decrease the anticoagulant activities of Bivalirudin.,Progesterone,DB00006
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Bivalirudin.,Medroxyprogesterone acetate,DB00006
DB00717,Norethisterone may decrease the anticoagulant activities of Bivalirudin.,Norethisterone,DB00006
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Bivalirudin.,Ethynodiol diacetate,DB00006
DB00957,Norgestimate may decrease the anticoagulant activities of Bivalirudin.,Norgestimate,DB00006
DB01395,Drospirenone may decrease the anticoagulant activities of Bivalirudin.,Drospirenone,DB00006
DB01431,Allylestrenol may decrease the anticoagulant activities of Bivalirudin.,Allylestrenol,DB00006
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Bivalirudin.,Cyproterone acetate,DB00006
DB06713,Norelgestromin may decrease the anticoagulant activities of Bivalirudin.,Norelgestromin,DB00006
DB06730,Gestodene may decrease the anticoagulant activities of Bivalirudin.,Gestodene,DB00006
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Bivalirudin.,Hydroxyprogesterone caproate,DB00006
DB09123,Dienogest may decrease the anticoagulant activities of Bivalirudin.,Dienogest,DB00006
DB09124,Medrogestone may decrease the anticoagulant activities of Bivalirudin.,Medrogestone,DB00006
DB09371,Norethynodrel may decrease the anticoagulant activities of Bivalirudin.,Norethynodrel,DB00006
DB09389,Norgestrel may decrease the anticoagulant activities of Bivalirudin.,Norgestrel,DB00006
DB11372,Altrenogest may decrease the anticoagulant activities of Bivalirudin.,Altrenogest,DB00006
DB11619,Gestrinone may decrease the anticoagulant activities of Bivalirudin.,Gestrinone,DB00006
DB11636,Nomegestrol may decrease the anticoagulant activities of Bivalirudin.,Nomegestrol,DB00006
DB12474,Lynestrenol may decrease the anticoagulant activities of Bivalirudin.,Lynestrenol,DB00006
DB13230,Gestonorone may decrease the anticoagulant activities of Bivalirudin.,Gestonorone,DB00006
DB13528,Chlormadinone may decrease the anticoagulant activities of Bivalirudin.,Chlormadinone,DB00006
DB13533,Methylestrenolone may decrease the anticoagulant activities of Bivalirudin.,Methylestrenolone,DB00006
DB13563,Norgestrienone may decrease the anticoagulant activities of Bivalirudin.,Norgestrienone,DB00006
DB13602,Promegestone may decrease the anticoagulant activities of Bivalirudin.,Promegestone,DB00006
DB13685,Quingestanol may decrease the anticoagulant activities of Bivalirudin.,Quingestanol,DB00006
DB13857,Demegestone may decrease the anticoagulant activities of Bivalirudin.,Demegestone,DB00006
DB13866,Etynodiol may decrease the anticoagulant activities of Bivalirudin.,Etynodiol,DB00006
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Bivalirudin.,Nomegestrol acetate,DB00006
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Bivalirudin.,Hydroxyprogesterone,DB00006
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Bivalirudin.,Norethindrone enanthate,DB00006
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Bivalirudin.,Quingestanol acetate,DB00006
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Bivalirudin.,Aminosalicylic acid,DB00006
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bivalirudin.,Bismuth subsalicylate,DB00006
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Bivalirudin.,Dersalazine,DB00006
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Bivalirudin.,Phenyl aminosalicylate,DB00006
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Bivalirudin.,Methyl salicylate,DB00006
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Bivalirudin.,Trolamine salicylate,DB00006
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Bivalirudin.,Aloxiprin,DB00006
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Bivalirudin.,Choline salicylate,DB00006
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Bivalirudin.,Thiosalicylic acid,DB00006
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.,Abciximab,DB00006
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Bivalirudin.,Eptifibatide,DB00006
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Bivalirudin.,Ticlopidine,DB00006
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Bivalirudin.,Anagrelide,DB00006
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Bivalirudin.,Clopidogrel,DB00006
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Bivalirudin.,Tirofiban,DB00006
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Bivalirudin.,Dipyridamole,DB00006
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Bivalirudin.,Iloprost,DB00006
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bivalirudin.,Sulfinpyrazone,DB00006
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Bivalirudin.,Cilostazol,DB00006
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Bivalirudin.,Ridogrel,DB00006
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Bivalirudin.,Sevoflurane,DB00006
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin.,Epoprostenol,DB00006
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Bivalirudin.,Resveratrol,DB00006
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Bivalirudin.,Nimesulide,DB00006
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Bivalirudin.,Tesmilifene,DB00006
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Bivalirudin.,Defibrotide,DB00006
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Bivalirudin.,Beraprost,DB00006
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Bivalirudin.,Ibudilast,DB00006
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Bivalirudin.,Andrographolide,DB00006
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Bivalirudin.,Caplacizumab,DB00006
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Bivalirudin.,Prasugrel,DB00006
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Bivalirudin.,Cangrelor,DB00006
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Bivalirudin.,Tranilast,DB00006
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Bivalirudin.,Triflusal,DB00006
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Bivalirudin.,Ticagrelor,DB00006
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bivalirudin.,Icosapent ethyl,DB00006
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Bivalirudin.,Trapidil,DB00006
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Bivalirudin.,Naftopidil,DB00006
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Bivalirudin.,Sarpogrelate,DB00006
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Bivalirudin.,Ifetroban,DB00006
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bivalirudin.,Nitroaspirin,DB00006
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Bivalirudin.,Ketanserin,DB00006
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Bivalirudin.,Indobufen,DB00006
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Bivalirudin.,Butylphthalide,DB00006
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Bivalirudin.,Hydroxytyrosol,DB00006
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Bivalirudin.,Ramatroban,DB00006
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Bivalirudin.,Picotamide,DB00006
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Bivalirudin.,Cloricromen,DB00006
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Bivalirudin.,Linsidomine,DB00006
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Bivalirudin.,Buflomedil,DB00006
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Bivalirudin.,Relcovaptan,DB00006
DB00374,The risk or severity of bleeding can be increased when Treprostinil is combined with Bivalirudin.,Treprostinil,DB00006
DB03404,Hemin may increase the anticoagulant activities of Bivalirudin.,Hemin,DB00006
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Bivalirudin.,Acemetacin,DB00006
DB00624,Testosterone may increase the anticoagulant activities of Bivalirudin.,Testosterone,DB00006
DB01420,Testosterone propionate may increase the anticoagulant activities of Bivalirudin.,Testosterone propionate,DB00006
DB01481,1-Testosterone may increase the anticoagulant activities of Bivalirudin.,1-Testosterone,DB00006
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Bivalirudin.,4-Hydroxytestosterone,DB00006
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Bivalirudin.,Dehydrochloromethyltestosterone,DB00006
DB01541,Boldenone may increase the anticoagulant activities of Bivalirudin.,Boldenone,DB00006
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Bivalirudin.,18-methyl-19-nortestosterone,DB00006
DB01564,Calusterone may increase the anticoagulant activities of Bivalirudin.,Calusterone,DB00006
DB01569,Formebolone may increase the anticoagulant activities of Bivalirudin.,Formebolone,DB00006
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Bivalirudin.,Methyl-1-testosterone,DB00006
DB02901,Stanolone may increase the anticoagulant activities of Bivalirudin.,Stanolone,DB00006
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Bivalirudin.,5beta-dihydrotestosterone,DB00006
DB08619,Testosterone succinate may increase the anticoagulant activities of Bivalirudin.,Testosterone succinate,DB00006
DB11429,Mibolerone may increase the anticoagulant activities of Bivalirudin.,Mibolerone,DB00006
DB13943,Testosterone cypionate may increase the anticoagulant activities of Bivalirudin.,Testosterone cypionate,DB00006
DB13944,Testosterone enanthate may increase the anticoagulant activities of Bivalirudin.,Testosterone enanthate,DB00006
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Bivalirudin.,Testosterone undecanoate,DB00006
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Bivalirudin.,Testosterone enantate benzilic acid hydrazone,DB00006
DB13951,Stanolone acetate may increase the anticoagulant activities of Bivalirudin.,Stanolone acetate,DB00006
DB13958,Trestolone acetate may increase the anticoagulant activities of Bivalirudin.,Trestolone acetate,DB00006
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Bivalirudin.","(1,2,6,7-3H)Testosterone",DB00006
DB14655,Drostanolone propionate may increase the anticoagulant activities of Bivalirudin.,Drostanolone propionate,DB00006
DB11051,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Azficel-T.,Azficel-T,DB00006
DB09568,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00006
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.","Antihemophilic factor, human recombinant",DB00006
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.,Coagulation factor VIIa Recombinant Human,DB00006
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Bivalirudin.,Coagulation Factor IX (Recombinant),DB00006
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Bivalirudin.,Calcium acetate,DB00006
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Bivalirudin.,Calcium chloride,DB00006
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Bivalirudin.,Calcium,DB00006
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Bivalirudin.,Pantothenic acid,DB00006
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Bivalirudin.,Formic acid,DB00006
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bivalirudin.,Platelet Activating Factor,DB00006
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Bivalirudin.,Calcium carbonate,DB00006
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Bivalirudin.,Turoctocog alfa,DB00006
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Bivalirudin.,Fibrinogen human,DB00006
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Bivalirudin.,Catridecacog,DB00006
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Bivalirudin.","Antihemophilic Factor (Recombinant), PEGylated",DB00006
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Bivalirudin.,Calcium citrate,DB00006
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Bivalirudin.,Calcium gluconate,DB00006
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Bivalirudin.,Calcium threonate,DB00006
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Bivalirudin.,Prothrombin,DB00006
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Bivalirudin.,Factor IX Complex (Human),DB00006
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Bivalirudin.,Calcium Phosphate,DB00006
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Bivalirudin.,Susoctocog alfa,DB00006
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Bivalirudin.,Eftrenonacog alfa,DB00006
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Bivalirudin.,Rusalatide acetate,DB00006
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Bivalirudin.,Vatreptacog alfa,DB00006
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Bivalirudin.,Factor XIII (human),DB00006
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Bivalirudin.,Von Willebrand Factor Human,DB00006
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Bivalirudin.,Coagulation factor X human,DB00006
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Bivalirudin.,Coagulation factor VII human,DB00006
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Bivalirudin.,Anti-inhibitor coagulant complex,DB00006
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Bivalirudin.,Coagulation Factor IX Human,DB00006
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Bivalirudin.,Antihemophilic factor human,DB00006
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Bivalirudin.,Kallidinogenase,DB00006
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Bivalirudin.,Trenonacog alfa,DB00006
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Bivalirudin.,Albutrepenonacog alfa,DB00006
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Bivalirudin.,Emicizumab,DB00006
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Bivalirudin.,Nonacog beta pegol,DB00006
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Bivalirudin.,Moroctocog alfa,DB00006
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Bivalirudin.,Beroctocog alfa,DB00006
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Bivalirudin.,Andexanet alfa,DB00006
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Bivalirudin.,Calcium cation,DB00006
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Bivalirudin.,Damoctocog alfa pegol,DB00006
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Bivalirudin.,Turoctocog alfa pegol,DB00006
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Bivalirudin.,Fluvoxamine,DB00006
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Bivalirudin.,Citalopram,DB00006
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Bivalirudin.,Fluoxetine,DB00006
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Bivalirudin.,Paroxetine,DB00006
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Bivalirudin.,Nefazodone,DB00006
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Bivalirudin.,Zimelidine,DB00006
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Bivalirudin.,Dapoxetine,DB00006
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Bivalirudin.,Seproxetine,DB00006
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Bivalirudin.,Indalpine,DB00006
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Bivalirudin.,Ritanserin,DB00006
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Bivalirudin.,Alaproclate,DB00006
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Bivalirudin.,Duloxetine,DB00006
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Bivalirudin.,Sibutramine,DB00006
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Bivalirudin.,Milnacipran,DB00006
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Bivalirudin.,Desvenlafaxine,DB00006
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Bivalirudin.,Levomilnacipran,DB00006
DB00285,Venlafaxine may increase the antiplatelet activities of Bivalirudin.,Venlafaxine,DB00006
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Bivalirudin.,Amphetamine,DB00006
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Bivalirudin.,Linezolid,DB00006
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Bivalirudin.,Furazolidone,DB00006
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Bivalirudin.,Procaine,DB00006
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Bivalirudin.,Tranylcypromine,DB00006
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Bivalirudin.,Phenelzine,DB00006
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Bivalirudin.,Minaprine,DB00006
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Bivalirudin.,Selegiline,DB00006
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Bivalirudin.,Procarbazine,DB00006
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Bivalirudin.,Moclobemide,DB00006
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Bivalirudin.,Isocarboxazid,DB00006
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Bivalirudin.,Rasagiline,DB00006
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Bivalirudin.,Pargyline,DB00006
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Bivalirudin.,Clorgiline,DB00006
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Bivalirudin.,Iproniazid,DB00006
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Bivalirudin.,Nialamide,DB00006
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Bivalirudin.,Safinamide,DB00006
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Bivalirudin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00006
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Bivalirudin.,Methylene blue,DB00006
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Bivalirudin.,Hydracarbazine,DB00006
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Bivalirudin.,Pirlindole,DB00006
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Bivalirudin.,Toloxatone,DB00006
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Bivalirudin.,Benmoxin,DB00006
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Bivalirudin.,Mebanazine,DB00006
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Bivalirudin.,Octamoxin,DB00006
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Bivalirudin.,Pheniprazine,DB00006
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Bivalirudin.,Phenoxypropazine,DB00006
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Bivalirudin.,Pivhydrazine,DB00006
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Bivalirudin.,Safrazine,DB00006
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Bivalirudin.,Caroxazone,DB00006
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Bivalirudin.,Harmaline,DB00006
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Bivalirudin.,Brofaromine,DB00006
DB00266,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dicoumarol.,Dicoumarol,DB00006
DB00278,The risk or severity of bleeding can be increased when Bivalirudin is combined with Argatroban.,Argatroban,DB00006
DB00407,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ardeparin.,Ardeparin,DB00006
DB00498,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenindione.,Phenindione,DB00006
DB00569,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fondaparinux.,Fondaparinux,DB00006
DB00682,The risk or severity of bleeding can be increased when Bivalirudin is combined with Warfarin.,Warfarin,DB00006
DB00946,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenprocoumon.,Phenprocoumon,DB00006
DB00974,The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetic acid.,Edetic acid,DB00006
DB01109,The risk or severity of bleeding can be increased when Bivalirudin is combined with Heparin.,Heparin,DB00006
DB01225,The risk or severity of bleeding can be increased when Bivalirudin is combined with Enoxaparin.,Enoxaparin,DB00006
DB01418,The risk or severity of bleeding can be increased when Bivalirudin is combined with Acenocoumarol.,Acenocoumarol,DB00006
DB04898,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ximelagatran.,Ximelagatran,DB00006
DB05099,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ancrod.,Ancrod,DB00006
DB06271,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sulodexide.,Sulodexide,DB00006
DB06406,The risk or severity of bleeding can be increased when Bivalirudin is combined with Idraparinux.,Idraparinux,DB00006
DB06635,The risk or severity of bleeding can be increased when Bivalirudin is combined with Otamixaban.,Otamixaban,DB00006
DB06754,The risk or severity of bleeding can be increased when Bivalirudin is combined with Danaparoid.,Danaparoid,DB00006
DB06779,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dalteparin.,Dalteparin,DB00006
DB07767,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ferulic acid.,Ferulic acid,DB00006
DB08794,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00006
DB08813,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nadroparin.,Nadroparin,DB00006
DB09255,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dextran.,Dextran,DB00006
DB09259,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reviparin.,Reviparin,DB00006
DB09261,The risk or severity of bleeding can be increased when Bivalirudin is combined with Certoparin.,Certoparin,DB00006
DB11095,The risk or severity of bleeding can be increased when Bivalirudin is combined with Desirudin.,Desirudin,DB00006
DB11268,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protocatechualdehyde.,Protocatechualdehyde,DB00006
DB11312,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein C.,Protein C,DB00006
DB11598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin III human.,Antithrombin III human,DB00006
DB11984,The risk or severity of bleeding can be increased when Bivalirudin is combined with Letaxaban.,Letaxaban,DB00006
DB12289,The risk or severity of bleeding can be increased when Bivalirudin is combined with Darexaban.,Darexaban,DB00006
DB12598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nafamostat.,Nafamostat,DB00006
DB12831,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gabexate.,Gabexate,DB00006
DB13124,The risk or severity of bleeding can be increased when Bivalirudin is combined with Troxerutin.,Troxerutin,DB00006
DB13136,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluindione.,Fluindione,DB00006
DB13149,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein S human.,Protein S human,DB00006
DB13616,The risk or severity of bleeding can be increased when Bivalirudin is combined with Melagatran.,Melagatran,DB00006
DB09125,The risk or severity of bleeding can be increased when Bivalirudin is combined with Potassium citrate.,Potassium citrate,DB00006
DB09154,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sodium citrate.,Sodium citrate,DB00006
DB00031,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.,Tenecteplase,DB00006
DB00055,The risk or severity of bleeding can be increased when Bivalirudin is combined with Drotrecogin alfa.,Drotrecogin alfa,DB00006
DB06822,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tinzaparin.,Tinzaparin,DB00006
DB13199,The risk or severity of bleeding can be increased when Bivalirudin is combined with Brinase.,Brinase,DB00006
DB13646,The risk or severity of bleeding can be increased when Bivalirudin is combined with Saruplase.,Saruplase,DB00006
DB00086,The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptokinase.,Streptokinase,DB00006
DB04925,The risk or severity of bleeding can be increased when Bivalirudin is combined with Desmoteplase.,Desmoteplase,DB00006
DB05254,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fibrinolysin.,Fibrinolysin,DB00006
DB06543,The risk or severity of bleeding can be increased when Bivalirudin is combined with Astaxanthin.,Astaxanthin,DB00006
DB08994,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ditazole.,Ditazole,DB00006
DB09258,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bemiparin.,Bemiparin,DB00006
DB09260,The risk or severity of bleeding can be increased when Bivalirudin is combined with Parnaparin.,Parnaparin,DB00006
DB13275,The risk or severity of bleeding can be increased when Bivalirudin is combined with Clorindione.,Clorindione,DB00006
DB13347,The risk or severity of bleeding can be increased when Bivalirudin is combined with Diphenadione.,Diphenadione,DB00006
DB13451,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioclomarol.,Tioclomarol,DB00006
DB00001,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.,Lepirudin,DB00006
DB00009,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.,Alteplase,DB00006
DB00015,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.,Reteplase,DB00006
DB00029,The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.,Anistreplase,DB00006
DB14094,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tocopherylquinone.,Tocopherylquinone,DB00006
DB06679,The risk or severity of bleeding can be increased when Bivalirudin is combined with Amediplase.,Amediplase,DB00006
DB03410,The risk or severity of bleeding can be increased when Bivalirudin is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00006
DB08496,The risk or severity of bleeding can be increased when Bivalirudin is combined with (R)-warfarin.,(R)-warfarin,DB00006
DB14055,The risk or severity of bleeding can be increased when Bivalirudin is combined with (S)-Warfarin.,(S)-Warfarin,DB00006
DB12364,The risk or severity of bleeding can be increased when Bivalirudin is combined with Betrixaban.,Betrixaban,DB00006
DB14598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00006
DB11154,The risk or severity of bleeding can be increased when Bivalirudin is combined with Zinc citrate.,Zinc citrate,DB00006
DB11166,The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00006
DB04665,The risk or severity of bleeding can be increased when Bivalirudin is combined with Coumarin.,Coumarin,DB00006
DB14726,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dabigatran.,Dabigatran,DB00006
DB06294,The risk or severity of bleeding can be increased when Bivalirudin is combined with Semuloparin.,Semuloparin,DB00006
DB12726,The risk or severity of bleeding can be increased when Bivalirudin is combined with Monteplase.,Monteplase,DB00006
DB00203,The risk or severity of hemorrhage can be increased when Bivalirudin is combined with Sildenafil.,Sildenafil,DB00006
DB00008,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00006
DB00011,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00006
DB00018,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00006
DB00022,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00006
DB00033,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00006
DB00034,"The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00006
DB00041,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.,Aldesleukin,DB00006
DB00056,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00006
DB00068,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon beta-1b.,Interferon beta-1b,DB00006
DB00069,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00006
DB00073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Rituximab.,Rituximab,DB00006
DB00078,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00006
DB00087,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alemtuzumab.,Alemtuzumab,DB00006
DB00105,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00006
DB00120,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenylalanine.,Phenylalanine,DB00006
DB00188,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bortezomib.,Bortezomib,DB00006
DB00242,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cladribine.,Cladribine,DB00006
DB00262,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carmustine.,Carmustine,DB00006
DB00276,The risk or severity of bleeding can be increased when Bivalirudin is combined with Amsacrine.,Amsacrine,DB00006
DB00291,The risk or severity of bleeding can be increased when Bivalirudin is combined with Chlorambucil.,Chlorambucil,DB00006
DB00293,The risk or severity of bleeding can be increased when Bivalirudin is combined with Raltitrexed.,Raltitrexed,DB00006
DB00305,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitomycin.,Mitomycin,DB00006
DB00307,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bexarotene.,Bexarotene,DB00006
DB00309,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vindesine.,Vindesine,DB00006
DB00322,The risk or severity of bleeding can be increased when Bivalirudin is combined with Floxuridine.,Floxuridine,DB00006
DB00352,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioguanine.,Tioguanine,DB00006
DB00361,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinorelbine.,Vinorelbine,DB00006
DB00380,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dexrazoxane.,Dexrazoxane,DB00006
DB00398,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sorafenib.,Sorafenib,DB00006
DB00428,The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptozocin.,Streptozocin,DB00006
DB00441,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemcitabine.,Gemcitabine,DB00006
DB00444,The risk or severity of bleeding can be increased when Bivalirudin is combined with Teniposide.,Teniposide,DB00006
DB00445,The risk or severity of bleeding can be increased when Bivalirudin is combined with Epirubicin.,Epirubicin,DB00006
DB00446,The risk or severity of bleeding can be increased when Bivalirudin is combined with Chloramphenicol.,Chloramphenicol,DB00006
DB00480,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lenalidomide.,Lenalidomide,DB00006
DB00488,The risk or severity of bleeding can be increased when Bivalirudin is combined with Altretamine.,Altretamine,DB00006
DB00495,The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.,Zidovudine,DB00006
DB00515,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cisplatin.,Cisplatin,DB00006
DB00526,The risk or severity of bleeding can be increased when Bivalirudin is combined with Oxaliplatin.,Oxaliplatin,DB00006
DB00531,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cyclophosphamide.,Cyclophosphamide,DB00006
DB00544,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluorouracil.,Fluorouracil,DB00006
DB00552,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pentostatin.,Pentostatin,DB00006
DB00563,The risk or severity of bleeding can be increased when Bivalirudin is combined with Methotrexate.,Methotrexate,DB00006
DB00564,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carbamazepine.,Carbamazepine,DB00006
DB00570,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinblastine.,Vinblastine,DB00006
DB00619,The risk or severity of bleeding can be increased when Bivalirudin is combined with Imatinib.,Imatinib,DB00006
DB00631,The risk or severity of bleeding can be increased when Bivalirudin is combined with Clofarabine.,Clofarabine,DB00006
DB00642,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pemetrexed.,Pemetrexed,DB00006
DB00694,The risk or severity of bleeding can be increased when Bivalirudin is combined with Daunorubicin.,Daunorubicin,DB00006
DB00762,The risk or severity of bleeding can be increased when Bivalirudin is combined with Irinotecan.,Irinotecan,DB00006
DB00773,The risk or severity of bleeding can be increased when Bivalirudin is combined with Etoposide.,Etoposide,DB00006
DB00851,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dacarbazine.,Dacarbazine,DB00006
DB00853,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temozolomide.,Temozolomide,DB00006
DB00859,The risk or severity of bleeding can be increased when Bivalirudin is combined with Penicillamine.,Penicillamine,DB00006
DB00864,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tacrolimus.,Tacrolimus,DB00006
DB00877,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sirolimus.,Sirolimus,DB00006
DB00888,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mechlorethamine.,Mechlorethamine,DB00006
DB00928,The risk or severity of bleeding can be increased when Bivalirudin is combined with Azacitidine.,Azacitidine,DB00006
DB00958,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carboplatin.,Carboplatin,DB00006
DB00970,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dactinomycin.,Dactinomycin,DB00006
DB00987,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cytarabine.,Cytarabine,DB00006
DB00997,The risk or severity of bleeding can be increased when Bivalirudin is combined with Doxorubicin.,Doxorubicin,DB00006
DB01005,The risk or severity of bleeding can be increased when Bivalirudin is combined with Hydroxyurea.,Hydroxyurea,DB00006
DB01008,The risk or severity of bleeding can be increased when Bivalirudin is combined with Busulfan.,Busulfan,DB00006
DB01030,The risk or severity of bleeding can be increased when Bivalirudin is combined with Topotecan.,Topotecan,DB00006
DB01033,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mercaptopurine.,Mercaptopurine,DB00006
DB01041,The risk or severity of bleeding can be increased when Bivalirudin is combined with Thalidomide.,Thalidomide,DB00006
DB01042,The risk or severity of bleeding can be increased when Bivalirudin is combined with Melphalan.,Melphalan,DB00006
DB01073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fludarabine.,Fludarabine,DB00006
DB01099,The risk or severity of bleeding can be increased when Bivalirudin is combined with Flucytosine.,Flucytosine,DB00006
DB01101,The risk or severity of bleeding can be increased when Bivalirudin is combined with Capecitabine.,Capecitabine,DB00006
DB01169,The risk or severity of bleeding can be increased when Bivalirudin is combined with Arsenic trioxide.,Arsenic trioxide,DB00006
DB01177,The risk or severity of bleeding can be increased when Bivalirudin is combined with Idarubicin.,Idarubicin,DB00006
DB01204,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitoxantrone.,Mitoxantrone,DB00006
DB01206,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lomustine.,Lomustine,DB00006
DB01229,The risk or severity of bleeding can be increased when Bivalirudin is combined with Paclitaxel.,Paclitaxel,DB00006
DB01248,The risk or severity of bleeding can be increased when Bivalirudin is combined with Docetaxel.,Docetaxel,DB00006
DB01262,The risk or severity of bleeding can be increased when Bivalirudin is combined with Decitabine.,Decitabine,DB00006
DB01280,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nelarabine.,Nelarabine,DB00006
DB01590,The risk or severity of bleeding can be increased when Bivalirudin is combined with Everolimus.,Everolimus,DB00006
DB02546,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vorinostat.,Vorinostat,DB00006
DB04572,The risk or severity of bleeding can be increased when Bivalirudin is combined with Thiotepa.,Thiotepa,DB00006
DB04845,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ixabepilone.,Ixabepilone,DB00006
DB04868,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nilotinib.,Nilotinib,DB00006
DB05015,The risk or severity of bleeding can be increased when Bivalirudin is combined with Belinostat.,Belinostat,DB00006
DB05109,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trabectedin.,Trabectedin,DB00006
DB05258,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa.,Interferon alfa,DB00006
DB05472,The risk or severity of bleeding can be increased when Bivalirudin is combined with omega interferon.,omega interferon,DB00006
DB05773,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00006
DB06287,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temsirolimus.,Temsirolimus,DB00006
DB06616,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bosutinib.,Bosutinib,DB00006
DB06769,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bendamustine.,Bendamustine,DB00006
DB06772,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cabazitaxel.,Cabazitaxel,DB00006
DB08871,The risk or severity of bleeding can be increased when Bivalirudin is combined with Eribulin.,Eribulin,DB00006
DB08877,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ruxolitinib.,Ruxolitinib,DB00006
DB08889,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carfilzomib.,Carfilzomib,DB00006
DB08895,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tofacitinib.,Tofacitinib,DB00006
DB08901,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ponatinib.,Ponatinib,DB00006
DB08910,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pomalidomide.,Pomalidomide,DB00006
DB09042,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00006
DB09052,The risk or severity of bleeding can be increased when Bivalirudin is combined with Blinatumomab.,Blinatumomab,DB00006
DB09073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Palbociclib.,Palbociclib,DB00006
DB09074,The risk or severity of bleeding can be increased when Bivalirudin is combined with Olaparib.,Olaparib,DB00006
DB09077,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dinutuximab.,Dinutuximab,DB00006
DB09122,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00006
DB12814,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00006
DB00229,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotiam.,Cefotiam,DB00006
DB00267,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00006
DB00274,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00006
DB00430,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00006
DB00438,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00006
DB00447,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Loracarbef.,Loracarbef,DB00006
DB00456,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefalotin.,Cefalotin,DB00006
DB00493,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00006
DB00535,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefdinir.,Cefdinir,DB00006
DB00567,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephalexin.,Cephalexin,DB00006
DB00671,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefixime.,Cefixime,DB00006
DB00689,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00006
DB00833,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaclor.,Cefaclor,DB00006
DB00923,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceforanide.,Ceforanide,DB00006
DB01066,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefditoren.,Cefditoren,DB00006
DB01112,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00006
DB01139,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefapirin.,Cefapirin,DB00006
DB01140,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00006
DB01150,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefprozil.,Cefprozil,DB00006
DB01212,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00006
DB01326,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole.,Cefamandole,DB00006
DB01327,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazolin.,Cefazolin,DB00006
DB01328,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefonicid.,Cefonicid,DB00006
DB01329,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00006
DB01330,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotetan.,Cefotetan,DB00006
DB01331,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00006
DB01332,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00006
DB01333,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefradine.,Cefradine,DB00006
DB01413,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefepime.,Cefepime,DB00006
DB01414,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00006
DB01415,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00006
DB01416,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00006
DB04570,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Latamoxef.,Latamoxef,DB00006
DB04918,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00006
DB06590,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00006
DB09008,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00006
DB09050,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00006
DB09062,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefminox.,Cefminox,DB00006
DB11367,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00006
DB11935,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Flomoxef.,Flomoxef,DB00006
DB13266,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00006
DB13461,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefcapene.,Cefcapene,DB00006
DB13470,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefodizime.,Cefodizime,DB00006
DB13499,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00006
DB13504,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefetamet.,Cefetamet,DB00006
DB13638,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00006
DB13667,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefozopran.,Cefozopran,DB00006
DB13682,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpirome.,Cefpirome,DB00006
DB13778,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazedone.,Cefazedone,DB00006
DB13821,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftezole.,Ceftezole,DB00006
DB14725,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00006
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Bivalirudin.,Doxycycline,DB00006
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Bivalirudin.,Azithromycin,DB00006
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Bivalirudin.,Omega-3-acid ethyl esters,DB00006
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.,Acetylsalicylic acid,DB00006
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Bivalirudin.,Tazobactam,DB00006
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Bivalirudin.,Erythromycin,DB00006
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Bivalirudin.,Trazodone,DB00006
DB00620,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00006
DB09079,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nintedanib.,Nintedanib,DB00006
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Bivalirudin.,Escitalopram,DB00006
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Bivalirudin.,Sertraline,DB00006
DB00232,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00006
DB00436,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00006
DB00562,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00006
DB00606,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00006
DB00774,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00006
DB00880,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00006
DB00999,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00006
DB01021,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00006
DB01324,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Polythiazide.,Polythiazide,DB00006
DB13430,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mebutizide.,Mebutizide,DB00006
DB13532,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00006
DB09066,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Leuprolide.,Corifollitropin alfa,DB00007
DB09083,Ivabradine may increase the QTc-prolonging activities of Leuprolide.,Ivabradine,DB00007
DB08894,The risk or severity of Thrombosis can be increased when Leuprolide is combined with Peginesatide.,Peginesatide,DB00007
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Leuprolide.,Darbepoetin alfa,DB00007
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.,Erythropoietin,DB00007
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Leuprolide.,Methoxy polyethylene glycol-epoetin beta,DB00007
DB09277,Leuprolide may decrease effectiveness of Choline C 11 as a diagnostic agent.,Choline C 11,DB00007
DB00089,Leuprolide may decrease effectiveness of Capromab pendetide as a diagnostic agent.,Capromab pendetide,DB00007
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Leuprolide.,Insulin human,DB00007
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Leuprolide.,Insulin lispro,DB00007
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Leuprolide.,Insulin glargine,DB00007
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Leuprolide.,Insulin pork,DB00007
DB00197,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Leuprolide.,Troglitazone,DB00007
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Leuprolide.,Glimepiride,DB00007
DB00284,The therapeutic efficacy of Acarbose can be decreased when used in combination with Leuprolide.,Acarbose,DB00007
DB00359,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Leuprolide.,Sulfadiazine,DB00007
DB00412,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Leuprolide.,Rosiglitazone,DB00007
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Leuprolide.,Acetohexamide,DB00007
DB00491,The therapeutic efficacy of Miglitol can be decreased when used in combination with Leuprolide.,Miglitol,DB00007
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Leuprolide.,Chlorpropamide,DB00007
DB00731,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Leuprolide.,Nateglinide,DB00007
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Leuprolide.,Tolazamide,DB00007
DB00912,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Leuprolide.,Repaglinide,DB00007
DB00914,The therapeutic efficacy of Phenformin can be decreased when used in combination with Leuprolide.,Phenformin,DB00007
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Leuprolide.,Glyburide,DB00007
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Leuprolide.,Glipizide,DB00007
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Leuprolide.,Gliclazide,DB00007
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Leuprolide.,Tolbutamide,DB00007
DB01132,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Leuprolide.,Pioglitazone,DB00007
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Leuprolide.,Gliquidone,DB00007
DB01252,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Leuprolide.,Mitiglinide,DB00007
DB01261,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Leuprolide.,Sitagliptin,DB00007
DB01276,The therapeutic efficacy of Exenatide can be decreased when used in combination with Leuprolide.,Exenatide,DB00007
DB01277,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Leuprolide.,Mecasermin,DB00007
DB01278,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Leuprolide.,Pramlintide,DB00007
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Leuprolide.,Glisoxepide,DB00007
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Leuprolide.,Insulin aspart,DB00007
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Leuprolide.,Insulin detemir,DB00007
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Leuprolide.,Insulin glulisine,DB00007
DB01382,The therapeutic efficacy of Glymidine can be decreased when used in combination with Leuprolide.,Glymidine,DB00007
DB01700,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Leuprolide.,AICA ribonucleotide,DB00007
DB04830,The therapeutic efficacy of Buformin can be decreased when used in combination with Leuprolide.,Buformin,DB00007
DB04876,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Leuprolide.,Vildagliptin,DB00007
DB04878,The therapeutic efficacy of Voglibose can be decreased when used in combination with Leuprolide.,Voglibose,DB00007
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Leuprolide.,NN344,DB00007
DB05819,The therapeutic efficacy of NBI-6024 can be decreased when used in combination with Leuprolide.,NBI-6024,DB00007
DB06011,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Leuprolide.,AMG-222,DB00007
DB06127,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Leuprolide.,Bisegliptin,DB00007
DB06203,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Leuprolide.,Alogliptin,DB00007
DB06292,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Leuprolide.,Dapagliflozin,DB00007
DB06335,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Leuprolide.,Saxagliptin,DB00007
DB06655,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Leuprolide.,Liraglutide,DB00007
DB08382,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Leuprolide.,Gosogliptin,DB00007
DB08882,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Leuprolide.,Linagliptin,DB00007
DB08907,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Leuprolide.,Canagliflozin,DB00007
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Leuprolide.,Glibornuride,DB00007
DB09022,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Leuprolide.,Benfluorex,DB00007
DB09038,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Leuprolide.,Empagliflozin,DB00007
DB09043,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Leuprolide.,Albiglutide,DB00007
DB09045,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Leuprolide.,Dulaglutide,DB00007
DB09198,The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Leuprolide.,Lobeglitazone,DB00007
DB09199,The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Leuprolide.,Netoglitazone,DB00007
DB09200,The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Leuprolide.,Rivoglitazone,DB00007
DB09201,The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Leuprolide.,Ciglitazone,DB00007
DB09265,The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Leuprolide.,Lixisenatide,DB00007
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Leuprolide.,Insulin beef,DB00007
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Leuprolide.,Insulin degludec,DB00007
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Leuprolide.,Insulin peglispro,DB00007
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Leuprolide.,Insulin tregopil,DB00007
DB11698,The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Leuprolide.,Ipragliflozin,DB00007
DB11723,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Leuprolide.,Dutogliptin,DB00007
DB11780,The therapeutic efficacy of Allicin can be decreased when used in combination with Leuprolide.,Allicin,DB00007
DB11824,The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Leuprolide.,Tofogliflozin,DB00007
DB11827,The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Leuprolide.,Ertugliflozin,DB00007
DB11898,"The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Leuprolide.","2,4-thiazolidinedione",DB00007
DB11950,The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Leuprolide.,Teneligliptin,DB00007
DB11992,The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Leuprolide.,Omarigliptin,DB00007
DB12268,The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Leuprolide.,Carmegliptin,DB00007
DB12412,The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Leuprolide.,Gemigliptin,DB00007
DB12417,The therapeutic efficacy of Anagliptin can be decreased when used in combination with Leuprolide.,Anagliptin,DB00007
DB12625,The therapeutic efficacy of Evogliptin can be decreased when used in combination with Leuprolide.,Evogliptin,DB00007
DB12713,The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Leuprolide.,Sotagliflozin,DB00007
DB12781,The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Leuprolide.,Balaglitazone,DB00007
DB12935,The therapeutic efficacy of Remogliflozin etabonate can be decreased when used in combination with Leuprolide.,Remogliflozin etabonate,DB00007
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Leuprolide.,Carbutamide,DB00007
DB13446,The therapeutic efficacy of Guar gum can be decreased when used in combination with Leuprolide.,Guar gum,DB00007
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Leuprolide.,Metahexamide,DB00007
DB13928,The therapeutic efficacy of Semaglutide can be decreased when used in combination with Leuprolide.,Semaglutide,DB00007
DB14027,The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Leuprolide.,Taspoglutide,DB00007
DB14035,The therapeutic efficacy of Englitazone can be decreased when used in combination with Leuprolide.,Englitazone,DB00007
DB15171,The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Leuprolide.,Tirzepatide,DB00007
DB15217,The therapeutic efficacy of Gastric inhibitory polypeptide can be decreased when used in combination with Leuprolide.,Gastric inhibitory polypeptide,DB00007
DB01200,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Leuprolide.,Bromocriptine,DB00007
DB00215,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Citalopram.,Citalopram,DB00007
DB00261,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Anagrelide.,Anagrelide,DB00007
DB00280,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Disopyramide.,Disopyramide,DB00007
DB00283,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clemastine.,Clemastine,DB00007
DB00308,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ibutilide.,Ibutilide,DB00007
DB00313,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Valproic acid.,Valproic acid,DB00007
DB00365,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Grepafloxacin.,Grepafloxacin,DB00007
DB00468,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quinine.,Quinine,DB00007
DB00489,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sotalol.,Sotalol,DB00007
DB00530,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erlotinib.,Erlotinib,DB00007
DB00539,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Toremifene.,Toremifene,DB00007
DB00619,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imatinib.,Imatinib,DB00007
DB00679,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Thioridazine.,Thioridazine,DB00007
DB00685,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Trovafloxacin.,Trovafloxacin,DB00007
DB00834,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mifepristone.,Mifepristone,DB00007
DB00875,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Flupentixol.,Flupentixol,DB00007
DB00907,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cocaine.,Cocaine,DB00007
DB01035,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Procainamide.,Procainamide,DB00007
DB01169,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Arsenic trioxide.,Arsenic trioxide,DB00007
DB01175,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Escitalopram.,Escitalopram,DB00007
DB01184,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Domperidone.,Domperidone,DB00007
DB01208,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sparfloxacin.,Sparfloxacin,DB00007
DB01218,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Halofantrine.,Halofantrine,DB00007
DB01244,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bepridil.,Bepridil,DB00007
DB01267,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Paliperidone.,Paliperidone,DB00007
DB01356,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lithium cation.,Lithium cation,DB00007
DB01405,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Temafloxacin.,Temafloxacin,DB00007
DB01624,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Zuclopenthixol.,Zuclopenthixol,DB00007
DB04844,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tetrabenazine.,Tetrabenazine,DB00007
DB04868,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nilotinib.,Nilotinib,DB00007
DB04946,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Iloperidone.,Iloperidone,DB00007
DB05294,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Vandetanib.,Vandetanib,DB00007
DB06176,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Romidepsin.,Romidepsin,DB00007
DB06216,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Asenapine.,Asenapine,DB00007
DB06697,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Artemether.,Artemether,DB00007
DB06708,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lumefantrine.,Lumefantrine,DB00007
DB08881,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Vemurafenib.,Vemurafenib,DB00007
DB11730,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ribociclib.,Ribociclib,DB00007
DB11978,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Glasdegib.,Glasdegib,DB00007
DB12161,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Deutetrabenazine.,Deutetrabenazine,DB00007
DB13074,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Macimorelin.,Macimorelin,DB00007
DB13725,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terodiline.,Terodiline,DB00007
DB00204,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dofetilide.,Dofetilide,DB00007
DB00342,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terfenadine.,Terfenadine,DB00007
DB00604,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cisapride.,Cisapride,DB00007
DB00637,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Astemizole.,Astemizole,DB00007
DB00908,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quinidine.,Quinidine,DB00007
DB01100,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pimozide.,Pimozide,DB00007
DB01118,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amiodarone.,Amiodarone,DB00007
DB04855,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dronedarone.,Dronedarone,DB00007
DB09039,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Eliglustat.,Eliglustat,DB00007
DB00014,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Goserelin.,Goserelin,DB00007
DB00195,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Betaxolol.,Betaxolol,DB00007
DB00199,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erythromycin.,Erythromycin,DB00007
DB00207,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azithromycin.,Azithromycin,DB00007
DB00218,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Moxifloxacin.,Moxifloxacin,DB00007
DB00243,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ranolazine.,Ranolazine,DB00007
DB00263,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sulfisoxazole.,Sulfisoxazole,DB00007
DB00333,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Methadone.,Methadone,DB00007
DB00343,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Diltiazem.,Diltiazem,DB00007
DB00363,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clozapine.,Clozapine,DB00007
DB00391,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sulpiride.,Sulpiride,DB00007
DB00393,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nimodipine.,Nimodipine,DB00007
DB00420,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Promazine.,Promazine,DB00007
DB00433,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Prochlorperazine.,Prochlorperazine,DB00007
DB00450,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Droperidol.,Droperidol,DB00007
DB00477,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpromazine.,Chlorpromazine,DB00007
DB00526,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxaliplatin.,Oxaliplatin,DB00007
DB00537,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ciprofloxacin.,Ciprofloxacin,DB00007
DB00544,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluorouracil.,Fluorouracil,DB00007
DB00556,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Perflutren.,Perflutren,DB00007
DB00568,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinnarizine.,Cinnarizine,DB00007
DB00571,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propranolol.,Propranolol,DB00007
DB00572,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Atropine.,Atropine,DB00007
DB00608,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chloroquine.,Chloroquine,DB00007
DB00640,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Adenosine.,Adenosine,DB00007
DB00738,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pentamidine.,Pentamidine,DB00007
DB00743,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gadobenic acid.,Gadobenic acid,DB00007
DB00748,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Carbinoxamine.,Carbinoxamine,DB00007
DB00757,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dolasetron.,Dolasetron,DB00007
DB00778,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Roxithromycin.,Roxithromycin,DB00007
DB00779,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nalidixic acid.,Nalidixic acid,DB00007
DB00827,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinoxacin.,Cinoxacin,DB00007
DB00889,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Granisetron.,Granisetron,DB00007
DB00904,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ondansetron.,Ondansetron,DB00007
DB00922,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levosimendan.,Levosimendan,DB00007
DB00933,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mesoridazine.,Mesoridazine,DB00007
DB00967,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Desloratadine.,Desloratadine,DB00007
DB00978,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lomefloxacin.,Lomefloxacin,DB00007
DB00985,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dimenhydrinate.,Dimenhydrinate,DB00007
DB01087,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Primaquine.,Primaquine,DB00007
DB01113,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Papaverine.,Papaverine,DB00007
DB01114,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpheniramine.,Chlorpheniramine,DB00007
DB01115,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nifedipine.,Nifedipine,DB00007
DB01137,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levofloxacin.,Levofloxacin,DB00007
DB01155,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gemifloxacin.,Gemifloxacin,DB00007
DB01165,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ofloxacin.,Ofloxacin,DB00007
DB01182,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propafenone.,Propafenone,DB00007
DB01193,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Acebutolol.,Acebutolol,DB00007
DB01195,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Flecainide.,Flecainide,DB00007
DB01580,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxprenolol.,Oxprenolol,DB00007
DB01599,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Probucol.,Probucol,DB00007
DB01615,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Aceprometazine.,Aceprometazine,DB00007
DB02638,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terlipressin.,Terlipressin,DB00007
DB04825,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Prenylamine.,Prenylamine,DB00007
DB04842,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluspirilene.,Fluspirilene,DB00007
DB04948,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lofexidine.,Lofexidine,DB00007
DB04957,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azimilide.,Azimilide,DB00007
DB05223,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pracinostat.,Pracinostat,DB00007
DB05488,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin,DB00007
DB06160,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Garenoxacin.,Garenoxacin,DB00007
DB06200,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tedisamil.,Tedisamil,DB00007
DB06334,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tucidinostat.,Tucidinostat,DB00007
DB06402,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telavancin.,Telavancin,DB00007
DB06589,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pazopanib.,Pazopanib,DB00007
DB06600,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nemonoxacin.,Nemonoxacin,DB00007
DB06603,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Panobinostat.,Panobinostat,DB00007
DB06712,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nilvadipine.,Nilvadipine,DB00007
DB08799,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Antazoline.,Antazoline,DB00007
DB08865,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Crizotinib.,Crizotinib,DB00007
DB08903,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bedaquiline.,Bedaquiline,DB00007
DB08980,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fendiline.,Fendiline,DB00007
DB08992,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Eperisone.,Eperisone,DB00007
DB09016,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Butriptyline.,Butriptyline,DB00007
DB09063,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ceritinib.,Ceritinib,DB00007
DB09078,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lenvatinib.,Lenvatinib,DB00007
DB09224,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Melperone.,Melperone,DB00007
DB09231,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Benidipine.,Benidipine,DB00007
DB09555,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine maleate.,Dexchlorpheniramine maleate,DB00007
DB11640,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amifampridine.,Amifampridine,DB00007
DB11830,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mocetinostat.,Mocetinostat,DB00007
DB11841,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entinostat.,Entinostat,DB00007
DB12141,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gilteritinib.,Gilteritinib,DB00007
DB12174,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with CUDC-101.,CUDC-101,DB00007
DB12286,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Simendan.,Simendan,DB00007
DB12376,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ricolinostat.,Ricolinostat,DB00007
DB12523,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mizolastine.,Mizolastine,DB00007
DB12565,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Abexinostat.,Abexinostat,DB00007
DB12877,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxatomide.,Oxatomide,DB00007
DB13261,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sitafloxacin.,Sitafloxacin,DB00007
DB13273,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sultopride.,Sultopride,DB00007
DB13500,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Otilonium.,Otilonium,DB00007
DB13546,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nizofenone.,Nizofenone,DB00007
DB13652,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bunaftine.,Bunaftine,DB00007
DB13653,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lorcainide.,Lorcainide,DB00007
DB13679,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine.,Dexchlorpheniramine,DB00007
DB13791,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Penfluridol.,Penfluridol,DB00007
DB14063,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexverapamil.,Dexverapamil,DB00007
DB14568,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ivosidenib.,Ivosidenib,DB00007
DB00625,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Efavirenz.,Efavirenz,DB00007
DB00836,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Loperamide.,Loperamide,DB00007
DB00976,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telithromycin.,Telithromycin,DB00007
DB01211,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clarithromycin.,Clarithromycin,DB00007
DB01224,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quetiapine.,Quetiapine,DB00007
DB01227,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levacetylmethadol.,Levacetylmethadol,DB00007
DB01232,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Saquinavir.,Saquinavir,DB00007
DB01388,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mibefradil.,Mibefradil,DB00007
DB00321,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amitriptyline.,Amitriptyline,DB00007
DB00458,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imipramine.,Imipramine,DB00007
DB01242,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clomipramine.,Clomipramine,DB00007
DB11718,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Encorafenib.,Encorafenib,DB00007
DB00104,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Leuprolide.,Octreotide,DB00007
DB00107,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Leuprolide.,Oxytocin,DB00007
DB00187,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Leuprolide.,Esmolol,DB00007
DB00188,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Leuprolide.,Bortezomib,DB00007
DB00196,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Leuprolide.,Fluconazole,DB00007
DB00230,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Leuprolide.,Pregabalin,DB00007
DB00245,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Leuprolide.,Benzatropine,DB00007
DB00270,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Leuprolide.,Isradipine,DB00007
DB00285,The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Leuprolide.,Venlafaxine,DB00007
DB00289,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Leuprolide.,Atomoxetine,DB00007
DB00334,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Leuprolide.,Olanzapine,DB00007
DB00341,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Leuprolide.,Cetirizine,DB00007
DB00344,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Leuprolide.,Protriptyline,DB00007
DB00346,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Leuprolide.,Alfuzosin,DB00007
DB00347,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Leuprolide.,Trimethadione,DB00007
DB00354,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Leuprolide.,Buclizine,DB00007
DB00358,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Leuprolide.,Mefloquine,DB00007
DB00366,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Leuprolide.,Doxylamine,DB00007
DB00370,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Leuprolide.,Mirtazapine,DB00007
DB00373,The risk or severity of QTc prolongation can be increased when Timolol is combined with Leuprolide.,Timolol,DB00007
DB00374,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Leuprolide.,Treprostinil,DB00007
DB00398,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Leuprolide.,Sorafenib,DB00007
DB00405,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Leuprolide.,Dexbrompheniramine,DB00007
DB00424,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Leuprolide.,Hyoscyamine,DB00007
DB00427,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Leuprolide.,Triprolidine,DB00007
DB00434,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Leuprolide.,Cyproheptadine,DB00007
DB00467,The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Leuprolide.,Enoxacin,DB00007
DB00487,The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Leuprolide.,Pefloxacin,DB00007
DB00529,The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Leuprolide.,Foscarnet,DB00007
DB00543,The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Leuprolide.,Amoxapine,DB00007
DB00555,The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Leuprolide.,Lamotrigine,DB00007
DB00613,The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Leuprolide.,Amodiaquine,DB00007
DB00622,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Leuprolide.,Nicardipine,DB00007
DB00674,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Leuprolide.,Galantamine,DB00007
DB00675,The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Leuprolide.,Tamoxifen,DB00007
DB00678,The risk or severity of QTc prolongation can be increased when Losartan is combined with Leuprolide.,Losartan,DB00007
DB00680,The risk or severity of QTc prolongation can be increased when Moricizine is combined with Leuprolide.,Moricizine,DB00007
DB00691,The risk or severity of QTc prolongation can be increased when Moexipril is combined with Leuprolide.,Moexipril,DB00007
DB00697,The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Leuprolide.,Tizanidine,DB00007
DB00710,The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Leuprolide.,Ibandronate,DB00007
DB00714,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Leuprolide.,Apomorphine,DB00007
DB00719,The risk or severity of QTc prolongation can be increased when Azatadine is combined with Leuprolide.,Azatadine,DB00007
DB00734,The risk or severity of QTc prolongation can be increased when Risperidone is combined with Leuprolide.,Risperidone,DB00007
DB00753,The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Leuprolide.,Isoflurane,DB00007
DB00808,The risk or severity of QTc prolongation can be increased when Indapamide is combined with Leuprolide.,Indapamide,DB00007
DB00817,The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Leuprolide.,Rosoxacin,DB00007
DB00818,The risk or severity of QTc prolongation can be increased when Propofol is combined with Leuprolide.,Propofol,DB00007
DB00822,The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Leuprolide.,Disulfiram,DB00007
DB00825,The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Leuprolide.,Levomenthol,DB00007
DB00835,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Leuprolide.,Brompheniramine,DB00007
DB00871,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Leuprolide.,Terbutaline,DB00007
DB00909,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Leuprolide.,Zonisamide,DB00007
DB00915,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Leuprolide.,Amantadine,DB00007
DB00916,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Leuprolide.,Metronidazole,DB00007
DB00920,The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Leuprolide.,Ketotifen,DB00007
DB00927,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Leuprolide.,Famotidine,DB00007
DB00934,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Leuprolide.,Maprotiline,DB00007
DB00938,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Leuprolide.,Salmeterol,DB00007
DB00949,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Leuprolide.,Felbamate,DB00007
DB00983,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Leuprolide.,Formoterol,DB00007
DB00999,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Leuprolide.,Hydrochlorothiazide,DB00007
DB01001,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Leuprolide.,Salbutamol,DB00007
DB01015,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Leuprolide.,Sulfamethoxazole,DB00007
DB01036,The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Leuprolide.,Tolterodine,DB00007
DB01044,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Leuprolide.,Gatifloxacin,DB00007
DB01054,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Leuprolide.,Nitrendipine,DB00007
DB01059,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Leuprolide.,Norfloxacin,DB00007
DB01069,The risk or severity of QTc prolongation can be increased when Promethazine is combined with Leuprolide.,Promethazine,DB00007
DB01071,The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Leuprolide.,Mequitazine,DB00007
DB01074,The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Leuprolide.,Perhexiline,DB00007
DB01075,The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Leuprolide.,Diphenhydramine,DB00007
DB01106,The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Leuprolide.,Levocabastine,DB00007
DB01158,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Leuprolide.,Bretylium,DB00007
DB01166,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Leuprolide.,Cilostazol,DB00007
DB01173,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Leuprolide.,Orphenadrine,DB00007
DB01176,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Leuprolide.,Cyclizine,DB00007
DB01189,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Leuprolide.,Desflurane,DB00007
DB01228,The risk or severity of QTc prolongation can be increased when Encainide is combined with Leuprolide.,Encainide,DB00007
DB01233,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Leuprolide.,Metoclopramide,DB00007
DB01236,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Leuprolide.,Sevoflurane,DB00007
DB01238,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Leuprolide.,Aripiprazole,DB00007
DB01239,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Leuprolide.,Chlorprothixene,DB00007
DB01246,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Leuprolide.,Alimemazine,DB00007
DB01259,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Leuprolide.,Lapatinib,DB00007
DB01268,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Leuprolide.,Sunitinib,DB00007
DB01274,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Leuprolide.,Arformoterol,DB00007
DB01403,The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Leuprolide.,Methotrimeprazine,DB00007
DB01426,The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Leuprolide.,Ajmaline,DB00007
DB01591,The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Leuprolide.,Solifenacin,DB00007
DB01611,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Leuprolide.,Hydroxychloroquine,DB00007
DB01620,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Leuprolide.,Pheniramine,DB00007
DB01623,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Leuprolide.,Thiothixene,DB00007
DB02546,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Leuprolide.,Vorinostat,DB00007
DB04576,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Leuprolide.,Fleroxacin,DB00007
DB04695,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Leuprolide.,Farnesyl thiopyrophosphate,DB00007
DB04846,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Leuprolide.,Celiprolol,DB00007
DB04953,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Leuprolide.,Ezogabine,DB00007
DB05039,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Leuprolide.,Indacaterol,DB00007
DB05246,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Leuprolide.,Methsuximide,DB00007
DB05465,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Leuprolide.,Tandutinib,DB00007
DB06217,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Leuprolide.,Vernakalant,DB00007
DB06282,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Leuprolide.,Levocetirizine,DB00007
DB06288,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Leuprolide.,Amisulpride,DB00007
DB06468,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Leuprolide.,Cariporide,DB00007
DB06663,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Leuprolide.,Pasireotide,DB00007
DB06691,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Leuprolide.,Mepyramine,DB00007
DB06699,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Leuprolide.,Degarelix,DB00007
DB06719,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Leuprolide.,Buserelin,DB00007
DB06788,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Leuprolide.,Histrelin,DB00007
DB06825,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Leuprolide.,Triptorelin,DB00007
DB07780,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Leuprolide.,Farnesyl diphosphate,DB00007
DB07841,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Leuprolide.,Geranylgeranyl diphosphate,DB00007
DB08808,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Leuprolide.,Bupranolol,DB00007
DB08871,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Leuprolide.,Eribulin,DB00007
DB08893,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Leuprolide.,Mirabegron,DB00007
DB08912,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Leuprolide.,Dabrafenib,DB00007
DB08936,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Leuprolide.,Chlorcyclizine,DB00007
DB08952,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Leuprolide.,Indenolol,DB00007
DB08972,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Leuprolide.,Flumequine,DB00007
DB09080,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Leuprolide.,Olodaterol,DB00007
DB09082,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Leuprolide.,Vilanterol,DB00007
DB09089,The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Leuprolide.,Trimebutine,DB00007
DB09090,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Leuprolide.,Pinaverium,DB00007
DB09167,The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Leuprolide.,Dosulepin,DB00007
DB09229,The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Leuprolide.,Aranidipine,DB00007
DB09235,The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Leuprolide.,Efonidipine,DB00007
DB09236,The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Leuprolide.,Lacidipine,DB00007
DB09239,The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Leuprolide.,Niguldipine,DB00007
DB09488,The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Leuprolide.,Acrivastine,DB00007
DB11390,The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Leuprolide.,Coumaphos,DB00007
DB11397,The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Leuprolide.,Dichlorvos,DB00007
DB11408,The risk or severity of QTc prolongation can be increased when Famphur is combined with Leuprolide.,Famphur,DB00007
DB11412,The risk or severity of QTc prolongation can be increased when Fenthion is combined with Leuprolide.,Fenthion,DB00007
DB11443,The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Leuprolide.,Orbifloxacin,DB00007
DB11448,The risk or severity of QTc prolongation can be increased when Phosmet is combined with Leuprolide.,Phosmet,DB00007
DB11491,The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Leuprolide.,Sarafloxacin,DB00007
DB11511,The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Leuprolide.,Difloxacin,DB00007
DB11591,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Leuprolide.,Bilastine,DB00007
DB11614,The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Leuprolide.,Rupatadine,DB00007
DB11770,The risk or severity of QTc prolongation can be increased when Talinolol is combined with Leuprolide.,Talinolol,DB00007
DB11774,The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Leuprolide.,Pazufloxacin,DB00007
DB11785,The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Leuprolide.,Anisodamine,DB00007
DB11891,The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Leuprolide.,CUDC-907,DB00007
DB11892,The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Leuprolide.,Prulifloxacin,DB00007
DB11943,The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Leuprolide.,Delafloxacin,DB00007
DB12093,The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Leuprolide.,Tetrahydropalmatine,DB00007
DB12231,The risk or severity of QTc prolongation can be increased when Temefos is combined with Leuprolide.,Temefos,DB00007
DB12245,The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Leuprolide.,Triclabendazole,DB00007
DB12645,The risk or severity of QTc prolongation can be increased when Givinostat is combined with Leuprolide.,Givinostat,DB00007
DB12712,The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Leuprolide.,Pilsicainide,DB00007
DB12766,The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Leuprolide.,Cicletanine,DB00007
DB12923,The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Leuprolide.,Gallopamil,DB00007
DB13358,The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Leuprolide.,Cibenzoline,DB00007
DB13488,The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Leuprolide.,Bencyclane,DB00007
DB13555,The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Leuprolide.,Prajmaline,DB00007
DB13627,The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Leuprolide.,Oxolinic acid,DB00007
DB13651,The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Leuprolide.,Lorajmine,DB00007
DB13691,The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Leuprolide.,Acetyldigoxin,DB00007
DB13744,The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Leuprolide.,Piromidic acid,DB00007
DB13766,The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Leuprolide.,Lidoflazine,DB00007
DB13772,The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Leuprolide.,Rufloxacin,DB00007
DB13823,The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Leuprolide.,Pipemidic acid,DB00007
DB14185,The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Leuprolide.,Aripiprazole lauroxil,DB00007
DB14713,The risk or severity of QTc prolongation can be increased when Inotersen is combined with Leuprolide.,Inotersen,DB00007
DB00220,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nelfinavir.,Nelfinavir,DB00007
DB00726,The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Leuprolide.,Trimipramine,DB00007
DB00540,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Leuprolide.,Nortriptyline,DB00007
DB00582,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Leuprolide.,Voriconazole,DB00007
DB00593,The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Leuprolide.,Ethosuximide,DB00007
DB00862,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Leuprolide.,Vardenafil,DB00007
DB00864,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Leuprolide.,Tacrolimus,DB00007
DB01023,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Leuprolide.,Felodipine,DB00007
DB01026,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Leuprolide.,Ketoconazole,DB00007
DB01072,The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Leuprolide.,Atazanavir,DB00007
DB01167,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Leuprolide.,Itraconazole,DB00007
DB01254,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Leuprolide.,Dasatinib,DB00007
DB01263,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Leuprolide.,Posaconazole,DB00007
DB01396,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Leuprolide.,Digitoxin,DB00007
DB08815,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Leuprolide.,Lurasidone,DB00007
DB08864,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Leuprolide.,Rilpivirine,DB00007
DB11742,The risk or severity of QTc prolongation can be increased when Ebastine is combined with Leuprolide.,Ebastine,DB00007
DB01142,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Doxepin.,Doxepin,DB00007
DB01151,The risk or severity of QTc prolongation can be increased when Desipramine is combined with Leuprolide.,Desipramine,DB00007
DB00503,The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Leuprolide.,Ritonavir,DB00007
DB00845,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Leuprolide.,Clofazimine,DB00007
DB11637,Leuprolide may increase the QTc-prolonging activities of Delamanid.,Delamanid,DB00007
DB00159,Icosapent may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Icosapent,DB00007
DB00229,Cefotiam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotiam,DB00007
DB00244,Mesalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mesalazine,DB00007
DB00267,Cefmenoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefmenoxime,DB00007
DB00274,Cefmetazole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefmetazole,DB00007
DB00282,Pamidronic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pamidronic acid,DB00007
DB00300,Tenofovir disoproxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir disoproxil,DB00007
DB00328,Indomethacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indomethacin,DB00007
DB00369,Cidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cidofovir,DB00007
DB00384,Triamterene may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Triamterene,DB00007
DB00430,Cefpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpiramide,DB00007
DB00438,Ceftazidime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftazidime,DB00007
DB00447,Loracarbef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Loracarbef,DB00007
DB00456,Cefalotin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefalotin,DB00007
DB00461,Nabumetone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nabumetone,DB00007
DB00465,Ketorolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ketorolac,DB00007
DB00469,Tenoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenoxicam,DB00007
DB00482,Celecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Celecoxib,DB00007
DB00493,Cefotaxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotaxime,DB00007
DB00500,Tolmetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tolmetin,DB00007
DB00533,Rofecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Rofecoxib,DB00007
DB00554,Piroxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Piroxicam,DB00007
DB00563,Methotrexate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Methotrexate,DB00007
DB00567,Cephalexin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephalexin,DB00007
DB00573,Fenoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fenoprofen,DB00007
DB00577,Valaciclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Valaciclovir,DB00007
DB00580,Valdecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Valdecoxib,DB00007
DB00586,Diclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Diclofenac,DB00007
DB00605,Sulindac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sulindac,DB00007
DB00626,Bacitracin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bacitracin,DB00007
DB00681,Amphotericin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Amphotericin B,DB00007
DB00689,Cephaloglycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephaloglycin,DB00007
DB00712,Flurbiprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flurbiprofen,DB00007
DB00718,Adefovir dipivoxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Adefovir dipivoxil,DB00007
DB00742,Mannitol may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mannitol,DB00007
DB00749,Etodolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etodolac,DB00007
DB00784,Mefenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mefenamic acid,DB00007
DB00787,Acyclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acyclovir,DB00007
DB00788,Naproxen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Naproxen,DB00007
DB00795,Sulfasalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sulfasalazine,DB00007
DB00812,Phenylbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Phenylbutazone,DB00007
DB00814,Meloxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Meloxicam,DB00007
DB00821,Carprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carprofen,DB00007
DB00833,Cefaclor may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefaclor,DB00007
DB00861,Diflunisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Diflunisal,DB00007
DB00903,Etacrynic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etacrynic acid,DB00007
DB00923,Ceforanide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceforanide,DB00007
DB00936,Salicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salicylic acid,DB00007
DB00939,Meclofenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Meclofenamic acid,DB00007
DB00945,Acetylsalicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acetylsalicylic acid,DB00007
DB00958,Carboplatin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carboplatin,DB00007
DB00991,Oxaprozin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Oxaprozin,DB00007
DB01009,Ketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ketoprofen,DB00007
DB01014,Balsalazide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Balsalazide,DB00007
DB01050,Ibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ibuprofen,DB00007
DB01066,Cefditoren may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefditoren,DB00007
DB01111,Colistimethate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Colistimethate,DB00007
DB01112,Cefuroxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefuroxime,DB00007
DB01139,Cefapirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefapirin,DB00007
DB01140,Cefadroxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefadroxil,DB00007
DB01150,Cefprozil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefprozil,DB00007
DB01212,Ceftriaxone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftriaxone,DB00007
DB01250,Olsalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Olsalazine,DB00007
DB01283,Lumiracoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lumiracoxib,DB00007
DB01326,Cefamandole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefamandole,DB00007
DB01327,Cefazolin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefazolin,DB00007
DB01328,Cefonicid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefonicid,DB00007
DB01329,Cefoperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefoperazone,DB00007
DB01330,Cefotetan may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotetan,DB00007
DB01331,Cefoxitin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefoxitin,DB00007
DB01332,Ceftizoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftizoxime,DB00007
DB01333,Cefradine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefradine,DB00007
DB01397,Magnesium salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Magnesium salicylate,DB00007
DB01399,Salsalate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salsalate,DB00007
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Choline magnesium trisalicylate,DB00007
DB01413,Cefepime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefepime,DB00007
DB01414,Cefacetrile may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefacetrile,DB00007
DB01415,Ceftibuten may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftibuten,DB00007
DB01416,Cefpodoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpodoxime,DB00007
DB01419,Antrafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Antrafenine,DB00007
DB01424,Aminophenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Aminophenazone,DB00007
DB01435,Antipyrine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Antipyrine,DB00007
DB01600,Tiaprofenic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tiaprofenic acid,DB00007
DB01628,Etoricoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etoricoxib,DB00007
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Hydrolyzed Cephalothin,DB00007
DB03450,Cephalothin Group may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephalothin Group,DB00007
DB03585,Oxyphenbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Oxyphenbutazone,DB00007
DB04552,Niflumic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Niflumic acid,DB00007
DB04570,Latamoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Latamoxef,DB00007
DB04743,Nimesulide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nimesulide,DB00007
DB04812,Benoxaprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benoxaprofen,DB00007
DB04817,Metamizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Metamizole,DB00007
DB04828,Zomepirac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Zomepirac,DB00007
DB04918,Ceftobiprole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftobiprole,DB00007
DB05095,Cimicoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cimicoxib,DB00007
DB06590,Ceftaroline fosamil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftaroline fosamil,DB00007
DB06725,Lornoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lornoxicam,DB00007
DB06736,Aceclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Aceclofenac,DB00007
DB06737,Zaltoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Zaltoprofen,DB00007
DB07402,Azapropazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Azapropazone,DB00007
DB07477,Felbinac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Felbinac,DB00007
DB08439,Parecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Parecoxib,DB00007
DB08797,Salicylamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salicylamide,DB00007
DB08940,Kebuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Kebuzone,DB00007
DB08942,Isoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Isoxicam,DB00007
DB08951,Indoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indoprofen,DB00007
DB08955,Ibuproxam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ibuproxam,DB00007
DB08976,Floctafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Floctafenine,DB00007
DB08981,Fenbufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fenbufen,DB00007
DB08984,Etofenamate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etofenamate,DB00007
DB08991,Epirizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Epirizole,DB00007
DB09008,Cefaloridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefaloridine,DB00007
DB09062,Cefminox may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefminox,DB00007
DB09084,Benzydamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benzydamine,DB00007
DB09212,Loxoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Loxoprofen,DB00007
DB09213,Dexibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dexibuprofen,DB00007
DB09214,Dexketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dexketoprofen,DB00007
DB09215,Droxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Droxicam,DB00007
DB09216,Tolfenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tolfenamic acid,DB00007
DB09217,Firocoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Firocoxib,DB00007
DB09218,Clonixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Clonixin,DB00007
DB09285,Morniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Morniflumate,DB00007
DB09288,Propacetamol may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Propacetamol,DB00007
DB09295,Talniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Talniflumate,DB00007
DB09299,Tenofovir alafenamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir alafenamide,DB00007
DB11367,Cefroxadine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefroxadine,DB00007
DB11455,Robenacoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Robenacoxib,DB00007
DB11466,Tepoxalin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tepoxalin,DB00007
DB11518,Flunixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flunixin,DB00007
DB11935,Flomoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flomoxef,DB00007
DB12151,Brincidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Brincidofovir,DB00007
DB12445,Nitroaspirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nitroaspirin,DB00007
DB12545,Indobufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indobufen,DB00007
DB13001,Tinoridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tinoridine,DB00007
DB13167,Alclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Alclofenac,DB00007
DB13217,Fentiazac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fentiazac,DB00007
DB13232,Suxibuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Suxibuzone,DB00007
DB13266,Cefatrizine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefatrizine,DB00007
DB13286,Bumadizone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bumadizone,DB00007
DB13314,Alminoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Alminoprofen,DB00007
DB13317,Flunoxaprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flunoxaprofen,DB00007
DB13364,Feprazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Feprazone,DB00007
DB13371,Difenpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Difenpiramide,DB00007
DB13407,Nifenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nifenazone,DB00007
DB13432,Lonazolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lonazolac,DB00007
DB13461,Cefcapene may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefcapene,DB00007
DB13470,Cefodizime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefodizime,DB00007
DB13481,Tenidap may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenidap,DB00007
DB13499,Cefsulodin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefsulodin,DB00007
DB13501,Bendazac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bendazac,DB00007
DB13504,Cefetamet may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefetamet,DB00007
DB13514,Pranoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pranoprofen,DB00007
DB13524,Propyphenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Propyphenazone,DB00007
DB13527,Proglumetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Proglumetacin,DB00007
DB13538,Guacetisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Guacetisal,DB00007
DB13544,Ethenzamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ethenzamide,DB00007
DB13612,Carbaspirin calcium may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carbaspirin calcium,DB00007
DB13629,Mofebutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mofebutazone,DB00007
DB13638,Cefbuperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefbuperazone,DB00007
DB13649,Proquazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Proquazone,DB00007
DB13657,Benorilate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benorilate,DB00007
DB13667,Cefozopran may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefozopran,DB00007
DB13682,Cefpirome may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpirome,DB00007
DB13722,Pirprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pirprofen,DB00007
DB13778,Cefazedone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefazedone,DB00007
DB13783,Acemetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acemetacin,DB00007
DB13821,Ceftezole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftezole,DB00007
DB13860,Imidazole salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Imidazole salicylate,DB00007
DB13868,Adefovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Adefovir,DB00007
DB14059,SC-236 may decrease the excretion rate of Leuprolide which could result in a higher serum level.,SC-236,DB00007
DB14060,NS-398 may decrease the excretion rate of Leuprolide which could result in a higher serum level.,NS-398,DB00007
DB14126,Tenofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir,DB00007
DB01438,Phenazopyridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Phenazopyridine,DB00007
DB00091,Cyclosporine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cyclosporine,DB00007
DB15066,Givosiran may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Givosiran,DB00007
DB01601,Lopinavir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lopinavir,DB00007
DB14507,Lithium citrate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lithium citrate,DB00007
DB00017,Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salmon calcitonin,DB00007
DB00035,Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin,DB00007
DB00041,Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin,DB00007
DB00081,Leuprolide may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab,DB00007
DB00115,Leuprolide may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin,DB00007
DB00158,Leuprolide may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid,DB00007
DB00165,Leuprolide may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine,DB00007
DB00176,Leuprolide may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine,DB00007
DB00182,Leuprolide may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine,DB00007
DB00185,Leuprolide may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline,DB00007
DB00186,Leuprolide may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam,DB00007
DB00190,Leuprolide may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa,DB00007
DB00193,Leuprolide may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol,DB00007
DB00198,Leuprolide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir,DB00007
DB00200,Leuprolide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin,DB00007
DB00206,Leuprolide may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine,DB00007
DB00208,Leuprolide may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine,DB00007
DB00213,Leuprolide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole,DB00007
DB00225,Leuprolide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide,DB00007
DB00231,Leuprolide may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam,DB00007
DB00235,Leuprolide may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone,DB00007
DB00237,Leuprolide may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital,DB00007
DB00254,Leuprolide may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline,DB00007
DB00262,Leuprolide may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine,DB00007
DB00264,Leuprolide may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol,DB00007
DB00271,Leuprolide may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate,DB00007
DB00273,Leuprolide may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate,DB00007
DB00279,Leuprolide may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine,DB00007
DB00286,Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens,DB00007
DB00290,Leuprolide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin,DB00007
DB00292,Leuprolide may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate,DB00007
DB00294,Leuprolide may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel,DB00007
DB00296,Leuprolide may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine,DB00007
DB00303,Leuprolide may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem,DB00007
DB00316,Leuprolide may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen,DB00007
DB00319,Leuprolide may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin,DB00007
DB00322,Leuprolide may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine,DB00007
DB00323,Leuprolide may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone,DB00007
DB00325,Leuprolide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside,DB00007
DB00327,Leuprolide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone,DB00007
DB00330,Leuprolide may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol,DB00007
DB00339,Leuprolide may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide,DB00007
DB00349,Leuprolide may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam,DB00007
DB00351,Leuprolide may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate,DB00007
DB00355,Leuprolide may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam,DB00007
DB00356,Leuprolide may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone,DB00007
DB00364,Leuprolide may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate,DB00007
DB00372,Leuprolide may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine,DB00007
DB00377,Leuprolide may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron,DB00007
DB00380,Leuprolide may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane,DB00007
DB00402,Leuprolide may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone,DB00007
DB00413,Leuprolide may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole,DB00007
DB00415,Leuprolide may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin,DB00007
DB00418,Leuprolide may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital,DB00007
DB00422,Leuprolide may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate,DB00007
DB00432,Leuprolide may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine,DB00007
DB00435,Leuprolide may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide,DB00007
DB00437,Leuprolide may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol,DB00007
DB00441,Leuprolide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine,DB00007
DB00476,Leuprolide may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine,DB00007
DB00480,Leuprolide may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide,DB00007
DB00492,Leuprolide may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril,DB00007
DB00499,Leuprolide may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide,DB00007
DB00535,Leuprolide may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir,DB00007
DB00548,Leuprolide may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid,DB00007
DB00553,Leuprolide may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen,DB00007
DB00558,Leuprolide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir,DB00007
DB00569,Leuprolide may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux,DB00007
DB00583,Leuprolide may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine,DB00007
DB00591,Leuprolide may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide,DB00007
DB00597,Leuprolide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol,DB00007
DB00598,Leuprolide may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol,DB00007
DB00603,Leuprolide may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate,DB00007
DB00612,Leuprolide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol,DB00007
DB00624,Leuprolide may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone,DB00007
DB00628,Leuprolide may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid,DB00007
DB00631,Leuprolide may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine,DB00007
DB00633,Leuprolide may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine,DB00007
DB00635,Leuprolide may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone,DB00007
DB00651,Leuprolide may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline,DB00007
DB00657,Leuprolide may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine,DB00007
DB00660,Leuprolide may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone,DB00007
DB00665,Leuprolide may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide,DB00007
DB00669,Leuprolide may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan,DB00007
DB00690,Leuprolide may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam,DB00007
DB00692,Leuprolide may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine,DB00007
DB00698,Leuprolide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin,DB00007
DB00706,Leuprolide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin,DB00007
DB00713,Leuprolide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin,DB00007
DB00716,Leuprolide may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil,DB00007
DB00722,Leuprolide may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril,DB00007
DB00730,Leuprolide may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole,DB00007
DB00733,Leuprolide may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime,DB00007
DB00759,Leuprolide may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline,DB00007
DB00760,Leuprolide may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem,DB00007
DB00761,Leuprolide may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride,DB00007
DB00775,Leuprolide may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban,DB00007
DB00780,Leuprolide may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine,DB00007
DB00782,Leuprolide may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline,DB00007
DB00783,Leuprolide may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol,DB00007
DB00789,Leuprolide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid,DB00007
DB00790,Leuprolide may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril,DB00007
DB00800,Leuprolide may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam,DB00007
DB00804,Leuprolide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine,DB00007
DB00806,Leuprolide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline,DB00007
DB00811,Leuprolide may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin,DB00007
DB00828,Leuprolide may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin,DB00007
DB00829,Leuprolide may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam,DB00007
DB00841,Leuprolide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine,DB00007
DB00842,Leuprolide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam,DB00007
DB00851,Leuprolide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine,DB00007
DB00853,Leuprolide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide,DB00007
DB00894,Leuprolide may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone,DB00007
DB00900,Leuprolide may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine,DB00007
DB00911,Leuprolide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole,DB00007
DB00918,Leuprolide may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan,DB00007
DB00928,Leuprolide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine,DB00007
DB00953,Leuprolide may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan,DB00007
DB00960,Leuprolide may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol,DB00007
DB00961,Leuprolide may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine,DB00007
DB00962,Leuprolide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon,DB00007
DB00980,Leuprolide may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon,DB00007
DB00988,Leuprolide may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine,DB00007
DB00993,Leuprolide may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine,DB00007
DB00995,Leuprolide may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin,DB00007
DB01002,Leuprolide may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine,DB00007
DB01010,Leuprolide may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium,DB00007
DB01011,Leuprolide may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone,DB00007
DB01018,Leuprolide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine,DB00007
DB01020,Leuprolide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate,DB00007
DB01022,Leuprolide may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone,DB00007
DB01024,Leuprolide may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid,DB00007
DB01030,Leuprolide may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan,DB00007
DB01032,Leuprolide may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid,DB00007
DB01043,Leuprolide may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine,DB00007
DB01046,Leuprolide may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone,DB00007
DB01048,Leuprolide may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir,DB00007
DB01060,Leuprolide may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin,DB00007
DB01068,Leuprolide may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam,DB00007
DB01093,Leuprolide may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide,DB00007
DB01099,Leuprolide may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine,DB00007
DB01101,Leuprolide may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine,DB00007
DB01105,Leuprolide may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine,DB00007
DB01129,Leuprolide may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole,DB00007
DB01133,Leuprolide may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid,DB00007
DB01135,Leuprolide may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium,DB00007
DB01148,Leuprolide may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate,DB00007
DB01156,Leuprolide may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion,DB00007
DB01157,Leuprolide may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate,DB00007
DB01170,Leuprolide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine,DB00007
DB01181,Leuprolide may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide,DB00007
DB01203,Leuprolide may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol,DB00007
DB01205,Leuprolide may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil,DB00007
DB01213,Leuprolide may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole,DB00007
DB01215,Leuprolide may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam,DB00007
DB01221,Leuprolide may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine,DB00007
DB01240,Leuprolide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol,DB00007
DB01249,Leuprolide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol,DB00007
DB01273,Leuprolide may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline,DB00007
DB01275,Leuprolide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine,DB00007
DB01359,Leuprolide may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol,DB00007
DB01367,Leuprolide may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline,DB00007
DB01409,Leuprolide may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium,DB00007
DB01420,Leuprolide may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate,DB00007
DB01427,Leuprolide may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone,DB00007
DB01428,Leuprolide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone,DB00007
DB01431,Leuprolide may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol,DB00007
DB01550,Leuprolide may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex,DB00007
DB01558,Leuprolide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam,DB00007
DB01563,Leuprolide may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate,DB00007
DB01577,Leuprolide may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine,DB00007
DB01587,Leuprolide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam,DB00007
DB01610,Leuprolide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir,DB00007
DB01638,Leuprolide may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol,DB00007
DB01656,Leuprolide may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast,DB00007
DB01685,Leuprolide may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat,DB00007
DB04574,Leuprolide may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate,DB00007
DB04871,Leuprolide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin,DB00007
DB04895,Leuprolide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib,DB00007
DB04896,Leuprolide may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran,DB00007
DB04920,Leuprolide may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine,DB00007
DB05018,Leuprolide may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat,DB00007
DB05541,Leuprolide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam,DB00007
DB06154,Leuprolide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate,DB00007
DB06186,Leuprolide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab,DB00007
DB06196,Leuprolide may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant,DB00007
DB06209,Leuprolide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel,DB00007
DB06211,Leuprolide may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem,DB00007
DB06230,Leuprolide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene,DB00007
DB06262,Leuprolide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa,DB00007
DB06480,Leuprolide may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride,DB00007
DB06623,Leuprolide may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine,DB00007
DB06637,Leuprolide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine,DB00007
DB06695,Leuprolide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate,DB00007
DB06700,Leuprolide may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine,DB00007
DB06702,Leuprolide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine,DB00007
DB06705,Leuprolide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium,DB00007
DB06710,Leuprolide may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone,DB00007
DB06767,Leuprolide may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride,DB00007
DB06782,Leuprolide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol,DB00007
DB06796,Leuprolide may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir,DB00007
DB06800,Leuprolide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone,DB00007
DB06809,Leuprolide may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor,DB00007
DB06813,Leuprolide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate,DB00007
DB06823,Leuprolide may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin,DB00007
DB06824,Leuprolide may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine,DB00007
DB08824,Leuprolide may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123,DB00007
DB08826,Leuprolide may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone,DB00007
DB08840,Leuprolide may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide,DB00007
DB08872,Leuprolide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil,DB00007
DB08877,Leuprolide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib,DB00007
DB08897,Leuprolide may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium,DB00007
DB08900,Leuprolide may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide,DB00007
DB08905,Leuprolide may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane,DB00007
DB08909,Leuprolide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate,DB00007
DB08910,Leuprolide may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide,DB00007
DB08911,Leuprolide may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib,DB00007
DB08918,Leuprolide may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran,DB00007
DB08932,Leuprolide may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan,DB00007
DB08934,Leuprolide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir,DB00007
DB08964,Leuprolide may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost,DB00007
DB09027,Leuprolide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir,DB00007
DB09050,Leuprolide may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane,DB00007
DB09068,Leuprolide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine,DB00007
DB09071,Leuprolide may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon,DB00007
DB09075,Leuprolide may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban,DB00007
DB09081,Leuprolide may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone,DB00007
DB09091,Leuprolide may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol,DB00007
DB09103,Leuprolide may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim,DB00007
DB09104,Leuprolide may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide,DB00007
DB09106,Leuprolide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch,DB00007
DB09111,Leuprolide may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch,DB00007
DB09121,Leuprolide may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose,DB00007
DB09123,Leuprolide may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest,DB00007
DB09129,Leuprolide may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride,DB00007
DB09132,Leuprolide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid,DB00007
DB09133,Leuprolide may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid,DB00007
DB09134,Leuprolide may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol,DB00007
DB09135,Leuprolide may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan,DB00007
DB09136,Leuprolide may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue,DB00007
DB09137,Leuprolide may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin,DB00007
DB09139,Leuprolide may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate,DB00007
DB09148,Leuprolide may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F),DB00007
DB09149,Leuprolide may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F),DB00007
DB09156,Leuprolide may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide,DB00007
DB09163,Leuprolide may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime,DB00007
DB09165,Leuprolide may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate,DB00007
DB09185,Leuprolide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine,DB00007
DB09194,Leuprolide may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone,DB00007
DB09195,Leuprolide may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole,DB00007
DB09204,Leuprolide may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol,DB00007
DB09205,Leuprolide may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte,DB00007
DB09209,Leuprolide may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine,DB00007
DB09210,Leuprolide may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam,DB00007
DB09219,Leuprolide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin,DB00007
DB09220,Leuprolide may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil,DB00007
DB09223,Leuprolide may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin,DB00007
DB09241,Leuprolide may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue,DB00007
DB09244,Leuprolide may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole,DB00007
DB09245,Leuprolide may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone,DB00007
DB09255,Leuprolide may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran,DB00007
DB09256,Leuprolide may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur,DB00007
DB09257,Leuprolide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil,DB00007
DB09262,Leuprolide may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin,DB00007
DB09264,Leuprolide may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab,DB00007
DB09268,Leuprolide may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid,DB00007
DB09276,Leuprolide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate,DB00007
DB09281,Leuprolide may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate,DB00007
DB09292,Leuprolide may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril,DB00007
DB09301,Leuprolide may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate,DB00007
DB09317,"Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A",DB00007
DB09318,"Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B",DB00007
DB09320,Leuprolide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin,DB00007
DB09324,Leuprolide may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam,DB00007
DB09325,Leuprolide may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride,DB00007
DB09329,"Leuprolide may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated",DB00007
DB09344,Leuprolide may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar,DB00007
DB09357,Leuprolide may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol,DB00007
DB09394,Leuprolide may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid,DB00007
DB09395,Leuprolide may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate,DB00007
DB09407,Leuprolide may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride,DB00007
DB09418,Leuprolide may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate,DB00007
DB09472,Leuprolide may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate,DB00007
DB09477,Leuprolide may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat,DB00007
DB09481,Leuprolide may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate,DB00007
DB09496,Leuprolide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate,DB00007
DB09502,Leuprolide may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F),DB00007
DB09546,Leuprolide may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123,DB00007
DB09570,Leuprolide may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib,DB00007
DB11077,Leuprolide may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400,DB00007
DB11090,Leuprolide may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate,DB00007
DB11098,Leuprolide may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate,DB00007
DB11102,Leuprolide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine,DB00007
DB11114,Leuprolide may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil,DB00007
DB11127,Leuprolide may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid,DB00007
DB11130,Leuprolide may decrease the excretion rate of Opium which could result in a higher serum level.,Opium,DB00007
DB11135,Leuprolide may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium,DB00007
DB11136,Leuprolide may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium,DB00007
DB11145,Leuprolide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline,DB00007
DB11156,Leuprolide may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel,DB00007
DB11164,Leuprolide may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate,DB00007
DB11251,Leuprolide may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol,DB00007
DB11278,Leuprolide may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine,DB00007
DB11328,Leuprolide may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester),DB00007
DB11338,Leuprolide may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil,DB00007
DB11358,Leuprolide may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil,DB00007
DB11364,Leuprolide may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod,DB00007
DB11560,Leuprolide may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad,DB00007
DB11577,Leuprolide may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid,DB00007
DB11587,Leuprolide may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine,DB00007
DB11598,Leuprolide may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human,DB00007
DB11691,Leuprolide may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine,DB00007
DB11699,Leuprolide may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron,DB00007
DB11817,Leuprolide may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib,DB00007
DB11915,Leuprolide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine,DB00007
DB11989,Leuprolide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole,DB00007
DB12007,Leuprolide may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone,DB00007
DB12107,Leuprolide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam,DB00007
DB12278,Leuprolide may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine,DB00007
DB12783,Leuprolide may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide,DB00007
DB13025,Leuprolide may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride,DB00007
DB13139,Leuprolide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol,DB00007
DB13156,Leuprolide may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex,DB00007
DB13178,Leuprolide may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol,DB00007
DB13185,Leuprolide may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate,DB00007
DB13191,Leuprolide may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine,DB00007
DB13269,Leuprolide may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol,DB00007
DB13595,Leuprolide may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate,DB00007
DB13884,Leuprolide may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa,DB00007
DB13909,Leuprolide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate,DB00007
DB13943,Leuprolide may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate,DB00007
DB13944,Leuprolide may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate,DB00007
DB13946,Leuprolide may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate,DB00007
DB13952,Leuprolide may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate,DB00007
DB13954,Leuprolide may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate,DB00007
DB13955,Leuprolide may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate,DB00007
DB13956,Leuprolide may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate,DB00007
DB13967,Leuprolide may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue,DB00007
DB14006,Leuprolide may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate,DB00007
DB14007,Leuprolide may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid,DB00007
DB14498,Leuprolide may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate,DB00007
DB14499,Leuprolide may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate,DB00007
DB14526,Leuprolide may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate,DB00007
DB14527,Leuprolide may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate,DB00007
DB14528,Leuprolide may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate,DB00007
DB14529,Leuprolide may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate,DB00007
DB14530,Leuprolide may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate,DB00007
DB14754,Leuprolide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol,DB00007
DB06815,Leuprolide may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione,DB00007
DB11121,Leuprolide may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol,DB00007
DB11085,Leuprolide may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol,DB00007
DB00312,Leuprolide may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital,DB00007
DB00401,Leuprolide may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine,DB00007
DB00404,Leuprolide may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam,DB00007
DB00490,Leuprolide may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone,DB00007
DB00661,Leuprolide may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil,DB00007
DB00683,Leuprolide may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam,DB00007
DB00763,Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole,DB00007
DB00820,Leuprolide may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil,DB00007
DB01149,Leuprolide may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone,DB00007
DB01183,Leuprolide may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone,DB00007
DB01222,Leuprolide may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide,DB00007
DB05676,Leuprolide may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast,DB00007
DB06228,Leuprolide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban,DB00007
DB08899,Leuprolide may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide,DB00007
DB08904,Leuprolide may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol,DB00007
DB09118,Leuprolide may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol,DB00007
DB11901,Leuprolide may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide,DB00007
DB15593,Leuprolide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen,DB00007
DB00318,Leuprolide may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine,DB00007
DB00454,Leuprolide may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine,DB00007
DB00813,Leuprolide may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl,DB00007
DB00879,Leuprolide may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine,DB00007
DB08996,Leuprolide may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine,DB00007
DB14506,Leuprolide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide,DB00007
DB00452,Framycetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Framycetin,DB00007
DB00479,Amikacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Amikacin,DB00007
DB00684,Tobramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tobramycin,DB00007
DB00798,Gentamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Gentamicin,DB00007
DB00955,Netilmicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Netilmicin,DB00007
DB00994,Neomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Neomycin,DB00007
DB01082,Streptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Streptomycin,DB00007
DB01172,Kanamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Kanamycin,DB00007
DB01421,Paromomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Paromomycin,DB00007
DB03615,Ribostamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ribostamycin,DB00007
DB04263,Geneticin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Geneticin,DB00007
DB04626,Apramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Apramycin,DB00007
DB04729,Gentamicin C1a may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Gentamicin C1a,DB00007
DB04808,Neamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Neamine,DB00007
DB06696,Arbekacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Arbekacin,DB00007
DB08437,Puromycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Puromycin,DB00007
DB11512,Dihydrostreptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dihydrostreptomycin,DB00007
DB11520,Hygromycin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Hygromycin B,DB00007
DB12604,Sisomicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sisomicin,DB00007
DB13270,Dibekacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dibekacin,DB00007
DB13274,Micronomicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Micronomicin,DB00007
DB13540,Isepamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Isepamicin,DB00007
DB13673,Bekanamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bekanamycin,DB00007
DB00552,Leuprolide may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin,DB00007
DB13145,Leuprolide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin,DB00007
DB00314,Leuprolide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin,DB00007
DB00390,Leuprolide may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin,DB00007
DB00512,Leuprolide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin,DB00007
DB00515,Leuprolide may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin,DB00007
DB00642,Leuprolide may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed,DB00007
DB00982,Leuprolide may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin,DB00007
DB12615,Leuprolide may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin,DB00007
DB14509,Leuprolide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate,DB00007
DB00564,Leuprolide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine,DB00007
DB00682,Leuprolide may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin,DB00007
DB00524,Leuprolide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone,DB00007
DB00695,Leuprolide may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide,DB00007
DB09338,Leuprolide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl,DB00007
DB00214,Torasemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide,DB00007
DB00232,Methyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide,DB00007
DB00310,Chlorthalidone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone,DB00007
DB00311,Ethoxzolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide,DB00007
DB00421,Spironolactone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone,DB00007
DB00436,Bendroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide,DB00007
DB00562,Benzthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide,DB00007
DB00594,Amiloride may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride,DB00007
DB00606,Cyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide,DB00007
DB00774,Hydroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide,DB00007
DB00880,Chlorothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide,DB00007
DB01021,Trichlormethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide,DB00007
DB01119,Diazoxide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide,DB00007
DB01144,Diclofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide,DB00007
DB01324,Polythiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide,DB00007
DB01325,Quinethazone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone,DB00007
DB01412,Theobromine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00007
DB02925,Piretanide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide,DB00007
DB04831,Tienilic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid,DB00007
DB05034,Ularitide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide,DB00007
DB08961,Azosemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide,DB00007
DB09015,Canrenoic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid,DB00007
DB09125,Potassium citrate may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate,DB00007
DB09401,Isosorbide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide,DB00007
DB12221,Canrenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone,DB00007
DB12670,Rolofylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline,DB00007
DB12704,Spiradoline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline,DB00007
DB13284,Meticrane may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane,DB00007
DB13316,Ibopamine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine,DB00007
DB13405,Mefruside may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside,DB00007
DB13430,Mebutizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide,DB00007
DB13532,Cyclopenthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide,DB00007
DB13617,Clorexolone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone,DB00007
DB13663,Clofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide,DB00007
DB13708,Fenquizone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone,DB00007
DB13792,Clopamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide,DB00007
DB13801,Muzolimine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine,DB00007
DB13803,Xipamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide,DB00007
DB13989,Epitizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide,DB00007
DB14018,Bromotheophylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00007
DB14500,Potassium may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Potassium,DB00007
DB00703,Methazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide,DB00007
DB00700,Eplerenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone,DB00007
DB00819,Acetazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide,DB00007
DB00872,Conivaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan,DB00007
DB01395,Drospirenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone,DB00007
DB06212,Tolvaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan,DB00007
DB06370,Indisulam may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam,DB00007
DB00052,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.",Somatotropin,DB00007
DB00080,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Daptomycin.",Daptomycin,DB00007
DB00175,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pravastatin.",Pravastatin,DB00007
DB00181,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Baclofen.",Baclofen,DB00007
DB00242,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cladribine.",Cladribine,DB00007
DB00382,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tacrine.",Tacrine,DB00007
DB00389,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Carbimazole.",Carbimazole,DB00007
DB00439,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cerivastatin.",Cerivastatin,DB00007
DB00443,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Betamethasone.",Betamethasone,DB00007
DB00471,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Montelukast.",Montelukast,DB00007
DB00495,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Zidovudine.",Zidovudine,DB00007
DB00501,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cimetidine.",Cimetidine,DB00007
DB00528,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lercanidipine.",Lercanidipine,DB00007
DB00541,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Vincristine.",Vincristine,DB00007
DB00550,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Propylthiouracil.",Propylthiouracil,DB00007
DB00584,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Enalapril.",Enalapril,DB00007
DB00585,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nizatidine.",Nizatidine,DB00007
DB00602,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ivermectin.",Ivermectin,DB00007
DB00620,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triamcinolone.",Triamcinolone,DB00007
DB00627,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Niacin.",Niacin,DB00007
DB00630,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Alendronic acid.",Alendronic acid,DB00007
DB00636,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibrate.",Clofibrate,DB00007
DB00649,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Stavudine.",Stavudine,DB00007
DB00666,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nafarelin.",Nafarelin,DB00007
DB00688,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mycophenolate mofetil.",Mycophenolate mofetil,DB00007
DB00704,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Naltrexone.",Naltrexone,DB00007
DB00709,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lamivudine.",Lamivudine,DB00007
DB00857,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Terbinafine.",Terbinafine,DB00007
DB00859,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Penicillamine.",Penicillamine,DB00007
DB00863,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ranitidine.",Ranitidine,DB00007
DB00876,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Eprosartan.",Eprosartan,DB00007
DB00884,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Risedronic acid.",Risedronic acid,DB00007
DB00887,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bumetanide.",Bumetanide,DB00007
DB00898,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ethanol.",Ethanol,DB00007
DB00968,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Methyldopa.",Methyldopa,DB00007
DB00987,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cytarabine.",Cytarabine,DB00007
DB01004,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ganciclovir.",Ganciclovir,DB00007
DB01006,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Letrozole.",Letrozole,DB00007
DB01017,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Minocycline.",Minocycline,DB00007
DB01039,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibrate.",Fenofibrate,DB00007
DB01076,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Atorvastatin.",Atorvastatin,DB00007
DB01088,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Iloprost.",Iloprost,DB00007
DB01095,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fluvastatin.",Fluvastatin,DB00007
DB01097,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Leflunomide.",Leflunomide,DB00007
DB01098,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Rosuvastatin.",Rosuvastatin,DB00007
DB01168,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Procarbazine.",Procarbazine,DB00007
DB01197,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Captopril.",Captopril,DB00007
DB01241,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Gemfibrozil.",Gemfibrozil,DB00007
DB01248,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Docetaxel.",Docetaxel,DB00007
DB01393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bezafibrate.",Bezafibrate,DB00007
DB02703,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fusidic acid.",Fusidic acid,DB00007
DB05109,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trabectedin.",Trabectedin,DB00007
DB06693,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mevastatin.",Mevastatin,DB00007
DB06817,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Raltegravir.",Raltegravir,DB00007
DB08860,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pitavastatin.",Pitavastatin,DB00007
DB08983,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Etofibrate.",Etofibrate,DB00007
DB09055,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Acipimox.",Acipimox,DB00007
DB09064,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ciprofibrate.",Ciprofibrate,DB00007
DB09270,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ubidecarenone.",Ubidecarenone,DB00007
DB12554,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mebeverine.",Mebeverine,DB00007
DB13293,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ipecac.",Ipecac,DB00007
DB13393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Emetine.",Emetine,DB00007
DB13433,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simfibrate.",Simfibrate,DB00007
DB13460,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ronifibrate.",Ronifibrate,DB00007
DB13780,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Aluminium clofibrate.",Aluminium clofibrate,DB00007
DB13849,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibride.",Clofibride,DB00007
DB13873,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibric acid.",Fenofibric acid,DB00007
DB00951,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Isoniazid.",Isoniazid,DB00007
DB00897,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam.",Triazolam,DB00007
DB01394,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Colchicine.",Colchicine,DB00007
DB00065,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Infliximab.",Infliximab,DB00007
DB00203,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Sildenafil.",Sildenafil,DB00007
DB00224,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Indinavir.",Indinavir,DB00007
DB00227,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lovastatin.",Lovastatin,DB00007
DB00252,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Phenytoin.",Phenytoin,DB00007
DB00641,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simvastatin.",Simvastatin,DB00007
DB01229,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Paclitaxel.",Paclitaxel,DB00007
DB01234,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Dexamethasone.",Dexamethasone,DB00007
DB09289,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tianeptine.",Tianeptine,DB00007
DB00440,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trimethoprim.",Trimethoprim,DB00007
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Leuprolide.,Metformin,DB00007
DB00656,The risk or severity of QTc prolongation can be increased when Trazodone is combined with Leuprolide.,Trazodone,DB00007
DB11986,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entrectinib.,Entrectinib,DB00007
DB11642,Leuprolide may increase the QTc-prolonging activities of Pitolisant.,Pitolisant,DB00007
DB12825,Lefamulin may increase the QTc-prolonging activities of Leuprolide.,Lefamulin,DB00007
DB00557,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Leuprolide.,Hydroxyzine,DB00007
DB00246,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ziprasidone.,Ziprasidone,DB00007
DB00502,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Haloperidol.,Haloperidol,DB00007
DB00472,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluoxetine.,Fluoxetine,DB00007
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2a.,Denosumab,DB00008
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.,Etanercept,DB00008
DB00011,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00008
DB00018,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00008
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00008
DB00026,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.,Anakinra,DB00008
DB00033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00008
DB00034,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00008
DB00051,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.,Adalimumab,DB00008
DB00056,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00008
DB00059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pegaspargase.,Pegaspargase,DB00008
DB00065,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Infliximab.,Infliximab,DB00008
DB00068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon beta-1b.,Interferon beta-1b,DB00008
DB00069,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00008
DB00073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rituximab.,Rituximab,DB00008
DB00074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Basiliximab.,Basiliximab,DB00008
DB00075,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Muromonab.,Muromonab,DB00008
DB00078,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00008
DB00081,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tositumomab.,Tositumomab,DB00008
DB00087,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alemtuzumab.,Alemtuzumab,DB00008
DB00092,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alefacept.,Alefacept,DB00008
DB00095,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Efalizumab.,Efalizumab,DB00008
DB00098,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00008
DB00105,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00008
DB00111,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daclizumab.,Daclizumab,DB00008
DB00112,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bevacizumab.,Bevacizumab,DB00008
DB00120,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Phenylalanine.,Phenylalanine,DB00008
DB00180,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flunisolide.,Flunisolide,DB00008
DB00188,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bortezomib.,Bortezomib,DB00008
DB00242,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cladribine.,Cladribine,DB00008
DB00262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carmustine.,Carmustine,DB00008
DB00276,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Amsacrine.,Amsacrine,DB00008
DB00290,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleomycin.,Bleomycin,DB00008
DB00291,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chlorambucil.,Chlorambucil,DB00008
DB00293,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Raltitrexed.,Raltitrexed,DB00008
DB00305,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitomycin.,Mitomycin,DB00008
DB00307,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bexarotene.,Bexarotene,DB00008
DB00309,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vindesine.,Vindesine,DB00008
DB00322,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Floxuridine.,Floxuridine,DB00008
DB00328,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Indomethacin.,Indomethacin,DB00008
DB00352,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tioguanine.,Tioguanine,DB00008
DB00361,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinorelbine.,Vinorelbine,DB00008
DB00380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexrazoxane.,Dexrazoxane,DB00008
DB00394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00008
DB00398,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sorafenib.,Sorafenib,DB00008
DB00428,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Streptozocin.,Streptozocin,DB00008
DB00432,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trifluridine.,Trifluridine,DB00008
DB00441,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemcitabine.,Gemcitabine,DB00008
DB00443,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Betamethasone.,Betamethasone,DB00008
DB00444,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teniposide.,Teniposide,DB00008
DB00445,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Epirubicin.,Epirubicin,DB00008
DB00446,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chloramphenicol.,Chloramphenicol,DB00008
DB00480,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lenalidomide.,Lenalidomide,DB00008
DB00488,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Altretamine.,Altretamine,DB00008
DB00515,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cisplatin.,Cisplatin,DB00008
DB00526,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Oxaliplatin.,Oxaliplatin,DB00008
DB00531,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cyclophosphamide.,Cyclophosphamide,DB00008
DB00541,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vincristine.,Vincristine,DB00008
DB00544,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorouracil.,Fluorouracil,DB00008
DB00550,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Propylthiouracil.,Propylthiouracil,DB00008
DB00552,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pentostatin.,Pentostatin,DB00008
DB00563,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methotrexate.,Methotrexate,DB00008
DB00564,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carbamazepine.,Carbamazepine,DB00008
DB00570,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinblastine.,Vinblastine,DB00008
DB00588,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone propionate.,Fluticasone propionate,DB00008
DB00591,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00008
DB00601,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Linezolid.,Linezolid,DB00008
DB00619,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Imatinib.,Imatinib,DB00008
DB00620,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triamcinolone.,Triamcinolone,DB00008
DB00631,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clofarabine.,Clofarabine,DB00008
DB00635,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisone.,Prednisone,DB00008
DB00642,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pemetrexed.,Pemetrexed,DB00008
DB00687,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludrocortisone.,Fludrocortisone,DB00008
DB00688,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00008
DB00694,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daunorubicin.,Daunorubicin,DB00008
DB00755,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tretinoin.,Tretinoin,DB00008
DB00762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Irinotecan.,Irinotecan,DB00008
DB00763,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.,Methimazole,DB00008
DB00764,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone.,Mometasone,DB00008
DB00773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Etoposide.,Etoposide,DB00008
DB00795,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sulfasalazine.,Sulfasalazine,DB00008
DB00851,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dacarbazine.,Dacarbazine,DB00008
DB00853,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temozolomide.,Temozolomide,DB00008
DB00859,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Penicillamine.,Penicillamine,DB00008
DB00860,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisolone.,Prednisolone,DB00008
DB00877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirolimus.,Sirolimus,DB00008
DB00888,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mechlorethamine.,Mechlorethamine,DB00008
DB00928,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azacitidine.,Azacitidine,DB00008
DB00958,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carboplatin.,Carboplatin,DB00008
DB00959,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methylprednisolone.,Methylprednisolone,DB00008
DB00970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dactinomycin.,Dactinomycin,DB00008
DB00987,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cytarabine.,Cytarabine,DB00008
DB00993,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azathioprine.,Azathioprine,DB00008
DB00997,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxorubicin.,Doxorubicin,DB00008
DB01005,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxyurea.,Hydroxyurea,DB00008
DB01008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Busulfan.,Busulfan,DB00008
DB01024,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolic acid.,Mycophenolic acid,DB00008
DB01030,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Topotecan.,Topotecan,DB00008
DB01033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mercaptopurine.,Mercaptopurine,DB00008
DB01041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thalidomide.,Thalidomide,DB00008
DB01042,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melphalan.,Melphalan,DB00008
DB01073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludarabine.,Fludarabine,DB00008
DB01099,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flucytosine.,Flucytosine,DB00008
DB01101,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Capecitabine.,Capecitabine,DB00008
DB01108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trilostane.,Trilostane,DB00008
DB01168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Procarbazine.,Procarbazine,DB00008
DB01169,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Arsenic trioxide.,Arsenic trioxide,DB00008
DB01177,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idarubicin.,Idarubicin,DB00008
DB01181,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ifosfamide.,Ifosfamide,DB00008
DB01196,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Estramustine.,Estramustine,DB00008
DB01204,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitoxantrone.,Mitoxantrone,DB00008
DB01206,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lomustine.,Lomustine,DB00008
DB01222,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Budesonide.,Budesonide,DB00008
DB01229,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paclitaxel.,Paclitaxel,DB00008
DB01234,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone.,Dexamethasone,DB00008
DB01248,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Docetaxel.,Docetaxel,DB00008
DB01254,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dasatinib.,Dasatinib,DB00008
DB01257,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eculizumab.,Eculizumab,DB00008
DB01262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Decitabine.,Decitabine,DB00008
DB01268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sunitinib.,Sunitinib,DB00008
DB01280,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nelarabine.,Nelarabine,DB00008
DB01281,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abatacept.,Abatacept,DB00008
DB01285,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Corticotropin.,Corticotropin,DB00008
DB01380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortisone acetate.,Cortisone acetate,DB00008
DB01384,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paramethasone.,Paramethasone,DB00008
DB01394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Colchicine.,Colchicine,DB00008
DB01410,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ciclesonide.,Ciclesonide,DB00008
DB01423,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Stepronin.,Stepronin,DB00008
DB01590,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Everolimus.,Everolimus,DB00008
DB01611,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00008
DB01816,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Castanospermine.,Castanospermine,DB00008
DB02546,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vorinostat.,Vorinostat,DB00008
DB02806,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00008
DB03523,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brequinar.,Brequinar,DB00008
DB04572,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thiotepa.,Thiotepa,DB00008
DB04630,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldosterone.,Aldosterone,DB00008
DB04845,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixabepilone.,Ixabepilone,DB00008
DB04868,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nilotinib.,Nilotinib,DB00008
DB04951,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirfenidone.,Pirfenidone,DB00008
DB04956,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Afelimomab.,Afelimomab,DB00008
DB05015,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belinostat.,Belinostat,DB00008
DB05109,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trabectedin.,Trabectedin,DB00008
DB05258,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa.,Interferon alfa,DB00008
DB05259,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Glatiramer.,Glatiramer,DB00008
DB05260,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gallium nitrate.,Gallium nitrate,DB00008
DB05459,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Briakinumab.,Briakinumab,DB00008
DB05472,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with omega interferon.,omega interferon,DB00008
DB05676,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Apremilast.,Apremilast,DB00008
DB05773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00008
DB06168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Canakinumab.,Canakinumab,DB00008
DB06273,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tocilizumab.,Tocilizumab,DB00008
DB06287,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temsirolimus.,Temsirolimus,DB00008
DB06372,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rilonacept.,Rilonacept,DB00008
DB06589,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pazopanib.,Pazopanib,DB00008
DB06603,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Panobinostat.,Panobinostat,DB00008
DB06612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mepolizumab.,Mepolizumab,DB00008
DB06616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bosutinib.,Bosutinib,DB00008
DB06662,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abetimus.,Abetimus,DB00008
DB06674,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Golimumab.,Golimumab,DB00008
DB06681,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belatacept.,Belatacept,DB00008
DB06769,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bendamustine.,Bendamustine,DB00008
DB06772,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cabazitaxel.,Cabazitaxel,DB00008
DB06813,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pralatrexate.,Pralatrexate,DB00008
DB08059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Wortmannin.,Wortmannin,DB00008
DB08870,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00008
DB08871,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eribulin.,Eribulin,DB00008
DB08877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ruxolitinib.,Ruxolitinib,DB00008
DB08879,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belimumab.,Belimumab,DB00008
DB08880,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teriflunomide.,Teriflunomide,DB00008
DB08889,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carfilzomib.,Carfilzomib,DB00008
DB08901,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ponatinib.,Ponatinib,DB00008
DB08904,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Certolizumab pegol.,Certolizumab pegol,DB00008
DB08906,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone furoate.,Fluticasone furoate,DB00008
DB08908,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00008
DB08910,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pomalidomide.,Pomalidomide,DB00008
DB08935,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Obinutuzumab.,Obinutuzumab,DB00008
DB08970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednidene.,Fluprednidene,DB00008
DB08971,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortolone.,Fluocortolone,DB00008
DB09029,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Secukinumab.,Secukinumab,DB00008
DB09033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vedolizumab.,Vedolizumab,DB00008
DB09036,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siltuximab.,Siltuximab,DB00008
DB09052,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Blinatumomab.,Blinatumomab,DB00008
DB09053,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibrutinib.,Ibrutinib,DB00008
DB09054,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idelalisib.,Idelalisib,DB00008
DB09073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Palbociclib.,Palbociclib,DB00008
DB09074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Olaparib.,Olaparib,DB00008
DB09077,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dinutuximab.,Dinutuximab,DB00008
DB09082,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vilanterol.,Vilanterol,DB00008
DB09091,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tixocortol.,Tixocortol,DB00008
DB09122,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00008
DB09312,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00008
DB09378,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednisolone.,Fluprednisolone,DB00008
DB09383,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Meprednisone.,Meprednisone,DB00008
DB11466,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tepoxalin.,Tepoxalin,DB00008
DB11487,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00008
DB11529,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melengestrol.,Melengestrol,DB00008
DB11569,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixekizumab.,Ixekizumab,DB00008
DB11580,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ravulizumab.,Ravulizumab,DB00008
DB11616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirarubicin.,Pirarubicin,DB00008
DB11693,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Voclosporin.,Voclosporin,DB00008
DB11708,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peficitinib.,Peficitinib,DB00008
DB11750,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clobetasol.,Clobetasol,DB00008
DB11767,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sarilumab.,Sarilumab,DB00008
DB11776,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brodalumab.,Brodalumab,DB00008
DB11803,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirukumab.,Sirukumab,DB00008
DB11817,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Baricitinib.,Baricitinib,DB00008
DB11834,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Guselkumab.,Guselkumab,DB00008
DB11921,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deflazacort.,Deflazacort,DB00008
DB11988,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ocrelizumab.,Ocrelizumab,DB00008
DB12025,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triptolide.,Triptolide,DB00008
DB12371,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siponimod.,Siponimod,DB00008
DB12612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ozanimod.,Ozanimod,DB00008
DB12617,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mizoribine.,Mizoribine,DB00008
DB12692,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gusperimus.,Gusperimus,DB00008
DB12814,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00008
DB12902,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trofosfamide.,Trofosfamide,DB00008
DB12947,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxifluridine.,Doxifluridine,DB00008
DB12991,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deoxyspergualin.,Deoxyspergualin,DB00008
DB12996,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Acteoside.,Acteoside,DB00008
DB13003,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortivazol.,Cortivazol,DB00008
DB13014,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hypericin.,Hypericin,DB00008
DB13068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00008
DB13208,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednylidene.,Prednylidene,DB00008
DB13223,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortin.,Fluocortin,DB00008
DB13241,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Begelomab.,Begelomab,DB00008
DB13491,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluperolone.,Fluperolone,DB00008
DB13664,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Formocortal.,Formocortal,DB00008
DB13728,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Halometasone.,Halometasone,DB00008
DB13843,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cloprednol.,Cloprednol,DB00008
DB13856,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluclorolone.,Fluclorolone,DB00008
DB13867,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone.,Fluticasone,DB00008
DB14066,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tetrandrine.,Tetrandrine,DB00008
DB14219,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00008
DB14512,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone furoate.,Mometasone furoate,DB00008
DB14538,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00008
DB14539,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00008
DB14545,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00008
DB14724,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Emapalumab.,Emapalumab,DB00008
DB14762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Risankizumab.,Risankizumab,DB00008
DB14919,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rozanolixizumab.,Rozanolixizumab,DB00008
DB15253,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleselumab.,Bleselumab,DB00008
DB00108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Natalizumab.,Natalizumab,DB00008
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2a.,Pimecrolimus,DB00008
DB01656,Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2a.,Roflumilast,DB00008
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2a.,Sipuleucel-T,DB00008
DB00041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.,Aldesleukin,DB00008
DB00363,The risk or severity of neutropenia can be increased when Peginterferon alfa-2a is combined with Clozapine.,Clozapine,DB00008
DB00333,The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2a.,Methadone,DB00008
DB01265,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Telbivudine.,Telbivudine,DB00008
DB00495,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Zidovudine.,Zidovudine,DB00008
DB08894,The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Peginesatide.,Peginesatide,DB00008
DB09107,The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Methoxy polyethylene glycol-epoetin beta.,Methoxy polyethylene glycol-epoetin beta,DB00008
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Peginterferon alfa-2a.,Darbepoetin alfa,DB00008
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.,Erythropoietin,DB00008
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2a.,Zolmitriptan,DB00008
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2a.,Sulfamethoxazole,DB00008
DB04817,The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2a.,Metamizole,DB00008
DB01097,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Leflunomide.,Leflunomide,DB00008
DB08895,Peginterferon alfa-2a may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib,DB00008
DB00072,Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2a.,Trastuzumab,DB00008
DB00019,The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.,Pegfilgrastim,DB00008
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2a.,Pegademase,DB00008
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2a.,Pegvisomant,DB00008
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Propylene glycol,DB00008
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Heptaethylene glycol,DB00008
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2a.,Pegaptanib,DB00008
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2a.,Egaptivon pegol,DB00008
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2a.,PEG-uricase,DB00008
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfacon-1,DB00008
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2a.,GlycoPEG-GCSF,DB00008
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2a.,Pegnivacogin,DB00008
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2a.,Pegpleranib,DB00008
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2a.,Pegsunercept,DB00008
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2a.,Polidocanol,DB00008
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2a.,Pegloticase,DB00008
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Polyethylene glycol,DB00008
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2a.","Antihemophilic Factor (Recombinant), PEGylated",DB00008
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2a.,Polyethylene glycol 400,DB00008
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2a.,Insulin peglispro,DB00008
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2a.,Eptacog alfa pegol (activated),DB00008
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Olaptesed Pegol,DB00008
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Abicipar Pegol,DB00008
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Lexaptepid Pegol,DB00008
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2a.,Pegvaliase,DB00008
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2a.,Pegamotecan,DB00008
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2a.,Nonacog beta pegol,DB00008
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2a.,Damoctocog alfa pegol,DB00008
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2a.,Elapegademase,DB00008
DB08868,Peginterferon alfa-2a may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00008
DB00864,Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2a.,Tacrolimus,DB00008
DB00201,The metabolism of Caffeine can be decreased when combined with Peginterferon alfa-2a.,Caffeine,DB00008
DB00651,The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2a.,Dyphylline,DB00008
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Peginterferon alfa-2a.,Pentoxifylline,DB00008
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Peginterferon alfa-2a.,Oxtriphylline,DB00008
DB01412,The metabolism of Theobromine can be decreased when combined with Peginterferon alfa-2a.,Theobromine,DB00008
DB01482,The metabolism of Fenethylline can be decreased when combined with Peginterferon alfa-2a.,Fenethylline,DB00008
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Peginterferon alfa-2a.,8-azaguanine,DB00008
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2a.","7,9-Dimethylguanine",DB00008
DB02134,The metabolism of Xanthine can be decreased when combined with Peginterferon alfa-2a.,Xanthine,DB00008
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.,7-Deazaguanine,DB00008
DB02377,The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2a.,Guanine,DB00008
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Peginterferon alfa-2a.,9-Methylguanine,DB00008
DB02568,The metabolism of Peldesine can be decreased when combined with Peginterferon alfa-2a.,Peldesine,DB00008
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Peginterferon alfa-2a.,Hypoxanthine,DB00008
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.,9-Deazaguanine,DB00008
DB06479,The metabolism of Propentofylline can be decreased when combined with Peginterferon alfa-2a.,Propentofylline,DB00008
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2a.,Valomaciclovir,DB00008
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2a.,3-isobutyl-1-methyl-7H-xanthine,DB00008
DB08844,The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2a.,Uric acid,DB00008
DB09273,The metabolism of Doxofylline can be decreased when combined with Peginterferon alfa-2a.,Doxofylline,DB00008
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Peginterferon alfa-2a.,6-O-benzylguanine,DB00008
DB12406,The metabolism of Lisofylline can be decreased when combined with Peginterferon alfa-2a.,Lisofylline,DB00008
DB12531,The metabolism of Lobucavir can be decreased when combined with Peginterferon alfa-2a.,Lobucavir,DB00008
DB12926,The metabolism of Cafedrine can be decreased when combined with Peginterferon alfa-2a.,Cafedrine,DB00008
DB12927,The metabolism of Theodrenaline can be decreased when combined with Peginterferon alfa-2a.,Theodrenaline,DB00008
DB13203,The metabolism of Bamifylline can be decreased when combined with Peginterferon alfa-2a.,Bamifylline,DB00008
DB13449,The metabolism of Proxyphylline can be decreased when combined with Peginterferon alfa-2a.,Proxyphylline,DB00008
DB13573,The metabolism of Acefylline can be decreased when combined with Peginterferon alfa-2a.,Acefylline,DB00008
DB13592,The metabolism of Etamiphylline can be decreased when combined with Peginterferon alfa-2a.,Etamiphylline,DB00008
DB13634,The metabolism of Pentifylline can be decreased when combined with Peginterferon alfa-2a.,Pentifylline,DB00008
DB13812,The metabolism of Bufylline can be decreased when combined with Peginterferon alfa-2a.,Bufylline,DB00008
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Peginterferon alfa-2a.,Bromotheophylline,DB00008
DB14029,The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2a.,Furafylline,DB00008
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Peginterferon alfa-2a.,8-chlorotheophylline,DB00008
DB15122,The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2a.,PCS-499,DB00008
DB00390,Digoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Digoxin,DB00008
DB00511,Acetyldigitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Acetyldigitoxin,DB00008
DB01078,Deslanoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Deslanoside,DB00008
DB01092,Ouabain may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Ouabain,DB00008
DB01396,Digitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Digitoxin,DB00008
DB12843,Oleandrin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Oleandrin,DB00008
DB13240,Cymarin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Cymarin,DB00008
DB13307,Proscillaridin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Proscillaridin,DB00008
DB13401,Metildigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Metildigoxin,DB00008
DB13467,Lanatoside C may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Lanatoside C,DB00008
DB13537,Gitoformate may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Gitoformate,DB00008
DB13691,Acetyldigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Acetyldigoxin,DB00008
DB13756,Peruvoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Peruvoside,DB00008
DB01217,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Anastrozole.,Anastrozole,DB00008
DB06013,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Aldoxorubicin.,Aldoxorubicin,DB00008
DB06171,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel trevatide.,Paclitaxel trevatide,DB00008
DB13809,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex,DB00008
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2a.,G17DT,DB00008
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2a.,PEV3A,DB00008
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2a.,INGN 225,DB00008
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2a.,Rindopepimut,DB00008
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2a.,SRP 299,DB00008
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2a.,GI-5005,DB00008
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2a.,Vitespen,DB00008
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2a.,TG4010,DB00008
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2a.,Anthrax immune globulin human,DB00008
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2a.","Rabies virus inactivated antigen, B",DB00008
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00008
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Rotavirus vaccine,DB00008
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2a.","Rabies virus inactivated antigen, A",DB00008
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00008
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00008
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00008
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00008
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00008
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00008
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Typhoid Vi polysaccharide vaccine,DB00008
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Hepatitis A Vaccine,DB00008
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00008
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00008
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00008
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00008
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00008
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2a.,Human rabies virus immune globulin,DB00008
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.,Hepatitis B Vaccine (Recombinant),DB00008
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2a.,Tecemotide,DB00008
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Typhoid vaccine,DB00008
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00008
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00008
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00008
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00008
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00008
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00008
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00008
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Peginterferon alfa-2a.,Vaccinia virus strain new york city board of health live antigen,DB00008
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Pertussis vaccine,DB00008
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00008
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.,Varicella Zoster Vaccine (Recombinant),DB00008
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2a.,Modified vaccinia ankara,DB00008
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2a.","Ebola Zaire vaccine (live, attenuated)",DB00008
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.,Abciximab,DB00008
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2a.,Eptifibatide,DB00008
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2a.,Ticlopidine,DB00008
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2a.,Tirofiban,DB00008
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2a.,Acetylsalicylic acid,DB00008
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2a.,Dipyridamole,DB00008
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2a.,Iloprost,DB00008
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2a.,Sulfinpyrazone,DB00008
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2a.,Ridogrel,DB00008
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2a.,Sevoflurane,DB00008
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2a.,Epoprostenol,DB00008
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2a.,Nimesulide,DB00008
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2a.,Tesmilifene,DB00008
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2a.,Defibrotide,DB00008
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2a.,Beraprost,DB00008
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2a.,Ibudilast,DB00008
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2a.,Andrographolide,DB00008
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2a.,Caplacizumab,DB00008
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2a.,Prasugrel,DB00008
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2a.,Cangrelor,DB00008
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2a.,Tranilast,DB00008
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2a.,Triflusal,DB00008
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2a.,Ticagrelor,DB00008
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2a.,Icosapent ethyl,DB00008
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2a.,Vorapaxar,DB00008
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2a.,Trapidil,DB00008
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2a.,Naftopidil,DB00008
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2a.,Sarpogrelate,DB00008
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2a.,Ifetroban,DB00008
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2a.,Nitroaspirin,DB00008
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2a.,Ketanserin,DB00008
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2a.,Indobufen,DB00008
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2a.,Butylphthalide,DB00008
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2a.,Hydroxytyrosol,DB00008
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2a.,Ramatroban,DB00008
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2a.,Picotamide,DB00008
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2a.,Cloricromen,DB00008
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2a.,Linsidomine,DB00008
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2a.,Buflomedil,DB00008
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2a.,Relcovaptan,DB00008
DB13200,Peginterferon alfa-2a may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00008
DB10318,The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated),DB00008
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2a.,Rubella virus vaccine,DB00008
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain tice live antigen,DB00008
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain connaught live antigen,DB00008
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2a.,Yellow Fever Vaccine,DB00008
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2a.,Anthrax vaccine,DB00008
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2a.,Typhoid Vaccine Live,DB00008
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00008
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2a.,BCG vaccine,DB00008
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2a.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00008
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2a.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00008
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2a.,Adenovirus type 7 vaccine live,DB00008
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.,Palifermin,DB00008
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Peginterferon alfa-2a.,Fluvoxamine,DB00008
DB00184,The metabolism of Nicotine can be decreased when combined with Peginterferon alfa-2a.,Nicotine,DB00008
DB00195,The metabolism of Betaxolol can be decreased when combined with Peginterferon alfa-2a.,Betaxolol,DB00008
DB00261,The metabolism of Anagrelide can be decreased when combined with Peginterferon alfa-2a.,Anagrelide,DB00008
DB00280,The metabolism of Disopyramide can be decreased when combined with Peginterferon alfa-2a.,Disopyramide,DB00008
DB00281,The metabolism of Lidocaine can be decreased when combined with Peginterferon alfa-2a.,Lidocaine,DB00008
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.,Conjugated estrogens,DB00008
DB00296,The metabolism of Ropivacaine can be decreased when combined with Peginterferon alfa-2a.,Ropivacaine,DB00008
DB00316,The metabolism of Acetaminophen can be decreased when combined with Peginterferon alfa-2a.,Acetaminophen,DB00008
DB00334,The metabolism of Olanzapine can be decreased when combined with Peginterferon alfa-2a.,Olanzapine,DB00008
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Peginterferon alfa-2a.,Chlorzoxazone,DB00008
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Peginterferon alfa-2a.,Grepafloxacin,DB00008
DB00370,The metabolism of Mirtazapine can be decreased when combined with Peginterferon alfa-2a.,Mirtazapine,DB00008
DB00379,The metabolism of Mexiletine can be decreased when combined with Peginterferon alfa-2a.,Mexiletine,DB00008
DB00382,The metabolism of Tacrine can be decreased when combined with Peginterferon alfa-2a.,Tacrine,DB00008
DB00384,The metabolism of Triamterene can be decreased when combined with Peginterferon alfa-2a.,Triamterene,DB00008
DB00420,The metabolism of Promazine can be decreased when combined with Peginterferon alfa-2a.,Promazine,DB00008
DB00425,The metabolism of Zolpidem can be decreased when combined with Peginterferon alfa-2a.,Zolpidem,DB00008
DB00442,The metabolism of Entecavir can be decreased when combined with Peginterferon alfa-2a.,Entecavir,DB00008
DB00461,The metabolism of Nabumetone can be decreased when combined with Peginterferon alfa-2a.,Nabumetone,DB00008
DB00468,The metabolism of Quinine can be decreased when combined with Peginterferon alfa-2a.,Quinine,DB00008
DB00472,The metabolism of Fluoxetine can be decreased when combined with Peginterferon alfa-2a.,Fluoxetine,DB00008
DB00476,The metabolism of Duloxetine can be decreased when combined with Peginterferon alfa-2a.,Duloxetine,DB00008
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Peginterferon alfa-2a.,Chlorpromazine,DB00008
DB00499,The metabolism of Flutamide can be decreased when combined with Peginterferon alfa-2a.,Flutamide,DB00008
DB00502,The metabolism of Haloperidol can be decreased when combined with Peginterferon alfa-2a.,Haloperidol,DB00008
DB00518,The metabolism of Albendazole can be decreased when combined with Peginterferon alfa-2a.,Albendazole,DB00008
DB00533,The metabolism of Rofecoxib can be decreased when combined with Peginterferon alfa-2a.,Rofecoxib,DB00008
DB00568,The metabolism of Cinnarizine can be decreased when combined with Peginterferon alfa-2a.,Cinnarizine,DB00008
DB00571,The metabolism of Propranolol can be decreased when combined with Peginterferon alfa-2a.,Propranolol,DB00008
DB00586,The metabolism of Diclofenac can be decreased when combined with Peginterferon alfa-2a.,Diclofenac,DB00008
DB00629,The metabolism of Guanabenz can be decreased when combined with Peginterferon alfa-2a.,Guanabenz,DB00008
DB00661,The metabolism of Verapamil can be decreased when combined with Peginterferon alfa-2a.,Verapamil,DB00008
DB00715,The metabolism of Paroxetine can be decreased when combined with Peginterferon alfa-2a.,Paroxetine,DB00008
DB00730,The metabolism of Thiabendazole can be decreased when combined with Peginterferon alfa-2a.,Thiabendazole,DB00008
DB00740,The metabolism of Riluzole can be decreased when combined with Peginterferon alfa-2a.,Riluzole,DB00008
DB00744,The metabolism of Zileuton can be decreased when combined with Peginterferon alfa-2a.,Zileuton,DB00008
DB00758,The metabolism of Clopidogrel can be decreased when combined with Peginterferon alfa-2a.,Clopidogrel,DB00008
DB00783,The metabolism of Estradiol can be decreased when combined with Peginterferon alfa-2a.,Estradiol,DB00008
DB00787,The metabolism of Acyclovir can be decreased when combined with Peginterferon alfa-2a.,Acyclovir,DB00008
DB00788,The metabolism of Naproxen can be decreased when combined with Peginterferon alfa-2a.,Naproxen,DB00008
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Peginterferon alfa-2a.,Trifluoperazine,DB00008
DB00850,The metabolism of Perphenazine can be decreased when combined with Peginterferon alfa-2a.,Perphenazine,DB00008
DB00857,The metabolism of Terbinafine can be decreased when combined with Peginterferon alfa-2a.,Terbinafine,DB00008
DB00863,The metabolism of Ranitidine can be decreased when combined with Peginterferon alfa-2a.,Ranitidine,DB00008
DB00898,The metabolism of Ethanol can be decreased when combined with Peginterferon alfa-2a.,Ethanol,DB00008
DB00934,The metabolism of Maprotiline can be decreased when combined with Peginterferon alfa-2a.,Maprotiline,DB00008
DB00969,The metabolism of Alosetron can be decreased when combined with Peginterferon alfa-2a.,Alosetron,DB00008
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Peginterferon alfa-2a.,Lomefloxacin,DB00008
DB00980,The metabolism of Ramelteon can be decreased when combined with Peginterferon alfa-2a.,Ramelteon,DB00008
DB00998,The metabolism of Frovatriptan can be decreased when combined with Peginterferon alfa-2a.,Frovatriptan,DB00008
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Peginterferon alfa-2a.,Levobupivacaine,DB00008
DB01012,The metabolism of Cinacalcet can be decreased when combined with Peginterferon alfa-2a.,Cinacalcet,DB00008
DB01037,The metabolism of Selegiline can be decreased when combined with Peginterferon alfa-2a.,Selegiline,DB00008
DB01056,The metabolism of Tocainide can be decreased when combined with Peginterferon alfa-2a.,Tocainide,DB00008
DB01058,The metabolism of Praziquantel can be decreased when combined with Peginterferon alfa-2a.,Praziquantel,DB00008
DB01065,The metabolism of Melatonin can be decreased when combined with Peginterferon alfa-2a.,Melatonin,DB00008
DB01087,The metabolism of Primaquine can be decreased when combined with Peginterferon alfa-2a.,Primaquine,DB00008
DB01094,The metabolism of Hesperetin can be decreased when combined with Peginterferon alfa-2a.,Hesperetin,DB00008
DB01115,The metabolism of Nifedipine can be decreased when combined with Peginterferon alfa-2a.,Nifedipine,DB00008
DB01136,The metabolism of Carvedilol can be decreased when combined with Peginterferon alfa-2a.,Carvedilol,DB00008
DB01166,The metabolism of Cilostazol can be decreased when combined with Peginterferon alfa-2a.,Cilostazol,DB00008
DB01182,The metabolism of Propafenone can be decreased when combined with Peginterferon alfa-2a.,Propafenone,DB00008
DB01184,The metabolism of Domperidone can be decreased when combined with Peginterferon alfa-2a.,Domperidone,DB00008
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Peginterferon alfa-2a.,Dexfenfluramine,DB00008
DB01367,The metabolism of Rasagiline can be decreased when combined with Peginterferon alfa-2a.,Rasagiline,DB00008
DB01405,The metabolism of Temafloxacin can be decreased when combined with Peginterferon alfa-2a.,Temafloxacin,DB00008
DB01424,The metabolism of Aminophenazone can be decreased when combined with Peginterferon alfa-2a.,Aminophenazone,DB00008
DB01435,The metabolism of Antipyrine can be decreased when combined with Peginterferon alfa-2a.,Antipyrine,DB00008
DB01558,The metabolism of Bromazepam can be decreased when combined with Peginterferon alfa-2a.,Bromazepam,DB00008
DB01623,The metabolism of Thiothixene can be decreased when combined with Peginterferon alfa-2a.,Thiothixene,DB00008
DB01628,The metabolism of Etoricoxib can be decreased when combined with Peginterferon alfa-2a.,Etoricoxib,DB00008
DB01645,The metabolism of Genistein can be decreased when combined with Peginterferon alfa-2a.,Genistein,DB00008
DB02709,The metabolism of Resveratrol can be decreased when combined with Peginterferon alfa-2a.,Resveratrol,DB00008
DB03783,The metabolism of Phenacetin can be decreased when combined with Peginterferon alfa-2a.,Phenacetin,DB00008
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Peginterferon alfa-2a.,Estrone sulfate,DB00008
DB04841,The metabolism of Flunarizine can be decreased when combined with Peginterferon alfa-2a.,Flunarizine,DB00008
DB04871,The metabolism of Lorcaserin can be decreased when combined with Peginterferon alfa-2a.,Lorcaserin,DB00008
DB04948,The metabolism of Lofexidine can be decreased when combined with Peginterferon alfa-2a.,Lofexidine,DB00008
DB06148,The metabolism of Mianserin can be decreased when combined with Peginterferon alfa-2a.,Mianserin,DB00008
DB06210,The metabolism of Eltrombopag can be decreased when combined with Peginterferon alfa-2a.,Eltrombopag,DB00008
DB06216,The metabolism of Asenapine can be decreased when combined with Peginterferon alfa-2a.,Asenapine,DB00008
DB06235,The metabolism of Vadimezan can be decreased when combined with Peginterferon alfa-2a.,Vadimezan,DB00008
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Peginterferon alfa-2a.,Dapagliflozin,DB00008
DB06594,The metabolism of Agomelatine can be decreased when combined with Peginterferon alfa-2a.,Agomelatine,DB00008
DB06626,The metabolism of Axitinib can be decreased when combined with Peginterferon alfa-2a.,Axitinib,DB00008
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Peginterferon alfa-2a.,Benzyl alcohol,DB00008
DB06774,The metabolism of Capsaicin can be decreased when combined with Peginterferon alfa-2a.,Capsaicin,DB00008
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Peginterferon alfa-2a.,(R)-warfarin,DB00008
DB08883,The metabolism of Perampanel can be decreased when combined with Peginterferon alfa-2a.,Perampanel,DB00008
DB09071,The metabolism of Tasimelteon can be decreased when combined with Peginterferon alfa-2a.,Tasimelteon,DB00008
DB09118,The metabolism of Stiripentol can be decreased when combined with Peginterferon alfa-2a.,Stiripentol,DB00008
DB09225,The metabolism of Zotepine can be decreased when combined with Peginterferon alfa-2a.,Zotepine,DB00008
DB09288,The metabolism of Propacetamol can be decreased when combined with Peginterferon alfa-2a.,Propacetamol,DB00008
DB09290,The metabolism of Ramosetron can be decreased when combined with Peginterferon alfa-2a.,Ramosetron,DB00008
DB11967,The metabolism of Binimetinib can be decreased when combined with Peginterferon alfa-2a.,Binimetinib,DB00008
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Peginterferon alfa-2a.,Voxilaprevir,DB00008
DB12245,The metabolism of Triclabendazole can be decreased when combined with Peginterferon alfa-2a.,Triclabendazole,DB00008
DB12332,The metabolism of Rucaparib can be decreased when combined with Peginterferon alfa-2a.,Rucaparib,DB00008
DB12945,The metabolism of Dihydralazine can be decreased when combined with Peginterferon alfa-2a.,Dihydralazine,DB00008
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Peginterferon alfa-2a.,Estradiol acetate,DB00008
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Peginterferon alfa-2a.,Estradiol benzoate,DB00008
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Peginterferon alfa-2a.,Estradiol cypionate,DB00008
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Peginterferon alfa-2a.,Estradiol dienanthate,DB00008
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Peginterferon alfa-2a.,Estradiol valerate,DB00008
DB11757,The metabolism of Istradefylline can be decreased when combined with Peginterferon alfa-2a.,Istradefylline,DB00008
DB00972,The metabolism of Azelastine can be decreased when combined with Peginterferon alfa-2a.,Azelastine,DB00008
DB00625,The metabolism of Efavirenz can be decreased when combined with Peginterferon alfa-2a.,Efavirenz,DB00008
DB01233,The metabolism of Metoclopramide can be decreased when combined with Peginterferon alfa-2a.,Metoclopramide,DB00008
DB04889,The metabolism of Bicifadine can be decreased when combined with Peginterferon alfa-2a.,Bicifadine,DB00008
DB05708,The metabolism of GTS-21 can be decreased when combined with Peginterferon alfa-2a.,GTS-21,DB00008
DB01195,The metabolism of Flecainide can be decreased when combined with Peginterferon alfa-2a.,Flecainide,DB00008
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Peginterferon alfa-2a.,Ethinylestradiol,DB00008
DB00321,The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2a.,Amitriptyline,DB00008
DB00458,The metabolism of Imipramine can be decreased when combined with Peginterferon alfa-2a.,Imipramine,DB00008
DB01142,The metabolism of Doxepin can be decreased when combined with Peginterferon alfa-2a.,Doxepin,DB00008
DB00532,The metabolism of Mephenytoin can be decreased when combined with Peginterferon alfa-2a.,Mephenytoin,DB00008
DB00540,The metabolism of Nortriptyline can be decreased when combined with Peginterferon alfa-2a.,Nortriptyline,DB00008
DB00575,The metabolism of Clonidine can be decreased when combined with Peginterferon alfa-2a.,Clonidine,DB00008
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Peginterferon alfa-2a.,Cyclobenzaprine,DB00008
DB01151,The metabolism of Desipramine can be decreased when combined with Peginterferon alfa-2a.,Desipramine,DB00008
DB01242,The metabolism of Clomipramine can be decreased when combined with Peginterferon alfa-2a.,Clomipramine,DB00008
DB11689,The metabolism of Selumetinib can be decreased when combined with Peginterferon alfa-2a.,Selumetinib,DB00008
DB00675,The metabolism of Tamoxifen can be decreased when combined with Peginterferon alfa-2a.,Tamoxifen,DB00008
DB00277,The metabolism of Theophylline can be decreased when combined with Peginterferon alfa-2a.,Theophylline,DB00008
DB00682,The metabolism of Warfarin can be decreased when combined with Peginterferon alfa-2a.,Warfarin,DB00008
DB00697,The metabolism of Tizanidine can be decreased when combined with Peginterferon alfa-2a.,Tizanidine,DB00008
DB01100,The metabolism of Pimozide can be decreased when combined with Peginterferon alfa-2a.,Pimozide,DB00008
DB01223,The metabolism of Aminophylline can be decreased when combined with Peginterferon alfa-2a.,Aminophylline,DB00008
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Peginterferon alfa-2a.,Acenocoumarol,DB00008
DB00530,The metabolism of Erlotinib can be decreased when combined with Peginterferon alfa-2a.,Erlotinib,DB00008
DB09256,The metabolism of Tegafur can be decreased when combined with Peginterferon alfa-2a.,Tegafur,DB00008
DB13874,The metabolism of Enasidenib can be decreased when combined with Peginterferon alfa-2a.,Enasidenib,DB00008
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.,Lepirudin,DB00008
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.,Bivalirudin,DB00008
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.,Alteplase,DB00008
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2a.,Urokinase,DB00008
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.,Reteplase,DB00008
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.,Anistreplase,DB00008
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.,Tenecteplase,DB00008
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2a.,Drotrecogin alfa,DB00008
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2a.,Streptokinase,DB00008
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Peginterferon alfa-2a.,Dicoumarol,DB00008
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2a.,Argatroban,DB00008
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2a.,Ardeparin,DB00008
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2a.,Phenindione,DB00008
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2a.,Fondaparinux,DB00008
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2a.,Pentosan polysulfate,DB00008
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Peginterferon alfa-2a.,Phenprocoumon,DB00008
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2a.,Heparin,DB00008
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2a.,Enoxaparin,DB00008
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2a.,4-hydroxycoumarin,DB00008
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2a.,Coumarin,DB00008
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2a.,Ximelagatran,DB00008
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2a.,Desmoteplase,DB00008
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2a.,Ancrod,DB00008
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2a.,Fibrinolysin,DB00008
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2a.,Rivaroxaban,DB00008
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2a.,Sulodexide,DB00008
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2a.,Semuloparin,DB00008
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2a.,Idraparinux,DB00008
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2a.,Astaxanthin,DB00008
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2a.,Apixaban,DB00008
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2a.,Otamixaban,DB00008
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2a.,Amediplase,DB00008
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2a.,Dabigatran etexilate,DB00008
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2a.,Danaparoid,DB00008
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2a.,Dalteparin,DB00008
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2a.,Tinzaparin,DB00008
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2a.,Ferulic acid,DB00008
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2a.,Ethyl biscoumacetate,DB00008
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2a.,Nadroparin,DB00008
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2a.,Ditazole,DB00008
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2a.,Edoxaban,DB00008
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2a.,Potassium citrate,DB00008
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2a.,Sodium citrate,DB00008
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2a.,Dextran,DB00008
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2a.,Bemiparin,DB00008
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2a.,Reviparin,DB00008
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2a.,Parnaparin,DB00008
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Peginterferon alfa-2a.,Certoparin,DB00008
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2a.,Desirudin,DB00008
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2a.,Zinc citrate,DB00008
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2a.,Antithrombin Alfa,DB00008
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2a.,Protein C,DB00008
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2a.,Antithrombin III human,DB00008
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2a.,Letaxaban,DB00008
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2a.,Darexaban,DB00008
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2a.,Betrixaban,DB00008
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2a.,Nafamostat,DB00008
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2a.,Monteplase,DB00008
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2a.,Gabexate,DB00008
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Peginterferon alfa-2a.,Fluindione,DB00008
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2a.,Protein S human,DB00008
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2a.,Brinase,DB00008
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2a.,Clorindione,DB00008
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2a.,Diphenadione,DB00008
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2a.,Tioclomarol,DB00008
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2a.,Melagatran,DB00008
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2a.,Saruplase,DB00008
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2a.,(S)-Warfarin,DB00008
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2a.,Tocopherylquinone,DB00008
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2a.,Edetate calcium disodium anhydrous,DB00008
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2a.,Dabigatran,DB00008
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2a.,Methyclothiazide,DB00008
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2a.,Bendroflumethiazide,DB00008
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2a.,Benzthiazide,DB00008
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2a.,Cyclothiazide,DB00008
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2a.,Hydroflumethiazide,DB00008
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2a.,Chlorothiazide,DB00008
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2a.,Hydrochlorothiazide,DB00008
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2a.,Trichlormethiazide,DB00008
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2a.,Polythiazide,DB00008
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2a.,Mebutizide,DB00008
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2a.,Cyclopenthiazide,DB00008
DB09042,The risk or severity of myelosuppression can be increased when Peginterferon alfa-2a is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00008
DB00091,Peginterferon alfa-2a may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00008
DB00268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ropinirole.,Ropinirole,DB00008
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2a.,Cyanocobalamin,DB00008
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2a.,Allopurinol,DB00008
DB12978,Peginterferon alfa-2a may increase the hepatotoxic activities of Pexidartinib.,Pexidartinib,DB00008
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2a.,Magnesium,DB00008
DB01601,The serum concentration of Peginterferon alfa-2a can be increased when it is combined with Lopinavir.,Lopinavir,DB00008
DB12530,The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Inebilizumab.,Inebilizumab,DB00008
DB06605,Apixaban may increase the anticoagulant activities of Alteplase.,Apixaban,DB00009
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Alteplase.,Dabigatran etexilate,DB00009
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Alteplase.,Dasatinib,DB00009
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Alteplase is combined with Deferasirox.,Deferasirox,DB00009
DB01586,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00009
DB02123,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00009
DB02659,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Cholic Acid.,Cholic Acid,DB00009
DB02691,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Glycocholic acid.,Glycocholic acid,DB00009
DB03619,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Deoxycholic acid.,Deoxycholic acid,DB00009
DB04348,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Taurocholic acid.,Taurocholic acid,DB00009
DB05990,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Obeticholic acid.,Obeticholic acid,DB00009
DB06777,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00009
DB08833,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00009
DB08834,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00009
DB08857,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Bamet-UD2.,Bamet-UD2,DB00009
DB11622,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00009
DB11789,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00009
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Alteplase.,Edoxaban,DB00009
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Alteplase.,Ibrutinib,DB00009
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Obinutuzumab.,Obinutuzumab,DB00009
DB06228,Alteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00009
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Sugammadex.,Sugammadex,DB00009
DB09070,Tibolone may increase the anticoagulant activities of Alteplase.,Tibolone,DB00009
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Alteplase.,Tipranavir,DB00009
DB00013,Urokinase may increase the anticoagulant activities of Alteplase.,Urokinase,DB00009
DB00163,Vitamin E may increase the anticoagulant activities of Alteplase.,Vitamin E,DB00009
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Alteplase.,Vorapaxar,DB00009
DB06692,The therapeutic efficacy of Alteplase can be decreased when used in combination with Aprotinin.,Aprotinin,DB00009
DB00727,The serum concentration of Alteplase can be decreased when it is combined with Nitroglycerin.,Nitroglycerin,DB00009
DB01381,The therapeutic efficacy of Alteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00009
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Alteplase.,Ifosfamide,DB00009
DB00468,The therapeutic efficacy of Alteplase can be increased when used in combination with Quinine.,Quinine,DB00009
DB00908,The therapeutic efficacy of Alteplase can be increased when used in combination with Quinidine.,Quinidine,DB00009
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Alteplase.,Tamoxifen,DB00009
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Alteplase.,Toremifene,DB00009
DB00806,The therapeutic efficacy of Alteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00009
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Alteplase.,Pentosan polysulfate,DB00009
DB00583,The therapeutic efficacy of Alteplase can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00009
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Alteplase.,Diethylstilbestrol,DB00009
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Alteplase.,Chlorotrianisene,DB00009
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Alteplase.,Conjugated estrogens,DB00009
DB00783,Estradiol may decrease the anticoagulant activities of Alteplase.,Estradiol,DB00009
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Alteplase.,Ethinylestradiol,DB00009
DB01357,Mestranol may decrease the anticoagulant activities of Alteplase.,Mestranol,DB00009
DB04573,Estriol may decrease the anticoagulant activities of Alteplase.,Estriol,DB00009
DB04574,Estrone sulfate may decrease the anticoagulant activities of Alteplase.,Estrone sulfate,DB00009
DB04575,Quinestrol may decrease the anticoagulant activities of Alteplase.,Quinestrol,DB00009
DB07931,Hexestrol may decrease the anticoagulant activities of Alteplase.,Hexestrol,DB00009
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Alteplase.","Synthetic Conjugated Estrogens, A",DB00009
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Alteplase.","Synthetic Conjugated Estrogens, B",DB00009
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Alteplase.,Polyestradiol phosphate,DB00009
DB09381,Esterified estrogens may decrease the anticoagulant activities of Alteplase.,Esterified estrogens,DB00009
DB11478,Zeranol may decrease the anticoagulant activities of Alteplase.,Zeranol,DB00009
DB11674,Equol may decrease the anticoagulant activities of Alteplase.,Equol,DB00009
DB12487,Promestriene may decrease the anticoagulant activities of Alteplase.,Promestriene,DB00009
DB13143,Methallenestril may decrease the anticoagulant activities of Alteplase.,Methallenestril,DB00009
DB13386,Epimestrol may decrease the anticoagulant activities of Alteplase.,Epimestrol,DB00009
DB13418,Moxestrol may decrease the anticoagulant activities of Alteplase.,Moxestrol,DB00009
DB13952,Estradiol acetate may decrease the anticoagulant activities of Alteplase.,Estradiol acetate,DB00009
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Alteplase.,Estradiol benzoate,DB00009
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Alteplase.,Estradiol cypionate,DB00009
DB13956,Estradiol valerate may decrease the anticoagulant activities of Alteplase.,Estradiol valerate,DB00009
DB15334,Biochanin A may decrease the anticoagulant activities of Alteplase.,Biochanin A,DB00009
DB15335,Formononetin may decrease the anticoagulant activities of Alteplase.,Formononetin,DB00009
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Alteplase.,Icosapent,DB00009
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Alteplase.,Mesalazine,DB00009
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Alteplase.,Indomethacin,DB00009
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Alteplase.,Nabumetone,DB00009
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Alteplase.,Ketorolac,DB00009
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Alteplase.,Tenoxicam,DB00009
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Alteplase.,Celecoxib,DB00009
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Alteplase.,Tolmetin,DB00009
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Alteplase.,Rofecoxib,DB00009
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Alteplase.,Piroxicam,DB00009
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Alteplase.,Fenoprofen,DB00009
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Alteplase.,Valdecoxib,DB00009
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Alteplase.,Diclofenac,DB00009
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Alteplase.,Sulindac,DB00009
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Alteplase.,Flurbiprofen,DB00009
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Alteplase.,Etodolac,DB00009
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Alteplase.,Mefenamic acid,DB00009
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Alteplase.,Naproxen,DB00009
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Alteplase.,Sulfasalazine,DB00009
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Alteplase.,Phenylbutazone,DB00009
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Alteplase.,Meloxicam,DB00009
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Alteplase.,Carprofen,DB00009
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Alteplase.,Diflunisal,DB00009
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Alteplase.,Salicylic acid,DB00009
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Alteplase.,Meclofenamic acid,DB00009
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Alteplase.,Oxaprozin,DB00009
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Alteplase.,Ketoprofen,DB00009
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Alteplase.,Balsalazide,DB00009
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Alteplase.,Olsalazine,DB00009
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Alteplase.,Lumiracoxib,DB00009
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Alteplase.,Magnesium salicylate,DB00009
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Alteplase.,Salsalate,DB00009
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Alteplase.,Choline magnesium trisalicylate,DB00009
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Alteplase.,Antrafenine,DB00009
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Alteplase.,Aminophenazone,DB00009
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Alteplase.,Antipyrine,DB00009
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Alteplase.,Tiaprofenic acid,DB00009
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Alteplase.,Etoricoxib,DB00009
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Alteplase.,Taxifolin,DB00009
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Alteplase.,Oxyphenbutazone,DB00009
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Alteplase.,Niflumic acid,DB00009
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Alteplase.,Licofelone,DB00009
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Alteplase.,Benoxaprofen,DB00009
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Alteplase.,Metamizole,DB00009
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Alteplase.,Zomepirac,DB00009
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Alteplase.,Cimicoxib,DB00009
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Alteplase.,Lornoxicam,DB00009
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Alteplase.,Aceclofenac,DB00009
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Alteplase.,Zaltoprofen,DB00009
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Alteplase.,Azapropazone,DB00009
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Alteplase.,Felbinac,DB00009
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Alteplase.,Parecoxib,DB00009
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Alteplase.,Salicylamide,DB00009
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Alteplase.,Kebuzone,DB00009
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Alteplase.,Isoxicam,DB00009
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Alteplase.,Indoprofen,DB00009
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Alteplase.,Ibuproxam,DB00009
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Alteplase.,Floctafenine,DB00009
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Alteplase.,Fenbufen,DB00009
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Alteplase.,Etofenamate,DB00009
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Alteplase.,Epirizole,DB00009
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Alteplase.,Benzydamine,DB00009
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Alteplase.,Loxoprofen,DB00009
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Alteplase.,Dexketoprofen,DB00009
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Alteplase.,Droxicam,DB00009
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Alteplase.,Tolfenamic acid,DB00009
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Alteplase.,Firocoxib,DB00009
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Alteplase.,Clonixin,DB00009
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Alteplase.,Morniflumate,DB00009
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Alteplase.,Propacetamol,DB00009
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Alteplase.,Talniflumate,DB00009
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Alteplase.,Robenacoxib,DB00009
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Alteplase.,Tepoxalin,DB00009
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Alteplase.,Flunixin,DB00009
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Alteplase.,Polmacoxib,DB00009
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Alteplase.,Betulinic Acid,DB00009
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Alteplase.,Ebselen,DB00009
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Alteplase.,Tinoridine,DB00009
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Alteplase.,Alclofenac,DB00009
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Alteplase.,Fentiazac,DB00009
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Alteplase.,Suxibuzone,DB00009
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Alteplase.,Bumadizone,DB00009
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Alteplase.,Alminoprofen,DB00009
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Alteplase.,Flunoxaprofen,DB00009
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Alteplase.,Feprazone,DB00009
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Alteplase.,Difenpiramide,DB00009
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Alteplase.,Nifenazone,DB00009
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Alteplase.,Lonazolac,DB00009
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Alteplase.,Tenidap,DB00009
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Alteplase.,Bendazac,DB00009
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Alteplase.,Pranoprofen,DB00009
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Alteplase.,Propyphenazone,DB00009
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Alteplase.,Proglumetacin,DB00009
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Alteplase.,Guacetisal,DB00009
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Alteplase.,Ethenzamide,DB00009
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Alteplase.,Carbaspirin calcium,DB00009
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Alteplase.,Mofebutazone,DB00009
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Alteplase.,Proquazone,DB00009
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Alteplase.,Benorilate,DB00009
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Alteplase.,Pirprofen,DB00009
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Alteplase.,Imidazole salicylate,DB00009
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Alteplase.,SC-236,DB00009
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Alteplase.,NS-398,DB00009
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Alteplase.,Flurbiprofen axetil,DB00009
DB04865,The risk or severity of bleeding can be increased when Alteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00009
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Alteplase.,Omega-3 fatty acids,DB00009
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Tositumomab.,Tositumomab,DB00009
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Alteplase.,Limaprost,DB00009
DB00048,The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00009
DB00389,Carbimazole may increase the anticoagulant activities of Alteplase.,Carbimazole,DB00009
DB00550,Propylthiouracil may increase the anticoagulant activities of Alteplase.,Propylthiouracil,DB00009
DB00763,Methimazole may increase the anticoagulant activities of Alteplase.,Methimazole,DB00009
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Alteplase.","3,5-Diiodotyrosine",DB00009
DB06715,Potassium Iodide may increase the anticoagulant activities of Alteplase.,Potassium Iodide,DB00009
DB07637,Dibromotyrosine may increase the anticoagulant activities of Alteplase.,Dibromotyrosine,DB00009
DB09418,Potassium perchlorate may increase the anticoagulant activities of Alteplase.,Potassium perchlorate,DB00009
DB13644,Methylthiouracil may increase the anticoagulant activities of Alteplase.,Methylthiouracil,DB00009
DB13804,Benzylthiouracil may increase the anticoagulant activities of Alteplase.,Benzylthiouracil,DB00009
DB00834,The therapeutic efficacy of Alteplase can be decreased when used in combination with Mifepristone.,Mifepristone,DB00009
DB04066,The therapeutic efficacy of Alteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00009
DB04682,The therapeutic efficacy of Alteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00009
DB05830,The therapeutic efficacy of Alteplase can be decreased when used in combination with Trestolone.,Trestolone,DB00009
DB06266,The therapeutic efficacy of Alteplase can be decreased when used in combination with Lonidamine.,Lonidamine,DB00009
DB08867,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ulipristal.,Ulipristal,DB00009
DB09401,The therapeutic efficacy of Alteplase can be decreased when used in combination with Isosorbide.,Isosorbide,DB00009
DB11507,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00009
DB12025,The therapeutic efficacy of Alteplase can be decreased when used in combination with Triptolide.,Triptolide,DB00009
DB13044,The therapeutic efficacy of Alteplase can be decreased when used in combination with Gossypol.,Gossypol,DB00009
DB13310,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00009
DB00294,Etonogestrel may decrease the anticoagulant activities of Alteplase.,Etonogestrel,DB00009
DB00304,Desogestrel may decrease the anticoagulant activities of Alteplase.,Desogestrel,DB00009
DB00351,Megestrol acetate may decrease the anticoagulant activities of Alteplase.,Megestrol acetate,DB00009
DB00367,Levonorgestrel may decrease the anticoagulant activities of Alteplase.,Levonorgestrel,DB00009
DB00378,Dydrogesterone may decrease the anticoagulant activities of Alteplase.,Dydrogesterone,DB00009
DB00396,Progesterone may decrease the anticoagulant activities of Alteplase.,Progesterone,DB00009
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Alteplase.,Medroxyprogesterone acetate,DB00009
DB00717,Norethisterone may decrease the anticoagulant activities of Alteplase.,Norethisterone,DB00009
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Alteplase.,Ethynodiol diacetate,DB00009
DB00957,Norgestimate may decrease the anticoagulant activities of Alteplase.,Norgestimate,DB00009
DB01395,Drospirenone may decrease the anticoagulant activities of Alteplase.,Drospirenone,DB00009
DB01431,Allylestrenol may decrease the anticoagulant activities of Alteplase.,Allylestrenol,DB00009
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Alteplase.,Cyproterone acetate,DB00009
DB06713,Norelgestromin may decrease the anticoagulant activities of Alteplase.,Norelgestromin,DB00009
DB06730,Gestodene may decrease the anticoagulant activities of Alteplase.,Gestodene,DB00009
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Alteplase.,Hydroxyprogesterone caproate,DB00009
DB09123,Dienogest may decrease the anticoagulant activities of Alteplase.,Dienogest,DB00009
DB09124,Medrogestone may decrease the anticoagulant activities of Alteplase.,Medrogestone,DB00009
DB09371,Norethynodrel may decrease the anticoagulant activities of Alteplase.,Norethynodrel,DB00009
DB09389,Norgestrel may decrease the anticoagulant activities of Alteplase.,Norgestrel,DB00009
DB11372,Altrenogest may decrease the anticoagulant activities of Alteplase.,Altrenogest,DB00009
DB11619,Gestrinone may decrease the anticoagulant activities of Alteplase.,Gestrinone,DB00009
DB11636,Nomegestrol may decrease the anticoagulant activities of Alteplase.,Nomegestrol,DB00009
DB12474,Lynestrenol may decrease the anticoagulant activities of Alteplase.,Lynestrenol,DB00009
DB13230,Gestonorone may decrease the anticoagulant activities of Alteplase.,Gestonorone,DB00009
DB13528,Chlormadinone may decrease the anticoagulant activities of Alteplase.,Chlormadinone,DB00009
DB13533,Methylestrenolone may decrease the anticoagulant activities of Alteplase.,Methylestrenolone,DB00009
DB13563,Norgestrienone may decrease the anticoagulant activities of Alteplase.,Norgestrienone,DB00009
DB13602,Promegestone may decrease the anticoagulant activities of Alteplase.,Promegestone,DB00009
DB13685,Quingestanol may decrease the anticoagulant activities of Alteplase.,Quingestanol,DB00009
DB13857,Demegestone may decrease the anticoagulant activities of Alteplase.,Demegestone,DB00009
DB13866,Etynodiol may decrease the anticoagulant activities of Alteplase.,Etynodiol,DB00009
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Alteplase.,Nomegestrol acetate,DB00009
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Alteplase.,Hydroxyprogesterone,DB00009
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Alteplase.,Norethindrone enanthate,DB00009
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Alteplase.,Quingestanol acetate,DB00009
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Alteplase.,Aminosalicylic acid,DB00009
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Alteplase.,Bismuth subsalicylate,DB00009
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Alteplase.,Dersalazine,DB00009
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Alteplase.,Phenyl aminosalicylate,DB00009
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Alteplase.,Methyl salicylate,DB00009
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Alteplase.,Trolamine salicylate,DB00009
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Alteplase.,Aloxiprin,DB00009
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Alteplase.,Choline salicylate,DB00009
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Alteplase.,Thiosalicylic acid,DB00009
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.,Abciximab,DB00009
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Alteplase.,Eptifibatide,DB00009
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Alteplase.,Ticlopidine,DB00009
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Alteplase.,Anagrelide,DB00009
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Alteplase.,Clopidogrel,DB00009
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Alteplase.,Tirofiban,DB00009
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Alteplase.,Dipyridamole,DB00009
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Alteplase.,Iloprost,DB00009
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Alteplase.,Sulfinpyrazone,DB00009
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Alteplase.,Cilostazol,DB00009
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Alteplase.,Ridogrel,DB00009
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Alteplase.,Sevoflurane,DB00009
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Alteplase.,Epoprostenol,DB00009
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Alteplase.,Resveratrol,DB00009
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Alteplase.,Nimesulide,DB00009
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Alteplase.,Tesmilifene,DB00009
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Alteplase.,Defibrotide,DB00009
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Alteplase.,Beraprost,DB00009
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Alteplase.,Ibudilast,DB00009
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Alteplase.,Andrographolide,DB00009
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Alteplase.,Caplacizumab,DB00009
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Alteplase.,Prasugrel,DB00009
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Alteplase.,Cangrelor,DB00009
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Alteplase.,Tranilast,DB00009
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Alteplase.,Triflusal,DB00009
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Alteplase.,Ticagrelor,DB00009
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Alteplase.,Icosapent ethyl,DB00009
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Alteplase.,Trapidil,DB00009
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Alteplase.,Naftopidil,DB00009
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Alteplase.,Sarpogrelate,DB00009
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Alteplase.,Ifetroban,DB00009
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Alteplase.,Nitroaspirin,DB00009
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Alteplase.,Ketanserin,DB00009
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Alteplase.,Indobufen,DB00009
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Alteplase.,Butylphthalide,DB00009
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Alteplase.,Hydroxytyrosol,DB00009
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Alteplase.,Ramatroban,DB00009
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Alteplase.,Picotamide,DB00009
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Alteplase.,Cloricromen,DB00009
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Alteplase.,Linsidomine,DB00009
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Alteplase.,Buflomedil,DB00009
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Alteplase.,Relcovaptan,DB00009
DB00374,The risk or severity of adverse effects can be increased when Alteplase is combined with Treprostinil.,Treprostinil,DB00009
DB03404,Hemin may increase the anticoagulant activities of Alteplase.,Hemin,DB00009
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Alteplase.,Acemetacin,DB00009
DB00624,Testosterone may increase the anticoagulant activities of Alteplase.,Testosterone,DB00009
DB01420,Testosterone propionate may increase the anticoagulant activities of Alteplase.,Testosterone propionate,DB00009
DB01481,1-Testosterone may increase the anticoagulant activities of Alteplase.,1-Testosterone,DB00009
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Alteplase.,4-Hydroxytestosterone,DB00009
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Alteplase.,Dehydrochloromethyltestosterone,DB00009
DB01541,Boldenone may increase the anticoagulant activities of Alteplase.,Boldenone,DB00009
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Alteplase.,18-methyl-19-nortestosterone,DB00009
DB01564,Calusterone may increase the anticoagulant activities of Alteplase.,Calusterone,DB00009
DB01569,Formebolone may increase the anticoagulant activities of Alteplase.,Formebolone,DB00009
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Alteplase.,Methyl-1-testosterone,DB00009
DB02901,Stanolone may increase the anticoagulant activities of Alteplase.,Stanolone,DB00009
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Alteplase.,5beta-dihydrotestosterone,DB00009
DB08619,Testosterone succinate may increase the anticoagulant activities of Alteplase.,Testosterone succinate,DB00009
DB11429,Mibolerone may increase the anticoagulant activities of Alteplase.,Mibolerone,DB00009
DB13943,Testosterone cypionate may increase the anticoagulant activities of Alteplase.,Testosterone cypionate,DB00009
DB13944,Testosterone enanthate may increase the anticoagulant activities of Alteplase.,Testosterone enanthate,DB00009
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Alteplase.,Testosterone undecanoate,DB00009
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Alteplase.,Testosterone enantate benzilic acid hydrazone,DB00009
DB13951,Stanolone acetate may increase the anticoagulant activities of Alteplase.,Stanolone acetate,DB00009
DB13958,Trestolone acetate may increase the anticoagulant activities of Alteplase.,Trestolone acetate,DB00009
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase.","(1,2,6,7-3H)Testosterone",DB00009
DB14655,Drostanolone propionate may increase the anticoagulant activities of Alteplase.,Drostanolone propionate,DB00009
DB11051,The risk or severity of adverse effects can be increased when Alteplase is combined with Azficel-T.,Azficel-T,DB00009
DB09568,The therapeutic efficacy of Alteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00009
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Alteplase.,Calcium acetate,DB00009
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Alteplase.,Calcium chloride,DB00009
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Alteplase.,Calcium,DB00009
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Alteplase.,Calcium gluconate,DB00009
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Alteplase.,Eftrenonacog alfa,DB00009
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Alteplase.,Albutrepenonacog alfa,DB00009
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Alteplase.,Emicizumab,DB00009
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Alteplase.,Turoctocog alfa pegol,DB00009
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.","Antihemophilic factor, human recombinant",DB00009
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.,Coagulation factor VIIa Recombinant Human,DB00009
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Alteplase.,Coagulation Factor IX (Recombinant),DB00009
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Alteplase.,Pantothenic acid,DB00009
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Alteplase.,Formic acid,DB00009
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Alteplase.,Platelet Activating Factor,DB00009
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Alteplase.,Calcium carbonate,DB00009
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Alteplase.,Turoctocog alfa,DB00009
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Alteplase.,Fibrinogen human,DB00009
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Alteplase.,Catridecacog,DB00009
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Alteplase.","Antihemophilic Factor (Recombinant), PEGylated",DB00009
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Alteplase.,Calcium citrate,DB00009
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Alteplase.,Calcium threonate,DB00009
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Alteplase.,Prothrombin,DB00009
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Alteplase.,Factor IX Complex (Human),DB00009
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Alteplase.,Calcium Phosphate,DB00009
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Alteplase.,Susoctocog alfa,DB00009
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Alteplase.,Rusalatide acetate,DB00009
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Alteplase.,Vatreptacog alfa,DB00009
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Alteplase.,Factor XIII (human),DB00009
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Alteplase.,Von Willebrand Factor Human,DB00009
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Alteplase.,Coagulation factor X human,DB00009
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Alteplase.,Coagulation factor VII human,DB00009
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Alteplase.,Anti-inhibitor coagulant complex,DB00009
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Alteplase.,Coagulation Factor IX Human,DB00009
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Alteplase.,Antihemophilic factor human,DB00009
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Alteplase.,Kallidinogenase,DB00009
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Alteplase.,Trenonacog alfa,DB00009
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Alteplase.,Nonacog beta pegol,DB00009
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Alteplase.,Moroctocog alfa,DB00009
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Alteplase.,Beroctocog alfa,DB00009
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Alteplase.,Andexanet alfa,DB00009
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Alteplase.,Calcium cation,DB00009
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Alteplase.,Damoctocog alfa pegol,DB00009
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Alteplase.,Fluvoxamine,DB00009
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Alteplase.,Citalopram,DB00009
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Alteplase.,Fluoxetine,DB00009
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Alteplase.,Paroxetine,DB00009
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Alteplase.,Nefazodone,DB00009
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Alteplase.,Zimelidine,DB00009
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Alteplase.,Dapoxetine,DB00009
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Alteplase.,Seproxetine,DB00009
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Alteplase.,Indalpine,DB00009
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Alteplase.,Ritanserin,DB00009
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Alteplase.,Alaproclate,DB00009
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Alteplase.,Duloxetine,DB00009
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Alteplase.,Sibutramine,DB00009
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Alteplase.,Milnacipran,DB00009
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Alteplase.,Desvenlafaxine,DB00009
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Alteplase.,Levomilnacipran,DB00009
DB00285,Venlafaxine may increase the antiplatelet activities of Alteplase.,Venlafaxine,DB00009
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Alteplase.,Amphetamine,DB00009
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Alteplase.,Linezolid,DB00009
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Alteplase.,Furazolidone,DB00009
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Alteplase.,Procaine,DB00009
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Alteplase.,Tranylcypromine,DB00009
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Alteplase.,Phenelzine,DB00009
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Alteplase.,Minaprine,DB00009
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Alteplase.,Selegiline,DB00009
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Alteplase.,Procarbazine,DB00009
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Alteplase.,Moclobemide,DB00009
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Alteplase.,Isocarboxazid,DB00009
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Alteplase.,Rasagiline,DB00009
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Alteplase.,Pargyline,DB00009
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Alteplase.,Clorgiline,DB00009
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Alteplase.,Iproniazid,DB00009
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Alteplase.,Nialamide,DB00009
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Alteplase.,Safinamide,DB00009
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Alteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00009
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Alteplase.,Methylene blue,DB00009
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Alteplase.,Hydracarbazine,DB00009
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Alteplase.,Pirlindole,DB00009
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Alteplase.,Toloxatone,DB00009
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Alteplase.,Benmoxin,DB00009
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Alteplase.,Mebanazine,DB00009
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Alteplase.,Octamoxin,DB00009
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Alteplase.,Pheniprazine,DB00009
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Alteplase.,Phenoxypropazine,DB00009
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Alteplase.,Pivhydrazine,DB00009
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Alteplase.,Safrazine,DB00009
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Alteplase.,Caroxazone,DB00009
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Alteplase.,Harmaline,DB00009
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Alteplase.,Brofaromine,DB00009
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.,Bivalirudin,DB00009
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Alteplase.,Dicoumarol,DB00009
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Alteplase.,Argatroban,DB00009
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Alteplase.,Ardeparin,DB00009
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Alteplase.,Phenindione,DB00009
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Alteplase.,Fondaparinux,DB00009
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Alteplase.,Warfarin,DB00009
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Alteplase.,Phenprocoumon,DB00009
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Alteplase.,Edetic acid,DB00009
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Alteplase.,Heparin,DB00009
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Alteplase.,Enoxaparin,DB00009
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Alteplase.,Acenocoumarol,DB00009
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Alteplase.,Ximelagatran,DB00009
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Alteplase.,Ancrod,DB00009
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Alteplase.,Sulodexide,DB00009
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Alteplase.,Idraparinux,DB00009
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Alteplase.,Otamixaban,DB00009
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Alteplase.,Danaparoid,DB00009
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Alteplase.,Dalteparin,DB00009
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Alteplase.,Ferulic acid,DB00009
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Alteplase.,Ethyl biscoumacetate,DB00009
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Alteplase.,Nadroparin,DB00009
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Alteplase.,Dextran,DB00009
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Alteplase.,Reviparin,DB00009
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Alteplase.,Certoparin,DB00009
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Alteplase.,Desirudin,DB00009
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Alteplase.,Protocatechualdehyde,DB00009
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Alteplase.,Protein C,DB00009
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Alteplase.,Antithrombin III human,DB00009
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Alteplase.,Letaxaban,DB00009
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Alteplase.,Darexaban,DB00009
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Alteplase.,Nafamostat,DB00009
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Alteplase.,Gabexate,DB00009
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Alteplase.,Troxerutin,DB00009
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Alteplase.,Fluindione,DB00009
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Alteplase.,Protein S human,DB00009
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Alteplase.,Melagatran,DB00009
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Alteplase.,Potassium citrate,DB00009
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Alteplase.,Sodium citrate,DB00009
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.,Tenecteplase,DB00009
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Alteplase.,Drotrecogin alfa,DB00009
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Alteplase.,Tinzaparin,DB00009
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Alteplase.,Brinase,DB00009
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Alteplase.,Saruplase,DB00009
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Alteplase.,Streptokinase,DB00009
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Alteplase.,Desmoteplase,DB00009
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Alteplase.,Fibrinolysin,DB00009
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Alteplase.,Astaxanthin,DB00009
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Alteplase.,Ditazole,DB00009
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Alteplase.,Bemiparin,DB00009
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Alteplase.,Parnaparin,DB00009
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Alteplase.,Clorindione,DB00009
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Alteplase.,Diphenadione,DB00009
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Alteplase.,Tioclomarol,DB00009
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.,Lepirudin,DB00009
DB00015,The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.,Reteplase,DB00009
DB00029,The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.,Anistreplase,DB00009
DB14094,The risk or severity of bleeding can be increased when Alteplase is combined with Tocopherylquinone.,Tocopherylquinone,DB00009
DB06679,The risk or severity of bleeding can be increased when Alteplase is combined with Amediplase.,Amediplase,DB00009
DB03410,The risk or severity of bleeding can be increased when Alteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00009
DB08496,The risk or severity of bleeding can be increased when Alteplase is combined with (R)-warfarin.,(R)-warfarin,DB00009
DB14055,The risk or severity of bleeding can be increased when Alteplase is combined with (S)-Warfarin.,(S)-Warfarin,DB00009
DB12364,The risk or severity of bleeding can be increased when Alteplase is combined with Betrixaban.,Betrixaban,DB00009
DB14598,The risk or severity of bleeding can be increased when Alteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00009
DB11154,The risk or severity of bleeding can be increased when Alteplase is combined with Zinc citrate.,Zinc citrate,DB00009
DB11166,The risk or severity of bleeding can be increased when Alteplase is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00009
DB04665,The risk or severity of bleeding can be increased when Alteplase is combined with Coumarin.,Coumarin,DB00009
DB14726,The risk or severity of bleeding can be increased when Alteplase is combined with Dabigatran.,Dabigatran,DB00009
DB06294,The risk or severity of bleeding can be increased when Alteplase is combined with Semuloparin.,Semuloparin,DB00009
DB12726,The risk or severity of bleeding can be increased when Alteplase is combined with Monteplase.,Monteplase,DB00009
DB00177,The risk or severity of angioedema can be increased when Alteplase is combined with Valsartan.,Valsartan,DB00009
DB00178,The risk or severity of angioedema can be increased when Alteplase is combined with Ramipril.,Ramipril,DB00009
DB00230,The risk or severity of angioedema can be increased when Alteplase is combined with Pregabalin.,Pregabalin,DB00009
DB00492,The risk or severity of angioedema can be increased when Alteplase is combined with Fosinopril.,Fosinopril,DB00009
DB00519,The risk or severity of angioedema can be increased when Alteplase is combined with Trandolapril.,Trandolapril,DB00009
DB00542,The risk or severity of angioedema can be increased when Alteplase is combined with Benazepril.,Benazepril,DB00009
DB00584,The risk or severity of angioedema can be increased when Alteplase is combined with Enalapril.,Enalapril,DB00009
DB00678,The risk or severity of angioedema can be increased when Alteplase is combined with Losartan.,Losartan,DB00009
DB00691,The risk or severity of angioedema can be increased when Alteplase is combined with Moexipril.,Moexipril,DB00009
DB00722,The risk or severity of angioedema can be increased when Alteplase is combined with Lisinopril.,Lisinopril,DB00009
DB00790,The risk or severity of angioedema can be increased when Alteplase is combined with Perindopril.,Perindopril,DB00009
DB00876,The risk or severity of angioedema can be increased when Alteplase is combined with Eprosartan.,Eprosartan,DB00009
DB00877,The risk or severity of angioedema can be increased when Alteplase is combined with Sirolimus.,Sirolimus,DB00009
DB00881,The risk or severity of angioedema can be increased when Alteplase is combined with Quinapril.,Quinapril,DB00009
DB00886,The risk or severity of angioedema can be increased when Alteplase is combined with Omapatrilat.,Omapatrilat,DB00009
DB00966,The risk or severity of angioedema can be increased when Alteplase is combined with Telmisartan.,Telmisartan,DB00009
DB01050,The risk or severity of angioedema can be increased when Alteplase is combined with Ibuprofen.,Ibuprofen,DB00009
DB01180,The risk or severity of angioedema can be increased when Alteplase is combined with Rescinnamine.,Rescinnamine,DB00009
DB01197,The risk or severity of angioedema can be increased when Alteplase is combined with Captopril.,Captopril,DB00009
DB01261,The risk or severity of angioedema can be increased when Alteplase is combined with Sitagliptin.,Sitagliptin,DB00009
DB01340,The risk or severity of angioedema can be increased when Alteplase is combined with Cilazapril.,Cilazapril,DB00009
DB01342,The risk or severity of angioedema can be increased when Alteplase is combined with Forasartan.,Forasartan,DB00009
DB01347,The risk or severity of angioedema can be increased when Alteplase is combined with Saprisartan.,Saprisartan,DB00009
DB01348,The risk or severity of angioedema can be increased when Alteplase is combined with Spirapril.,Spirapril,DB00009
DB04876,The risk or severity of angioedema can be increased when Alteplase is combined with Vildagliptin.,Vildagliptin,DB00009
DB06011,The risk or severity of angioedema can be increased when Alteplase is combined with AMG-222.,AMG-222,DB00009
DB06127,The risk or severity of angioedema can be increased when Alteplase is combined with Bisegliptin.,Bisegliptin,DB00009
DB06196,The risk or severity of angioedema can be increased when Alteplase is combined with Icatibant.,Icatibant,DB00009
DB06203,The risk or severity of angioedema can be increased when Alteplase is combined with Alogliptin.,Alogliptin,DB00009
DB06245,The risk or severity of angioedema can be increased when Alteplase is combined with Lanoteplase.,Lanoteplase,DB00009
DB06287,The risk or severity of angioedema can be increased when Alteplase is combined with Temsirolimus.,Temsirolimus,DB00009
DB06335,The risk or severity of angioedema can be increased when Alteplase is combined with Saxagliptin.,Saxagliptin,DB00009
DB08382,The risk or severity of angioedema can be increased when Alteplase is combined with Gosogliptin.,Gosogliptin,DB00009
DB08822,The risk or severity of angioedema can be increased when Alteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00009
DB08836,The risk or severity of angioedema can be increased when Alteplase is combined with Temocapril.,Temocapril,DB00009
DB08882,The risk or severity of angioedema can be increased when Alteplase is combined with Linagliptin.,Linagliptin,DB00009
DB09292,The risk or severity of angioedema can be increased when Alteplase is combined with Sacubitril.,Sacubitril,DB00009
DB09477,The risk or severity of angioedema can be increased when Alteplase is combined with Enalaprilat.,Enalaprilat,DB00009
DB11723,The risk or severity of angioedema can be increased when Alteplase is combined with Dutogliptin.,Dutogliptin,DB00009
DB11783,The risk or severity of angioedema can be increased when Alteplase is combined with Imidapril.,Imidapril,DB00009
DB11950,The risk or severity of angioedema can be increased when Alteplase is combined with Teneligliptin.,Teneligliptin,DB00009
DB11992,The risk or severity of angioedema can be increased when Alteplase is combined with Omarigliptin.,Omarigliptin,DB00009
DB12268,The risk or severity of angioedema can be increased when Alteplase is combined with Carmegliptin.,Carmegliptin,DB00009
DB12412,The risk or severity of angioedema can be increased when Alteplase is combined with Gemigliptin.,Gemigliptin,DB00009
DB12417,The risk or severity of angioedema can be increased when Alteplase is combined with Anagliptin.,Anagliptin,DB00009
DB12625,The risk or severity of angioedema can be increased when Alteplase is combined with Evogliptin.,Evogliptin,DB00009
DB13166,The risk or severity of angioedema can be increased when Alteplase is combined with Zofenopril.,Zofenopril,DB00009
DB13312,The risk or severity of angioedema can be increased when Alteplase is combined with Delapril.,Delapril,DB00009
DB14125,The risk or severity of angioedema can be increased when Alteplase is combined with Benazeprilat.,Benazeprilat,DB00009
DB14207,The risk or severity of angioedema can be increased when Alteplase is combined with Fosinoprilat.,Fosinoprilat,DB00009
DB14208,The risk or severity of angioedema can be increased when Alteplase is combined with Ramiprilat.,Ramiprilat,DB00009
DB14209,The risk or severity of angioedema can be increased when Alteplase is combined with Trandolaprilat.,Trandolaprilat,DB00009
DB14210,The risk or severity of angioedema can be increased when Alteplase is combined with Moexiprilat.,Moexiprilat,DB00009
DB14213,The risk or severity of angioedema can be increased when Alteplase is combined with Perindoprilat.,Perindoprilat,DB00009
DB14217,The risk or severity of angioedema can be increased when Alteplase is combined with Quinaprilat.,Quinaprilat,DB00009
DB14231,The risk or severity of angioedema can be increased when Alteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00009
DB00203,The risk or severity of hemorrhage can be increased when Alteplase is combined with Sildenafil.,Sildenafil,DB00009
DB00008,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00009
DB00011,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00009
DB00018,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00009
DB00022,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00009
DB00033,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00009
DB00034,"The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00009
DB00041,The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.,Aldesleukin,DB00009
DB00056,The risk or severity of bleeding can be increased when Alteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00009
DB00068,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon beta-1b.,Interferon beta-1b,DB00009
DB00069,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00009
DB00073,The risk or severity of bleeding can be increased when Alteplase is combined with Rituximab.,Rituximab,DB00009
DB00078,The risk or severity of bleeding can be increased when Alteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00009
DB00087,The risk or severity of bleeding can be increased when Alteplase is combined with Alemtuzumab.,Alemtuzumab,DB00009
DB00105,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00009
DB00120,The risk or severity of bleeding can be increased when Alteplase is combined with Phenylalanine.,Phenylalanine,DB00009
DB00188,The risk or severity of bleeding can be increased when Alteplase is combined with Bortezomib.,Bortezomib,DB00009
DB00242,The risk or severity of bleeding can be increased when Alteplase is combined with Cladribine.,Cladribine,DB00009
DB00262,The risk or severity of bleeding can be increased when Alteplase is combined with Carmustine.,Carmustine,DB00009
DB00276,The risk or severity of bleeding can be increased when Alteplase is combined with Amsacrine.,Amsacrine,DB00009
DB00291,The risk or severity of bleeding can be increased when Alteplase is combined with Chlorambucil.,Chlorambucil,DB00009
DB00293,The risk or severity of bleeding can be increased when Alteplase is combined with Raltitrexed.,Raltitrexed,DB00009
DB00305,The risk or severity of bleeding can be increased when Alteplase is combined with Mitomycin.,Mitomycin,DB00009
DB00307,The risk or severity of bleeding can be increased when Alteplase is combined with Bexarotene.,Bexarotene,DB00009
DB00309,The risk or severity of bleeding can be increased when Alteplase is combined with Vindesine.,Vindesine,DB00009
DB00322,The risk or severity of bleeding can be increased when Alteplase is combined with Floxuridine.,Floxuridine,DB00009
DB00352,The risk or severity of bleeding can be increased when Alteplase is combined with Tioguanine.,Tioguanine,DB00009
DB00361,The risk or severity of bleeding can be increased when Alteplase is combined with Vinorelbine.,Vinorelbine,DB00009
DB00380,The risk or severity of bleeding can be increased when Alteplase is combined with Dexrazoxane.,Dexrazoxane,DB00009
DB00398,The risk or severity of bleeding can be increased when Alteplase is combined with Sorafenib.,Sorafenib,DB00009
DB00428,The risk or severity of bleeding can be increased when Alteplase is combined with Streptozocin.,Streptozocin,DB00009
DB00441,The risk or severity of bleeding can be increased when Alteplase is combined with Gemcitabine.,Gemcitabine,DB00009
DB00444,The risk or severity of bleeding can be increased when Alteplase is combined with Teniposide.,Teniposide,DB00009
DB00445,The risk or severity of bleeding can be increased when Alteplase is combined with Epirubicin.,Epirubicin,DB00009
DB00446,The risk or severity of bleeding can be increased when Alteplase is combined with Chloramphenicol.,Chloramphenicol,DB00009
DB00480,The risk or severity of bleeding can be increased when Alteplase is combined with Lenalidomide.,Lenalidomide,DB00009
DB00488,The risk or severity of bleeding can be increased when Alteplase is combined with Altretamine.,Altretamine,DB00009
DB00495,The risk or severity of bleeding can be increased when Alteplase is combined with Zidovudine.,Zidovudine,DB00009
DB00515,The risk or severity of bleeding can be increased when Alteplase is combined with Cisplatin.,Cisplatin,DB00009
DB00526,The risk or severity of bleeding can be increased when Alteplase is combined with Oxaliplatin.,Oxaliplatin,DB00009
DB00531,The risk or severity of bleeding can be increased when Alteplase is combined with Cyclophosphamide.,Cyclophosphamide,DB00009
DB00544,The risk or severity of bleeding can be increased when Alteplase is combined with Fluorouracil.,Fluorouracil,DB00009
DB00552,The risk or severity of bleeding can be increased when Alteplase is combined with Pentostatin.,Pentostatin,DB00009
DB00563,The risk or severity of bleeding can be increased when Alteplase is combined with Methotrexate.,Methotrexate,DB00009
DB00564,The risk or severity of bleeding can be increased when Alteplase is combined with Carbamazepine.,Carbamazepine,DB00009
DB00570,The risk or severity of bleeding can be increased when Alteplase is combined with Vinblastine.,Vinblastine,DB00009
DB00619,The risk or severity of bleeding can be increased when Alteplase is combined with Imatinib.,Imatinib,DB00009
DB00631,The risk or severity of bleeding can be increased when Alteplase is combined with Clofarabine.,Clofarabine,DB00009
DB00642,The risk or severity of bleeding can be increased when Alteplase is combined with Pemetrexed.,Pemetrexed,DB00009
DB00694,The risk or severity of bleeding can be increased when Alteplase is combined with Daunorubicin.,Daunorubicin,DB00009
DB00762,The risk or severity of bleeding can be increased when Alteplase is combined with Irinotecan.,Irinotecan,DB00009
DB00773,The risk or severity of bleeding can be increased when Alteplase is combined with Etoposide.,Etoposide,DB00009
DB00851,The risk or severity of bleeding can be increased when Alteplase is combined with Dacarbazine.,Dacarbazine,DB00009
DB00853,The risk or severity of bleeding can be increased when Alteplase is combined with Temozolomide.,Temozolomide,DB00009
DB00859,The risk or severity of bleeding can be increased when Alteplase is combined with Penicillamine.,Penicillamine,DB00009
DB00864,The risk or severity of bleeding can be increased when Alteplase is combined with Tacrolimus.,Tacrolimus,DB00009
DB00888,The risk or severity of bleeding can be increased when Alteplase is combined with Mechlorethamine.,Mechlorethamine,DB00009
DB00928,The risk or severity of bleeding can be increased when Alteplase is combined with Azacitidine.,Azacitidine,DB00009
DB00958,The risk or severity of bleeding can be increased when Alteplase is combined with Carboplatin.,Carboplatin,DB00009
DB00970,The risk or severity of bleeding can be increased when Alteplase is combined with Dactinomycin.,Dactinomycin,DB00009
DB00987,The risk or severity of bleeding can be increased when Alteplase is combined with Cytarabine.,Cytarabine,DB00009
DB00997,The risk or severity of bleeding can be increased when Alteplase is combined with Doxorubicin.,Doxorubicin,DB00009
DB01005,The risk or severity of bleeding can be increased when Alteplase is combined with Hydroxyurea.,Hydroxyurea,DB00009
DB01008,The risk or severity of bleeding can be increased when Alteplase is combined with Busulfan.,Busulfan,DB00009
DB01030,The risk or severity of bleeding can be increased when Alteplase is combined with Topotecan.,Topotecan,DB00009
DB01033,The risk or severity of bleeding can be increased when Alteplase is combined with Mercaptopurine.,Mercaptopurine,DB00009
DB01041,The risk or severity of bleeding can be increased when Alteplase is combined with Thalidomide.,Thalidomide,DB00009
DB01042,The risk or severity of bleeding can be increased when Alteplase is combined with Melphalan.,Melphalan,DB00009
DB01073,The risk or severity of bleeding can be increased when Alteplase is combined with Fludarabine.,Fludarabine,DB00009
DB01099,The risk or severity of bleeding can be increased when Alteplase is combined with Flucytosine.,Flucytosine,DB00009
DB01101,The risk or severity of bleeding can be increased when Alteplase is combined with Capecitabine.,Capecitabine,DB00009
DB01169,The risk or severity of bleeding can be increased when Alteplase is combined with Arsenic trioxide.,Arsenic trioxide,DB00009
DB01177,The risk or severity of bleeding can be increased when Alteplase is combined with Idarubicin.,Idarubicin,DB00009
DB01204,The risk or severity of bleeding can be increased when Alteplase is combined with Mitoxantrone.,Mitoxantrone,DB00009
DB01206,The risk or severity of bleeding can be increased when Alteplase is combined with Lomustine.,Lomustine,DB00009
DB01229,The risk or severity of bleeding can be increased when Alteplase is combined with Paclitaxel.,Paclitaxel,DB00009
DB01248,The risk or severity of bleeding can be increased when Alteplase is combined with Docetaxel.,Docetaxel,DB00009
DB01262,The risk or severity of bleeding can be increased when Alteplase is combined with Decitabine.,Decitabine,DB00009
DB01280,The risk or severity of bleeding can be increased when Alteplase is combined with Nelarabine.,Nelarabine,DB00009
DB01590,The risk or severity of bleeding can be increased when Alteplase is combined with Everolimus.,Everolimus,DB00009
DB02546,The risk or severity of bleeding can be increased when Alteplase is combined with Vorinostat.,Vorinostat,DB00009
DB04572,The risk or severity of bleeding can be increased when Alteplase is combined with Thiotepa.,Thiotepa,DB00009
DB04845,The risk or severity of bleeding can be increased when Alteplase is combined with Ixabepilone.,Ixabepilone,DB00009
DB04868,The risk or severity of bleeding can be increased when Alteplase is combined with Nilotinib.,Nilotinib,DB00009
DB05015,The risk or severity of bleeding can be increased when Alteplase is combined with Belinostat.,Belinostat,DB00009
DB05109,The risk or severity of bleeding can be increased when Alteplase is combined with Trabectedin.,Trabectedin,DB00009
DB05258,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa.,Interferon alfa,DB00009
DB05472,The risk or severity of bleeding can be increased when Alteplase is combined with omega interferon.,omega interferon,DB00009
DB05773,The risk or severity of bleeding can be increased when Alteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00009
DB06616,The risk or severity of bleeding can be increased when Alteplase is combined with Bosutinib.,Bosutinib,DB00009
DB06769,The risk or severity of bleeding can be increased when Alteplase is combined with Bendamustine.,Bendamustine,DB00009
DB06772,The risk or severity of bleeding can be increased when Alteplase is combined with Cabazitaxel.,Cabazitaxel,DB00009
DB08871,The risk or severity of bleeding can be increased when Alteplase is combined with Eribulin.,Eribulin,DB00009
DB08877,The risk or severity of bleeding can be increased when Alteplase is combined with Ruxolitinib.,Ruxolitinib,DB00009
DB08889,The risk or severity of bleeding can be increased when Alteplase is combined with Carfilzomib.,Carfilzomib,DB00009
DB08895,The risk or severity of bleeding can be increased when Alteplase is combined with Tofacitinib.,Tofacitinib,DB00009
DB08901,The risk or severity of bleeding can be increased when Alteplase is combined with Ponatinib.,Ponatinib,DB00009
DB08910,The risk or severity of bleeding can be increased when Alteplase is combined with Pomalidomide.,Pomalidomide,DB00009
DB09042,The risk or severity of bleeding can be increased when Alteplase is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00009
DB09052,The risk or severity of bleeding can be increased when Alteplase is combined with Blinatumomab.,Blinatumomab,DB00009
DB09073,The risk or severity of bleeding can be increased when Alteplase is combined with Palbociclib.,Palbociclib,DB00009
DB09074,The risk or severity of bleeding can be increased when Alteplase is combined with Olaparib.,Olaparib,DB00009
DB09077,The risk or severity of bleeding can be increased when Alteplase is combined with Dinutuximab.,Dinutuximab,DB00009
DB09122,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00009
DB12814,The risk or severity of bleeding can be increased when Alteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00009
DB00229,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotiam.,Cefotiam,DB00009
DB00267,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00009
DB00274,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00009
DB00430,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00009
DB00438,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00009
DB00447,The therapeutic efficacy of Alteplase can be decreased when used in combination with Loracarbef.,Loracarbef,DB00009
DB00456,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefalotin.,Cefalotin,DB00009
DB00493,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00009
DB00535,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefdinir.,Cefdinir,DB00009
DB00567,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephalexin.,Cephalexin,DB00009
DB00671,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefixime.,Cefixime,DB00009
DB00689,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00009
DB00833,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaclor.,Cefaclor,DB00009
DB00923,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceforanide.,Ceforanide,DB00009
DB01066,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefditoren.,Cefditoren,DB00009
DB01112,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00009
DB01139,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefapirin.,Cefapirin,DB00009
DB01140,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00009
DB01150,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefprozil.,Cefprozil,DB00009
DB01212,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00009
DB01326,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole.,Cefamandole,DB00009
DB01327,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazolin.,Cefazolin,DB00009
DB01328,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefonicid.,Cefonicid,DB00009
DB01329,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00009
DB01330,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotetan.,Cefotetan,DB00009
DB01331,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00009
DB01332,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00009
DB01333,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefradine.,Cefradine,DB00009
DB01413,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefepime.,Cefepime,DB00009
DB01414,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00009
DB01415,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00009
DB01416,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00009
DB04570,The therapeutic efficacy of Alteplase can be decreased when used in combination with Latamoxef.,Latamoxef,DB00009
DB04918,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00009
DB06590,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00009
DB09008,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00009
DB09050,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00009
DB09062,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefminox.,Cefminox,DB00009
DB11367,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00009
DB11935,The therapeutic efficacy of Alteplase can be decreased when used in combination with Flomoxef.,Flomoxef,DB00009
DB13266,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00009
DB13461,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefcapene.,Cefcapene,DB00009
DB13470,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefodizime.,Cefodizime,DB00009
DB13499,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00009
DB13504,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefetamet.,Cefetamet,DB00009
DB13638,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00009
DB13667,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefozopran.,Cefozopran,DB00009
DB13682,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpirome.,Cefpirome,DB00009
DB13778,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazedone.,Cefazedone,DB00009
DB13821,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftezole.,Ceftezole,DB00009
DB14725,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00009
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Alteplase.,Doxycycline,DB00009
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Alteplase.,Azithromycin,DB00009
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Alteplase.,Omega-3-acid ethyl esters,DB00009
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Alteplase.,Acetylsalicylic acid,DB00009
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Alteplase.,Tazobactam,DB00009
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Alteplase.,Erythromycin,DB00009
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Alteplase.,Trazodone,DB00009
DB00620,The therapeutic efficacy of Alteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00009
DB09079,The risk or severity of bleeding can be increased when Alteplase is combined with Nintedanib.,Nintedanib,DB00009
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Alteplase.,Escitalopram,DB00009
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Alteplase.,Sertraline,DB00009
DB00232,The therapeutic efficacy of Alteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00009
DB00436,The therapeutic efficacy of Alteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00009
DB00562,The therapeutic efficacy of Alteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00009
DB00606,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00009
DB00774,The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00009
DB00880,The therapeutic efficacy of Alteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00009
DB00999,The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00009
DB01021,The therapeutic efficacy of Alteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00009
DB01324,The therapeutic efficacy of Alteplase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00009
DB13430,The therapeutic efficacy of Alteplase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00009
DB13532,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00009
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-n1.,Denosumab,DB00011
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n1.,Etanercept,DB00011
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n1.,Peginterferon alfa-2a,DB00011
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00011
DB00022,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00011
DB00026,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Anakinra.,Anakinra,DB00011
DB00033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00011
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00011
DB00041,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldesleukin.,Aldesleukin,DB00011
DB00051,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Adalimumab.,Adalimumab,DB00011
DB00056,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00011
DB00059,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pegaspargase.,Pegaspargase,DB00011
DB00065,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Infliximab.,Infliximab,DB00011
DB00068,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon beta-1b.,Interferon beta-1b,DB00011
DB00069,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00011
DB00073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rituximab.,Rituximab,DB00011
DB00074,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Basiliximab.,Basiliximab,DB00011
DB00075,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Muromonab.,Muromonab,DB00011
DB00078,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00011
DB00081,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tositumomab.,Tositumomab,DB00011
DB00087,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Alemtuzumab.,Alemtuzumab,DB00011
DB00092,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Alefacept.,Alefacept,DB00011
DB00095,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Efalizumab.,Efalizumab,DB00011
DB00098,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00011
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00011
DB00111,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Daclizumab.,Daclizumab,DB00011
DB00112,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bevacizumab.,Bevacizumab,DB00011
DB00120,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Phenylalanine.,Phenylalanine,DB00011
DB00180,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Flunisolide.,Flunisolide,DB00011
DB00188,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bortezomib.,Bortezomib,DB00011
DB00242,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cladribine.,Cladribine,DB00011
DB00262,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carmustine.,Carmustine,DB00011
DB00276,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Amsacrine.,Amsacrine,DB00011
DB00290,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bleomycin.,Bleomycin,DB00011
DB00291,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Chlorambucil.,Chlorambucil,DB00011
DB00293,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Raltitrexed.,Raltitrexed,DB00011
DB00305,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mitomycin.,Mitomycin,DB00011
DB00307,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bexarotene.,Bexarotene,DB00011
DB00309,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vindesine.,Vindesine,DB00011
DB00322,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Floxuridine.,Floxuridine,DB00011
DB00328,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Indomethacin.,Indomethacin,DB00011
DB00352,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tioguanine.,Tioguanine,DB00011
DB00361,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinorelbine.,Vinorelbine,DB00011
DB00380,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexrazoxane.,Dexrazoxane,DB00011
DB00394,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00011
DB00398,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sorafenib.,Sorafenib,DB00011
DB00428,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Streptozocin.,Streptozocin,DB00011
DB00432,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trifluridine.,Trifluridine,DB00011
DB00441,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemcitabine.,Gemcitabine,DB00011
DB00443,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Betamethasone.,Betamethasone,DB00011
DB00444,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Teniposide.,Teniposide,DB00011
DB00445,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Epirubicin.,Epirubicin,DB00011
DB00446,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Chloramphenicol.,Chloramphenicol,DB00011
DB00480,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Lenalidomide.,Lenalidomide,DB00011
DB00488,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Altretamine.,Altretamine,DB00011
DB00495,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Zidovudine.,Zidovudine,DB00011
DB00515,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cisplatin.,Cisplatin,DB00011
DB00526,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Oxaliplatin.,Oxaliplatin,DB00011
DB00531,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cyclophosphamide.,Cyclophosphamide,DB00011
DB00541,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vincristine.,Vincristine,DB00011
DB00544,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluorouracil.,Fluorouracil,DB00011
DB00550,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Propylthiouracil.,Propylthiouracil,DB00011
DB00552,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pentostatin.,Pentostatin,DB00011
DB00563,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methotrexate.,Methotrexate,DB00011
DB00564,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carbamazepine.,Carbamazepine,DB00011
DB00570,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinblastine.,Vinblastine,DB00011
DB00588,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone propionate.,Fluticasone propionate,DB00011
DB00591,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00011
DB00601,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Linezolid.,Linezolid,DB00011
DB00619,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Imatinib.,Imatinib,DB00011
DB00620,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Triamcinolone.,Triamcinolone,DB00011
DB00631,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Clofarabine.,Clofarabine,DB00011
DB00635,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednisone.,Prednisone,DB00011
DB00642,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pemetrexed.,Pemetrexed,DB00011
DB00687,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fludrocortisone.,Fludrocortisone,DB00011
DB00688,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00011
DB00694,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Daunorubicin.,Daunorubicin,DB00011
DB00755,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tretinoin.,Tretinoin,DB00011
DB00762,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Irinotecan.,Irinotecan,DB00011
DB00763,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methimazole.,Methimazole,DB00011
DB00764,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mometasone.,Mometasone,DB00011
DB00773,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Etoposide.,Etoposide,DB00011
DB00795,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sulfasalazine.,Sulfasalazine,DB00011
DB00851,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dacarbazine.,Dacarbazine,DB00011
DB00853,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Temozolomide.,Temozolomide,DB00011
DB00859,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Penicillamine.,Penicillamine,DB00011
DB00860,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednisolone.,Prednisolone,DB00011
DB00877,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sirolimus.,Sirolimus,DB00011
DB00888,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mechlorethamine.,Mechlorethamine,DB00011
DB00928,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Azacitidine.,Azacitidine,DB00011
DB00958,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carboplatin.,Carboplatin,DB00011
DB00959,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methylprednisolone.,Methylprednisolone,DB00011
DB00970,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dactinomycin.,Dactinomycin,DB00011
DB00987,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cytarabine.,Cytarabine,DB00011
DB00993,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Azathioprine.,Azathioprine,DB00011
DB00997,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Doxorubicin.,Doxorubicin,DB00011
DB01005,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxyurea.,Hydroxyurea,DB00011
DB01008,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Busulfan.,Busulfan,DB00011
DB01024,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mycophenolic acid.,Mycophenolic acid,DB00011
DB01030,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Topotecan.,Topotecan,DB00011
DB01033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mercaptopurine.,Mercaptopurine,DB00011
DB01041,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Thalidomide.,Thalidomide,DB00011
DB01042,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Melphalan.,Melphalan,DB00011
DB01073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fludarabine.,Fludarabine,DB00011
DB01099,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Flucytosine.,Flucytosine,DB00011
DB01101,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Capecitabine.,Capecitabine,DB00011
DB01108,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trilostane.,Trilostane,DB00011
DB01168,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Procarbazine.,Procarbazine,DB00011
DB01169,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Arsenic trioxide.,Arsenic trioxide,DB00011
DB01177,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Idarubicin.,Idarubicin,DB00011
DB01181,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ifosfamide.,Ifosfamide,DB00011
DB01196,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Estramustine.,Estramustine,DB00011
DB01204,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mitoxantrone.,Mitoxantrone,DB00011
DB01206,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Lomustine.,Lomustine,DB00011
DB01222,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Budesonide.,Budesonide,DB00011
DB01229,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Paclitaxel.,Paclitaxel,DB00011
DB01234,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone.,Dexamethasone,DB00011
DB01248,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Docetaxel.,Docetaxel,DB00011
DB01254,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dasatinib.,Dasatinib,DB00011
DB01257,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Eculizumab.,Eculizumab,DB00011
DB01262,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Decitabine.,Decitabine,DB00011
DB01268,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sunitinib.,Sunitinib,DB00011
DB01280,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Nelarabine.,Nelarabine,DB00011
DB01281,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Abatacept.,Abatacept,DB00011
DB01285,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Corticotropin.,Corticotropin,DB00011
DB01380,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cortisone acetate.,Cortisone acetate,DB00011
DB01384,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Paramethasone.,Paramethasone,DB00011
DB01394,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Colchicine.,Colchicine,DB00011
DB01410,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ciclesonide.,Ciclesonide,DB00011
DB01423,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Stepronin.,Stepronin,DB00011
DB01590,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Everolimus.,Everolimus,DB00011
DB01611,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00011
DB01816,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Castanospermine.,Castanospermine,DB00011
DB02546,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vorinostat.,Vorinostat,DB00011
DB02806,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00011
DB03523,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brequinar.,Brequinar,DB00011
DB04572,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Thiotepa.,Thiotepa,DB00011
DB04630,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldosterone.,Aldosterone,DB00011
DB04845,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ixabepilone.,Ixabepilone,DB00011
DB04868,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Nilotinib.,Nilotinib,DB00011
DB04951,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pirfenidone.,Pirfenidone,DB00011
DB04956,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Afelimomab.,Afelimomab,DB00011
DB05015,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belinostat.,Belinostat,DB00011
DB05109,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trabectedin.,Trabectedin,DB00011
DB05258,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa.,Interferon alfa,DB00011
DB05259,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Glatiramer.,Glatiramer,DB00011
DB05260,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gallium nitrate.,Gallium nitrate,DB00011
DB05459,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Briakinumab.,Briakinumab,DB00011
DB05472,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with omega interferon.,omega interferon,DB00011
DB05676,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Apremilast.,Apremilast,DB00011
DB05773,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00011
DB06168,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Canakinumab.,Canakinumab,DB00011
DB06273,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tocilizumab.,Tocilizumab,DB00011
DB06287,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Temsirolimus.,Temsirolimus,DB00011
DB06372,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rilonacept.,Rilonacept,DB00011
DB06589,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pazopanib.,Pazopanib,DB00011
DB06603,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Panobinostat.,Panobinostat,DB00011
DB06612,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mepolizumab.,Mepolizumab,DB00011
DB06616,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bosutinib.,Bosutinib,DB00011
DB06662,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Abetimus.,Abetimus,DB00011
DB06674,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Golimumab.,Golimumab,DB00011
DB06681,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belatacept.,Belatacept,DB00011
DB06769,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bendamustine.,Bendamustine,DB00011
DB06772,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cabazitaxel.,Cabazitaxel,DB00011
DB06813,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pralatrexate.,Pralatrexate,DB00011
DB08059,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Wortmannin.,Wortmannin,DB00011
DB08870,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00011
DB08871,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Eribulin.,Eribulin,DB00011
DB08877,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ruxolitinib.,Ruxolitinib,DB00011
DB08879,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belimumab.,Belimumab,DB00011
DB08880,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Teriflunomide.,Teriflunomide,DB00011
DB08889,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carfilzomib.,Carfilzomib,DB00011
DB08901,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ponatinib.,Ponatinib,DB00011
DB08904,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Certolizumab pegol.,Certolizumab pegol,DB00011
DB08906,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone furoate.,Fluticasone furoate,DB00011
DB08908,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00011
DB08910,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pomalidomide.,Pomalidomide,DB00011
DB08935,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Obinutuzumab.,Obinutuzumab,DB00011
DB08970,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluprednidene.,Fluprednidene,DB00011
DB08971,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocortolone.,Fluocortolone,DB00011
DB09029,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Secukinumab.,Secukinumab,DB00011
DB09033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vedolizumab.,Vedolizumab,DB00011
DB09036,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Siltuximab.,Siltuximab,DB00011
DB09052,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Blinatumomab.,Blinatumomab,DB00011
DB09053,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ibrutinib.,Ibrutinib,DB00011
DB09054,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Idelalisib.,Idelalisib,DB00011
DB09073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Palbociclib.,Palbociclib,DB00011
DB09074,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Olaparib.,Olaparib,DB00011
DB09077,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dinutuximab.,Dinutuximab,DB00011
DB09082,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vilanterol.,Vilanterol,DB00011
DB09091,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tixocortol.,Tixocortol,DB00011
DB09122,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00011
DB09312,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00011
DB09378,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluprednisolone.,Fluprednisolone,DB00011
DB09383,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Meprednisone.,Meprednisone,DB00011
DB11466,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tepoxalin.,Tepoxalin,DB00011
DB11487,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00011
DB11529,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Melengestrol.,Melengestrol,DB00011
DB11569,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ixekizumab.,Ixekizumab,DB00011
DB11580,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ravulizumab.,Ravulizumab,DB00011
DB11616,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pirarubicin.,Pirarubicin,DB00011
DB11693,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Voclosporin.,Voclosporin,DB00011
DB11708,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peficitinib.,Peficitinib,DB00011
DB11750,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Clobetasol.,Clobetasol,DB00011
DB11767,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sarilumab.,Sarilumab,DB00011
DB11776,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brodalumab.,Brodalumab,DB00011
DB11803,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sirukumab.,Sirukumab,DB00011
DB11817,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Baricitinib.,Baricitinib,DB00011
DB11834,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Guselkumab.,Guselkumab,DB00011
DB11921,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Deflazacort.,Deflazacort,DB00011
DB11988,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ocrelizumab.,Ocrelizumab,DB00011
DB12025,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Triptolide.,Triptolide,DB00011
DB12371,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Siponimod.,Siponimod,DB00011
DB12612,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ozanimod.,Ozanimod,DB00011
DB12617,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mizoribine.,Mizoribine,DB00011
DB12692,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gusperimus.,Gusperimus,DB00011
DB12814,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00011
DB12902,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trofosfamide.,Trofosfamide,DB00011
DB12947,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Doxifluridine.,Doxifluridine,DB00011
DB12991,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Deoxyspergualin.,Deoxyspergualin,DB00011
DB12996,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Acteoside.,Acteoside,DB00011
DB13003,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cortivazol.,Cortivazol,DB00011
DB13014,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hypericin.,Hypericin,DB00011
DB13068,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00011
DB13208,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednylidene.,Prednylidene,DB00011
DB13223,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocortin.,Fluocortin,DB00011
DB13241,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Begelomab.,Begelomab,DB00011
DB13491,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluperolone.,Fluperolone,DB00011
DB13664,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Formocortal.,Formocortal,DB00011
DB13728,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Halometasone.,Halometasone,DB00011
DB13843,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cloprednol.,Cloprednol,DB00011
DB13856,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluclorolone.,Fluclorolone,DB00011
DB13867,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone.,Fluticasone,DB00011
DB14066,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tetrandrine.,Tetrandrine,DB00011
DB14219,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00011
DB14512,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mometasone furoate.,Mometasone furoate,DB00011
DB14538,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00011
DB14539,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00011
DB14545,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00011
DB14724,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Emapalumab.,Emapalumab,DB00011
DB14762,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Risankizumab.,Risankizumab,DB00011
DB14919,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rozanolixizumab.,Rozanolixizumab,DB00011
DB15253,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bleselumab.,Bleselumab,DB00011
DB00108,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Natalizumab.,Natalizumab,DB00011
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-n1.,Pimecrolimus,DB00011
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon alfa-n1.,Roflumilast,DB00011
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-n1.,Sipuleucel-T,DB00011
DB00363,The risk or severity of neutropenia can be increased when Interferon alfa-n1 is combined with Clozapine.,Clozapine,DB00011
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n1.,Zolmitriptan,DB00011
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-n1.,Sulfamethoxazole,DB00011
DB01097,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Leflunomide.,Leflunomide,DB00011
DB08895,Interferon alfa-n1 may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib,DB00011
DB00072,Trastuzumab may increase the neutropenic activities of Interferon alfa-n1.,Trastuzumab,DB00011
DB08868,Interferon alfa-n1 may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00011
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon alfa-n1.,Tacrolimus,DB00011
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon alfa-n1.,Caffeine,DB00011
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon alfa-n1.,Dyphylline,DB00011
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n1.,Pentoxifylline,DB00011
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n1.,Oxtriphylline,DB00011
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon alfa-n1.,Theobromine,DB00011
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon alfa-n1.,Fenethylline,DB00011
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-n1.,8-azaguanine,DB00011
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-n1.","7,9-Dimethylguanine",DB00011
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon alfa-n1.,Xanthine,DB00011
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-n1.,7-Deazaguanine,DB00011
DB02377,The metabolism of Guanine can be decreased when combined with Interferon alfa-n1.,Guanine,DB00011
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-n1.,9-Methylguanine,DB00011
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon alfa-n1.,Peldesine,DB00011
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-n1.,Hypoxanthine,DB00011
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-n1.,9-Deazaguanine,DB00011
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon alfa-n1.,Propentofylline,DB00011
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-n1.,Valomaciclovir,DB00011
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-n1.,3-isobutyl-1-methyl-7H-xanthine,DB00011
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon alfa-n1.,Uric acid,DB00011
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon alfa-n1.,Doxofylline,DB00011
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-n1.,6-O-benzylguanine,DB00011
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon alfa-n1.,Lisofylline,DB00011
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon alfa-n1.,Lobucavir,DB00011
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon alfa-n1.,Cafedrine,DB00011
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-n1.,Theodrenaline,DB00011
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon alfa-n1.,Bamifylline,DB00011
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-n1.,Proxyphylline,DB00011
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon alfa-n1.,Acefylline,DB00011
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-n1.,Etamiphylline,DB00011
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon alfa-n1.,Pentifylline,DB00011
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon alfa-n1.,Bufylline,DB00011
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-n1.,Bromotheophylline,DB00011
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon alfa-n1.,Furafylline,DB00011
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-n1.,8-chlorotheophylline,DB00011
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon alfa-n1.,PCS-499,DB00011
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-n1.,G17DT,DB00011
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-n1.,PEV3A,DB00011
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-n1.,INGN 225,DB00011
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-n1.,Rindopepimut,DB00011
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-n1.,SRP 299,DB00011
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-n1.,GI-5005,DB00011
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-n1.,Vitespen,DB00011
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-n1.,TG4010,DB00011
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-n1.,Anthrax immune globulin human,DB00011
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-n1.","Rabies virus inactivated antigen, B",DB00011
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00011
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-n1.,Rotavirus vaccine,DB00011
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-n1.","Rabies virus inactivated antigen, A",DB00011
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00011
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00011
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00011
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00011
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00011
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00011
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-n1.,Typhoid Vi polysaccharide vaccine,DB00011
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n1.,Hepatitis A Vaccine,DB00011
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00011
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00011
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00011
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00011
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00011
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-n1.,Human rabies virus immune globulin,DB00011
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n1.,Hepatitis B Vaccine (Recombinant),DB00011
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-n1.,Tecemotide,DB00011
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-n1.,Typhoid vaccine,DB00011
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00011
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00011
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00011
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00011
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00011
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00011
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00011
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-n1.,Vaccinia virus strain new york city board of health live antigen,DB00011
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-n1.,Pertussis vaccine,DB00011
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00011
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n1.,Varicella Zoster Vaccine (Recombinant),DB00011
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-n1.,Modified vaccinia ankara,DB00011
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-n1.","Ebola Zaire vaccine (live, attenuated)",DB00011
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n1.,Abciximab,DB00011
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-n1.,Eptifibatide,DB00011
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-n1.,Ticlopidine,DB00011
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-n1.,Tirofiban,DB00011
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n1.,Acetylsalicylic acid,DB00011
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-n1.,Dipyridamole,DB00011
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-n1.,Iloprost,DB00011
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-n1.,Sulfinpyrazone,DB00011
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-n1.,Ridogrel,DB00011
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-n1.,Sevoflurane,DB00011
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-n1.,Epoprostenol,DB00011
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-n1.,Nimesulide,DB00011
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-n1.,Tesmilifene,DB00011
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-n1.,Defibrotide,DB00011
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-n1.,Beraprost,DB00011
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-n1.,Ibudilast,DB00011
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-n1.,Andrographolide,DB00011
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-n1.,Caplacizumab,DB00011
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-n1.,Prasugrel,DB00011
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-n1.,Cangrelor,DB00011
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-n1.,Tranilast,DB00011
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-n1.,Triflusal,DB00011
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-n1.,Ticagrelor,DB00011
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-n1.,Icosapent ethyl,DB00011
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n1.,Vorapaxar,DB00011
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-n1.,Trapidil,DB00011
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-n1.,Naftopidil,DB00011
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-n1.,Sarpogrelate,DB00011
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-n1.,Ifetroban,DB00011
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-n1.,Nitroaspirin,DB00011
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-n1.,Ketanserin,DB00011
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-n1.,Indobufen,DB00011
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-n1.,Butylphthalide,DB00011
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-n1.,Hydroxytyrosol,DB00011
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-n1.,Ramatroban,DB00011
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-n1.,Picotamide,DB00011
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-n1.,Cloricromen,DB00011
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-n1.,Linsidomine,DB00011
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-n1.,Buflomedil,DB00011
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-n1.,Relcovaptan,DB00011
DB13200,Interferon alfa-n1 may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00011
DB10318,The risk or severity of infection can be increased when Interferon alfa-n1 is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated),DB00011
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-n1.,Rubella virus vaccine,DB00011
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain tice live antigen,DB00011
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain connaught live antigen,DB00011
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-n1.,Yellow Fever Vaccine,DB00011
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-n1.,Anthrax vaccine,DB00011
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-n1.,Typhoid Vaccine Live,DB00011
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00011
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-n1.,BCG vaccine,DB00011
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n1.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00011
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-n1.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00011
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-n1.,Adenovirus type 7 vaccine live,DB00011
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1.,Palifermin,DB00011
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-n1.,Fluvoxamine,DB00011
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon alfa-n1.,Nicotine,DB00011
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon alfa-n1.,Betaxolol,DB00011
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon alfa-n1.,Anagrelide,DB00011
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon alfa-n1.,Disopyramide,DB00011
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon alfa-n1.,Lidocaine,DB00011
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n1.,Conjugated estrogens,DB00011
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-n1.,Ropivacaine,DB00011
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-n1.,Acetaminophen,DB00011
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n1.,Olanzapine,DB00011
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-n1.,Chlorzoxazone,DB00011
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n1.,Grepafloxacin,DB00011
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-n1.,Mirtazapine,DB00011
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon alfa-n1.,Mexiletine,DB00011
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon alfa-n1.,Tacrine,DB00011
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon alfa-n1.,Triamterene,DB00011
DB00420,The metabolism of Promazine can be decreased when combined with Interferon alfa-n1.,Promazine,DB00011
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n1.,Zolpidem,DB00011
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon alfa-n1.,Entecavir,DB00011
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon alfa-n1.,Nabumetone,DB00011
DB00468,The metabolism of Quinine can be decreased when combined with Interferon alfa-n1.,Quinine,DB00011
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-n1.,Fluoxetine,DB00011
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon alfa-n1.,Duloxetine,DB00011
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-n1.,Chlorpromazine,DB00011
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon alfa-n1.,Flutamide,DB00011
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n1.,Haloperidol,DB00011
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon alfa-n1.,Albendazole,DB00011
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-n1.,Rofecoxib,DB00011
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-n1.,Cinnarizine,DB00011
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon alfa-n1.,Propranolol,DB00011
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon alfa-n1.,Diclofenac,DB00011
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n1.,Guanabenz,DB00011
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n1.,Verapamil,DB00011
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon alfa-n1.,Paroxetine,DB00011
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-n1.,Thiabendazole,DB00011
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon alfa-n1.,Riluzole,DB00011
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n1.,Zileuton,DB00011
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n1.,Clopidogrel,DB00011
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon alfa-n1.,Estradiol,DB00011
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon alfa-n1.,Acyclovir,DB00011
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon alfa-n1.,Naproxen,DB00011
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-n1.,Trifluoperazine,DB00011
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon alfa-n1.,Perphenazine,DB00011
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon alfa-n1.,Terbinafine,DB00011
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon alfa-n1.,Ranitidine,DB00011
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon alfa-n1.,Ethanol,DB00011
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon alfa-n1.,Maprotiline,DB00011
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon alfa-n1.,Alosetron,DB00011
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-n1.,Lomefloxacin,DB00011
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon alfa-n1.,Ramelteon,DB00011
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-n1.,Frovatriptan,DB00011
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-n1.,Levobupivacaine,DB00011
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-n1.,Cinacalcet,DB00011
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon alfa-n1.,Selegiline,DB00011
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon alfa-n1.,Tocainide,DB00011
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon alfa-n1.,Praziquantel,DB00011
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon alfa-n1.,Melatonin,DB00011
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon alfa-n1.,Primaquine,DB00011
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon alfa-n1.,Hesperetin,DB00011
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n1.,Nifedipine,DB00011
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon alfa-n1.,Carvedilol,DB00011
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon alfa-n1.,Cilostazol,DB00011
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon alfa-n1.,Propafenone,DB00011
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon alfa-n1.,Domperidone,DB00011
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-n1.,Dexfenfluramine,DB00011
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon alfa-n1.,Rasagiline,DB00011
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-n1.,Temafloxacin,DB00011
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-n1.,Aminophenazone,DB00011
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon alfa-n1.,Antipyrine,DB00011
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon alfa-n1.,Bromazepam,DB00011
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon alfa-n1.,Thiothixene,DB00011
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-n1.,Etoricoxib,DB00011
DB01645,The metabolism of Genistein can be decreased when combined with Interferon alfa-n1.,Genistein,DB00011
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon alfa-n1.,Resveratrol,DB00011
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon alfa-n1.,Phenacetin,DB00011
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-n1.,Estrone sulfate,DB00011
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon alfa-n1.,Flunarizine,DB00011
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-n1.,Lorcaserin,DB00011
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon alfa-n1.,Lofexidine,DB00011
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon alfa-n1.,Mianserin,DB00011
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-n1.,Eltrombopag,DB00011
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon alfa-n1.,Asenapine,DB00011
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon alfa-n1.,Vadimezan,DB00011
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-n1.,Dapagliflozin,DB00011
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon alfa-n1.,Agomelatine,DB00011
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon alfa-n1.,Axitinib,DB00011
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-n1.,Benzyl alcohol,DB00011
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon alfa-n1.,Capsaicin,DB00011
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-n1.,(R)-warfarin,DB00011
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon alfa-n1.,Perampanel,DB00011
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-n1.,Tasimelteon,DB00011
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n1.,Stiripentol,DB00011
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n1.,Zotepine,DB00011
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon alfa-n1.,Propacetamol,DB00011
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon alfa-n1.,Ramosetron,DB00011
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon alfa-n1.,Binimetinib,DB00011
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n1.,Voxilaprevir,DB00011
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-n1.,Triclabendazole,DB00011
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon alfa-n1.,Rucaparib,DB00011
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-n1.,Dihydralazine,DB00011
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-n1.,Estradiol acetate,DB00011
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-n1.,Estradiol benzoate,DB00011
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-n1.,Estradiol cypionate,DB00011
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-n1.,Estradiol dienanthate,DB00011
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-n1.,Estradiol valerate,DB00011
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon alfa-n1.,Istradefylline,DB00011
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon alfa-n1.,Azelastine,DB00011
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon alfa-n1.,Efavirenz,DB00011
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-n1.,Metoclopramide,DB00011
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon alfa-n1.,Bicifadine,DB00011
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon alfa-n1.,GTS-21,DB00011
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon alfa-n1.,Flecainide,DB00011
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-n1.,Ethinylestradiol,DB00011
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-n1.,Amitriptyline,DB00011
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon alfa-n1.,Imipramine,DB00011
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon alfa-n1.,Doxepin,DB00011
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-n1.,Mephenytoin,DB00011
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-n1.,Nortriptyline,DB00011
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon alfa-n1.,Clonidine,DB00011
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-n1.,Cyclobenzaprine,DB00011
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon alfa-n1.,Desipramine,DB00011
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon alfa-n1.,Clomipramine,DB00011
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon alfa-n1.,Selumetinib,DB00011
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon alfa-n1.,Theophylline,DB00011
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n1.,Warfarin,DB00011
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon alfa-n1.,Tizanidine,DB00011
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon alfa-n1.,Pimozide,DB00011
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon alfa-n1.,Aminophylline,DB00011
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-n1.,Acenocoumarol,DB00011
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon alfa-n1.,Erlotinib,DB00011
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon alfa-n1.,Tegafur,DB00011
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon alfa-n1.,Enasidenib,DB00011
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-n1.,Tamoxifen,DB00011
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.,Lepirudin,DB00011
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n1.,Bivalirudin,DB00011
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n1.,Alteplase,DB00011
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n1.,Urokinase,DB00011
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n1.,Reteplase,DB00011
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n1.,Anistreplase,DB00011
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n1.,Tenecteplase,DB00011
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-n1.,Drotrecogin alfa,DB00011
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-n1.,Streptokinase,DB00011
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-n1.,Dicoumarol,DB00011
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-n1.,Argatroban,DB00011
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-n1.,Ardeparin,DB00011
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-n1.,Phenindione,DB00011
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-n1.,Fondaparinux,DB00011
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-n1.,Pentosan polysulfate,DB00011
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-n1.,Phenprocoumon,DB00011
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n1.,Heparin,DB00011
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-n1.,Enoxaparin,DB00011
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-n1.,4-hydroxycoumarin,DB00011
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-n1.,Coumarin,DB00011
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n1.,Ximelagatran,DB00011
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-n1.,Desmoteplase,DB00011
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-n1.,Ancrod,DB00011
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-n1.,Fibrinolysin,DB00011
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n1.,Rivaroxaban,DB00011
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-n1.,Sulodexide,DB00011
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-n1.,Semuloparin,DB00011
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-n1.,Idraparinux,DB00011
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-n1.,Astaxanthin,DB00011
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-n1.,Apixaban,DB00011
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-n1.,Otamixaban,DB00011
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-n1.,Amediplase,DB00011
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-n1.,Dabigatran etexilate,DB00011
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-n1.,Danaparoid,DB00011
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-n1.,Dalteparin,DB00011
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-n1.,Tinzaparin,DB00011
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-n1.,Ferulic acid,DB00011
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-n1.,Ethyl biscoumacetate,DB00011
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-n1.,Nadroparin,DB00011
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-n1.,Ditazole,DB00011
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-n1.,Edoxaban,DB00011
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-n1.,Potassium citrate,DB00011
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-n1.,Sodium citrate,DB00011
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-n1.,Dextran,DB00011
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-n1.,Bemiparin,DB00011
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-n1.,Reviparin,DB00011
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-n1.,Parnaparin,DB00011
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-n1.,Certoparin,DB00011
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-n1.,Desirudin,DB00011
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-n1.,Zinc citrate,DB00011
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-n1.,Antithrombin Alfa,DB00011
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-n1.,Protein C,DB00011
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-n1.,Antithrombin III human,DB00011
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-n1.,Letaxaban,DB00011
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-n1.,Darexaban,DB00011
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-n1.,Betrixaban,DB00011
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-n1.,Nafamostat,DB00011
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-n1.,Monteplase,DB00011
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-n1.,Gabexate,DB00011
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-n1.,Fluindione,DB00011
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-n1.,Protein S human,DB00011
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-n1.,Brinase,DB00011
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-n1.,Clorindione,DB00011
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-n1.,Diphenadione,DB00011
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-n1.,Tioclomarol,DB00011
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-n1.,Melagatran,DB00011
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-n1.,Saruplase,DB00011
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-n1.,(S)-Warfarin,DB00011
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-n1.,Tocopherylquinone,DB00011
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-n1.,Edetate calcium disodium anhydrous,DB00011
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-n1.,Dabigatran,DB00011
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-n1.,Methyclothiazide,DB00011
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-n1.,Bendroflumethiazide,DB00011
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-n1.,Benzthiazide,DB00011
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-n1.,Cyclothiazide,DB00011
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n1.,Hydroflumethiazide,DB00011
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-n1.,Chlorothiazide,DB00011
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n1.,Hydrochlorothiazide,DB00011
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-n1.,Trichlormethiazide,DB00011
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-n1.,Polythiazide,DB00011
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-n1.,Mebutizide,DB00011
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-n1.,Cyclopenthiazide,DB00011
DB09042,The risk or severity of myelosuppression can be increased when Interferon alfa-n1 is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00011
DB00091,Interferon alfa-n1 may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00011
DB00268,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ropinirole.,Ropinirole,DB00011
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-n1.,Cyanocobalamin,DB00011
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n1.,Allopurinol,DB00011
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-n1.,Magnesium,DB00011
DB01601,The serum concentration of Interferon alfa-n1 can be increased when it is combined with Lopinavir.,Lopinavir,DB00011
DB12530,The risk or severity of infection can be increased when Interferon alfa-n1 is combined with Inebilizumab.,Inebilizumab,DB00011
DB00480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lenalidomide.,Lenalidomide,DB00012
DB01041,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thalidomide.,Thalidomide,DB00012
DB08910,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pomalidomide.,Pomalidomide,DB00012
DB00002,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cetuximab.,Cetuximab,DB00012
DB00004,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Denileukin diftitox.,Denileukin diftitox,DB00012
DB00007,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Leuprolide.,Leuprolide,DB00012
DB00008,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00012
DB00014,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Goserelin.,Goserelin,DB00012
DB00023,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.,Asparaginase Escherichia coli,DB00012
DB00041,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldesleukin.,Aldesleukin,DB00012
DB00056,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00012
DB00059,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pegaspargase.,Pegaspargase,DB00012
DB00072,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trastuzumab.,Trastuzumab,DB00012
DB00073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rituximab.,Rituximab,DB00012
DB00081,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tositumomab.,Tositumomab,DB00012
DB00087,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alemtuzumab.,Alemtuzumab,DB00012
DB00104,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Octreotide.,Octreotide,DB00012
DB00105,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00012
DB00112,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bevacizumab.,Bevacizumab,DB00012
DB00179,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Masoprocol.,Masoprocol,DB00012
DB00188,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bortezomib.,Bortezomib,DB00012
DB00236,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pipobroman.,Pipobroman,DB00012
DB00242,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cladribine.,Cladribine,DB00012
DB00248,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabergoline.,Cabergoline,DB00012
DB00261,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anagrelide.,Anagrelide,DB00012
DB00262,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carmustine.,Carmustine,DB00012
DB00269,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Chlorotrianisene.,Chlorotrianisene,DB00012
DB00276,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amsacrine.,Amsacrine,DB00012
DB00282,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pamidronic acid.,Pamidronic acid,DB00012
DB00290,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bleomycin.,Bleomycin,DB00012
DB00291,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Chlorambucil.,Chlorambucil,DB00012
DB00293,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Raltitrexed.,Raltitrexed,DB00012
DB00305,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitomycin.,Mitomycin,DB00012
DB00307,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bexarotene.,Bexarotene,DB00012
DB00313,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valproic acid.,Valproic acid,DB00012
DB00317,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gefitinib.,Gefitinib,DB00012
DB00322,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Floxuridine.,Floxuridine,DB00012
DB00351,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Megestrol acetate.,Megestrol acetate,DB00012
DB00352,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tioguanine.,Tioguanine,DB00012
DB00357,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aminoglutethimide.,Aminoglutethimide,DB00012
DB00385,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valrubicin.,Valrubicin,DB00012
DB00398,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sorafenib.,Sorafenib,DB00012
DB00428,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Streptozocin.,Streptozocin,DB00012
DB00432,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trifluridine.,Trifluridine,DB00012
DB00441,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemcitabine.,Gemcitabine,DB00012
DB00444,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Teniposide.,Teniposide,DB00012
DB00445,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epirubicin.,Epirubicin,DB00012
DB00488,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Altretamine.,Altretamine,DB00012
DB00499,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Flutamide.,Flutamide,DB00012
DB00515,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cisplatin.,Cisplatin,DB00012
DB00523,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alitretinoin.,Alitretinoin,DB00012
DB00526,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oxaliplatin.,Oxaliplatin,DB00012
DB00530,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Erlotinib.,Erlotinib,DB00012
DB00539,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Toremifene.,Toremifene,DB00012
DB00544,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fluorouracil.,Fluorouracil,DB00012
DB00552,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pentostatin.,Pentostatin,DB00012
DB00563,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methotrexate.,Methotrexate,DB00012
DB00603,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Medroxyprogesterone acetate.,Medroxyprogesterone acetate,DB00012
DB00619,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Imatinib.,Imatinib,DB00012
DB00631,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Clofarabine.,Clofarabine,DB00012
DB00635,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisone.,Prednisone,DB00012
DB00642,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pemetrexed.,Pemetrexed,DB00012
DB00648,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitotane.,Mitotane,DB00012
DB00665,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nilutamide.,Nilutamide,DB00012
DB00675,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tamoxifen.,Tamoxifen,DB00012
DB00694,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daunorubicin.,Daunorubicin,DB00012
DB00707,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Porfimer sodium.,Porfimer sodium,DB00012
DB00755,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretinoin.,Tretinoin,DB00012
DB00762,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Irinotecan.,Irinotecan,DB00012
DB00773,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etoposide.,Etoposide,DB00012
DB00791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Uracil mustard.,Uracil mustard,DB00012
DB00851,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacarbazine.,Dacarbazine,DB00012
DB00853,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temozolomide.,Temozolomide,DB00012
DB00855,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aminolevulinic acid.,Aminolevulinic acid,DB00012
DB00860,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisolone.,Prednisolone,DB00012
DB00888,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mechlorethamine.,Mechlorethamine,DB00012
DB00894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Testolactone.,Testolactone,DB00012
DB00928,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Azacitidine.,Azacitidine,DB00012
DB00947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fulvestrant.,Fulvestrant,DB00012
DB00958,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboplatin.,Carboplatin,DB00012
DB00959,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylprednisolone.,Methylprednisolone,DB00012
DB00970,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dactinomycin.,Dactinomycin,DB00012
DB00987,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cytarabine.,Cytarabine,DB00012
DB00990,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exemestane.,Exemestane,DB00012
DB00997,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Doxorubicin.,Doxorubicin,DB00012
DB01005,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyurea.,Hydroxyurea,DB00012
DB01006,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Letrozole.,Letrozole,DB00012
DB01008,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Busulfan.,Busulfan,DB00012
DB01030,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Topotecan.,Topotecan,DB00012
DB01033,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mercaptopurine.,Mercaptopurine,DB00012
DB01042,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Melphalan.,Melphalan,DB00012
DB01073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fludarabine.,Fludarabine,DB00012
DB01101,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Capecitabine.,Capecitabine,DB00012
DB01108,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trilostane.,Trilostane,DB00012
DB01128,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bicalutamide.,Bicalutamide,DB00012
DB01157,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trimetrexate.,Trimetrexate,DB00012
DB01168,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Procarbazine.,Procarbazine,DB00012
DB01169,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Arsenic trioxide.,Arsenic trioxide,DB00012
DB01177,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idarubicin.,Idarubicin,DB00012
DB01181,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ifosfamide.,Ifosfamide,DB00012
DB01196,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Estramustine.,Estramustine,DB00012
DB01204,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitoxantrone.,Mitoxantrone,DB00012
DB01206,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lomustine.,Lomustine,DB00012
DB01217,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anastrozole.,Anastrozole,DB00012
DB01229,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel.,Paclitaxel,DB00012
DB01234,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexamethasone.,Dexamethasone,DB00012
DB01248,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Docetaxel.,Docetaxel,DB00012
DB01254,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dasatinib.,Dasatinib,DB00012
DB01259,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lapatinib.,Lapatinib,DB00012
DB01262,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Decitabine.,Decitabine,DB00012
DB01268,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sunitinib.,Sunitinib,DB00012
DB01269,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Panitumumab.,Panitumumab,DB00012
DB01280,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nelarabine.,Nelarabine,DB00012
DB01590,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Everolimus.,Everolimus,DB00012
DB01645,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Genistein.,Genistein,DB00012
DB01667,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 8-azaguanine.,8-azaguanine,DB00012
DB01873,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epothilone D.,Epothilone D,DB00012
DB01933,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 7-Hydroxystaurosporine.,7-Hydroxystaurosporine,DB00012
DB02109,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hadacidin.,Hadacidin,DB00012
DB02342,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-Methoxyestradiol.,2-Methoxyestradiol,DB00012
DB02424,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Geldanamycin.,Geldanamycin,DB00012
DB02546,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vorinostat.,Vorinostat,DB00012
DB02640,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fumagillin.,Fumagillin,DB00012
DB03010,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Patupilone.,Patupilone,DB00012
DB03172,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tubercidin.,Tubercidin,DB00012
DB03459,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sparfosic acid.,Sparfosic acid,DB00012
DB03496,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alvocidib.,Alvocidib,DB00012
DB03509,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,DB00012
DB03523,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brequinar.,Brequinar,DB00012
DB03695,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Piritrexim.,Piritrexim,DB00012
DB03825,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rhodamine 6G.,Rhodamine 6G,DB00012
DB03880,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Batimastat.,Batimastat,DB00012
DB03946,"The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 3,4-Dihydroxybenzoic Acid.","3,4-Dihydroxybenzoic Acid",DB00012
DB04106,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fotemustine.,Fotemustine,DB00012
DB04222,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sparsomycin.,Sparsomycin,DB00012
DB04253,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretazicar.,Tretazicar,DB00012
DB04258,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Seocalcitol.,Seocalcitol,DB00012
DB04331,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Monastrol.,Monastrol,DB00012
DB04440,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nebularine.,Nebularine,DB00012
DB04468,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Afimoxifene.,Afimoxifene,DB00012
DB04572,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thiotepa.,Thiotepa,DB00012
DB04576,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fleroxacin.,Fleroxacin,DB00012
DB04655,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Metoprine.,Metoprine,DB00012
DB04690,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Camptothecin.,Camptothecin,DB00012
DB04786,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Suramin.,Suramin,DB00012
DB04827,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Urethane.,Urethane,DB00012
DB04839,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cyproterone acetate.,Cyproterone acetate,DB00012
DB04845,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ixabepilone.,Ixabepilone,DB00012
DB04849,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cediranib.,Cediranib,DB00012
DB04858,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tirapazamine.,Tirapazamine,DB00012
DB04865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00012
DB04866,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Halofuginone.,Halofuginone,DB00012
DB04868,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nilotinib.,Nilotinib,DB00012
DB04894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vapreotide.,Vapreotide,DB00012
DB04900,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thymalfasin.,Thymalfasin,DB00012
DB04901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Galiximab.,Galiximab,DB00012
DB04907,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sitimagene ceradenovec.,Sitimagene ceradenovec,DB00012
DB04950,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ranpirnase.,Ranpirnase,DB00012
DB04951,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pirfenidone.,Pirfenidone,DB00012
DB04958,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epratuzumab.,Epratuzumab,DB00012
DB04960,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tipifarnib.,Tipifarnib,DB00012
DB04961,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Troxacitabine.,Troxacitabine,DB00012
DB04964,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oregovomab.,Oregovomab,DB00012
DB04975,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Banoxantrone.,Banoxantrone,DB00012
DB04977,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plitidepsin.,Plitidepsin,DB00012
DB04996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Satraplatin.,Satraplatin,DB00012
DB05015,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Belinostat.,Belinostat,DB00012
DB05022,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amonafide.,Amonafide,DB00012
DB05076,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fenretinide.,Fenretinide,DB00012
DB05088,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tetrathiomolybdate.,Tetrathiomolybdate,DB00012
DB05097,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Labetuzumab.,Labetuzumab,DB00012
DB05109,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trabectedin.,Trabectedin,DB00012
DB05129,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Elsamitrucin.,Elsamitrucin,DB00012
DB05136,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bavituximab.,Bavituximab,DB00012
DB05223,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pracinostat.,Pracinostat,DB00012
DB05239,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cobimetinib.,Cobimetinib,DB00012
DB05260,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gallium nitrate.,Gallium nitrate,DB00012
DB05265,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ecabet.,Ecabet,DB00012
DB05294,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vandetanib.,Vandetanib,DB00012
DB05374,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rindopepimut.,Rindopepimut,DB00012
DB05424,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Canertinib.,Canertinib,DB00012
DB05428,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Motexafin gadolinium.,Motexafin gadolinium,DB00012
DB05482,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 7-ethyl-10-hydroxycamptothecin.,7-ethyl-10-hydroxycamptothecin,DB00012
DB05524,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pelitinib.,Pelitinib,DB00012
DB05540,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alanosine.,Alanosine,DB00012
DB05578,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ramucirumab.,Ramucirumab,DB00012
DB05595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Farletuzumab.,Farletuzumab,DB00012
DB05656,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Veltuzumab.,Veltuzumab,DB00012
DB05668,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Palifosfamide.,Palifosfamide,DB00012
DB05697,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AP 12009.,AP 12009,DB00012
DB05773,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00012
DB05779,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oglufanide.,Oglufanide,DB00012
DB05786,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Irofulven.,Irofulven,DB00012
DB05812,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abiraterone.,Abiraterone,DB00012
DB05889,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00012
DB05903,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KOS-1584.,KOS-1584,DB00012
DB05916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CT-011.,CT-011,DB00012
DB05974,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Transcrocetinate.,Transcrocetinate,DB00012
DB05996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00012
DB06013,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldoxorubicin.,Aldoxorubicin,DB00012
DB06021,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AV-412.,AV-412,DB00012
DB06040,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Filanesib.,Filanesib,DB00012
DB06043,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaratumab.,Olaratumab,DB00012
DB06159,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rubitecan.,Rubitecan,DB00012
DB06160,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Garenoxacin.,Garenoxacin,DB00012
DB06163,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plevitrexed.,Plevitrexed,DB00012
DB06171,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel trevatide.,Paclitaxel trevatide,DB00012
DB06176,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Romidepsin.,Romidepsin,DB00012
DB06181,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with IMO-2055.,IMO-2055,DB00012
DB06186,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ipilimumab.,Ipilimumab,DB00012
DB06192,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nimotuzumab.,Nimotuzumab,DB00012
DB06193,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pixantrone.,Pixantrone,DB00012
DB06195,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Seliciclib.,Seliciclib,DB00012
DB06199,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Atrasentan.,Atrasentan,DB00012
DB06233,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ridaforolimus.,Ridaforolimus,DB00012
DB06235,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vadimezan.,Vadimezan,DB00012
DB06246,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exisulind.,Exisulind,DB00012
DB06263,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amrubicin.,Amrubicin,DB00012
DB06266,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lonidamine.,Lonidamine,DB00012
DB06272,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Maxacalcitol.,Maxacalcitol,DB00012
DB06287,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temsirolimus.,Temsirolimus,DB00012
DB06317,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Elotuzumab.,Elotuzumab,DB00012
DB06334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tucidinostat.,Tucidinostat,DB00012
DB06365,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sapacitabine.,Sapacitabine,DB00012
DB06366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pertuzumab.,Pertuzumab,DB00012
DB06370,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indisulam.,Indisulam,DB00012
DB06420,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Annamycin.,Annamycin,DB00012
DB06423,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Endostatin.,Endostatin,DB00012
DB06433,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tezacitabine.,Tezacitabine,DB00012
DB06436,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Semaxanib.,Semaxanib,DB00012
DB06445,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Diethylnorspermine.,Diethylnorspermine,DB00012
DB06461,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Squalamine.,Squalamine,DB00012
DB06478,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Porfiromycin.,Porfiromycin,DB00012
DB06517,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with MLN576.,MLN576,DB00012
DB06589,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pazopanib.,Pazopanib,DB00012
DB06595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Midostaurin.,Midostaurin,DB00012
DB06603,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Panobinostat.,Panobinostat,DB00012
DB06607,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Catumaxomab.,Catumaxomab,DB00012
DB06616,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bosutinib.,Bosutinib,DB00012
DB06626,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Axitinib.,Axitinib,DB00012
DB06647,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Volociximab.,Volociximab,DB00012
DB06650,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ofatumumab.,Ofatumumab,DB00012
DB06699,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Degarelix.,Degarelix,DB00012
DB06710,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methyltestosterone.,Methyltestosterone,DB00012
DB06719,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Buserelin.,Buserelin,DB00012
DB06748,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ginsenoside C.,Ginsenoside C,DB00012
DB06769,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bendamustine.,Bendamustine,DB00012
DB06772,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabazitaxel.,Cabazitaxel,DB00012
DB06789,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate,DB00012
DB06791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lanreotide.,Lanreotide,DB00012
DB06810,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plicamycin.,Plicamycin,DB00012
DB06813,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pralatrexate.,Pralatrexate,DB00012
DB06825,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triptorelin.,Triptorelin,DB00012
DB07232,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Veliparib.,Veliparib,DB00012
DB07931,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hexestrol.,Hexestrol,DB00012
DB08313,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nocodazole.,Nocodazole,DB00012
DB08437,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Puromycin.,Puromycin,DB00012
DB08486,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Efaproxiral.,Efaproxiral,DB00012
DB08633,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with TNP-470.,TNP-470,DB00012
DB08828,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vismodegib.,Vismodegib,DB00012
DB08865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Crizotinib.,Crizotinib,DB00012
DB08870,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00012
DB08871,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Eribulin.,Eribulin,DB00012
DB08875,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabozantinib.,Cabozantinib,DB00012
DB08877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ruxolitinib.,Ruxolitinib,DB00012
DB08881,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vemurafenib.,Vemurafenib,DB00012
DB08886,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Erwinia chrysanthemi.,Asparaginase Erwinia chrysanthemi,DB00012
DB08889,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carfilzomib.,Carfilzomib,DB00012
DB08896,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Regorafenib.,Regorafenib,DB00012
DB08899,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Enzalutamide.,Enzalutamide,DB00012
DB08901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ponatinib.,Ponatinib,DB00012
DB08905,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Formestane.,Formestane,DB00012
DB08911,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trametinib.,Trametinib,DB00012
DB08912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dabrafenib.,Dabrafenib,DB00012
DB08913,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Radium Ra 223 dichloride.,Radium Ra 223 dichloride,DB00012
DB08916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Afatinib.,Afatinib,DB00012
DB08935,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Obinutuzumab.,Obinutuzumab,DB00012
DB08972,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Flumequine.,Flumequine,DB00012
DB09010,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carmofur.,Carmofur,DB00012
DB09031,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Miltefosine.,Miltefosine,DB00012
DB09035,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nivolumab.,Nivolumab,DB00012
DB09036,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Siltuximab.,Siltuximab,DB00012
DB09037,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pembrolizumab.,Pembrolizumab,DB00012
DB09052,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Blinatumomab.,Blinatumomab,DB00012
DB09053,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ibrutinib.,Ibrutinib,DB00012
DB09054,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idelalisib.,Idelalisib,DB00012
DB09063,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ceritinib.,Ceritinib,DB00012
DB09073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Palbociclib.,Palbociclib,DB00012
DB09074,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaparib.,Olaparib,DB00012
DB09077,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dinutuximab.,Dinutuximab,DB00012
DB09078,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lenvatinib.,Lenvatinib,DB00012
DB09079,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nintedanib.,Nintedanib,DB00012
DB09123,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dienogest.,Dienogest,DB00012
DB09143,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sonidegib.,Sonidegib,DB00012
DB09239,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Niguldipine.,Niguldipine,DB00012
DB09256,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tegafur.,Tegafur,DB00012
DB09274,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Artesunate.,Artesunate,DB00012
DB09298,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Silibinin.,Silibinin,DB00012
DB09330,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Osimertinib.,Osimertinib,DB00012
DB09331,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daratumumab.,Daratumumab,DB00012
DB09559,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Necitumumab.,Necitumumab,DB00012
DB09570,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ixazomib.,Ixazomib,DB00012
DB11363,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alectinib.,Alectinib,DB00012
DB11366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Roquinimex.,Roquinimex,DB00012
DB11526,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Masitinib.,Masitinib,DB00012
DB11581,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Venetoclax.,Venetoclax,DB00012
DB11595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Atezolizumab.,Atezolizumab,DB00012
DB11616,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pirarubicin.,Pirarubicin,DB00012
DB11617,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aclarubicin.,Aclarubicin,DB00012
DB11618,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zorubicin.,Zorubicin,DB00012
DB11630,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temoporfin.,Temoporfin,DB00012
DB11646,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Conatumumab.,Conatumumab,DB00012
DB11651,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dactolisib.,Dactolisib,DB00012
DB11662,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rabusertib.,Rabusertib,DB00012
DB11669,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ortataxel.,Ortataxel,DB00012
DB11678,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Treosulfan.,Treosulfan,DB00012
DB11688,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.,2-chloroethyl-3-sarcosinamide-1-nitrosourea,DB00012
DB11694,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ilorasertib.,Ilorasertib,DB00012
DB11714,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Durvalumab.,Durvalumab,DB00012
DB11716,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Misonidazole.,Misonidazole,DB00012
DB11717,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epacadostat.,Epacadostat,DB00012
DB11718,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Encorafenib.,Encorafenib,DB00012
DB11727,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Endostar.,Endostar,DB00012
DB11730,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ribociclib.,Ribociclib,DB00012
DB11737,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Icotinib.,Icotinib,DB00012
DB11752,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bryostatin 1.,Bryostatin 1,DB00012
DB11760,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talazoparib.,Talazoparib,DB00012
DB11771,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tremelimumab.,Tremelimumab,DB00012
DB11793,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Niraparib.,Niraparib,DB00012
DB11795,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with GSK-2636771.,GSK-2636771,DB00012
DB11800,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tivozanib.,Tivozanib,DB00012
DB11805,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Saracatinib.,Saracatinib,DB00012
DB11812,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talaporfin.,Talaporfin,DB00012
DB11828,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Neratinib.,Neratinib,DB00012
DB11830,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mocetinostat.,Mocetinostat,DB00012
DB11832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Crenolanib.,Crenolanib,DB00012
DB11841,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Entinostat.,Entinostat,DB00012
DB11880,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Acridine Carboxamide.,Acridine Carboxamide,DB00012
DB11886,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Infigratinib.,Infigratinib,DB00012
DB11891,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CUDC-907.,CUDC-907,DB00012
DB11894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Efatutazone.,Efatutazone,DB00012
DB11901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Apalutamide.,Apalutamide,DB00012
DB11907,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rociletinib.,Rociletinib,DB00012
DB11918,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Guadecitabine.,Guadecitabine,DB00012
DB11919,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 6-O-benzylguanine.,6-O-benzylguanine,DB00012
DB11945,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Avelumab.,Avelumab,DB00012
DB11960,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboxyamidotriazole.,Carboxyamidotriazole,DB00012
DB11963,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacomitinib.,Dacomitinib,DB00012
DB11967,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Binimetinib.,Binimetinib,DB00012
DB11972,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rilotumumab.,Rilotumumab,DB00012
DB11973,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tesevatinib.,Tesevatinib,DB00012
DB11978,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glasdegib.,Glasdegib,DB00012
DB11986,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Entrectinib.,Entrectinib,DB00012
DB11999,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vosaroxin.,Vosaroxin,DB00012
DB12001,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abemaciclib.,Abemaciclib,DB00012
DB12015,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alpelisib.,Alpelisib,DB00012
DB12025,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triptolide.,Triptolide,DB00012
DB12028,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Broxuridine.,Broxuridine,DB00012
DB12036,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Naquotinib.,Naquotinib,DB00012
DB12056,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trebananib.,Trebananib,DB00012
DB12081,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anecortave.,Anecortave,DB00012
DB12082,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vesnarinone.,Vesnarinone,DB00012
DB12083,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mafosfamide.,Mafosfamide,DB00012
DB12085,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with LCL-161.,LCL-161,DB00012
DB12089,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00012
DB12108,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Taselisib.,Taselisib,DB00012
DB12124,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Namitecan.,Namitecan,DB00012
DB12130,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lorlatinib.,Lorlatinib,DB00012
DB12141,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gilteritinib.,Gilteritinib,DB00012
DB12142,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Duligotuzumab.,Duligotuzumab,DB00012
DB12146,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rigosertib.,Rigosertib,DB00012
DB12147,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Erdafitinib.,Erdafitinib,DB00012
DB12156,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cordycepin.,Cordycepin,DB00012
DB12174,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CUDC-101.,CUDC-101,DB00012
DB12182,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Binetrakin.,Binetrakin,DB00012
DB12185,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exatecan.,Exatecan,DB00012
DB12202,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zalutumumab.,Zalutumumab,DB00012
DB12222,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lurtotecan.,Lurtotecan,DB00012
DB12232,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KRN-7000.,KRN-7000,DB00012
DB12257,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Platinum.,Platinum,DB00012
DB12259,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CG-200745.,CG-200745,DB00012
DB12266,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epofolate.,Epofolate,DB00012
DB12267,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brigatinib.,Brigatinib,DB00012
DB12279,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with OBP-801.,OBP-801,DB00012
DB12332,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rucaparib.,Rucaparib,DB00012
DB12340,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Navitoclax.,Navitoclax,DB00012
DB12352,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bizelesin.,Bizelesin,DB00012
DB12376,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ricolinostat.,Ricolinostat,DB00012
DB12379,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indirubin.,Indirubin,DB00012
DB12381,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Merestinib.,Merestinib,DB00012
DB12382,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with R-306465.,R-306465,DB00012
DB12385,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 10-hydroxycamptothecin.,10-hydroxycamptothecin,DB00012
DB12391,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sagopilone.,Sagopilone,DB00012
DB12422,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sulforaphane.,Sulforaphane,DB00012
DB12459,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Belotecan.,Belotecan,DB00012
DB12473,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Taurolidine.,Taurolidine,DB00012
DB12480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Betulinic Acid.,Betulinic Acid,DB00012
DB12483,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Copanlisib.,Copanlisib,DB00012
DB12498,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mogamulizumab.,Mogamulizumab,DB00012
DB12515,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 9-aminocamptothecin.,9-aminocamptothecin,DB00012
DB12525,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Molgramostim.,Molgramostim,DB00012
DB12539,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oltipraz.,Oltipraz,DB00012
DB12549,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pyrazoloacridine.,Pyrazoloacridine,DB00012
DB12565,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abexinostat.,Abexinostat,DB00012
DB12577,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fosbretabulin.,Fosbretabulin,DB00012
DB12589,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacetuzumab.,Dacetuzumab,DB00012
DB12593,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Apaziquone.,Apaziquone,DB00012
DB12596,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Combretastatin.,Combretastatin,DB00012
DB12617,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mizoribine.,Mizoribine,DB00012
DB12637,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Onapristone.,Onapristone,DB00012
DB12638,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with PU-H71.,PU-H71,DB00012
DB12645,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Givinostat.,Givinostat,DB00012
DB12671,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Beloranib.,Beloranib,DB00012
DB12677,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Soblidotin.,Soblidotin,DB00012
DB12681,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Salirasib.,Salirasib,DB00012
DB12688,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Moxetumomab Pasudotox.,Moxetumomab Pasudotox,DB00012
DB12692,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gusperimus.,Gusperimus,DB00012
DB12695,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Phenethyl Isothiocyanate.,Phenethyl Isothiocyanate,DB00012
DB12697,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylselenocysteine.,Methylselenocysteine,DB00012
DB12701,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Intetumumab.,Intetumumab,DB00012
DB12730,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dolastatin 10.,Dolastatin 10,DB00012
DB12736,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etanidazole.,Etanidazole,DB00012
DB12769,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lometrexol.,Lometrexol,DB00012
DB12797,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ecromeximab.,Ecromeximab,DB00012
DB12832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednimustine.,Prednimustine,DB00012
DB12870,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Buthionine Sulfoximine.,Buthionine Sulfoximine,DB00012
DB12873,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dianhydrogalactitol.,Dianhydrogalactitol,DB00012
DB12881,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indole-3-carbinol.,Indole-3-carbinol,DB00012
DB12901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fiacitabine.,Fiacitabine,DB00012
DB12902,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trofosfamide.,Trofosfamide,DB00012
DB12912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nolatrexed.,Nolatrexed,DB00012
DB12916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitolactol.,Mitolactol,DB00012
DB12920,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pinometostat.,Pinometostat,DB00012
DB12947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Doxifluridine.,Doxifluridine,DB00012
DB12948,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Didox.,Didox,DB00012
DB12967,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitoguazone.,Mitoguazone,DB00012
DB12978,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pexidartinib.,Pexidartinib,DB00012
DB12987,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Penclomedine.,Penclomedine,DB00012
DB12991,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Deoxyspergualin.,Deoxyspergualin,DB00012
DB12996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Acteoside.,Acteoside,DB00012
DB13005,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rebastinib.,Rebastinib,DB00012
DB13014,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hypericin.,Hypericin,DB00012
DB13046,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tocladesine.,Tocladesine,DB00012
DB13066,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Liarozole.,Liarozole,DB00012
DB13069,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nimustine.,Nimustine,DB00012
DB13104,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with X-396.,X-396,DB00012
DB13128,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sizofiran.,Sizofiran,DB00012
DB13145,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nedaplatin.,Nedaplatin,DB00012
DB13164,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olmutinib.,Olmutinib,DB00012
DB13182,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daidzein.,Daidzein,DB00012
DB13243,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tiazofurine.,Tiazofurine,DB00012
DB13304,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triaziquone.,Triaziquone,DB00012
DB13318,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Demecolcine.,Demecolcine,DB00012
DB13334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mannosulfan.,Mannosulfan,DB00012
DB13339,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etoglucid.,Etoglucid,DB00012
DB13375,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Edrecolomab.,Edrecolomab,DB00012
DB13480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lentinan.,Lentinan,DB00012
DB13543,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitobronitol.,Mitobronitol,DB00012
DB13627,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oxolinic acid.,Oxolinic acid,DB00012
DB13647,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Semustine.,Semustine,DB00012
DB13677,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboquone.,Carboquone,DB00012
DB13767,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vorozole.,Vorozole,DB00012
DB13809,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex,DB00012
DB13811,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oblimersen.,Oblimersen,DB00012
DB13832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ranimustine.,Ranimustine,DB00012
DB13874,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Enasidenib.,Enasidenib,DB00012
DB13877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Iniparib.,Iniparib,DB00012
DB13896,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talimogene laherparepvec.,Talimogene laherparepvec,DB00012
DB13912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Coumermycin A1.,Coumermycin A1,DB00012
DB13916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Toyocamycin.,Toyocamycin,DB00012
DB14031,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretamine.,Tretamine,DB00012
DB14066,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tetrandrine.,Tetrandrine,DB00012
DB14067,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dofequidar.,Dofequidar,DB00012
DB14068,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexniguldipine.,Dexniguldipine,DB00012
DB14568,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ivosidenib.,Ivosidenib,DB00012
DB14644,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate,DB00012
DB14646,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisone acetate.,Prednisone acetate,DB00012
DB14680,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Combretastatin A4.,Combretastatin A4,DB00012
DB14707,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cemiplimab.,Cemiplimab,DB00012
DB14723,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Larotrectinib.,Larotrectinib,DB00012
DB14731,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tagraxofusp.,Tagraxofusp,DB00012
DB14765,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rivoceranib.,Rivoceranib,DB00012
DB14792,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AZD-5991.,AZD-5991,DB00012
DB14844,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with ONC-201.,ONC-201,DB00012
DB14860,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ensartinib.,Ensartinib,DB00012
DB14865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Human interleukin-2.,Human interleukin-2,DB00012
DB14877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lintuzumab.,Lintuzumab,DB00012
DB14947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bermekimab.,Bermekimab,DB00012
DB14951,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etirinotecan pegol.,Etirinotecan pegol,DB00012
DB15035,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zanubrutinib.,Zanubrutinib,DB00012
DB15057,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with NUC-1031.,NUC-1031,DB00012
DB15157,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Voruciclib.,Voruciclib,DB00012
DB15215,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KRN-5500.,KRN-5500,DB00012
DB15289,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Perillyl alcohol.,Perillyl alcohol,DB00012
DB15321,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tefinostat.,Tefinostat,DB00012
DB15334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Biochanin A.,Biochanin A,DB00012
DB15351,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dihematoporphyrin ether.,Dihematoporphyrin ether,DB00012
DB15366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with SOR-C13.,SOR-C13,DB00012
DB15383,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pidilizumab.,Pidilizumab,DB00012
DB15419,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nanatinostat.,Nanatinostat,DB00012
DB15466,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tallimustine.,Tallimustine,DB00012
DB12062,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Volasertib.,Volasertib,DB00012
DB14811,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Isatuximab.,Isatuximab,DB00012
DB15102,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pemigatinib.,Pemigatinib,DB00012
DB11791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Capmatinib.,Capmatinib,DB00012
DB15685,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Selpercatinib.,Selpercatinib,DB00012
DB00531,The risk or severity of pulmonary toxicity can be increased when Darbepoetin alfa is combined with Cyclophosphamide.,Cyclophosphamide,DB00012
DB00984,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone phenpropionate.,Nandrolone phenpropionate,DB00012
DB08804,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone decanoate.,Nandrolone decanoate,DB00012
DB13169,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone.,Nandrolone,DB00012
DB00309,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vindesine.,Vindesine,DB00012
DB00361,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinorelbine.,Vinorelbine,DB00012
DB00541,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vincristine.,Vincristine,DB00012
DB00570,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinblastine.,Vinblastine,DB00012
DB05168,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vintafolide.,Vintafolide,DB00012
DB11641,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinflunine.,Vinflunine,DB00012
DB13374,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vincamine.,Vincamine,DB00012
DB06605,Apixaban may increase the anticoagulant activities of Urokinase.,Apixaban,DB00013
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Urokinase.,Dabigatran etexilate,DB00013
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Urokinase.,Dasatinib,DB00013
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Urokinase is combined with Deferasirox.,Deferasirox,DB00013
DB01586,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00013
DB02123,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00013
DB02659,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Cholic Acid.,Cholic Acid,DB00013
DB02691,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycocholic acid.,Glycocholic acid,DB00013
DB03619,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Deoxycholic acid.,Deoxycholic acid,DB00013
DB04348,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurocholic acid.,Taurocholic acid,DB00013
DB05990,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.,Obeticholic acid,DB00013
DB06777,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00013
DB08833,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00013
DB08834,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00013
DB08857,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Bamet-UD2.,Bamet-UD2,DB00013
DB11622,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00013
DB11789,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00013
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Urokinase.,Edoxaban,DB00013
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Urokinase.,Ibrutinib,DB00013
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Obinutuzumab.,Obinutuzumab,DB00013
DB06228,Urokinase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00013
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Sugammadex.,Sugammadex,DB00013
DB09070,Tibolone may increase the anticoagulant activities of Urokinase.,Tibolone,DB00013
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Urokinase.,Tipranavir,DB00013
DB00001,Urokinase may increase the anticoagulant activities of Lepirudin.,Lepirudin,DB00013
DB00006,Urokinase may increase the anticoagulant activities of Bivalirudin.,Bivalirudin,DB00013
DB00009,Urokinase may increase the anticoagulant activities of Alteplase.,Alteplase,DB00013
DB00015,Urokinase may increase the anticoagulant activities of Reteplase.,Reteplase,DB00013
DB00029,Urokinase may increase the anticoagulant activities of Anistreplase.,Anistreplase,DB00013
DB00031,Urokinase may increase the anticoagulant activities of Tenecteplase.,Tenecteplase,DB00013
DB00054,Urokinase may increase the anticoagulant activities of Abciximab.,Abciximab,DB00013
DB00055,Urokinase may increase the anticoagulant activities of Drotrecogin alfa.,Drotrecogin alfa,DB00013
DB00086,Urokinase may increase the anticoagulant activities of Streptokinase.,Streptokinase,DB00013
DB00266,Urokinase may increase the anticoagulant activities of Dicoumarol.,Dicoumarol,DB00013
DB00278,Urokinase may increase the anticoagulant activities of Argatroban.,Argatroban,DB00013
DB00407,Urokinase may increase the anticoagulant activities of Ardeparin.,Ardeparin,DB00013
DB00498,Urokinase may increase the anticoagulant activities of Phenindione.,Phenindione,DB00013
DB00569,Urokinase may increase the anticoagulant activities of Fondaparinux.,Fondaparinux,DB00013
DB00682,Urokinase may increase the anticoagulant activities of Warfarin.,Warfarin,DB00013
DB00686,Urokinase may increase the anticoagulant activities of Pentosan polysulfate.,Pentosan polysulfate,DB00013
DB00945,Urokinase may increase the anticoagulant activities of Acetylsalicylic acid.,Acetylsalicylic acid,DB00013
DB00946,Urokinase may increase the anticoagulant activities of Phenprocoumon.,Phenprocoumon,DB00013
DB00975,Urokinase may increase the anticoagulant activities of Dipyridamole.,Dipyridamole,DB00013
DB01088,Urokinase may increase the anticoagulant activities of Iloprost.,Iloprost,DB00013
DB01109,Urokinase may increase the anticoagulant activities of Heparin.,Heparin,DB00013
DB01225,Urokinase may increase the anticoagulant activities of Enoxaparin.,Enoxaparin,DB00013
DB01240,Urokinase may increase the anticoagulant activities of Epoprostenol.,Epoprostenol,DB00013
DB01418,Urokinase may increase the anticoagulant activities of Acenocoumarol.,Acenocoumarol,DB00013
DB03410,Urokinase may increase the anticoagulant activities of 4-hydroxycoumarin.,4-hydroxycoumarin,DB00013
DB04665,Urokinase may increase the anticoagulant activities of Coumarin.,Coumarin,DB00013
DB04898,Urokinase may increase the anticoagulant activities of Ximelagatran.,Ximelagatran,DB00013
DB04925,Urokinase may increase the anticoagulant activities of Desmoteplase.,Desmoteplase,DB00013
DB04932,Urokinase may increase the anticoagulant activities of Defibrotide.,Defibrotide,DB00013
DB05099,Urokinase may increase the anticoagulant activities of Ancrod.,Ancrod,DB00013
DB05229,Urokinase may increase the anticoagulant activities of Beraprost.,Beraprost,DB00013
DB05254,Urokinase may increase the anticoagulant activities of Fibrinolysin.,Fibrinolysin,DB00013
DB06209,Urokinase may increase the anticoagulant activities of Prasugrel.,Prasugrel,DB00013
DB06271,Urokinase may increase the anticoagulant activities of Sulodexide.,Sulodexide,DB00013
DB06294,Urokinase may increase the anticoagulant activities of Semuloparin.,Semuloparin,DB00013
DB06406,Urokinase may increase the anticoagulant activities of Idraparinux.,Idraparinux,DB00013
DB06441,Urokinase may increase the anticoagulant activities of Cangrelor.,Cangrelor,DB00013
DB06543,Urokinase may increase the anticoagulant activities of Astaxanthin.,Astaxanthin,DB00013
DB06635,Urokinase may increase the anticoagulant activities of Otamixaban.,Otamixaban,DB00013
DB06679,Urokinase may increase the anticoagulant activities of Amediplase.,Amediplase,DB00013
DB06754,Urokinase may increase the anticoagulant activities of Danaparoid.,Danaparoid,DB00013
DB06779,Urokinase may increase the anticoagulant activities of Dalteparin.,Dalteparin,DB00013
DB06822,Urokinase may increase the anticoagulant activities of Tinzaparin.,Tinzaparin,DB00013
DB07767,Urokinase may increase the anticoagulant activities of Ferulic acid.,Ferulic acid,DB00013
DB08496,Urokinase may increase the anticoagulant activities of (R)-warfarin.,(R)-warfarin,DB00013
DB08794,Urokinase may increase the anticoagulant activities of Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00013
DB08813,Urokinase may increase the anticoagulant activities of Nadroparin.,Nadroparin,DB00013
DB08814,Urokinase may increase the anticoagulant activities of Triflusal.,Triflusal,DB00013
DB08816,Urokinase may increase the anticoagulant activities of Ticagrelor.,Ticagrelor,DB00013
DB08994,Urokinase may increase the anticoagulant activities of Ditazole.,Ditazole,DB00013
DB09030,Urokinase may increase the anticoagulant activities of Vorapaxar.,Vorapaxar,DB00013
DB09125,Urokinase may increase the anticoagulant activities of Potassium citrate.,Potassium citrate,DB00013
DB09154,Urokinase may increase the anticoagulant activities of Sodium citrate.,Sodium citrate,DB00013
DB09255,Urokinase may increase the anticoagulant activities of Dextran.,Dextran,DB00013
DB09258,Urokinase may increase the anticoagulant activities of Bemiparin.,Bemiparin,DB00013
DB09259,Urokinase may increase the anticoagulant activities of Reviparin.,Reviparin,DB00013
DB09260,Urokinase may increase the anticoagulant activities of Parnaparin.,Parnaparin,DB00013
DB09261,Urokinase may increase the anticoagulant activities of Certoparin.,Certoparin,DB00013
DB11095,Urokinase may increase the anticoagulant activities of Desirudin.,Desirudin,DB00013
DB11154,Urokinase may increase the anticoagulant activities of Zinc citrate.,Zinc citrate,DB00013
DB11166,Urokinase may increase the anticoagulant activities of Antithrombin Alfa.,Antithrombin Alfa,DB00013
DB11312,Urokinase may increase the anticoagulant activities of Protein C.,Protein C,DB00013
DB11598,Urokinase may increase the anticoagulant activities of Antithrombin III human.,Antithrombin III human,DB00013
DB11984,Urokinase may increase the anticoagulant activities of Letaxaban.,Letaxaban,DB00013
DB12289,Urokinase may increase the anticoagulant activities of Darexaban.,Darexaban,DB00013
DB12364,Urokinase may increase the anticoagulant activities of Betrixaban.,Betrixaban,DB00013
DB12598,Urokinase may increase the anticoagulant activities of Nafamostat.,Nafamostat,DB00013
DB12726,Urokinase may increase the anticoagulant activities of Monteplase.,Monteplase,DB00013
DB12831,Urokinase may increase the anticoagulant activities of Gabexate.,Gabexate,DB00013
DB13136,Urokinase may increase the anticoagulant activities of Fluindione.,Fluindione,DB00013
DB13149,Urokinase may increase the anticoagulant activities of Protein S human.,Protein S human,DB00013
DB13199,Urokinase may increase the anticoagulant activities of Brinase.,Brinase,DB00013
DB13275,Urokinase may increase the anticoagulant activities of Clorindione.,Clorindione,DB00013
DB13347,Urokinase may increase the anticoagulant activities of Diphenadione.,Diphenadione,DB00013
DB13451,Urokinase may increase the anticoagulant activities of Tioclomarol.,Tioclomarol,DB00013
DB13616,Urokinase may increase the anticoagulant activities of Melagatran.,Melagatran,DB00013
DB13646,Urokinase may increase the anticoagulant activities of Saruplase.,Saruplase,DB00013
DB14055,Urokinase may increase the anticoagulant activities of (S)-Warfarin.,(S)-Warfarin,DB00013
DB14094,Urokinase may increase the anticoagulant activities of Tocopherylquinone.,Tocopherylquinone,DB00013
DB14598,Urokinase may increase the anticoagulant activities of Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00013
DB14726,Urokinase may increase the anticoagulant activities of Dabigatran.,Dabigatran,DB00013
DB00163,Vitamin E may increase the anticoagulant activities of Urokinase.,Vitamin E,DB00013
DB06692,The therapeutic efficacy of Urokinase can be decreased when used in combination with Aprotinin.,Aprotinin,DB00013
DB00063,Eptifibatide may increase the anticoagulant activities of Urokinase.,Eptifibatide,DB00013
DB00208,Ticlopidine may increase the anticoagulant activities of Urokinase.,Ticlopidine,DB00013
DB00758,Clopidogrel may increase the anticoagulant activities of Urokinase.,Clopidogrel,DB00013
DB00775,Tirofiban may increase the anticoagulant activities of Urokinase.,Tirofiban,DB00013
DB00806,Pentoxifylline may increase the anticoagulant activities of Urokinase.,Pentoxifylline,DB00013
DB01138,Sulfinpyrazone may increase the anticoagulant activities of Urokinase.,Sulfinpyrazone,DB00013
DB01166,Cilostazol may increase the anticoagulant activities of Urokinase.,Cilostazol,DB00013
DB01207,Ridogrel may increase the anticoagulant activities of Urokinase.,Ridogrel,DB00013
DB01236,Sevoflurane may increase the anticoagulant activities of Urokinase.,Sevoflurane,DB00013
DB02709,Resveratrol may increase the anticoagulant activities of Urokinase.,Resveratrol,DB00013
DB04743,Nimesulide may increase the anticoagulant activities of Urokinase.,Nimesulide,DB00013
DB04905,Tesmilifene may increase the anticoagulant activities of Urokinase.,Tesmilifene,DB00013
DB05266,Ibudilast may increase the anticoagulant activities of Urokinase.,Ibudilast,DB00013
DB05767,Andrographolide may increase the anticoagulant activities of Urokinase.,Andrographolide,DB00013
DB06081,Caplacizumab may increase the anticoagulant activities of Urokinase.,Caplacizumab,DB00013
DB07615,Tranilast may increase the anticoagulant activities of Urokinase.,Tranilast,DB00013
DB08887,Icosapent ethyl may increase the anticoagulant activities of Urokinase.,Icosapent ethyl,DB00013
DB09283,Trapidil may increase the anticoagulant activities of Urokinase.,Trapidil,DB00013
DB12092,Naftopidil may increase the anticoagulant activities of Urokinase.,Naftopidil,DB00013
DB12163,Sarpogrelate may increase the anticoagulant activities of Urokinase.,Sarpogrelate,DB00013
DB12321,Ifetroban may increase the anticoagulant activities of Urokinase.,Ifetroban,DB00013
DB12445,Nitroaspirin may increase the anticoagulant activities of Urokinase.,Nitroaspirin,DB00013
DB12465,Ketanserin may increase the anticoagulant activities of Urokinase.,Ketanserin,DB00013
DB12545,Indobufen may increase the anticoagulant activities of Urokinase.,Indobufen,DB00013
DB12749,Butylphthalide may increase the anticoagulant activities of Urokinase.,Butylphthalide,DB00013
DB12771,Hydroxytyrosol may increase the anticoagulant activities of Urokinase.,Hydroxytyrosol,DB00013
DB13036,Ramatroban may increase the anticoagulant activities of Urokinase.,Ramatroban,DB00013
DB13327,Picotamide may increase the anticoagulant activities of Urokinase.,Picotamide,DB00013
DB13367,Cloricromen may increase the anticoagulant activities of Urokinase.,Cloricromen,DB00013
DB13400,Linsidomine may increase the anticoagulant activities of Urokinase.,Linsidomine,DB00013
DB13510,Buflomedil may increase the anticoagulant activities of Urokinase.,Buflomedil,DB00013
DB13929,Relcovaptan may increase the anticoagulant activities of Urokinase.,Relcovaptan,DB00013
DB00261,Anagrelide may increase the anticoagulant activities of Urokinase.,Anagrelide,DB00013
DB01381,The therapeutic efficacy of Urokinase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00013
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Urokinase.,Ifosfamide,DB00013
DB00468,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinine.,Quinine,DB00013
DB00908,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.,Quinidine,DB00013
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Urokinase.,Tamoxifen,DB00013
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Urokinase.,Toremifene,DB00013
DB00583,The therapeutic efficacy of Urokinase can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00013
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Urokinase.,Diethylstilbestrol,DB00013
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Urokinase.,Chlorotrianisene,DB00013
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Urokinase.,Conjugated estrogens,DB00013
DB00783,Estradiol may decrease the anticoagulant activities of Urokinase.,Estradiol,DB00013
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Urokinase.,Ethinylestradiol,DB00013
DB01357,Mestranol may decrease the anticoagulant activities of Urokinase.,Mestranol,DB00013
DB04573,Estriol may decrease the anticoagulant activities of Urokinase.,Estriol,DB00013
DB04574,Estrone sulfate may decrease the anticoagulant activities of Urokinase.,Estrone sulfate,DB00013
DB04575,Quinestrol may decrease the anticoagulant activities of Urokinase.,Quinestrol,DB00013
DB07931,Hexestrol may decrease the anticoagulant activities of Urokinase.,Hexestrol,DB00013
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Urokinase.","Synthetic Conjugated Estrogens, A",DB00013
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Urokinase.","Synthetic Conjugated Estrogens, B",DB00013
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Urokinase.,Polyestradiol phosphate,DB00013
DB09381,Esterified estrogens may decrease the anticoagulant activities of Urokinase.,Esterified estrogens,DB00013
DB11478,Zeranol may decrease the anticoagulant activities of Urokinase.,Zeranol,DB00013
DB11674,Equol may decrease the anticoagulant activities of Urokinase.,Equol,DB00013
DB12487,Promestriene may decrease the anticoagulant activities of Urokinase.,Promestriene,DB00013
DB13143,Methallenestril may decrease the anticoagulant activities of Urokinase.,Methallenestril,DB00013
DB13386,Epimestrol may decrease the anticoagulant activities of Urokinase.,Epimestrol,DB00013
DB13418,Moxestrol may decrease the anticoagulant activities of Urokinase.,Moxestrol,DB00013
DB13952,Estradiol acetate may decrease the anticoagulant activities of Urokinase.,Estradiol acetate,DB00013
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Urokinase.,Estradiol benzoate,DB00013
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Urokinase.,Estradiol cypionate,DB00013
DB13956,Estradiol valerate may decrease the anticoagulant activities of Urokinase.,Estradiol valerate,DB00013
DB15334,Biochanin A may decrease the anticoagulant activities of Urokinase.,Biochanin A,DB00013
DB15335,Formononetin may decrease the anticoagulant activities of Urokinase.,Formononetin,DB00013
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Urokinase.,Icosapent,DB00013
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Urokinase.,Mesalazine,DB00013
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Urokinase.,Indomethacin,DB00013
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Urokinase.,Nabumetone,DB00013
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Urokinase.,Ketorolac,DB00013
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Urokinase.,Tenoxicam,DB00013
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Urokinase.,Celecoxib,DB00013
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Urokinase.,Tolmetin,DB00013
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Urokinase.,Rofecoxib,DB00013
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Urokinase.,Piroxicam,DB00013
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Urokinase.,Fenoprofen,DB00013
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Urokinase.,Valdecoxib,DB00013
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Urokinase.,Diclofenac,DB00013
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Urokinase.,Sulindac,DB00013
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Urokinase.,Flurbiprofen,DB00013
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Urokinase.,Etodolac,DB00013
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Urokinase.,Mefenamic acid,DB00013
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Urokinase.,Naproxen,DB00013
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Urokinase.,Sulfasalazine,DB00013
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Urokinase.,Phenylbutazone,DB00013
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Urokinase.,Meloxicam,DB00013
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Urokinase.,Carprofen,DB00013
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Urokinase.,Diflunisal,DB00013
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Urokinase.,Salicylic acid,DB00013
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Urokinase.,Meclofenamic acid,DB00013
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Urokinase.,Oxaprozin,DB00013
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Urokinase.,Ketoprofen,DB00013
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Urokinase.,Balsalazide,DB00013
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Urokinase.,Olsalazine,DB00013
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Urokinase.,Lumiracoxib,DB00013
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Urokinase.,Magnesium salicylate,DB00013
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Urokinase.,Salsalate,DB00013
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Urokinase.,Choline magnesium trisalicylate,DB00013
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Urokinase.,Antrafenine,DB00013
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Urokinase.,Aminophenazone,DB00013
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Urokinase.,Antipyrine,DB00013
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Urokinase.,Tiaprofenic acid,DB00013
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Urokinase.,Etoricoxib,DB00013
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Urokinase.,Taxifolin,DB00013
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Urokinase.,Oxyphenbutazone,DB00013
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Urokinase.,Niflumic acid,DB00013
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Urokinase.,Licofelone,DB00013
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Urokinase.,Benoxaprofen,DB00013
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Urokinase.,Metamizole,DB00013
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Urokinase.,Zomepirac,DB00013
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Urokinase.,Cimicoxib,DB00013
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Urokinase.,Lornoxicam,DB00013
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Urokinase.,Aceclofenac,DB00013
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Urokinase.,Zaltoprofen,DB00013
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Urokinase.,Azapropazone,DB00013
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Urokinase.,Felbinac,DB00013
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Urokinase.,Parecoxib,DB00013
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Urokinase.,Salicylamide,DB00013
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Urokinase.,Kebuzone,DB00013
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Urokinase.,Isoxicam,DB00013
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Urokinase.,Indoprofen,DB00013
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Urokinase.,Ibuproxam,DB00013
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Urokinase.,Floctafenine,DB00013
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Urokinase.,Fenbufen,DB00013
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Urokinase.,Etofenamate,DB00013
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Urokinase.,Epirizole,DB00013
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Urokinase.,Benzydamine,DB00013
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Urokinase.,Loxoprofen,DB00013
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Urokinase.,Dexketoprofen,DB00013
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Urokinase.,Droxicam,DB00013
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Urokinase.,Tolfenamic acid,DB00013
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Urokinase.,Firocoxib,DB00013
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Urokinase.,Clonixin,DB00013
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Urokinase.,Morniflumate,DB00013
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Urokinase.,Propacetamol,DB00013
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Urokinase.,Talniflumate,DB00013
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Urokinase.,Robenacoxib,DB00013
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Urokinase.,Tepoxalin,DB00013
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Urokinase.,Flunixin,DB00013
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Urokinase.,Polmacoxib,DB00013
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Urokinase.,Betulinic Acid,DB00013
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Urokinase.,Ebselen,DB00013
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Urokinase.,Tinoridine,DB00013
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Urokinase.,Alclofenac,DB00013
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Urokinase.,Fentiazac,DB00013
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Urokinase.,Suxibuzone,DB00013
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Urokinase.,Bumadizone,DB00013
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Urokinase.,Alminoprofen,DB00013
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Urokinase.,Flunoxaprofen,DB00013
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Urokinase.,Feprazone,DB00013
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Urokinase.,Difenpiramide,DB00013
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Urokinase.,Nifenazone,DB00013
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Urokinase.,Lonazolac,DB00013
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Urokinase.,Tenidap,DB00013
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Urokinase.,Bendazac,DB00013
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Urokinase.,Pranoprofen,DB00013
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Urokinase.,Propyphenazone,DB00013
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Urokinase.,Proglumetacin,DB00013
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Urokinase.,Guacetisal,DB00013
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Urokinase.,Ethenzamide,DB00013
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Urokinase.,Carbaspirin calcium,DB00013
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Urokinase.,Mofebutazone,DB00013
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Urokinase.,Proquazone,DB00013
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Urokinase.,Benorilate,DB00013
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Urokinase.,Pirprofen,DB00013
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Urokinase.,Imidazole salicylate,DB00013
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Urokinase.,SC-236,DB00013
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Urokinase.,NS-398,DB00013
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Urokinase.,Flurbiprofen axetil,DB00013
DB04865,The risk or severity of bleeding can be increased when Urokinase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00013
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Urokinase.,Omega-3 fatty acids,DB00013
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Tositumomab.,Tositumomab,DB00013
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Urokinase.,Limaprost,DB00013
DB00048,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00013
DB00389,Carbimazole may increase the anticoagulant activities of Urokinase.,Carbimazole,DB00013
DB00550,Propylthiouracil may increase the anticoagulant activities of Urokinase.,Propylthiouracil,DB00013
DB00763,Methimazole may increase the anticoagulant activities of Urokinase.,Methimazole,DB00013
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Urokinase.","3,5-Diiodotyrosine",DB00013
DB06715,Potassium Iodide may increase the anticoagulant activities of Urokinase.,Potassium Iodide,DB00013
DB07637,Dibromotyrosine may increase the anticoagulant activities of Urokinase.,Dibromotyrosine,DB00013
DB09418,Potassium perchlorate may increase the anticoagulant activities of Urokinase.,Potassium perchlorate,DB00013
DB13644,Methylthiouracil may increase the anticoagulant activities of Urokinase.,Methylthiouracil,DB00013
DB13804,Benzylthiouracil may increase the anticoagulant activities of Urokinase.,Benzylthiouracil,DB00013
DB00834,The therapeutic efficacy of Urokinase can be decreased when used in combination with Mifepristone.,Mifepristone,DB00013
DB04066,The therapeutic efficacy of Urokinase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00013
DB04682,The therapeutic efficacy of Urokinase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00013
DB05830,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trestolone.,Trestolone,DB00013
DB06266,The therapeutic efficacy of Urokinase can be decreased when used in combination with Lonidamine.,Lonidamine,DB00013
DB08867,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ulipristal.,Ulipristal,DB00013
DB09401,The therapeutic efficacy of Urokinase can be decreased when used in combination with Isosorbide.,Isosorbide,DB00013
DB11507,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00013
DB12025,The therapeutic efficacy of Urokinase can be decreased when used in combination with Triptolide.,Triptolide,DB00013
DB13044,The therapeutic efficacy of Urokinase can be decreased when used in combination with Gossypol.,Gossypol,DB00013
DB13310,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00013
DB00294,Etonogestrel may decrease the anticoagulant activities of Urokinase.,Etonogestrel,DB00013
DB00304,Desogestrel may decrease the anticoagulant activities of Urokinase.,Desogestrel,DB00013
DB00351,Megestrol acetate may decrease the anticoagulant activities of Urokinase.,Megestrol acetate,DB00013
DB00367,Levonorgestrel may decrease the anticoagulant activities of Urokinase.,Levonorgestrel,DB00013
DB00378,Dydrogesterone may decrease the anticoagulant activities of Urokinase.,Dydrogesterone,DB00013
DB00396,Progesterone may decrease the anticoagulant activities of Urokinase.,Progesterone,DB00013
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Urokinase.,Medroxyprogesterone acetate,DB00013
DB00717,Norethisterone may decrease the anticoagulant activities of Urokinase.,Norethisterone,DB00013
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Urokinase.,Ethynodiol diacetate,DB00013
DB00957,Norgestimate may decrease the anticoagulant activities of Urokinase.,Norgestimate,DB00013
DB01395,Drospirenone may decrease the anticoagulant activities of Urokinase.,Drospirenone,DB00013
DB01431,Allylestrenol may decrease the anticoagulant activities of Urokinase.,Allylestrenol,DB00013
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Urokinase.,Cyproterone acetate,DB00013
DB06713,Norelgestromin may decrease the anticoagulant activities of Urokinase.,Norelgestromin,DB00013
DB06730,Gestodene may decrease the anticoagulant activities of Urokinase.,Gestodene,DB00013
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Urokinase.,Hydroxyprogesterone caproate,DB00013
DB09123,Dienogest may decrease the anticoagulant activities of Urokinase.,Dienogest,DB00013
DB09124,Medrogestone may decrease the anticoagulant activities of Urokinase.,Medrogestone,DB00013
DB09371,Norethynodrel may decrease the anticoagulant activities of Urokinase.,Norethynodrel,DB00013
DB09389,Norgestrel may decrease the anticoagulant activities of Urokinase.,Norgestrel,DB00013
DB11372,Altrenogest may decrease the anticoagulant activities of Urokinase.,Altrenogest,DB00013
DB11619,Gestrinone may decrease the anticoagulant activities of Urokinase.,Gestrinone,DB00013
DB11636,Nomegestrol may decrease the anticoagulant activities of Urokinase.,Nomegestrol,DB00013
DB12474,Lynestrenol may decrease the anticoagulant activities of Urokinase.,Lynestrenol,DB00013
DB13230,Gestonorone may decrease the anticoagulant activities of Urokinase.,Gestonorone,DB00013
DB13528,Chlormadinone may decrease the anticoagulant activities of Urokinase.,Chlormadinone,DB00013
DB13533,Methylestrenolone may decrease the anticoagulant activities of Urokinase.,Methylestrenolone,DB00013
DB13563,Norgestrienone may decrease the anticoagulant activities of Urokinase.,Norgestrienone,DB00013
DB13602,Promegestone may decrease the anticoagulant activities of Urokinase.,Promegestone,DB00013
DB13685,Quingestanol may decrease the anticoagulant activities of Urokinase.,Quingestanol,DB00013
DB13857,Demegestone may decrease the anticoagulant activities of Urokinase.,Demegestone,DB00013
DB13866,Etynodiol may decrease the anticoagulant activities of Urokinase.,Etynodiol,DB00013
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Urokinase.,Nomegestrol acetate,DB00013
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Urokinase.,Hydroxyprogesterone,DB00013
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Urokinase.,Norethindrone enanthate,DB00013
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Urokinase.,Quingestanol acetate,DB00013
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Urokinase.,Aminosalicylic acid,DB00013
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase.,Bismuth subsalicylate,DB00013
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Urokinase.,Dersalazine,DB00013
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Urokinase.,Phenyl aminosalicylate,DB00013
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Urokinase.,Methyl salicylate,DB00013
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Urokinase.,Trolamine salicylate,DB00013
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Urokinase.,Aloxiprin,DB00013
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Urokinase.,Choline salicylate,DB00013
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Urokinase.,Thiosalicylic acid,DB00013
DB00374,The risk or severity of adverse effects can be increased when Urokinase is combined with Treprostinil.,Treprostinil,DB00013
DB03404,Hemin may increase the anticoagulant activities of Urokinase.,Hemin,DB00013
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Urokinase.,Acemetacin,DB00013
DB00624,Testosterone may increase the anticoagulant activities of Urokinase.,Testosterone,DB00013
DB01420,Testosterone propionate may increase the anticoagulant activities of Urokinase.,Testosterone propionate,DB00013
DB01481,1-Testosterone may increase the anticoagulant activities of Urokinase.,1-Testosterone,DB00013
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Urokinase.,4-Hydroxytestosterone,DB00013
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Urokinase.,Dehydrochloromethyltestosterone,DB00013
DB01541,Boldenone may increase the anticoagulant activities of Urokinase.,Boldenone,DB00013
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Urokinase.,18-methyl-19-nortestosterone,DB00013
DB01564,Calusterone may increase the anticoagulant activities of Urokinase.,Calusterone,DB00013
DB01569,Formebolone may increase the anticoagulant activities of Urokinase.,Formebolone,DB00013
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Urokinase.,Methyl-1-testosterone,DB00013
DB02901,Stanolone may increase the anticoagulant activities of Urokinase.,Stanolone,DB00013
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Urokinase.,5beta-dihydrotestosterone,DB00013
DB08619,Testosterone succinate may increase the anticoagulant activities of Urokinase.,Testosterone succinate,DB00013
DB11429,Mibolerone may increase the anticoagulant activities of Urokinase.,Mibolerone,DB00013
DB13943,Testosterone cypionate may increase the anticoagulant activities of Urokinase.,Testosterone cypionate,DB00013
DB13944,Testosterone enanthate may increase the anticoagulant activities of Urokinase.,Testosterone enanthate,DB00013
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Urokinase.,Testosterone undecanoate,DB00013
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Urokinase.,Testosterone enantate benzilic acid hydrazone,DB00013
DB13951,Stanolone acetate may increase the anticoagulant activities of Urokinase.,Stanolone acetate,DB00013
DB13958,Trestolone acetate may increase the anticoagulant activities of Urokinase.,Trestolone acetate,DB00013
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Urokinase.","(1,2,6,7-3H)Testosterone",DB00013
DB14655,Drostanolone propionate may increase the anticoagulant activities of Urokinase.,Drostanolone propionate,DB00013
DB11051,The risk or severity of adverse effects can be increased when Urokinase is combined with Azficel-T.,Azficel-T,DB00013
DB09568,The therapeutic efficacy of Urokinase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00013
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Urokinase.,Calcium acetate,DB00013
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Urokinase.,Calcium chloride,DB00013
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Urokinase.,Calcium,DB00013
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Urokinase.,Calcium gluconate,DB00013
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Urokinase.,Eftrenonacog alfa,DB00013
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Urokinase.,Albutrepenonacog alfa,DB00013
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Urokinase.,Emicizumab,DB00013
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Urokinase.,Turoctocog alfa pegol,DB00013
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase.","Antihemophilic factor, human recombinant",DB00013
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.,Coagulation factor VIIa Recombinant Human,DB00013
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Urokinase.,Coagulation Factor IX (Recombinant),DB00013
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Urokinase.,Pantothenic acid,DB00013
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Urokinase.,Formic acid,DB00013
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Urokinase.,Platelet Activating Factor,DB00013
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Urokinase.,Calcium carbonate,DB00013
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Urokinase.,Turoctocog alfa,DB00013
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Urokinase.,Fibrinogen human,DB00013
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Urokinase.,Catridecacog,DB00013
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Urokinase.","Antihemophilic Factor (Recombinant), PEGylated",DB00013
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Urokinase.,Calcium citrate,DB00013
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Urokinase.,Calcium threonate,DB00013
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Urokinase.,Prothrombin,DB00013
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Urokinase.,Factor IX Complex (Human),DB00013
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Urokinase.,Calcium Phosphate,DB00013
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Urokinase.,Susoctocog alfa,DB00013
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Urokinase.,Rusalatide acetate,DB00013
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Urokinase.,Vatreptacog alfa,DB00013
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Urokinase.,Factor XIII (human),DB00013
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Urokinase.,Von Willebrand Factor Human,DB00013
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Urokinase.,Coagulation factor X human,DB00013
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Urokinase.,Coagulation factor VII human,DB00013
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Urokinase.,Anti-inhibitor coagulant complex,DB00013
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Urokinase.,Coagulation Factor IX Human,DB00013
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Urokinase.,Antihemophilic factor human,DB00013
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Urokinase.,Kallidinogenase,DB00013
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Urokinase.,Trenonacog alfa,DB00013
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Urokinase.,Nonacog beta pegol,DB00013
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Urokinase.,Moroctocog alfa,DB00013
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Urokinase.,Beroctocog alfa,DB00013
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Urokinase.,Andexanet alfa,DB00013
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Urokinase.,Calcium cation,DB00013
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Urokinase.,Damoctocog alfa pegol,DB00013
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Urokinase.,Fluvoxamine,DB00013
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Urokinase.,Citalopram,DB00013
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Urokinase.,Fluoxetine,DB00013
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Urokinase.,Paroxetine,DB00013
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Urokinase.,Nefazodone,DB00013
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Urokinase.,Zimelidine,DB00013
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Urokinase.,Dapoxetine,DB00013
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Urokinase.,Seproxetine,DB00013
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Urokinase.,Indalpine,DB00013
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Urokinase.,Ritanserin,DB00013
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Urokinase.,Alaproclate,DB00013
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Urokinase.,Duloxetine,DB00013
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Urokinase.,Sibutramine,DB00013
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Urokinase.,Milnacipran,DB00013
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Urokinase.,Desvenlafaxine,DB00013
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Urokinase.,Levomilnacipran,DB00013
DB00285,Venlafaxine may increase the antiplatelet activities of Urokinase.,Venlafaxine,DB00013
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Urokinase.,Amphetamine,DB00013
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Urokinase.,Linezolid,DB00013
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Urokinase.,Furazolidone,DB00013
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Urokinase.,Procaine,DB00013
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Urokinase.,Tranylcypromine,DB00013
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Urokinase.,Phenelzine,DB00013
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Urokinase.,Minaprine,DB00013
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Urokinase.,Selegiline,DB00013
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Urokinase.,Procarbazine,DB00013
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Urokinase.,Moclobemide,DB00013
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Urokinase.,Isocarboxazid,DB00013
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Urokinase.,Rasagiline,DB00013
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Urokinase.,Pargyline,DB00013
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Urokinase.,Clorgiline,DB00013
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Urokinase.,Iproniazid,DB00013
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Urokinase.,Nialamide,DB00013
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Urokinase.,Safinamide,DB00013
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Urokinase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00013
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Urokinase.,Methylene blue,DB00013
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Urokinase.,Hydracarbazine,DB00013
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Urokinase.,Pirlindole,DB00013
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Urokinase.,Toloxatone,DB00013
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Urokinase.,Benmoxin,DB00013
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Urokinase.,Mebanazine,DB00013
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Urokinase.,Octamoxin,DB00013
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Urokinase.,Pheniprazine,DB00013
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Urokinase.,Phenoxypropazine,DB00013
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Urokinase.,Pivhydrazine,DB00013
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Urokinase.,Safrazine,DB00013
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Urokinase.,Caroxazone,DB00013
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Urokinase.,Harmaline,DB00013
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Urokinase.,Brofaromine,DB00013
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Urokinase.,Edetic acid,DB00013
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Urokinase.,Protocatechualdehyde,DB00013
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Urokinase.,Troxerutin,DB00013
DB00177,The risk or severity of angioedema can be increased when Urokinase is combined with Valsartan.,Valsartan,DB00013
DB00178,The risk or severity of angioedema can be increased when Urokinase is combined with Ramipril.,Ramipril,DB00013
DB00230,The risk or severity of angioedema can be increased when Urokinase is combined with Pregabalin.,Pregabalin,DB00013
DB00492,The risk or severity of angioedema can be increased when Urokinase is combined with Fosinopril.,Fosinopril,DB00013
DB00519,The risk or severity of angioedema can be increased when Urokinase is combined with Trandolapril.,Trandolapril,DB00013
DB00542,The risk or severity of angioedema can be increased when Urokinase is combined with Benazepril.,Benazepril,DB00013
DB00584,The risk or severity of angioedema can be increased when Urokinase is combined with Enalapril.,Enalapril,DB00013
DB00678,The risk or severity of angioedema can be increased when Urokinase is combined with Losartan.,Losartan,DB00013
DB00691,The risk or severity of angioedema can be increased when Urokinase is combined with Moexipril.,Moexipril,DB00013
DB00722,The risk or severity of angioedema can be increased when Urokinase is combined with Lisinopril.,Lisinopril,DB00013
DB00790,The risk or severity of angioedema can be increased when Urokinase is combined with Perindopril.,Perindopril,DB00013
DB00876,The risk or severity of angioedema can be increased when Urokinase is combined with Eprosartan.,Eprosartan,DB00013
DB00877,The risk or severity of angioedema can be increased when Urokinase is combined with Sirolimus.,Sirolimus,DB00013
DB00881,The risk or severity of angioedema can be increased when Urokinase is combined with Quinapril.,Quinapril,DB00013
DB00886,The risk or severity of angioedema can be increased when Urokinase is combined with Omapatrilat.,Omapatrilat,DB00013
DB00966,The risk or severity of angioedema can be increased when Urokinase is combined with Telmisartan.,Telmisartan,DB00013
DB01050,The risk or severity of angioedema can be increased when Urokinase is combined with Ibuprofen.,Ibuprofen,DB00013
DB01180,The risk or severity of angioedema can be increased when Urokinase is combined with Rescinnamine.,Rescinnamine,DB00013
DB01197,The risk or severity of angioedema can be increased when Urokinase is combined with Captopril.,Captopril,DB00013
DB01261,The risk or severity of angioedema can be increased when Urokinase is combined with Sitagliptin.,Sitagliptin,DB00013
DB01340,The risk or severity of angioedema can be increased when Urokinase is combined with Cilazapril.,Cilazapril,DB00013
DB01342,The risk or severity of angioedema can be increased when Urokinase is combined with Forasartan.,Forasartan,DB00013
DB01347,The risk or severity of angioedema can be increased when Urokinase is combined with Saprisartan.,Saprisartan,DB00013
DB01348,The risk or severity of angioedema can be increased when Urokinase is combined with Spirapril.,Spirapril,DB00013
DB04876,The risk or severity of angioedema can be increased when Urokinase is combined with Vildagliptin.,Vildagliptin,DB00013
DB06011,The risk or severity of angioedema can be increased when Urokinase is combined with AMG-222.,AMG-222,DB00013
DB06127,The risk or severity of angioedema can be increased when Urokinase is combined with Bisegliptin.,Bisegliptin,DB00013
DB06196,The risk or severity of angioedema can be increased when Urokinase is combined with Icatibant.,Icatibant,DB00013
DB06203,The risk or severity of angioedema can be increased when Urokinase is combined with Alogliptin.,Alogliptin,DB00013
DB06245,The risk or severity of angioedema can be increased when Urokinase is combined with Lanoteplase.,Lanoteplase,DB00013
DB06287,The risk or severity of angioedema can be increased when Urokinase is combined with Temsirolimus.,Temsirolimus,DB00013
DB06335,The risk or severity of angioedema can be increased when Urokinase is combined with Saxagliptin.,Saxagliptin,DB00013
DB08382,The risk or severity of angioedema can be increased when Urokinase is combined with Gosogliptin.,Gosogliptin,DB00013
DB08822,The risk or severity of angioedema can be increased when Urokinase is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00013
DB08836,The risk or severity of angioedema can be increased when Urokinase is combined with Temocapril.,Temocapril,DB00013
DB08882,The risk or severity of angioedema can be increased when Urokinase is combined with Linagliptin.,Linagliptin,DB00013
DB09292,The risk or severity of angioedema can be increased when Urokinase is combined with Sacubitril.,Sacubitril,DB00013
DB09477,The risk or severity of angioedema can be increased when Urokinase is combined with Enalaprilat.,Enalaprilat,DB00013
DB11723,The risk or severity of angioedema can be increased when Urokinase is combined with Dutogliptin.,Dutogliptin,DB00013
DB11783,The risk or severity of angioedema can be increased when Urokinase is combined with Imidapril.,Imidapril,DB00013
DB11950,The risk or severity of angioedema can be increased when Urokinase is combined with Teneligliptin.,Teneligliptin,DB00013
DB11992,The risk or severity of angioedema can be increased when Urokinase is combined with Omarigliptin.,Omarigliptin,DB00013
DB12268,The risk or severity of angioedema can be increased when Urokinase is combined with Carmegliptin.,Carmegliptin,DB00013
DB12412,The risk or severity of angioedema can be increased when Urokinase is combined with Gemigliptin.,Gemigliptin,DB00013
DB12417,The risk or severity of angioedema can be increased when Urokinase is combined with Anagliptin.,Anagliptin,DB00013
DB12625,The risk or severity of angioedema can be increased when Urokinase is combined with Evogliptin.,Evogliptin,DB00013
DB13166,The risk or severity of angioedema can be increased when Urokinase is combined with Zofenopril.,Zofenopril,DB00013
DB13312,The risk or severity of angioedema can be increased when Urokinase is combined with Delapril.,Delapril,DB00013
DB14125,The risk or severity of angioedema can be increased when Urokinase is combined with Benazeprilat.,Benazeprilat,DB00013
DB14207,The risk or severity of angioedema can be increased when Urokinase is combined with Fosinoprilat.,Fosinoprilat,DB00013
DB14208,The risk or severity of angioedema can be increased when Urokinase is combined with Ramiprilat.,Ramiprilat,DB00013
DB14209,The risk or severity of angioedema can be increased when Urokinase is combined with Trandolaprilat.,Trandolaprilat,DB00013
DB14210,The risk or severity of angioedema can be increased when Urokinase is combined with Moexiprilat.,Moexiprilat,DB00013
DB14213,The risk or severity of angioedema can be increased when Urokinase is combined with Perindoprilat.,Perindoprilat,DB00013
DB14217,The risk or severity of angioedema can be increased when Urokinase is combined with Quinaprilat.,Quinaprilat,DB00013
DB14231,The risk or severity of angioedema can be increased when Urokinase is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00013
DB00203,The risk or severity of hemorrhage can be increased when Urokinase is combined with Sildenafil.,Sildenafil,DB00013
DB00008,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00013
DB00011,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00013
DB00018,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00013
DB00022,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00013
DB00033,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00013
DB00034,"The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00013
DB00041,The risk or severity of bleeding can be increased when Urokinase is combined with Aldesleukin.,Aldesleukin,DB00013
DB00056,The risk or severity of bleeding can be increased when Urokinase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00013
DB00068,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon beta-1b.,Interferon beta-1b,DB00013
DB00069,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00013
DB00073,The risk or severity of bleeding can be increased when Urokinase is combined with Rituximab.,Rituximab,DB00013
DB00078,The risk or severity of bleeding can be increased when Urokinase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00013
DB00087,The risk or severity of bleeding can be increased when Urokinase is combined with Alemtuzumab.,Alemtuzumab,DB00013
DB00105,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00013
DB00120,The risk or severity of bleeding can be increased when Urokinase is combined with Phenylalanine.,Phenylalanine,DB00013
DB00188,The risk or severity of bleeding can be increased when Urokinase is combined with Bortezomib.,Bortezomib,DB00013
DB00242,The risk or severity of bleeding can be increased when Urokinase is combined with Cladribine.,Cladribine,DB00013
DB00262,The risk or severity of bleeding can be increased when Urokinase is combined with Carmustine.,Carmustine,DB00013
DB00276,The risk or severity of bleeding can be increased when Urokinase is combined with Amsacrine.,Amsacrine,DB00013
DB00291,The risk or severity of bleeding can be increased when Urokinase is combined with Chlorambucil.,Chlorambucil,DB00013
DB00293,The risk or severity of bleeding can be increased when Urokinase is combined with Raltitrexed.,Raltitrexed,DB00013
DB00305,The risk or severity of bleeding can be increased when Urokinase is combined with Mitomycin.,Mitomycin,DB00013
DB00307,The risk or severity of bleeding can be increased when Urokinase is combined with Bexarotene.,Bexarotene,DB00013
DB00309,The risk or severity of bleeding can be increased when Urokinase is combined with Vindesine.,Vindesine,DB00013
DB00322,The risk or severity of bleeding can be increased when Urokinase is combined with Floxuridine.,Floxuridine,DB00013
DB00352,The risk or severity of bleeding can be increased when Urokinase is combined with Tioguanine.,Tioguanine,DB00013
DB00361,The risk or severity of bleeding can be increased when Urokinase is combined with Vinorelbine.,Vinorelbine,DB00013
DB00380,The risk or severity of bleeding can be increased when Urokinase is combined with Dexrazoxane.,Dexrazoxane,DB00013
DB00398,The risk or severity of bleeding can be increased when Urokinase is combined with Sorafenib.,Sorafenib,DB00013
DB00428,The risk or severity of bleeding can be increased when Urokinase is combined with Streptozocin.,Streptozocin,DB00013
DB00441,The risk or severity of bleeding can be increased when Urokinase is combined with Gemcitabine.,Gemcitabine,DB00013
DB00444,The risk or severity of bleeding can be increased when Urokinase is combined with Teniposide.,Teniposide,DB00013
DB00445,The risk or severity of bleeding can be increased when Urokinase is combined with Epirubicin.,Epirubicin,DB00013
DB00446,The risk or severity of bleeding can be increased when Urokinase is combined with Chloramphenicol.,Chloramphenicol,DB00013
DB00480,The risk or severity of bleeding can be increased when Urokinase is combined with Lenalidomide.,Lenalidomide,DB00013
DB00488,The risk or severity of bleeding can be increased when Urokinase is combined with Altretamine.,Altretamine,DB00013
DB00495,The risk or severity of bleeding can be increased when Urokinase is combined with Zidovudine.,Zidovudine,DB00013
DB00515,The risk or severity of bleeding can be increased when Urokinase is combined with Cisplatin.,Cisplatin,DB00013
DB00526,The risk or severity of bleeding can be increased when Urokinase is combined with Oxaliplatin.,Oxaliplatin,DB00013
DB00531,The risk or severity of bleeding can be increased when Urokinase is combined with Cyclophosphamide.,Cyclophosphamide,DB00013
DB00544,The risk or severity of bleeding can be increased when Urokinase is combined with Fluorouracil.,Fluorouracil,DB00013
DB00552,The risk or severity of bleeding can be increased when Urokinase is combined with Pentostatin.,Pentostatin,DB00013
DB00563,The risk or severity of bleeding can be increased when Urokinase is combined with Methotrexate.,Methotrexate,DB00013
DB00564,The risk or severity of bleeding can be increased when Urokinase is combined with Carbamazepine.,Carbamazepine,DB00013
DB00570,The risk or severity of bleeding can be increased when Urokinase is combined with Vinblastine.,Vinblastine,DB00013
DB00619,The risk or severity of bleeding can be increased when Urokinase is combined with Imatinib.,Imatinib,DB00013
DB00631,The risk or severity of bleeding can be increased when Urokinase is combined with Clofarabine.,Clofarabine,DB00013
DB00642,The risk or severity of bleeding can be increased when Urokinase is combined with Pemetrexed.,Pemetrexed,DB00013
DB00694,The risk or severity of bleeding can be increased when Urokinase is combined with Daunorubicin.,Daunorubicin,DB00013
DB00762,The risk or severity of bleeding can be increased when Urokinase is combined with Irinotecan.,Irinotecan,DB00013
DB00773,The risk or severity of bleeding can be increased when Urokinase is combined with Etoposide.,Etoposide,DB00013
DB00851,The risk or severity of bleeding can be increased when Urokinase is combined with Dacarbazine.,Dacarbazine,DB00013
DB00853,The risk or severity of bleeding can be increased when Urokinase is combined with Temozolomide.,Temozolomide,DB00013
DB00859,The risk or severity of bleeding can be increased when Urokinase is combined with Penicillamine.,Penicillamine,DB00013
DB00864,The risk or severity of bleeding can be increased when Urokinase is combined with Tacrolimus.,Tacrolimus,DB00013
DB00888,The risk or severity of bleeding can be increased when Urokinase is combined with Mechlorethamine.,Mechlorethamine,DB00013
DB00928,The risk or severity of bleeding can be increased when Urokinase is combined with Azacitidine.,Azacitidine,DB00013
DB00958,The risk or severity of bleeding can be increased when Urokinase is combined with Carboplatin.,Carboplatin,DB00013
DB00970,The risk or severity of bleeding can be increased when Urokinase is combined with Dactinomycin.,Dactinomycin,DB00013
DB00987,The risk or severity of bleeding can be increased when Urokinase is combined with Cytarabine.,Cytarabine,DB00013
DB00997,The risk or severity of bleeding can be increased when Urokinase is combined with Doxorubicin.,Doxorubicin,DB00013
DB01005,The risk or severity of bleeding can be increased when Urokinase is combined with Hydroxyurea.,Hydroxyurea,DB00013
DB01008,The risk or severity of bleeding can be increased when Urokinase is combined with Busulfan.,Busulfan,DB00013
DB01030,The risk or severity of bleeding can be increased when Urokinase is combined with Topotecan.,Topotecan,DB00013
DB01033,The risk or severity of bleeding can be increased when Urokinase is combined with Mercaptopurine.,Mercaptopurine,DB00013
DB01041,The risk or severity of bleeding can be increased when Urokinase is combined with Thalidomide.,Thalidomide,DB00013
DB01042,The risk or severity of bleeding can be increased when Urokinase is combined with Melphalan.,Melphalan,DB00013
DB01073,The risk or severity of bleeding can be increased when Urokinase is combined with Fludarabine.,Fludarabine,DB00013
DB01099,The risk or severity of bleeding can be increased when Urokinase is combined with Flucytosine.,Flucytosine,DB00013
DB01101,The risk or severity of bleeding can be increased when Urokinase is combined with Capecitabine.,Capecitabine,DB00013
DB01169,The risk or severity of bleeding can be increased when Urokinase is combined with Arsenic trioxide.,Arsenic trioxide,DB00013
DB01177,The risk or severity of bleeding can be increased when Urokinase is combined with Idarubicin.,Idarubicin,DB00013
DB01204,The risk or severity of bleeding can be increased when Urokinase is combined with Mitoxantrone.,Mitoxantrone,DB00013
DB01206,The risk or severity of bleeding can be increased when Urokinase is combined with Lomustine.,Lomustine,DB00013
DB01229,The risk or severity of bleeding can be increased when Urokinase is combined with Paclitaxel.,Paclitaxel,DB00013
DB01248,The risk or severity of bleeding can be increased when Urokinase is combined with Docetaxel.,Docetaxel,DB00013
DB01262,The risk or severity of bleeding can be increased when Urokinase is combined with Decitabine.,Decitabine,DB00013
DB01280,The risk or severity of bleeding can be increased when Urokinase is combined with Nelarabine.,Nelarabine,DB00013
DB01590,The risk or severity of bleeding can be increased when Urokinase is combined with Everolimus.,Everolimus,DB00013
DB02546,The risk or severity of bleeding can be increased when Urokinase is combined with Vorinostat.,Vorinostat,DB00013
DB04572,The risk or severity of bleeding can be increased when Urokinase is combined with Thiotepa.,Thiotepa,DB00013
DB04845,The risk or severity of bleeding can be increased when Urokinase is combined with Ixabepilone.,Ixabepilone,DB00013
DB04868,The risk or severity of bleeding can be increased when Urokinase is combined with Nilotinib.,Nilotinib,DB00013
DB05015,The risk or severity of bleeding can be increased when Urokinase is combined with Belinostat.,Belinostat,DB00013
DB05109,The risk or severity of bleeding can be increased when Urokinase is combined with Trabectedin.,Trabectedin,DB00013
DB05258,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa.,Interferon alfa,DB00013
DB05472,The risk or severity of bleeding can be increased when Urokinase is combined with omega interferon.,omega interferon,DB00013
DB05773,The risk or severity of bleeding can be increased when Urokinase is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00013
DB06616,The risk or severity of bleeding can be increased when Urokinase is combined with Bosutinib.,Bosutinib,DB00013
DB06769,The risk or severity of bleeding can be increased when Urokinase is combined with Bendamustine.,Bendamustine,DB00013
DB06772,The risk or severity of bleeding can be increased when Urokinase is combined with Cabazitaxel.,Cabazitaxel,DB00013
DB08871,The risk or severity of bleeding can be increased when Urokinase is combined with Eribulin.,Eribulin,DB00013
DB08877,The risk or severity of bleeding can be increased when Urokinase is combined with Ruxolitinib.,Ruxolitinib,DB00013
DB08889,The risk or severity of bleeding can be increased when Urokinase is combined with Carfilzomib.,Carfilzomib,DB00013
DB08895,The risk or severity of bleeding can be increased when Urokinase is combined with Tofacitinib.,Tofacitinib,DB00013
DB08901,The risk or severity of bleeding can be increased when Urokinase is combined with Ponatinib.,Ponatinib,DB00013
DB08910,The risk or severity of bleeding can be increased when Urokinase is combined with Pomalidomide.,Pomalidomide,DB00013
DB09042,The risk or severity of bleeding can be increased when Urokinase is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00013
DB09052,The risk or severity of bleeding can be increased when Urokinase is combined with Blinatumomab.,Blinatumomab,DB00013
DB09073,The risk or severity of bleeding can be increased when Urokinase is combined with Palbociclib.,Palbociclib,DB00013
DB09074,The risk or severity of bleeding can be increased when Urokinase is combined with Olaparib.,Olaparib,DB00013
DB09077,The risk or severity of bleeding can be increased when Urokinase is combined with Dinutuximab.,Dinutuximab,DB00013
DB09122,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00013
DB12814,The risk or severity of bleeding can be increased when Urokinase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00013
DB00229,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotiam.,Cefotiam,DB00013
DB00267,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00013
DB00274,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00013
DB00430,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00013
DB00438,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00013
DB00447,The therapeutic efficacy of Urokinase can be decreased when used in combination with Loracarbef.,Loracarbef,DB00013
DB00456,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefalotin.,Cefalotin,DB00013
DB00493,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00013
DB00535,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefdinir.,Cefdinir,DB00013
DB00567,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephalexin.,Cephalexin,DB00013
DB00671,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefixime.,Cefixime,DB00013
DB00689,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00013
DB00833,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefaclor.,Cefaclor,DB00013
DB00923,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceforanide.,Ceforanide,DB00013
DB01066,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefditoren.,Cefditoren,DB00013
DB01112,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00013
DB01139,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefapirin.,Cefapirin,DB00013
DB01140,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00013
DB01150,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefprozil.,Cefprozil,DB00013
DB01212,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00013
DB01326,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefamandole.,Cefamandole,DB00013
DB01327,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefazolin.,Cefazolin,DB00013
DB01328,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefonicid.,Cefonicid,DB00013
DB01329,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00013
DB01330,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotetan.,Cefotetan,DB00013
DB01331,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00013
DB01332,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00013
DB01333,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefradine.,Cefradine,DB00013
DB01413,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefepime.,Cefepime,DB00013
DB01414,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00013
DB01415,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00013
DB01416,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00013
DB04570,The therapeutic efficacy of Urokinase can be decreased when used in combination with Latamoxef.,Latamoxef,DB00013
DB04918,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00013
DB06590,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00013
DB09008,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00013
DB09050,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00013
DB09062,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefminox.,Cefminox,DB00013
DB11367,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00013
DB11935,The therapeutic efficacy of Urokinase can be decreased when used in combination with Flomoxef.,Flomoxef,DB00013
DB13266,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00013
DB13461,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefcapene.,Cefcapene,DB00013
DB13470,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefodizime.,Cefodizime,DB00013
DB13499,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00013
DB13504,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefetamet.,Cefetamet,DB00013
DB13638,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00013
DB13667,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefozopran.,Cefozopran,DB00013
DB13682,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpirome.,Cefpirome,DB00013
DB13778,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefazedone.,Cefazedone,DB00013
DB13821,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftezole.,Ceftezole,DB00013
DB14725,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00013
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Urokinase.,Doxycycline,DB00013
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Urokinase.,Azithromycin,DB00013
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Urokinase.,Omega-3-acid ethyl esters,DB00013
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Urokinase.,Tazobactam,DB00013
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Urokinase.,Erythromycin,DB00013
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Urokinase.,Trazodone,DB00013
DB00620,The therapeutic efficacy of Urokinase can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00013
DB09079,The risk or severity of bleeding can be increased when Urokinase is combined with Nintedanib.,Nintedanib,DB00013
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Urokinase.,Escitalopram,DB00013
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Urokinase.,Sertraline,DB00013
DB00232,The therapeutic efficacy of Urokinase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00013
DB00436,The therapeutic efficacy of Urokinase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00013
DB00562,The therapeutic efficacy of Urokinase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00013
DB00606,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00013
DB00774,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00013
DB00880,The therapeutic efficacy of Urokinase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00013
DB00999,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00013
DB01021,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00013
DB01324,The therapeutic efficacy of Urokinase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00013
DB13430,The therapeutic efficacy of Urokinase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00013
DB13532,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00013
DB09066,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Goserelin.,Corifollitropin alfa,DB00014
DB09083,Ivabradine may increase the QTc-prolonging activities of Goserelin.,Ivabradine,DB00014
DB08894,The risk or severity of Thrombosis can be increased when Goserelin is combined with Peginesatide.,Peginesatide,DB00014
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Goserelin.,Darbepoetin alfa,DB00014
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.,Erythropoietin,DB00014
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Goserelin.,Methoxy polyethylene glycol-epoetin beta,DB00014
DB09277,Goserelin may decrease effectiveness of Choline C 11 as a diagnostic agent.,Choline C 11,DB00014
DB00089,Goserelin may decrease effectiveness of Capromab pendetide as a diagnostic agent.,Capromab pendetide,DB00014
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.,Insulin human,DB00014
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.,Insulin lispro,DB00014
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.,Insulin glargine,DB00014
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Goserelin.,Insulin pork,DB00014
DB00197,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Goserelin.,Troglitazone,DB00014
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Goserelin.,Glimepiride,DB00014
DB00284,The therapeutic efficacy of Acarbose can be decreased when used in combination with Goserelin.,Acarbose,DB00014
DB00359,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Goserelin.,Sulfadiazine,DB00014
DB00412,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Goserelin.,Rosiglitazone,DB00014
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Goserelin.,Acetohexamide,DB00014
DB00491,The therapeutic efficacy of Miglitol can be decreased when used in combination with Goserelin.,Miglitol,DB00014
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Goserelin.,Chlorpropamide,DB00014
DB00731,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Goserelin.,Nateglinide,DB00014
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Goserelin.,Tolazamide,DB00014
DB00912,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Goserelin.,Repaglinide,DB00014
DB00914,The therapeutic efficacy of Phenformin can be decreased when used in combination with Goserelin.,Phenformin,DB00014
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Goserelin.,Glyburide,DB00014
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Goserelin.,Glipizide,DB00014
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Goserelin.,Gliclazide,DB00014
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Goserelin.,Tolbutamide,DB00014
DB01132,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Goserelin.,Pioglitazone,DB00014
DB01200,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Goserelin.,Bromocriptine,DB00014
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Goserelin.,Gliquidone,DB00014
DB01252,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Goserelin.,Mitiglinide,DB00014
DB01261,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Goserelin.,Sitagliptin,DB00014
DB01276,The therapeutic efficacy of Exenatide can be decreased when used in combination with Goserelin.,Exenatide,DB00014
DB01277,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Goserelin.,Mecasermin,DB00014
DB01278,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Goserelin.,Pramlintide,DB00014
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Goserelin.,Glisoxepide,DB00014
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Goserelin.,Insulin aspart,DB00014
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Goserelin.,Insulin detemir,DB00014
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Goserelin.,Insulin glulisine,DB00014
DB01382,The therapeutic efficacy of Glymidine can be decreased when used in combination with Goserelin.,Glymidine,DB00014
DB01700,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Goserelin.,AICA ribonucleotide,DB00014
DB04830,The therapeutic efficacy of Buformin can be decreased when used in combination with Goserelin.,Buformin,DB00014
DB04876,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Goserelin.,Vildagliptin,DB00014
DB04878,The therapeutic efficacy of Voglibose can be decreased when used in combination with Goserelin.,Voglibose,DB00014
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Goserelin.,NN344,DB00014
DB05819,The therapeutic efficacy of NBI-6024 can be decreased when used in combination with Goserelin.,NBI-6024,DB00014
DB06011,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Goserelin.,AMG-222,DB00014
DB06127,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Goserelin.,Bisegliptin,DB00014
DB06203,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Goserelin.,Alogliptin,DB00014
DB06292,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Goserelin.,Dapagliflozin,DB00014
DB06335,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Goserelin.,Saxagliptin,DB00014
DB06655,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Goserelin.,Liraglutide,DB00014
DB08382,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Goserelin.,Gosogliptin,DB00014
DB08882,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Goserelin.,Linagliptin,DB00014
DB08907,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Goserelin.,Canagliflozin,DB00014
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Goserelin.,Glibornuride,DB00014
DB09022,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Goserelin.,Benfluorex,DB00014
DB09038,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Goserelin.,Empagliflozin,DB00014
DB09043,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Goserelin.,Albiglutide,DB00014
DB09045,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Goserelin.,Dulaglutide,DB00014
DB09198,The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Goserelin.,Lobeglitazone,DB00014
DB09199,The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Goserelin.,Netoglitazone,DB00014
DB09200,The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Goserelin.,Rivoglitazone,DB00014
DB09201,The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Goserelin.,Ciglitazone,DB00014
DB09265,The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Goserelin.,Lixisenatide,DB00014
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Goserelin.,Insulin beef,DB00014
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Goserelin.,Insulin degludec,DB00014
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Goserelin.,Insulin peglispro,DB00014
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Goserelin.,Insulin tregopil,DB00014
DB11698,The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Goserelin.,Ipragliflozin,DB00014
DB11723,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Goserelin.,Dutogliptin,DB00014
DB11780,The therapeutic efficacy of Allicin can be decreased when used in combination with Goserelin.,Allicin,DB00014
DB11824,The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Goserelin.,Tofogliflozin,DB00014
DB11827,The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Goserelin.,Ertugliflozin,DB00014
DB11898,"The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Goserelin.","2,4-thiazolidinedione",DB00014
DB11950,The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Goserelin.,Teneligliptin,DB00014
DB11992,The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Goserelin.,Omarigliptin,DB00014
DB12268,The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Goserelin.,Carmegliptin,DB00014
DB12412,The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Goserelin.,Gemigliptin,DB00014
DB12417,The therapeutic efficacy of Anagliptin can be decreased when used in combination with Goserelin.,Anagliptin,DB00014
DB12625,The therapeutic efficacy of Evogliptin can be decreased when used in combination with Goserelin.,Evogliptin,DB00014
DB12713,The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Goserelin.,Sotagliflozin,DB00014
DB12781,The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Goserelin.,Balaglitazone,DB00014
DB12935,The therapeutic efficacy of Remogliflozin etabonate can be decreased when used in combination with Goserelin.,Remogliflozin etabonate,DB00014
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Goserelin.,Carbutamide,DB00014
DB13446,The therapeutic efficacy of Guar gum can be decreased when used in combination with Goserelin.,Guar gum,DB00014
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Goserelin.,Metahexamide,DB00014
DB13928,The therapeutic efficacy of Semaglutide can be decreased when used in combination with Goserelin.,Semaglutide,DB00014
DB14027,The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Goserelin.,Taspoglutide,DB00014
DB14035,The therapeutic efficacy of Englitazone can be decreased when used in combination with Goserelin.,Englitazone,DB00014
DB15171,The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Goserelin.,Tirzepatide,DB00014
DB15217,The therapeutic efficacy of Gastric inhibitory polypeptide can be decreased when used in combination with Goserelin.,Gastric inhibitory polypeptide,DB00014
DB00204,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dofetilide.,Dofetilide,DB00014
DB00215,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Citalopram.,Citalopram,DB00014
DB00261,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Anagrelide.,Anagrelide,DB00014
DB00280,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Disopyramide.,Disopyramide,DB00014
DB00283,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clemastine.,Clemastine,DB00014
DB00308,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ibutilide.,Ibutilide,DB00014
DB00313,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Valproic acid.,Valproic acid,DB00014
DB00342,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terfenadine.,Terfenadine,DB00014
DB00365,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Grepafloxacin.,Grepafloxacin,DB00014
DB00468,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinine.,Quinine,DB00014
DB00489,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sotalol.,Sotalol,DB00014
DB00530,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erlotinib.,Erlotinib,DB00014
DB00539,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Toremifene.,Toremifene,DB00014
DB00604,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cisapride.,Cisapride,DB00014
DB00619,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Imatinib.,Imatinib,DB00014
DB00637,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Astemizole.,Astemizole,DB00014
DB00679,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Thioridazine.,Thioridazine,DB00014
DB00685,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Trovafloxacin.,Trovafloxacin,DB00014
DB00834,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mifepristone.,Mifepristone,DB00014
DB00875,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flupentixol.,Flupentixol,DB00014
DB00907,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cocaine.,Cocaine,DB00014
DB00908,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.,Quinidine,DB00014
DB01035,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Procainamide.,Procainamide,DB00014
DB01100,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pimozide.,Pimozide,DB00014
DB01118,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amiodarone.,Amiodarone,DB00014
DB01169,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Arsenic trioxide.,Arsenic trioxide,DB00014
DB01175,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Escitalopram.,Escitalopram,DB00014
DB01184,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Domperidone.,Domperidone,DB00014
DB01208,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sparfloxacin.,Sparfloxacin,DB00014
DB01218,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Halofantrine.,Halofantrine,DB00014
DB01244,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bepridil.,Bepridil,DB00014
DB01267,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Paliperidone.,Paliperidone,DB00014
DB01356,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lithium cation.,Lithium cation,DB00014
DB01405,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Temafloxacin.,Temafloxacin,DB00014
DB01624,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Zuclopenthixol.,Zuclopenthixol,DB00014
DB04844,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tetrabenazine.,Tetrabenazine,DB00014
DB04855,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dronedarone.,Dronedarone,DB00014
DB04868,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nilotinib.,Nilotinib,DB00014
DB04946,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Iloperidone.,Iloperidone,DB00014
DB05294,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vandetanib.,Vandetanib,DB00014
DB06176,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Romidepsin.,Romidepsin,DB00014
DB06216,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Asenapine.,Asenapine,DB00014
DB06697,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Artemether.,Artemether,DB00014
DB06708,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lumefantrine.,Lumefantrine,DB00014
DB08881,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vemurafenib.,Vemurafenib,DB00014
DB09039,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eliglustat.,Eliglustat,DB00014
DB11730,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ribociclib.,Ribociclib,DB00014
DB11978,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Glasdegib.,Glasdegib,DB00014
DB12161,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Deutetrabenazine.,Deutetrabenazine,DB00014
DB13074,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Macimorelin.,Macimorelin,DB00014
DB13725,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terodiline.,Terodiline,DB00014
DB00007,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Goserelin.,Leuprolide,DB00014
DB00195,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Betaxolol.,Betaxolol,DB00014
DB00199,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erythromycin.,Erythromycin,DB00014
DB00207,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azithromycin.,Azithromycin,DB00014
DB00218,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Moxifloxacin.,Moxifloxacin,DB00014
DB00243,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ranolazine.,Ranolazine,DB00014
DB00263,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sulfisoxazole.,Sulfisoxazole,DB00014
DB00333,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Methadone.,Methadone,DB00014
DB00343,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Diltiazem.,Diltiazem,DB00014
DB00363,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clozapine.,Clozapine,DB00014
DB00391,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sulpiride.,Sulpiride,DB00014
DB00393,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nimodipine.,Nimodipine,DB00014
DB00420,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Promazine.,Promazine,DB00014
DB00433,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prochlorperazine.,Prochlorperazine,DB00014
DB00450,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Droperidol.,Droperidol,DB00014
DB00477,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chlorpromazine.,Chlorpromazine,DB00014
DB00526,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxaliplatin.,Oxaliplatin,DB00014
DB00537,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ciprofloxacin.,Ciprofloxacin,DB00014
DB00544,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluorouracil.,Fluorouracil,DB00014
DB00556,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Perflutren.,Perflutren,DB00014
DB00568,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cinnarizine.,Cinnarizine,DB00014
DB00571,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Propranolol.,Propranolol,DB00014
DB00572,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Atropine.,Atropine,DB00014
DB00608,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chloroquine.,Chloroquine,DB00014
DB00625,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Efavirenz.,Efavirenz,DB00014
DB00640,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Adenosine.,Adenosine,DB00014
DB00738,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pentamidine.,Pentamidine,DB00014
DB00743,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gadobenic acid.,Gadobenic acid,DB00014
DB00748,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Carbinoxamine.,Carbinoxamine,DB00014
DB00757,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dolasetron.,Dolasetron,DB00014
DB00778,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Roxithromycin.,Roxithromycin,DB00014
DB00779,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nalidixic acid.,Nalidixic acid,DB00014
DB00827,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cinoxacin.,Cinoxacin,DB00014
DB00836,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Loperamide.,Loperamide,DB00014
DB00889,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Granisetron.,Granisetron,DB00014
DB00904,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron.,Ondansetron,DB00014
DB00922,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levosimendan.,Levosimendan,DB00014
DB00933,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mesoridazine.,Mesoridazine,DB00014
DB00967,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Desloratadine.,Desloratadine,DB00014
DB00976,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telithromycin.,Telithromycin,DB00014
DB00978,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lomefloxacin.,Lomefloxacin,DB00014
DB00985,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dimenhydrinate.,Dimenhydrinate,DB00014
DB01087,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Primaquine.,Primaquine,DB00014
DB01113,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Papaverine.,Papaverine,DB00014
DB01114,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chlorpheniramine.,Chlorpheniramine,DB00014
DB01115,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nifedipine.,Nifedipine,DB00014
DB01137,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levofloxacin.,Levofloxacin,DB00014
DB01155,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gemifloxacin.,Gemifloxacin,DB00014
DB01165,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ofloxacin.,Ofloxacin,DB00014
DB01182,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Propafenone.,Propafenone,DB00014
DB01193,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Acebutolol.,Acebutolol,DB00014
DB01195,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flecainide.,Flecainide,DB00014
DB01211,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clarithromycin.,Clarithromycin,DB00014
DB01227,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levacetylmethadol.,Levacetylmethadol,DB00014
DB01232,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Saquinavir.,Saquinavir,DB00014
DB01388,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mibefradil.,Mibefradil,DB00014
DB01580,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxprenolol.,Oxprenolol,DB00014
DB01599,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Probucol.,Probucol,DB00014
DB01615,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Aceprometazine.,Aceprometazine,DB00014
DB02638,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terlipressin.,Terlipressin,DB00014
DB04825,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prenylamine.,Prenylamine,DB00014
DB04842,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluspirilene.,Fluspirilene,DB00014
DB04948,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lofexidine.,Lofexidine,DB00014
DB04957,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azimilide.,Azimilide,DB00014
DB05223,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pracinostat.,Pracinostat,DB00014
DB05488,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin,DB00014
DB06160,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Garenoxacin.,Garenoxacin,DB00014
DB06200,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tedisamil.,Tedisamil,DB00014
DB06334,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tucidinostat.,Tucidinostat,DB00014
DB06402,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telavancin.,Telavancin,DB00014
DB06589,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pazopanib.,Pazopanib,DB00014
DB06600,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nemonoxacin.,Nemonoxacin,DB00014
DB06603,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Panobinostat.,Panobinostat,DB00014
DB06712,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nilvadipine.,Nilvadipine,DB00014
DB08799,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Antazoline.,Antazoline,DB00014
DB08865,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Crizotinib.,Crizotinib,DB00014
DB08903,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bedaquiline.,Bedaquiline,DB00014
DB08980,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fendiline.,Fendiline,DB00014
DB08992,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eperisone.,Eperisone,DB00014
DB09016,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Butriptyline.,Butriptyline,DB00014
DB09063,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ceritinib.,Ceritinib,DB00014
DB09078,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lenvatinib.,Lenvatinib,DB00014
DB09224,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Melperone.,Melperone,DB00014
DB09231,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Benidipine.,Benidipine,DB00014
DB09555,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexchlorpheniramine maleate.,Dexchlorpheniramine maleate,DB00014
DB11640,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amifampridine.,Amifampridine,DB00014
DB11830,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mocetinostat.,Mocetinostat,DB00014
DB11841,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Entinostat.,Entinostat,DB00014
DB12141,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gilteritinib.,Gilteritinib,DB00014
DB12174,The risk or severity of QTc prolongation can be increased when Goserelin is combined with CUDC-101.,CUDC-101,DB00014
DB12286,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Simendan.,Simendan,DB00014
DB12376,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ricolinostat.,Ricolinostat,DB00014
DB12523,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mizolastine.,Mizolastine,DB00014
DB12565,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Abexinostat.,Abexinostat,DB00014
DB12877,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxatomide.,Oxatomide,DB00014
DB13261,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sitafloxacin.,Sitafloxacin,DB00014
DB13273,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sultopride.,Sultopride,DB00014
DB13500,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Otilonium.,Otilonium,DB00014
DB13546,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nizofenone.,Nizofenone,DB00014
DB13652,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bunaftine.,Bunaftine,DB00014
DB13653,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lorcainide.,Lorcainide,DB00014
DB13679,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexchlorpheniramine.,Dexchlorpheniramine,DB00014
DB13791,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Penfluridol.,Penfluridol,DB00014
DB14063,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexverapamil.,Dexverapamil,DB00014
DB14568,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ivosidenib.,Ivosidenib,DB00014
DB01224,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quetiapine.,Quetiapine,DB00014
DB00321,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amitriptyline.,Amitriptyline,DB00014
DB00458,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Imipramine.,Imipramine,DB00014
DB01242,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clomipramine.,Clomipramine,DB00014
DB11718,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Encorafenib.,Encorafenib,DB00014
DB00104,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Goserelin.,Octreotide,DB00014
DB00107,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Goserelin.,Oxytocin,DB00014
DB00187,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Goserelin.,Esmolol,DB00014
DB00188,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Goserelin.,Bortezomib,DB00014
DB00196,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Goserelin.,Fluconazole,DB00014
DB00220,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Goserelin.,Nelfinavir,DB00014
DB00230,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Goserelin.,Pregabalin,DB00014
DB00245,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Goserelin.,Benzatropine,DB00014
DB00270,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Goserelin.,Isradipine,DB00014
DB00285,The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Goserelin.,Venlafaxine,DB00014
DB00289,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Goserelin.,Atomoxetine,DB00014
DB00334,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Goserelin.,Olanzapine,DB00014
DB00341,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Goserelin.,Cetirizine,DB00014
DB00344,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Goserelin.,Protriptyline,DB00014
DB00346,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Goserelin.,Alfuzosin,DB00014
DB00347,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Goserelin.,Trimethadione,DB00014
DB00354,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Goserelin.,Buclizine,DB00014
DB00358,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Goserelin.,Mefloquine,DB00014
DB00366,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Goserelin.,Doxylamine,DB00014
DB00370,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Goserelin.,Mirtazapine,DB00014
DB00373,The risk or severity of QTc prolongation can be increased when Timolol is combined with Goserelin.,Timolol,DB00014
DB00374,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Goserelin.,Treprostinil,DB00014
DB00398,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Goserelin.,Sorafenib,DB00014
DB00405,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Goserelin.,Dexbrompheniramine,DB00014
DB00424,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Goserelin.,Hyoscyamine,DB00014
DB00427,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Goserelin.,Triprolidine,DB00014
DB00434,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Goserelin.,Cyproheptadine,DB00014
DB00467,The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Goserelin.,Enoxacin,DB00014
DB00487,The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Goserelin.,Pefloxacin,DB00014
DB00503,The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Goserelin.,Ritonavir,DB00014
DB00529,The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Goserelin.,Foscarnet,DB00014
DB00540,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Goserelin.,Nortriptyline,DB00014
DB00543,The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Goserelin.,Amoxapine,DB00014
DB00555,The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Goserelin.,Lamotrigine,DB00014
DB00582,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Goserelin.,Voriconazole,DB00014
DB00593,The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Goserelin.,Ethosuximide,DB00014
DB00613,The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Goserelin.,Amodiaquine,DB00014
DB00622,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Goserelin.,Nicardipine,DB00014
DB00674,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Goserelin.,Galantamine,DB00014
DB00675,The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Goserelin.,Tamoxifen,DB00014
DB00678,The risk or severity of QTc prolongation can be increased when Losartan is combined with Goserelin.,Losartan,DB00014
DB00680,The risk or severity of QTc prolongation can be increased when Moricizine is combined with Goserelin.,Moricizine,DB00014
DB00691,The risk or severity of QTc prolongation can be increased when Moexipril is combined with Goserelin.,Moexipril,DB00014
DB00697,The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Goserelin.,Tizanidine,DB00014
DB00710,The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Goserelin.,Ibandronate,DB00014
DB00714,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Goserelin.,Apomorphine,DB00014
DB00719,The risk or severity of QTc prolongation can be increased when Azatadine is combined with Goserelin.,Azatadine,DB00014
DB00726,The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Goserelin.,Trimipramine,DB00014
DB00734,The risk or severity of QTc prolongation can be increased when Risperidone is combined with Goserelin.,Risperidone,DB00014
DB00753,The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Goserelin.,Isoflurane,DB00014
DB00808,The risk or severity of QTc prolongation can be increased when Indapamide is combined with Goserelin.,Indapamide,DB00014
DB00817,The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Goserelin.,Rosoxacin,DB00014
DB00818,The risk or severity of QTc prolongation can be increased when Propofol is combined with Goserelin.,Propofol,DB00014
DB00822,The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Goserelin.,Disulfiram,DB00014
DB00825,The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Goserelin.,Levomenthol,DB00014
DB00835,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Goserelin.,Brompheniramine,DB00014
DB00862,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Goserelin.,Vardenafil,DB00014
DB00871,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Goserelin.,Terbutaline,DB00014
DB00909,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Goserelin.,Zonisamide,DB00014
DB00915,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Goserelin.,Amantadine,DB00014
DB00916,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Goserelin.,Metronidazole,DB00014
DB00920,The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Goserelin.,Ketotifen,DB00014
DB00927,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Goserelin.,Famotidine,DB00014
DB00934,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Goserelin.,Maprotiline,DB00014
DB00938,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Goserelin.,Salmeterol,DB00014
DB00949,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Goserelin.,Felbamate,DB00014
DB00983,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Goserelin.,Formoterol,DB00014
DB00999,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Goserelin.,Hydrochlorothiazide,DB00014
DB01001,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Goserelin.,Salbutamol,DB00014
DB01015,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Goserelin.,Sulfamethoxazole,DB00014
DB01023,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Goserelin.,Felodipine,DB00014
DB01026,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Goserelin.,Ketoconazole,DB00014
DB01036,The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Goserelin.,Tolterodine,DB00014
DB01044,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Goserelin.,Gatifloxacin,DB00014
DB01054,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Goserelin.,Nitrendipine,DB00014
DB01059,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Goserelin.,Norfloxacin,DB00014
DB01069,The risk or severity of QTc prolongation can be increased when Promethazine is combined with Goserelin.,Promethazine,DB00014
DB01071,The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Goserelin.,Mequitazine,DB00014
DB01072,The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Goserelin.,Atazanavir,DB00014
DB01074,The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Goserelin.,Perhexiline,DB00014
DB01075,The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Goserelin.,Diphenhydramine,DB00014
DB01106,The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Goserelin.,Levocabastine,DB00014
DB01158,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Goserelin.,Bretylium,DB00014
DB01166,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Goserelin.,Cilostazol,DB00014
DB01167,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Goserelin.,Itraconazole,DB00014
DB01173,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Goserelin.,Orphenadrine,DB00014
DB01176,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Goserelin.,Cyclizine,DB00014
DB01189,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Goserelin.,Desflurane,DB00014
DB01228,The risk or severity of QTc prolongation can be increased when Encainide is combined with Goserelin.,Encainide,DB00014
DB01233,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Goserelin.,Metoclopramide,DB00014
DB01236,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Goserelin.,Sevoflurane,DB00014
DB01238,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Goserelin.,Aripiprazole,DB00014
DB01239,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Goserelin.,Chlorprothixene,DB00014
DB01246,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Goserelin.,Alimemazine,DB00014
DB01254,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Goserelin.,Dasatinib,DB00014
DB01259,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Goserelin.,Lapatinib,DB00014
DB01263,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Goserelin.,Posaconazole,DB00014
DB01268,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Goserelin.,Sunitinib,DB00014
DB01274,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Goserelin.,Arformoterol,DB00014
DB01396,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Goserelin.,Digitoxin,DB00014
DB01403,The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Goserelin.,Methotrimeprazine,DB00014
DB01426,The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Goserelin.,Ajmaline,DB00014
DB01591,The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Goserelin.,Solifenacin,DB00014
DB01611,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Goserelin.,Hydroxychloroquine,DB00014
DB01620,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Goserelin.,Pheniramine,DB00014
DB01623,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Goserelin.,Thiothixene,DB00014
DB02546,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Goserelin.,Vorinostat,DB00014
DB04576,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Goserelin.,Fleroxacin,DB00014
DB04695,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Goserelin.,Farnesyl thiopyrophosphate,DB00014
DB04846,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Goserelin.,Celiprolol,DB00014
DB04953,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Goserelin.,Ezogabine,DB00014
DB05039,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Goserelin.,Indacaterol,DB00014
DB05246,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Goserelin.,Methsuximide,DB00014
DB05465,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Goserelin.,Tandutinib,DB00014
DB06217,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin.,Vernakalant,DB00014
DB06282,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Goserelin.,Levocetirizine,DB00014
DB06288,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Goserelin.,Amisulpride,DB00014
DB06468,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Goserelin.,Cariporide,DB00014
DB06663,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Goserelin.,Pasireotide,DB00014
DB06691,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Goserelin.,Mepyramine,DB00014
DB06699,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Goserelin.,Degarelix,DB00014
DB06719,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Goserelin.,Buserelin,DB00014
DB06788,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Goserelin.,Histrelin,DB00014
DB06825,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Goserelin.,Triptorelin,DB00014
DB07780,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Goserelin.,Farnesyl diphosphate,DB00014
DB07841,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Goserelin.,Geranylgeranyl diphosphate,DB00014
DB08808,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Goserelin.,Bupranolol,DB00014
DB08815,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Goserelin.,Lurasidone,DB00014
DB08864,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Goserelin.,Rilpivirine,DB00014
DB08871,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Goserelin.,Eribulin,DB00014
DB08893,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Goserelin.,Mirabegron,DB00014
DB08912,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Goserelin.,Dabrafenib,DB00014
DB08936,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Goserelin.,Chlorcyclizine,DB00014
DB08952,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Goserelin.,Indenolol,DB00014
DB08972,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Goserelin.,Flumequine,DB00014
DB09080,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Goserelin.,Olodaterol,DB00014
DB09082,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Goserelin.,Vilanterol,DB00014
DB09089,The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Goserelin.,Trimebutine,DB00014
DB09090,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Goserelin.,Pinaverium,DB00014
DB09167,The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Goserelin.,Dosulepin,DB00014
DB09229,The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Goserelin.,Aranidipine,DB00014
DB09235,The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Goserelin.,Efonidipine,DB00014
DB09236,The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Goserelin.,Lacidipine,DB00014
DB09239,The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Goserelin.,Niguldipine,DB00014
DB09488,The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Goserelin.,Acrivastine,DB00014
DB11390,The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Goserelin.,Coumaphos,DB00014
DB11397,The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Goserelin.,Dichlorvos,DB00014
DB11408,The risk or severity of QTc prolongation can be increased when Famphur is combined with Goserelin.,Famphur,DB00014
DB11412,The risk or severity of QTc prolongation can be increased when Fenthion is combined with Goserelin.,Fenthion,DB00014
DB11443,The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Goserelin.,Orbifloxacin,DB00014
DB11448,The risk or severity of QTc prolongation can be increased when Phosmet is combined with Goserelin.,Phosmet,DB00014
DB11491,The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Goserelin.,Sarafloxacin,DB00014
DB11511,The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Goserelin.,Difloxacin,DB00014
DB11591,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Goserelin.,Bilastine,DB00014
DB11614,The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Goserelin.,Rupatadine,DB00014
DB11742,The risk or severity of QTc prolongation can be increased when Ebastine is combined with Goserelin.,Ebastine,DB00014
DB11770,The risk or severity of QTc prolongation can be increased when Talinolol is combined with Goserelin.,Talinolol,DB00014
DB11774,The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Goserelin.,Pazufloxacin,DB00014
DB11785,The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Goserelin.,Anisodamine,DB00014
DB11891,The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Goserelin.,CUDC-907,DB00014
DB11892,The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Goserelin.,Prulifloxacin,DB00014
DB11943,The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Goserelin.,Delafloxacin,DB00014
DB12093,The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Goserelin.,Tetrahydropalmatine,DB00014
DB12231,The risk or severity of QTc prolongation can be increased when Temefos is combined with Goserelin.,Temefos,DB00014
DB12245,The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Goserelin.,Triclabendazole,DB00014
DB12645,The risk or severity of QTc prolongation can be increased when Givinostat is combined with Goserelin.,Givinostat,DB00014
DB12712,The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Goserelin.,Pilsicainide,DB00014
DB12766,The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Goserelin.,Cicletanine,DB00014
DB12923,The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Goserelin.,Gallopamil,DB00014
DB13358,The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Goserelin.,Cibenzoline,DB00014
DB13488,The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Goserelin.,Bencyclane,DB00014
DB13555,The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Goserelin.,Prajmaline,DB00014
DB13627,The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Goserelin.,Oxolinic acid,DB00014
DB13651,The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Goserelin.,Lorajmine,DB00014
DB13691,The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Goserelin.,Acetyldigoxin,DB00014
DB13744,The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Goserelin.,Piromidic acid,DB00014
DB13766,The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Goserelin.,Lidoflazine,DB00014
DB13772,The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Goserelin.,Rufloxacin,DB00014
DB13823,The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Goserelin.,Pipemidic acid,DB00014
DB14185,The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Goserelin.,Aripiprazole lauroxil,DB00014
DB14713,The risk or severity of QTc prolongation can be increased when Inotersen is combined with Goserelin.,Inotersen,DB00014
DB01142,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Doxepin.,Doxepin,DB00014
DB01151,The risk or severity of QTc prolongation can be increased when Desipramine is combined with Goserelin.,Desipramine,DB00014
DB00845,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Goserelin.,Clofazimine,DB00014
DB11637,Goserelin may increase the QTc-prolonging activities of Delamanid.,Delamanid,DB00014
DB00091,Cyclosporine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cyclosporine,DB00014
DB00159,Icosapent may decrease the excretion rate of Goserelin which could result in a higher serum level.,Icosapent,DB00014
DB00229,Cefotiam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotiam,DB00014
DB00244,Mesalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mesalazine,DB00014
DB00267,Cefmenoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefmenoxime,DB00014
DB00274,Cefmetazole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefmetazole,DB00014
DB00282,Pamidronic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pamidronic acid,DB00014
DB00300,Tenofovir disoproxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir disoproxil,DB00014
DB00328,Indomethacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indomethacin,DB00014
DB00369,Cidofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cidofovir,DB00014
DB00384,Triamterene may decrease the excretion rate of Goserelin which could result in a higher serum level.,Triamterene,DB00014
DB00430,Cefpiramide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpiramide,DB00014
DB00438,Ceftazidime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftazidime,DB00014
DB00447,Loracarbef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Loracarbef,DB00014
DB00456,Cefalotin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefalotin,DB00014
DB00461,Nabumetone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nabumetone,DB00014
DB00465,Ketorolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ketorolac,DB00014
DB00469,Tenoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenoxicam,DB00014
DB00482,Celecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Celecoxib,DB00014
DB00493,Cefotaxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotaxime,DB00014
DB00500,Tolmetin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tolmetin,DB00014
DB00533,Rofecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Rofecoxib,DB00014
DB00554,Piroxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Piroxicam,DB00014
DB00563,Methotrexate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Methotrexate,DB00014
DB00567,Cephalexin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephalexin,DB00014
DB00573,Fenoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fenoprofen,DB00014
DB00577,Valaciclovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Valaciclovir,DB00014
DB00580,Valdecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Valdecoxib,DB00014
DB00586,Diclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Diclofenac,DB00014
DB00605,Sulindac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sulindac,DB00014
DB00626,Bacitracin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bacitracin,DB00014
DB00681,Amphotericin B may decrease the excretion rate of Goserelin which could result in a higher serum level.,Amphotericin B,DB00014
DB00689,Cephaloglycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephaloglycin,DB00014
DB00712,Flurbiprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flurbiprofen,DB00014
DB00718,Adefovir dipivoxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Adefovir dipivoxil,DB00014
DB00742,Mannitol may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mannitol,DB00014
DB00749,Etodolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etodolac,DB00014
DB00784,Mefenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mefenamic acid,DB00014
DB00787,Acyclovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acyclovir,DB00014
DB00788,Naproxen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Naproxen,DB00014
DB00795,Sulfasalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sulfasalazine,DB00014
DB00812,Phenylbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Phenylbutazone,DB00014
DB00814,Meloxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Meloxicam,DB00014
DB00821,Carprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carprofen,DB00014
DB00833,Cefaclor may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefaclor,DB00014
DB00861,Diflunisal may decrease the excretion rate of Goserelin which could result in a higher serum level.,Diflunisal,DB00014
DB00864,Tacrolimus may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tacrolimus,DB00014
DB00903,Etacrynic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etacrynic acid,DB00014
DB00923,Ceforanide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceforanide,DB00014
DB00936,Salicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salicylic acid,DB00014
DB00939,Meclofenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Meclofenamic acid,DB00014
DB00945,Acetylsalicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acetylsalicylic acid,DB00014
DB00958,Carboplatin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carboplatin,DB00014
DB00991,Oxaprozin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Oxaprozin,DB00014
DB01009,Ketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ketoprofen,DB00014
DB01014,Balsalazide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Balsalazide,DB00014
DB01050,Ibuprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ibuprofen,DB00014
DB01066,Cefditoren may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefditoren,DB00014
DB01111,Colistimethate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Colistimethate,DB00014
DB01112,Cefuroxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefuroxime,DB00014
DB01139,Cefapirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefapirin,DB00014
DB01140,Cefadroxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefadroxil,DB00014
DB01150,Cefprozil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefprozil,DB00014
DB01212,Ceftriaxone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftriaxone,DB00014
DB01250,Olsalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Olsalazine,DB00014
DB01283,Lumiracoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lumiracoxib,DB00014
DB01326,Cefamandole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefamandole,DB00014
DB01327,Cefazolin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefazolin,DB00014
DB01328,Cefonicid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefonicid,DB00014
DB01329,Cefoperazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefoperazone,DB00014
DB01330,Cefotetan may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotetan,DB00014
DB01331,Cefoxitin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefoxitin,DB00014
DB01332,Ceftizoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftizoxime,DB00014
DB01333,Cefradine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefradine,DB00014
DB01397,Magnesium salicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Magnesium salicylate,DB00014
DB01399,Salsalate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salsalate,DB00014
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Choline magnesium trisalicylate,DB00014
DB01413,Cefepime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefepime,DB00014
DB01414,Cefacetrile may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefacetrile,DB00014
DB01415,Ceftibuten may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftibuten,DB00014
DB01416,Cefpodoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpodoxime,DB00014
DB01419,Antrafenine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Antrafenine,DB00014
DB01424,Aminophenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Aminophenazone,DB00014
DB01435,Antipyrine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Antipyrine,DB00014
DB01600,Tiaprofenic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tiaprofenic acid,DB00014
DB01628,Etoricoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etoricoxib,DB00014
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Hydrolyzed Cephalothin,DB00014
DB03450,Cephalothin Group may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephalothin Group,DB00014
DB03585,Oxyphenbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Oxyphenbutazone,DB00014
DB04552,Niflumic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Niflumic acid,DB00014
DB04570,Latamoxef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Latamoxef,DB00014
DB04743,Nimesulide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nimesulide,DB00014
DB04812,Benoxaprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benoxaprofen,DB00014
DB04817,Metamizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Metamizole,DB00014
DB04828,Zomepirac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Zomepirac,DB00014
DB04918,Ceftobiprole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftobiprole,DB00014
DB05095,Cimicoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cimicoxib,DB00014
DB06590,Ceftaroline fosamil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftaroline fosamil,DB00014
DB06725,Lornoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lornoxicam,DB00014
DB06736,Aceclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Aceclofenac,DB00014
DB06737,Zaltoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Zaltoprofen,DB00014
DB07402,Azapropazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Azapropazone,DB00014
DB07477,Felbinac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Felbinac,DB00014
DB08439,Parecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Parecoxib,DB00014
DB08797,Salicylamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salicylamide,DB00014
DB08940,Kebuzone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Kebuzone,DB00014
DB08942,Isoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Isoxicam,DB00014
DB08951,Indoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indoprofen,DB00014
DB08955,Ibuproxam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ibuproxam,DB00014
DB08976,Floctafenine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Floctafenine,DB00014
DB08981,Fenbufen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fenbufen,DB00014
DB08984,Etofenamate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etofenamate,DB00014
DB08991,Epirizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Epirizole,DB00014
DB09008,Cefaloridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefaloridine,DB00014
DB09062,Cefminox may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefminox,DB00014
DB09084,Benzydamine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benzydamine,DB00014
DB09212,Loxoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Loxoprofen,DB00014
DB09213,Dexibuprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dexibuprofen,DB00014
DB09214,Dexketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dexketoprofen,DB00014
DB09215,Droxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Droxicam,DB00014
DB09216,Tolfenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tolfenamic acid,DB00014
DB09217,Firocoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Firocoxib,DB00014
DB09218,Clonixin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Clonixin,DB00014
DB09285,Morniflumate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Morniflumate,DB00014
DB09288,Propacetamol may decrease the excretion rate of Goserelin which could result in a higher serum level.,Propacetamol,DB00014
DB09295,Talniflumate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Talniflumate,DB00014
DB09299,Tenofovir alafenamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir alafenamide,DB00014
DB11367,Cefroxadine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefroxadine,DB00014
DB11455,Robenacoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Robenacoxib,DB00014
DB11466,Tepoxalin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tepoxalin,DB00014
DB11518,Flunixin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flunixin,DB00014
DB11935,Flomoxef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flomoxef,DB00014
DB12151,Brincidofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Brincidofovir,DB00014
DB12445,Nitroaspirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nitroaspirin,DB00014
DB12545,Indobufen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indobufen,DB00014
DB13001,Tinoridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tinoridine,DB00014
DB13167,Alclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Alclofenac,DB00014
DB13217,Fentiazac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fentiazac,DB00014
DB13232,Suxibuzone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Suxibuzone,DB00014
DB13266,Cefatrizine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefatrizine,DB00014
DB13286,Bumadizone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bumadizone,DB00014
DB13314,Alminoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Alminoprofen,DB00014
DB13317,Flunoxaprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flunoxaprofen,DB00014
DB13364,Feprazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Feprazone,DB00014
DB13371,Difenpiramide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Difenpiramide,DB00014
DB13407,Nifenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nifenazone,DB00014
DB13432,Lonazolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lonazolac,DB00014
DB13461,Cefcapene may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefcapene,DB00014
DB13470,Cefodizime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefodizime,DB00014
DB13481,Tenidap may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenidap,DB00014
DB13499,Cefsulodin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefsulodin,DB00014
DB13501,Bendazac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bendazac,DB00014
DB13504,Cefetamet may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefetamet,DB00014
DB13514,Pranoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pranoprofen,DB00014
DB13524,Propyphenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Propyphenazone,DB00014
DB13527,Proglumetacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Proglumetacin,DB00014
DB13538,Guacetisal may decrease the excretion rate of Goserelin which could result in a higher serum level.,Guacetisal,DB00014
DB13544,Ethenzamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ethenzamide,DB00014
DB13612,Carbaspirin calcium may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carbaspirin calcium,DB00014
DB13629,Mofebutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mofebutazone,DB00014
DB13638,Cefbuperazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefbuperazone,DB00014
DB13649,Proquazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Proquazone,DB00014
DB13657,Benorilate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benorilate,DB00014
DB13667,Cefozopran may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefozopran,DB00014
DB13682,Cefpirome may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpirome,DB00014
DB13722,Pirprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pirprofen,DB00014
DB13778,Cefazedone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefazedone,DB00014
DB13783,Acemetacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acemetacin,DB00014
DB13821,Ceftezole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftezole,DB00014
DB13860,Imidazole salicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Imidazole salicylate,DB00014
DB13868,Adefovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Adefovir,DB00014
DB14059,SC-236 may decrease the excretion rate of Goserelin which could result in a higher serum level.,SC-236,DB00014
DB14060,NS-398 may decrease the excretion rate of Goserelin which could result in a higher serum level.,NS-398,DB00014
DB14126,Tenofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir,DB00014
DB01438,Phenazopyridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Phenazopyridine,DB00014
DB15066,Givosiran may decrease the excretion rate of Goserelin which could result in a higher serum level.,Givosiran,DB00014
DB01601,Lopinavir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lopinavir,DB00014
DB14507,Lithium citrate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lithium citrate,DB00014
DB00017,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salmon calcitonin,DB00014
DB00035,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin,DB00014
DB00041,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin,DB00014
DB00080,Goserelin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin,DB00014
DB00081,Goserelin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab,DB00014
DB00115,Goserelin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin,DB00014
DB00158,Goserelin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid,DB00014
DB00165,Goserelin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine,DB00014
DB00176,Goserelin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine,DB00014
DB00181,Goserelin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen,DB00014
DB00182,Goserelin may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine,DB00014
DB00185,Goserelin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline,DB00014
DB00186,Goserelin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam,DB00014
DB00190,Goserelin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa,DB00014
DB00193,Goserelin may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol,DB00014
DB00198,Goserelin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir,DB00014
DB00200,Goserelin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin,DB00014
DB00206,Goserelin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine,DB00014
DB00208,Goserelin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine,DB00014
DB00213,Goserelin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole,DB00014
DB00225,Goserelin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide,DB00014
DB00231,Goserelin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam,DB00014
DB00235,Goserelin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone,DB00014
DB00237,Goserelin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital,DB00014
DB00254,Goserelin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline,DB00014
DB00262,Goserelin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine,DB00014
DB00264,Goserelin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol,DB00014
DB00271,Goserelin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate,DB00014
DB00273,Goserelin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate,DB00014
DB00279,Goserelin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine,DB00014
DB00286,Goserelin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens,DB00014
DB00290,Goserelin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin,DB00014
DB00292,Goserelin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate,DB00014
DB00294,Goserelin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel,DB00014
DB00296,Goserelin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine,DB00014
DB00303,Goserelin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem,DB00014
DB00312,Goserelin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital,DB00014
DB00316,Goserelin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen,DB00014
DB00319,Goserelin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin,DB00014
DB00322,Goserelin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine,DB00014
DB00323,Goserelin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone,DB00014
DB00325,Goserelin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside,DB00014
DB00327,Goserelin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone,DB00014
DB00330,Goserelin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol,DB00014
DB00339,Goserelin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide,DB00014
DB00349,Goserelin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam,DB00014
DB00351,Goserelin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate,DB00014
DB00355,Goserelin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam,DB00014
DB00356,Goserelin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone,DB00014
DB00364,Goserelin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate,DB00014
DB00372,Goserelin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine,DB00014
DB00377,Goserelin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron,DB00014
DB00380,Goserelin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane,DB00014
DB00401,Goserelin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine,DB00014
DB00402,Goserelin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone,DB00014
DB00404,Goserelin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam,DB00014
DB00413,Goserelin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole,DB00014
DB00415,Goserelin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin,DB00014
DB00418,Goserelin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital,DB00014
DB00422,Goserelin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate,DB00014
DB00432,Goserelin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine,DB00014
DB00435,Goserelin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide,DB00014
DB00437,Goserelin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol,DB00014
DB00441,Goserelin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine,DB00014
DB00476,Goserelin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine,DB00014
DB00480,Goserelin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide,DB00014
DB00490,Goserelin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone,DB00014
DB00492,Goserelin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril,DB00014
DB00499,Goserelin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide,DB00014
DB00501,Goserelin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine,DB00014
DB00535,Goserelin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir,DB00014
DB00548,Goserelin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid,DB00014
DB00553,Goserelin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen,DB00014
DB00558,Goserelin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir,DB00014
DB00569,Goserelin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux,DB00014
DB00583,Goserelin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine,DB00014
DB00591,Goserelin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide,DB00014
DB00597,Goserelin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol,DB00014
DB00598,Goserelin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol,DB00014
DB00603,Goserelin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate,DB00014
DB00612,Goserelin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol,DB00014
DB00624,Goserelin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone,DB00014
DB00628,Goserelin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid,DB00014
DB00631,Goserelin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine,DB00014
DB00633,Goserelin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine,DB00014
DB00635,Goserelin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone,DB00014
DB00651,Goserelin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline,DB00014
DB00657,Goserelin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine,DB00014
DB00660,Goserelin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone,DB00014
DB00665,Goserelin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide,DB00014
DB00669,Goserelin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan,DB00014
DB00683,Goserelin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam,DB00014
DB00688,Goserelin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil,DB00014
DB00690,Goserelin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam,DB00014
DB00692,Goserelin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine,DB00014
DB00698,Goserelin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin,DB00014
DB00706,Goserelin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin,DB00014
DB00709,Goserelin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine,DB00014
DB00713,Goserelin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin,DB00014
DB00716,Goserelin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil,DB00014
DB00722,Goserelin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril,DB00014
DB00730,Goserelin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole,DB00014
DB00733,Goserelin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime,DB00014
DB00759,Goserelin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline,DB00014
DB00760,Goserelin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem,DB00014
DB00761,Goserelin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride,DB00014
DB00763,Goserelin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole,DB00014
DB00775,Goserelin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban,DB00014
DB00780,Goserelin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine,DB00014
DB00782,Goserelin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline,DB00014
DB00783,Goserelin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol,DB00014
DB00789,Goserelin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid,DB00014
DB00790,Goserelin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril,DB00014
DB00800,Goserelin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam,DB00014
DB00804,Goserelin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine,DB00014
DB00806,Goserelin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline,DB00014
DB00811,Goserelin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin,DB00014
DB00820,Goserelin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil,DB00014
DB00828,Goserelin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin,DB00014
DB00829,Goserelin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam,DB00014
DB00841,Goserelin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine,DB00014
DB00842,Goserelin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam,DB00014
DB00851,Goserelin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine,DB00014
DB00853,Goserelin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide,DB00014
DB00863,Goserelin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine,DB00014
DB00894,Goserelin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone,DB00014
DB00897,Goserelin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam,DB00014
DB00900,Goserelin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine,DB00014
DB00911,Goserelin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole,DB00014
DB00918,Goserelin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan,DB00014
DB00928,Goserelin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine,DB00014
DB00951,Goserelin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid,DB00014
DB00953,Goserelin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan,DB00014
DB00960,Goserelin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol,DB00014
DB00961,Goserelin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine,DB00014
DB00962,Goserelin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon,DB00014
DB00968,Goserelin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa,DB00014
DB00980,Goserelin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon,DB00014
DB00988,Goserelin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine,DB00014
DB00993,Goserelin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine,DB00014
DB00995,Goserelin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin,DB00014
DB01002,Goserelin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine,DB00014
DB01004,Goserelin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir,DB00014
DB01010,Goserelin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium,DB00014
DB01011,Goserelin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone,DB00014
DB01018,Goserelin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine,DB00014
DB01020,Goserelin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate,DB00014
DB01022,Goserelin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone,DB00014
DB01024,Goserelin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid,DB00014
DB01030,Goserelin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan,DB00014
DB01032,Goserelin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid,DB00014
DB01039,Goserelin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate,DB00014
DB01043,Goserelin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine,DB00014
DB01046,Goserelin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone,DB00014
DB01048,Goserelin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir,DB00014
DB01060,Goserelin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin,DB00014
DB01068,Goserelin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam,DB00014
DB01093,Goserelin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide,DB00014
DB01099,Goserelin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine,DB00014
DB01101,Goserelin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine,DB00014
DB01105,Goserelin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine,DB00014
DB01129,Goserelin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole,DB00014
DB01133,Goserelin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid,DB00014
DB01135,Goserelin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium,DB00014
DB01148,Goserelin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate,DB00014
DB01149,Goserelin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone,DB00014
DB01156,Goserelin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion,DB00014
DB01157,Goserelin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate,DB00014
DB01170,Goserelin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine,DB00014
DB01181,Goserelin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide,DB00014
DB01183,Goserelin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone,DB00014
DB01203,Goserelin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol,DB00014
DB01205,Goserelin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil,DB00014
DB01213,Goserelin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole,DB00014
DB01215,Goserelin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam,DB00014
DB01221,Goserelin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine,DB00014
DB01222,Goserelin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide,DB00014
DB01240,Goserelin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol,DB00014
DB01241,Goserelin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil,DB00014
DB01249,Goserelin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol,DB00014
DB01273,Goserelin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline,DB00014
DB01275,Goserelin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine,DB00014
DB01359,Goserelin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol,DB00014
DB01367,Goserelin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline,DB00014
DB01394,Goserelin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine,DB00014
DB01409,Goserelin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium,DB00014
DB01420,Goserelin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate,DB00014
DB01427,Goserelin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone,DB00014
DB01428,Goserelin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone,DB00014
DB01431,Goserelin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol,DB00014
DB01550,Goserelin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex,DB00014
DB01558,Goserelin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam,DB00014
DB01563,Goserelin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate,DB00014
DB01577,Goserelin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine,DB00014
DB01587,Goserelin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam,DB00014
DB01610,Goserelin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir,DB00014
DB01638,Goserelin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol,DB00014
DB01656,Goserelin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast,DB00014
DB01685,Goserelin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat,DB00014
DB04574,Goserelin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate,DB00014
DB04871,Goserelin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin,DB00014
DB04895,Goserelin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib,DB00014
DB04896,Goserelin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran,DB00014
DB04920,Goserelin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine,DB00014
DB05018,Goserelin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat,DB00014
DB05541,Goserelin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam,DB00014
DB05676,Goserelin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast,DB00014
DB06154,Goserelin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate,DB00014
DB06186,Goserelin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab,DB00014
DB06196,Goserelin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant,DB00014
DB06209,Goserelin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel,DB00014
DB06211,Goserelin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem,DB00014
DB06228,Goserelin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban,DB00014
DB06230,Goserelin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene,DB00014
DB06262,Goserelin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa,DB00014
DB06480,Goserelin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride,DB00014
DB06623,Goserelin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine,DB00014
DB06637,Goserelin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine,DB00014
DB06695,Goserelin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate,DB00014
DB06700,Goserelin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine,DB00014
DB06702,Goserelin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine,DB00014
DB06705,Goserelin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium,DB00014
DB06710,Goserelin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone,DB00014
DB06767,Goserelin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride,DB00014
DB06782,Goserelin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol,DB00014
DB06796,Goserelin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir,DB00014
DB06800,Goserelin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone,DB00014
DB06809,Goserelin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor,DB00014
DB06813,Goserelin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate,DB00014
DB06823,Goserelin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin,DB00014
DB06824,Goserelin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine,DB00014
DB08824,Goserelin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123,DB00014
DB08826,Goserelin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone,DB00014
DB08840,Goserelin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide,DB00014
DB08872,Goserelin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil,DB00014
DB08877,Goserelin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib,DB00014
DB08897,Goserelin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium,DB00014
DB08899,Goserelin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide,DB00014
DB08900,Goserelin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide,DB00014
DB08904,Goserelin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol,DB00014
DB08905,Goserelin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane,DB00014
DB08909,Goserelin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate,DB00014
DB08910,Goserelin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide,DB00014
DB08911,Goserelin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib,DB00014
DB08918,Goserelin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran,DB00014
DB08932,Goserelin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan,DB00014
DB08934,Goserelin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir,DB00014
DB08964,Goserelin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost,DB00014
DB09027,Goserelin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir,DB00014
DB09050,Goserelin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane,DB00014
DB09068,Goserelin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine,DB00014
DB09071,Goserelin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon,DB00014
DB09075,Goserelin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban,DB00014
DB09081,Goserelin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone,DB00014
DB09091,Goserelin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol,DB00014
DB09103,Goserelin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim,DB00014
DB09104,Goserelin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide,DB00014
DB09106,Goserelin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch,DB00014
DB09111,Goserelin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch,DB00014
DB09118,Goserelin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol,DB00014
DB09121,Goserelin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose,DB00014
DB09123,Goserelin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest,DB00014
DB09129,Goserelin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride,DB00014
DB09132,Goserelin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid,DB00014
DB09133,Goserelin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid,DB00014
DB09134,Goserelin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol,DB00014
DB09135,Goserelin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan,DB00014
DB09136,Goserelin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue,DB00014
DB09137,Goserelin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin,DB00014
DB09139,Goserelin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate,DB00014
DB09148,Goserelin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F),DB00014
DB09149,Goserelin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F),DB00014
DB09156,Goserelin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide,DB00014
DB09163,Goserelin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime,DB00014
DB09165,Goserelin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate,DB00014
DB09185,Goserelin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine,DB00014
DB09194,Goserelin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone,DB00014
DB09195,Goserelin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole,DB00014
DB09204,Goserelin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol,DB00014
DB09205,Goserelin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte,DB00014
DB09209,Goserelin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine,DB00014
DB09210,Goserelin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam,DB00014
DB09219,Goserelin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin,DB00014
DB09220,Goserelin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil,DB00014
DB09223,Goserelin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin,DB00014
DB09241,Goserelin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue,DB00014
DB09244,Goserelin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole,DB00014
DB09245,Goserelin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone,DB00014
DB09255,Goserelin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran,DB00014
DB09256,Goserelin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur,DB00014
DB09257,Goserelin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil,DB00014
DB09262,Goserelin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin,DB00014
DB09264,Goserelin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab,DB00014
DB09268,Goserelin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid,DB00014
DB09276,Goserelin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate,DB00014
DB09281,Goserelin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate,DB00014
DB09292,Goserelin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril,DB00014
DB09301,Goserelin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate,DB00014
DB09317,"Goserelin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A",DB00014
DB09318,"Goserelin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B",DB00014
DB09320,Goserelin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin,DB00014
DB09324,Goserelin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam,DB00014
DB09325,Goserelin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride,DB00014
DB09329,"Goserelin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated",DB00014
DB09344,Goserelin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar,DB00014
DB09357,Goserelin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol,DB00014
DB09394,Goserelin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid,DB00014
DB09395,Goserelin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate,DB00014
DB09407,Goserelin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride,DB00014
DB09418,Goserelin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate,DB00014
DB09472,Goserelin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate,DB00014
DB09477,Goserelin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat,DB00014
DB09481,Goserelin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate,DB00014
DB09496,Goserelin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate,DB00014
DB09502,Goserelin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F),DB00014
DB09546,Goserelin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123,DB00014
DB09570,Goserelin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib,DB00014
DB11077,Goserelin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400,DB00014
DB11090,Goserelin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate,DB00014
DB11098,Goserelin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate,DB00014
DB11102,Goserelin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine,DB00014
DB11114,Goserelin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil,DB00014
DB11127,Goserelin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid,DB00014
DB11130,Goserelin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium,DB00014
DB11135,Goserelin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium,DB00014
DB11136,Goserelin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium,DB00014
DB11145,Goserelin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline,DB00014
DB11156,Goserelin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel,DB00014
DB11164,Goserelin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate,DB00014
DB11251,Goserelin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol,DB00014
DB11278,Goserelin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine,DB00014
DB11328,Goserelin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester),DB00014
DB11338,Goserelin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil,DB00014
DB11358,Goserelin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil,DB00014
DB11364,Goserelin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod,DB00014
DB11560,Goserelin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad,DB00014
DB11577,Goserelin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid,DB00014
DB11587,Goserelin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine,DB00014
DB11598,Goserelin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human,DB00014
DB11691,Goserelin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine,DB00014
DB11699,Goserelin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron,DB00014
DB11817,Goserelin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib,DB00014
DB11901,Goserelin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide,DB00014
DB11915,Goserelin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine,DB00014
DB11989,Goserelin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole,DB00014
DB12007,Goserelin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone,DB00014
DB12107,Goserelin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam,DB00014
DB12278,Goserelin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine,DB00014
DB12783,Goserelin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide,DB00014
DB13025,Goserelin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride,DB00014
DB13139,Goserelin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol,DB00014
DB13156,Goserelin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex,DB00014
DB13178,Goserelin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol,DB00014
DB13185,Goserelin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate,DB00014
DB13191,Goserelin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine,DB00014
DB13269,Goserelin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol,DB00014
DB13293,Goserelin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac,DB00014
DB13595,Goserelin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate,DB00014
DB13873,Goserelin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid,DB00014
DB13884,Goserelin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa,DB00014
DB13909,Goserelin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate,DB00014
DB13943,Goserelin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate,DB00014
DB13944,Goserelin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate,DB00014
DB13946,Goserelin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate,DB00014
DB13952,Goserelin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate,DB00014
DB13954,Goserelin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate,DB00014
DB13955,Goserelin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate,DB00014
DB13956,Goserelin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate,DB00014
DB13967,Goserelin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue,DB00014
DB14006,Goserelin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate,DB00014
DB14007,Goserelin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid,DB00014
DB14498,Goserelin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate,DB00014
DB14499,Goserelin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate,DB00014
DB14526,Goserelin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate,DB00014
DB14527,Goserelin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate,DB00014
DB14528,Goserelin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate,DB00014
DB14529,Goserelin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate,DB00014
DB14530,Goserelin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate,DB00014
DB14754,Goserelin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol,DB00014
DB06815,Goserelin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione,DB00014
DB11121,Goserelin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol,DB00014
DB11085,Goserelin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol,DB00014
DB00661,Goserelin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil,DB00014
DB15593,Goserelin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen,DB00014
DB00440,Goserelin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim,DB00014
DB00318,Goserelin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine,DB00014
DB00454,Goserelin may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine,DB00014
DB00813,Goserelin may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl,DB00014
DB00879,Goserelin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine,DB00014
DB08996,Goserelin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine,DB00014
DB14506,Goserelin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide,DB00014
DB00452,Framycetin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Framycetin,DB00014
DB00479,Amikacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Amikacin,DB00014
DB00684,Tobramycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tobramycin,DB00014
DB00798,Gentamicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Gentamicin,DB00014
DB00955,Netilmicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Netilmicin,DB00014
DB00994,Neomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Neomycin,DB00014
DB01082,Streptomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Streptomycin,DB00014
DB01172,Kanamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Kanamycin,DB00014
DB01421,Paromomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Paromomycin,DB00014
DB03615,Ribostamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ribostamycin,DB00014
DB04263,Geneticin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Geneticin,DB00014
DB04626,Apramycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Apramycin,DB00014
DB04729,Gentamicin C1a may decrease the excretion rate of Goserelin which could result in a higher serum level.,Gentamicin C1a,DB00014
DB04808,Neamine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Neamine,DB00014
DB06696,Arbekacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Arbekacin,DB00014
DB08437,Puromycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Puromycin,DB00014
DB11512,Dihydrostreptomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dihydrostreptomycin,DB00014
DB11520,Hygromycin B may decrease the excretion rate of Goserelin which could result in a higher serum level.,Hygromycin B,DB00014
DB12604,Sisomicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sisomicin,DB00014
DB13270,Dibekacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dibekacin,DB00014
DB13274,Micronomicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Micronomicin,DB00014
DB13540,Isepamicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Isepamicin,DB00014
DB13673,Bekanamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bekanamycin,DB00014
DB00552,Goserelin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin,DB00014
DB13145,Goserelin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin,DB00014
DB00314,Goserelin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin,DB00014
DB00390,Goserelin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin,DB00014
DB00512,Goserelin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin,DB00014
DB00515,Goserelin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin,DB00014
DB00564,Goserelin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine,DB00014
DB00642,Goserelin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed,DB00014
DB00682,Goserelin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin,DB00014
DB00982,Goserelin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin,DB00014
DB12615,Goserelin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin,DB00014
DB14509,Goserelin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate,DB00014
DB00524,Goserelin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone,DB00014
DB00695,Goserelin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide,DB00014
DB00887,Goserelin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide,DB00014
DB09338,Goserelin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl,DB00014
DB00214,Torasemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide,DB00014
DB00232,Methyclothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide,DB00014
DB00310,Chlorthalidone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone,DB00014
DB00311,Ethoxzolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide,DB00014
DB00421,Spironolactone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone,DB00014
DB00436,Bendroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide,DB00014
DB00562,Benzthiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide,DB00014
DB00594,Amiloride may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride,DB00014
DB00606,Cyclothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide,DB00014
DB00700,Eplerenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone,DB00014
DB00703,Methazolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide,DB00014
DB00774,Hydroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide,DB00014
DB00819,Acetazolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide,DB00014
DB00872,Conivaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan,DB00014
DB00880,Chlorothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide,DB00014
DB01021,Trichlormethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide,DB00014
DB01119,Diazoxide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide,DB00014
DB01144,Diclofenamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide,DB00014
DB01324,Polythiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide,DB00014
DB01325,Quinethazone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone,DB00014
DB01395,Drospirenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone,DB00014
DB01412,Theobromine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00014
DB02925,Piretanide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide,DB00014
DB04831,Tienilic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid,DB00014
DB05034,Ularitide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide,DB00014
DB06212,Tolvaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan,DB00014
DB06370,Indisulam may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam,DB00014
DB08961,Azosemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide,DB00014
DB09015,Canrenoic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid,DB00014
DB09125,Potassium citrate may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate,DB00014
DB09401,Isosorbide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide,DB00014
DB12221,Canrenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone,DB00014
DB12670,Rolofylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline,DB00014
DB12704,Spiradoline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline,DB00014
DB13284,Meticrane may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane,DB00014
DB13316,Ibopamine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine,DB00014
DB13405,Mefruside may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside,DB00014
DB13430,Mebutizide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide,DB00014
DB13532,Cyclopenthiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide,DB00014
DB13617,Clorexolone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone,DB00014
DB13663,Clofenamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide,DB00014
DB13708,Fenquizone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone,DB00014
DB13792,Clopamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide,DB00014
DB13801,Muzolimine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine,DB00014
DB13803,Xipamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide,DB00014
DB13989,Epitizide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide,DB00014
DB14018,Bromotheophylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00014
DB14500,Potassium may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium,DB00014
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Goserelin.,Metformin,DB00014
DB00656,The risk or severity of QTc prolongation can be increased when Trazodone is combined with Goserelin.,Trazodone,DB00014
DB11986,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Entrectinib.,Entrectinib,DB00014
DB11642,Goserelin may increase the QTc-prolonging activities of Pitolisant.,Pitolisant,DB00014
DB12825,Lefamulin may increase the QTc-prolonging activities of Goserelin.,Lefamulin,DB00014
DB00557,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Goserelin.,Hydroxyzine,DB00014
DB00246,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ziprasidone.,Ziprasidone,DB00014
DB00502,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Haloperidol.,Haloperidol,DB00014
DB00472,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluoxetine.,Fluoxetine,DB00014
DB06605,Apixaban may increase the anticoagulant activities of Reteplase.,Apixaban,DB00015
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Reteplase.,Dabigatran etexilate,DB00015
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Reteplase.,Dasatinib,DB00015
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Reteplase is combined with Deferasirox.,Deferasirox,DB00015
DB01586,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00015
DB02123,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00015
DB02659,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Cholic Acid.,Cholic Acid,DB00015
DB02691,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Glycocholic acid.,Glycocholic acid,DB00015
DB03619,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Deoxycholic acid.,Deoxycholic acid,DB00015
DB04348,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Taurocholic acid.,Taurocholic acid,DB00015
DB05990,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Obeticholic acid.,Obeticholic acid,DB00015
DB06777,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00015
DB08833,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00015
DB08834,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00015
DB08857,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Bamet-UD2.,Bamet-UD2,DB00015
DB11622,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00015
DB11789,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00015
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Reteplase.,Edoxaban,DB00015
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Reteplase.,Ibrutinib,DB00015
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Obinutuzumab.,Obinutuzumab,DB00015
DB06228,Reteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00015
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Sugammadex.,Sugammadex,DB00015
DB09070,Tibolone may increase the anticoagulant activities of Reteplase.,Tibolone,DB00015
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Reteplase.,Tipranavir,DB00015
DB00013,Urokinase may increase the anticoagulant activities of Reteplase.,Urokinase,DB00015
DB00163,Vitamin E may increase the anticoagulant activities of Reteplase.,Vitamin E,DB00015
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Reteplase.,Vorapaxar,DB00015
DB06692,The therapeutic efficacy of Reteplase can be decreased when used in combination with Aprotinin.,Aprotinin,DB00015
DB01381,The therapeutic efficacy of Reteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00015
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Reteplase.,Ifosfamide,DB00015
DB00468,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinine.,Quinine,DB00015
DB00908,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinidine.,Quinidine,DB00015
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Reteplase.,Tamoxifen,DB00015
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Reteplase.,Toremifene,DB00015
DB00806,The therapeutic efficacy of Reteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00015
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Reteplase.,Pentosan polysulfate,DB00015
DB00583,The therapeutic efficacy of Reteplase can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00015
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Reteplase.,Diethylstilbestrol,DB00015
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Reteplase.,Chlorotrianisene,DB00015
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Reteplase.,Conjugated estrogens,DB00015
DB00783,Estradiol may decrease the anticoagulant activities of Reteplase.,Estradiol,DB00015
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Reteplase.,Ethinylestradiol,DB00015
DB01357,Mestranol may decrease the anticoagulant activities of Reteplase.,Mestranol,DB00015
DB04573,Estriol may decrease the anticoagulant activities of Reteplase.,Estriol,DB00015
DB04574,Estrone sulfate may decrease the anticoagulant activities of Reteplase.,Estrone sulfate,DB00015
DB04575,Quinestrol may decrease the anticoagulant activities of Reteplase.,Quinestrol,DB00015
DB07931,Hexestrol may decrease the anticoagulant activities of Reteplase.,Hexestrol,DB00015
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Reteplase.","Synthetic Conjugated Estrogens, A",DB00015
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Reteplase.","Synthetic Conjugated Estrogens, B",DB00015
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Reteplase.,Polyestradiol phosphate,DB00015
DB09381,Esterified estrogens may decrease the anticoagulant activities of Reteplase.,Esterified estrogens,DB00015
DB11478,Zeranol may decrease the anticoagulant activities of Reteplase.,Zeranol,DB00015
DB11674,Equol may decrease the anticoagulant activities of Reteplase.,Equol,DB00015
DB12487,Promestriene may decrease the anticoagulant activities of Reteplase.,Promestriene,DB00015
DB13143,Methallenestril may decrease the anticoagulant activities of Reteplase.,Methallenestril,DB00015
DB13386,Epimestrol may decrease the anticoagulant activities of Reteplase.,Epimestrol,DB00015
DB13418,Moxestrol may decrease the anticoagulant activities of Reteplase.,Moxestrol,DB00015
DB13952,Estradiol acetate may decrease the anticoagulant activities of Reteplase.,Estradiol acetate,DB00015
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Reteplase.,Estradiol benzoate,DB00015
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Reteplase.,Estradiol cypionate,DB00015
DB13956,Estradiol valerate may decrease the anticoagulant activities of Reteplase.,Estradiol valerate,DB00015
DB15334,Biochanin A may decrease the anticoagulant activities of Reteplase.,Biochanin A,DB00015
DB15335,Formononetin may decrease the anticoagulant activities of Reteplase.,Formononetin,DB00015
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Reteplase.,Icosapent,DB00015
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Reteplase.,Mesalazine,DB00015
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Reteplase.,Indomethacin,DB00015
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Reteplase.,Nabumetone,DB00015
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Reteplase.,Ketorolac,DB00015
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Reteplase.,Tenoxicam,DB00015
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Reteplase.,Celecoxib,DB00015
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Reteplase.,Tolmetin,DB00015
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Reteplase.,Rofecoxib,DB00015
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Reteplase.,Piroxicam,DB00015
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Reteplase.,Fenoprofen,DB00015
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Reteplase.,Valdecoxib,DB00015
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Reteplase.,Diclofenac,DB00015
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Reteplase.,Sulindac,DB00015
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Reteplase.,Flurbiprofen,DB00015
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Reteplase.,Etodolac,DB00015
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Reteplase.,Mefenamic acid,DB00015
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Reteplase.,Naproxen,DB00015
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Reteplase.,Sulfasalazine,DB00015
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Reteplase.,Phenylbutazone,DB00015
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Reteplase.,Meloxicam,DB00015
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Reteplase.,Carprofen,DB00015
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Reteplase.,Diflunisal,DB00015
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Reteplase.,Salicylic acid,DB00015
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Reteplase.,Meclofenamic acid,DB00015
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Reteplase.,Oxaprozin,DB00015
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Reteplase.,Ketoprofen,DB00015
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Reteplase.,Balsalazide,DB00015
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Reteplase.,Olsalazine,DB00015
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Reteplase.,Lumiracoxib,DB00015
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Reteplase.,Magnesium salicylate,DB00015
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Reteplase.,Salsalate,DB00015
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Reteplase.,Choline magnesium trisalicylate,DB00015
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Reteplase.,Antrafenine,DB00015
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Reteplase.,Aminophenazone,DB00015
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Reteplase.,Antipyrine,DB00015
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Reteplase.,Tiaprofenic acid,DB00015
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Reteplase.,Etoricoxib,DB00015
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Reteplase.,Taxifolin,DB00015
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Reteplase.,Oxyphenbutazone,DB00015
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Reteplase.,Niflumic acid,DB00015
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Reteplase.,Licofelone,DB00015
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Reteplase.,Benoxaprofen,DB00015
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Reteplase.,Metamizole,DB00015
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Reteplase.,Zomepirac,DB00015
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Reteplase.,Cimicoxib,DB00015
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Reteplase.,Lornoxicam,DB00015
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Reteplase.,Aceclofenac,DB00015
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Reteplase.,Zaltoprofen,DB00015
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Reteplase.,Azapropazone,DB00015
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Reteplase.,Felbinac,DB00015
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Reteplase.,Parecoxib,DB00015
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Reteplase.,Salicylamide,DB00015
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Reteplase.,Kebuzone,DB00015
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Reteplase.,Isoxicam,DB00015
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Reteplase.,Indoprofen,DB00015
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Reteplase.,Ibuproxam,DB00015
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Reteplase.,Floctafenine,DB00015
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Reteplase.,Fenbufen,DB00015
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Reteplase.,Etofenamate,DB00015
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Reteplase.,Epirizole,DB00015
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Reteplase.,Benzydamine,DB00015
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Reteplase.,Loxoprofen,DB00015
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Reteplase.,Dexketoprofen,DB00015
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Reteplase.,Droxicam,DB00015
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Reteplase.,Tolfenamic acid,DB00015
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Reteplase.,Firocoxib,DB00015
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Reteplase.,Clonixin,DB00015
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Reteplase.,Morniflumate,DB00015
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Reteplase.,Propacetamol,DB00015
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Reteplase.,Talniflumate,DB00015
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Reteplase.,Robenacoxib,DB00015
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Reteplase.,Tepoxalin,DB00015
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Reteplase.,Flunixin,DB00015
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Reteplase.,Polmacoxib,DB00015
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Reteplase.,Betulinic Acid,DB00015
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Reteplase.,Ebselen,DB00015
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Reteplase.,Tinoridine,DB00015
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Reteplase.,Alclofenac,DB00015
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Reteplase.,Fentiazac,DB00015
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Reteplase.,Suxibuzone,DB00015
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Reteplase.,Bumadizone,DB00015
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Reteplase.,Alminoprofen,DB00015
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Reteplase.,Flunoxaprofen,DB00015
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Reteplase.,Feprazone,DB00015
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Reteplase.,Difenpiramide,DB00015
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Reteplase.,Nifenazone,DB00015
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Reteplase.,Lonazolac,DB00015
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Reteplase.,Tenidap,DB00015
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Reteplase.,Bendazac,DB00015
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Reteplase.,Pranoprofen,DB00015
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Reteplase.,Propyphenazone,DB00015
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Reteplase.,Proglumetacin,DB00015
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Reteplase.,Guacetisal,DB00015
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Reteplase.,Ethenzamide,DB00015
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Reteplase.,Carbaspirin calcium,DB00015
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Reteplase.,Mofebutazone,DB00015
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Reteplase.,Proquazone,DB00015
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Reteplase.,Benorilate,DB00015
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Reteplase.,Pirprofen,DB00015
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Reteplase.,Imidazole salicylate,DB00015
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Reteplase.,SC-236,DB00015
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Reteplase.,NS-398,DB00015
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Reteplase.,Flurbiprofen axetil,DB00015
DB04865,The risk or severity of bleeding can be increased when Reteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00015
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Reteplase.,Omega-3 fatty acids,DB00015
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Tositumomab.,Tositumomab,DB00015
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Reteplase.,Limaprost,DB00015
DB00048,The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00015
DB00389,Carbimazole may increase the anticoagulant activities of Reteplase.,Carbimazole,DB00015
DB00550,Propylthiouracil may increase the anticoagulant activities of Reteplase.,Propylthiouracil,DB00015
DB00763,Methimazole may increase the anticoagulant activities of Reteplase.,Methimazole,DB00015
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Reteplase.","3,5-Diiodotyrosine",DB00015
DB06715,Potassium Iodide may increase the anticoagulant activities of Reteplase.,Potassium Iodide,DB00015
DB07637,Dibromotyrosine may increase the anticoagulant activities of Reteplase.,Dibromotyrosine,DB00015
DB09418,Potassium perchlorate may increase the anticoagulant activities of Reteplase.,Potassium perchlorate,DB00015
DB13644,Methylthiouracil may increase the anticoagulant activities of Reteplase.,Methylthiouracil,DB00015
DB13804,Benzylthiouracil may increase the anticoagulant activities of Reteplase.,Benzylthiouracil,DB00015
DB00834,The therapeutic efficacy of Reteplase can be decreased when used in combination with Mifepristone.,Mifepristone,DB00015
DB04066,The therapeutic efficacy of Reteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00015
DB04682,The therapeutic efficacy of Reteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00015
DB05830,The therapeutic efficacy of Reteplase can be decreased when used in combination with Trestolone.,Trestolone,DB00015
DB06266,The therapeutic efficacy of Reteplase can be decreased when used in combination with Lonidamine.,Lonidamine,DB00015
DB08867,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ulipristal.,Ulipristal,DB00015
DB09401,The therapeutic efficacy of Reteplase can be decreased when used in combination with Isosorbide.,Isosorbide,DB00015
DB11507,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00015
DB12025,The therapeutic efficacy of Reteplase can be decreased when used in combination with Triptolide.,Triptolide,DB00015
DB13044,The therapeutic efficacy of Reteplase can be decreased when used in combination with Gossypol.,Gossypol,DB00015
DB13310,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00015
DB00294,Etonogestrel may decrease the anticoagulant activities of Reteplase.,Etonogestrel,DB00015
DB00304,Desogestrel may decrease the anticoagulant activities of Reteplase.,Desogestrel,DB00015
DB00351,Megestrol acetate may decrease the anticoagulant activities of Reteplase.,Megestrol acetate,DB00015
DB00367,Levonorgestrel may decrease the anticoagulant activities of Reteplase.,Levonorgestrel,DB00015
DB00378,Dydrogesterone may decrease the anticoagulant activities of Reteplase.,Dydrogesterone,DB00015
DB00396,Progesterone may decrease the anticoagulant activities of Reteplase.,Progesterone,DB00015
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Reteplase.,Medroxyprogesterone acetate,DB00015
DB00717,Norethisterone may decrease the anticoagulant activities of Reteplase.,Norethisterone,DB00015
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Reteplase.,Ethynodiol diacetate,DB00015
DB00957,Norgestimate may decrease the anticoagulant activities of Reteplase.,Norgestimate,DB00015
DB01395,Drospirenone may decrease the anticoagulant activities of Reteplase.,Drospirenone,DB00015
DB01431,Allylestrenol may decrease the anticoagulant activities of Reteplase.,Allylestrenol,DB00015
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Reteplase.,Cyproterone acetate,DB00015
DB06713,Norelgestromin may decrease the anticoagulant activities of Reteplase.,Norelgestromin,DB00015
DB06730,Gestodene may decrease the anticoagulant activities of Reteplase.,Gestodene,DB00015
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Reteplase.,Hydroxyprogesterone caproate,DB00015
DB09123,Dienogest may decrease the anticoagulant activities of Reteplase.,Dienogest,DB00015
DB09124,Medrogestone may decrease the anticoagulant activities of Reteplase.,Medrogestone,DB00015
DB09371,Norethynodrel may decrease the anticoagulant activities of Reteplase.,Norethynodrel,DB00015
DB09389,Norgestrel may decrease the anticoagulant activities of Reteplase.,Norgestrel,DB00015
DB11372,Altrenogest may decrease the anticoagulant activities of Reteplase.,Altrenogest,DB00015
DB11619,Gestrinone may decrease the anticoagulant activities of Reteplase.,Gestrinone,DB00015
DB11636,Nomegestrol may decrease the anticoagulant activities of Reteplase.,Nomegestrol,DB00015
DB12474,Lynestrenol may decrease the anticoagulant activities of Reteplase.,Lynestrenol,DB00015
DB13230,Gestonorone may decrease the anticoagulant activities of Reteplase.,Gestonorone,DB00015
DB13528,Chlormadinone may decrease the anticoagulant activities of Reteplase.,Chlormadinone,DB00015
DB13533,Methylestrenolone may decrease the anticoagulant activities of Reteplase.,Methylestrenolone,DB00015
DB13563,Norgestrienone may decrease the anticoagulant activities of Reteplase.,Norgestrienone,DB00015
DB13602,Promegestone may decrease the anticoagulant activities of Reteplase.,Promegestone,DB00015
DB13685,Quingestanol may decrease the anticoagulant activities of Reteplase.,Quingestanol,DB00015
DB13857,Demegestone may decrease the anticoagulant activities of Reteplase.,Demegestone,DB00015
DB13866,Etynodiol may decrease the anticoagulant activities of Reteplase.,Etynodiol,DB00015
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Reteplase.,Nomegestrol acetate,DB00015
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Reteplase.,Hydroxyprogesterone,DB00015
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Reteplase.,Norethindrone enanthate,DB00015
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Reteplase.,Quingestanol acetate,DB00015
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Reteplase.,Aminosalicylic acid,DB00015
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reteplase.,Bismuth subsalicylate,DB00015
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Reteplase.,Dersalazine,DB00015
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Reteplase.,Phenyl aminosalicylate,DB00015
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Reteplase.,Methyl salicylate,DB00015
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Reteplase.,Trolamine salicylate,DB00015
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Reteplase.,Aloxiprin,DB00015
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Reteplase.,Choline salicylate,DB00015
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Reteplase.,Thiosalicylic acid,DB00015
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase.,Abciximab,DB00015
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Reteplase.,Eptifibatide,DB00015
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Reteplase.,Ticlopidine,DB00015
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Reteplase.,Anagrelide,DB00015
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Reteplase.,Clopidogrel,DB00015
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Reteplase.,Tirofiban,DB00015
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Reteplase.,Dipyridamole,DB00015
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Reteplase.,Iloprost,DB00015
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Reteplase.,Sulfinpyrazone,DB00015
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Reteplase.,Cilostazol,DB00015
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Reteplase.,Ridogrel,DB00015
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Reteplase.,Sevoflurane,DB00015
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Reteplase.,Epoprostenol,DB00015
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Reteplase.,Resveratrol,DB00015
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Reteplase.,Nimesulide,DB00015
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Reteplase.,Tesmilifene,DB00015
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Reteplase.,Defibrotide,DB00015
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Reteplase.,Beraprost,DB00015
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Reteplase.,Ibudilast,DB00015
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Reteplase.,Andrographolide,DB00015
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Reteplase.,Caplacizumab,DB00015
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Reteplase.,Prasugrel,DB00015
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Reteplase.,Cangrelor,DB00015
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Reteplase.,Tranilast,DB00015
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Reteplase.,Triflusal,DB00015
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Reteplase.,Ticagrelor,DB00015
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Reteplase.,Icosapent ethyl,DB00015
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Reteplase.,Trapidil,DB00015
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Reteplase.,Naftopidil,DB00015
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Reteplase.,Sarpogrelate,DB00015
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Reteplase.,Ifetroban,DB00015
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Reteplase.,Nitroaspirin,DB00015
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Reteplase.,Ketanserin,DB00015
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Reteplase.,Indobufen,DB00015
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Reteplase.,Butylphthalide,DB00015
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Reteplase.,Hydroxytyrosol,DB00015
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Reteplase.,Ramatroban,DB00015
